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ABSTRACT 
 
 
Lindsay Fernández-Rhodes: Genomics and Epidemiology: Diverse Measures and 
Populations in the Trans-Ethnic Fine-Mapping of Genetic Loci for Body Mass Index  
(Under the direction of Kari E. North) 
 
 
 Obesity is a global epidemic with concerning disparities in burden across United 
States (US) racial/ethnic groups. In the absence of measured body weight, self-reports are a 
commonly used proxy in epidemiologic research. Previous studies have found that self-
reported body weight may, on average, underestimate weight. However, this research may 
not apply to US Hispanics/Latinos, many of whom are recent immigrants from Latin America. 
We investigated whether self-reported weight was an accurate proxy of measured weight in 
a sample of Hispanic/Latinos from various Hispanic/Latino backgrounds sampled as part of 
the baseline examination (2008-2011) of the Hispanic Community Health Study/Study of 
Latinos. We observed that self-reported weight was an accuracy proxy of measured weight 
(r2=0.95, average 0.3 kg over-reporting of weight), but differential patterns of misreporting 
were evident by age, gender, body mass index (BMI) categories, nativity, study site by 
background, unit of self-reported weight and end digit preference. 
Numerous studies of obesity in primarily non-Hispanic/Latino European descent 
populations have identified more than >100 BMI loci. However, these loci collectively explain 
a fraction of the estimated heritability of BMI perhaps, in part, due to the limited racial/ethnic 
diversity of the previous samples. I addressed this research gap by generalizing nearly a 
quarter of previously reported SNP-BMI associations and >80% of 36 fine-mapped BMI loci 
to racially/ethnically diverse US populations and then by trans-ethnically fine-mapping the 
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underlying functional variants at these loci in a sample of approximately 102,000 African, 
Hispanic/Latino, Asian, European and American Indian/Alaskan Native descent adults from 
the Population Architecture using Genomics and Epidemiology Study. These findings will 
help prioritize the putative functional variants for targeted molecular follow-up and gene-
environment interaction studies.  
In light of the current mismatch between the mounting body of genetic epidemiologic 
evidence and the populations most burdened by obesity, this research highlighted the utility 
of alternative measures, such as self-reported weight, and diverse populations in the search 
for the underlying functional genetic variants for obesity risk. As such, this work serves as a 
foundation for a wide-range of future research on the complex genetic and environmental 
determinants of obesity in US populations, like Hispanic/Latinos.   
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CHAPTER I: INTRODUCTION 
Obesity is a major cardiovascular disease (CVD) risk factor and public health 
concern both globally and for the United States (US) [1]. Racial and ethnic disparities in 
obesity have been described within the context of the US obesity epidemic [2, 3]. 
Hispanic/Latinos individuals comprise an ethnic group of diverse ancestries and 
heritages, which as of 2010 represented ~16% of the US population [4]. Yet 
Hispanic/Latino individuals have a higher prevalence of obesity (39%) than non-
Hispanic/Latino individuals of European descent (34%) and as such shoulder what 
appears to be an increasingly disparate proportion of the epidemic [2, 3, 5]. However, 
even within this diverse group there is substantial heterogeneity [2, 3, 6], which may in 
part be influenced by an individual’s level of acculturation [7, 8]—the complex process of 
cultural adaptation that occurs when individuals of different cultures come into contact 
with each other and experience changes in their cultural practices [9], including the 
maintenance and adoption of cultural patterns in diet and physical activity [8, 10, 11] .  
Recent studies have also suggested an influence of genetic factors in individual 
susceptibility within the obesity epidemic. Studies indicate that body mass index (BMI, 
kg/m2) may be between 40-70% heritable [12, 13]. Even though over 100 loci for BMI 
have been validated in predominantly European descent samples, the known genetic 
variants at these established loci explain a small proportion (<3%) of the overall 
phenotypic variance [14-33].  
Two potential explanations of the missing heritability are allelic heterogeneity [34] 
and the previously neglected gene-environment (GxE) interactions that contextualize 
inherited genetic susceptibility [35]. Studies of allelic heterogeneity are necessary in 
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order to obtain true estimates of genetic effect sizes [36, 37], as well as to prioritize 
strong candidates for future studies, e.g. GxE studies and functional follow-up. 
Specifically, the temporal and geographic trends in the global obesity epidemic [1, 38] 
point to the convergence of both thrifty genes and an obesogenic environment [39], and 
the future promise of targeted GxE studies in unraveling the complex origins of obesity. 
 The Population Architecture using Genomics and Epidemiology (PAGE) Study, a 
consortia of several observational studies or sub-consortia, has been created to facilitate 
the study of the genetic underpinnings of CVD risk factors, as well as address the gap 
between the most studied populations in genetic epidemiology and the populations with 
the greatest disease burden [40]. Thus this consortium offers a unique opportunity to 
investigate the determinants of obesity in US minority populations [41] as it includes 
several landmark studies of diverse racial and ethnic groups.  For example, the Hispanic 
Community Health Study/Study of Latinos (HCHS/SOL) is the first Hispanic/Latino 
cohort study of CVD to recruit >16,000 Hispanic/Latino adults (18-74 years at screening) 
from various diverse backgrounds as well as collect in a culturally- and linguistically-
appropriate manner information on anthropometrics, genetics, and acculturation [42, 43].  
As Hispanic/Latino individuals shoulder a disproportionate burden of obesity [2, 
3, 5], there is a potential for a ‘looming’ Hispanic/Latino CVD health crisis [44]. 
Therefore, this dissertation utilizes data on diverse US Hispanic/Latinos collected by the 
HCHS/SOL and other racial/ethnic groups represented in the studies of PAGE to 
address important gaps in the public health literature surrounding the application of 
diverse measures (Aim 1) and populations (Aim 2) to genomic and epidemiologic 
research intended to directly inform the complex obesity determinants of the US 
racial/ethnic groups with the greatest burden, such as Hispanic/Latinos.  
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CHAPTER II: SPECIFIC AIMS 
A. Rationale 
In order to address the gap between genetic epidemiology and obesity 
disparities, I have created a conceptual model to depict the complex relationships 
between acculturation, genetics, and obesity in diverse US populations, such as 
Hispanic/Latinos (Figure 1). Two interrelated dissertation manuscripts support this broad 
research agenda.  
First, in Aim 1 I established the accuracy of self-reported weight as an alternative 
to measured weight in HCHS/SOL, a key component of BMI for the measurement of 
obesity (Figure 1; upper corner). This work will directly inform the use of diverse 
measurement sources in obesity epidemiology, such as conducted in Aim 2. More 
generally, in future work I plan to use the self-reported weight histories as proxies of 
adulthood weight change in HCHS/SOL, which represents a dynamic predominantly 
immigrant populations that may not have had consistent access to health care or readily 
accessible information on weight pre- and post-immigrant. 
Second, in Aim 2 I fine-mapped the association of common genetic variants with 
BMI in five diverse ancestral populations of the PAGE Study: African, Hispanic/Latino 
(including HCHS/SOL), Asian, European and Asian ancestries (Figure 1; right hand 
corner). This work will directly inform future targeted investigations of the gene-
acculturation interactions on BMI in diverse Hispanic/Latino samples of the PAGE Study 
(Figure 1; center set of arrows) or the functional consequences of the genetic variant.  
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The two manuscripts of this dissertation will each highlight the utility of diverse 
measures and populations in current genomics and epidemiology research on obesity. 
An individual’s Hispanic/Latino background, migratory or acculturative history may relate 
to the accuracy of their self-reported weight (Aim 1), their innate genetic susceptibility 
(Aim 2), or their exposure to interacting obesogenic environments (Figure 1; center set 
of arrows).  
Acculturation may capture the broader sociocultural context through which 
Hispanic/Latinos integrate to the US obesogenic environment within and across 
generations leading to behavioral or cognitive changes relevant to CVD risk.  Given that 
some Hispanic/Latino backgrounds may be encountering an obesogenic environment for 
the first time in US, and yet others may have emigrated from countries with a rising 
obesity epidemic [e.g. recent birth cohorts from Mexico, which now has the highest 
prevalence of adult obesity in the world [45]], the consideration of heterogeneity across 
Hispanic/Latino backgrounds is of key importance. Future work that considers both 
acculturation and genetic predisposition to obesity may account for some of the 
previously unexplained hereditability (or phenotypic variation), and inform our 
understanding of how the sociocultural context may exacerbate innate genetic 
susceptibility.  
B. Aim 1 
The first aim of this dissertation was to establish the accuracy of self-reported 
current weight as a potential tool for future etiologic studies of self-reported weight or 
weight histories in US Hispanic/Latinos. After adjusting for the complex sampling design 
of HCHS/SOL, I described both the unadjusted mean differences between self-reported 
and measured weight (Aim 1A) and the adjusted estimated differences using a 
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multivariate model that simultaneously included a number of potential predictors of 
inaccuracy (Aim 1B).  
Throughout Aim 1 I used a quality-controlled dataset that was restricted to 
HCHS/SOL baseline participants with both self-reported and measured weights as part 
of the Anthropometry Questionnaire in the fasting block of the HCHS/SOL baseline 
examination (2008-2011) and who were not at the extremes of either self-reported 
weight or BMI (calculated from self-reported weight and measured height), not currently 
pregnant, or did not have a previous limb amputation (n=16,119, aged 18-74 years at 
screening). The quality control procedures and research methods are described briefly 
below.  
1. Aim 1A 
After a staged data cleaning and exclusion protocol, we performed a linear 
regression of self-reported on measured weight to estimate the correlation between the 
two and inform unity and modified Bland-Altman plots. We then calculated the difference 
between self-reported and measured weight in kg. Adjusting for the complex study 
design of HCHS/SOL, we generated mean differences overall and stratified by potential 
predictors of inaccuracy including: acculturation (language preference, nativity), 
demographics (age, education, field center, Hispanic/Latino background, household 
income, gender), and health/behavioral measures (cancer, diabetes, categories of body 
mass, self-reported physical activity and current smoking status). Additionally, we used 
multiple imputation to fill in missing covariate data, which prior to analyses were 
estimated to represent 5-10% of participants (≥1 missing covariate). 
Hypothesis: I hypothesize that self-reported weight will be a sufficiently accurate 
proxy of measured weight at baseline across Hispanic/Latino backgrounds, as measured 
by both the correlation (e.g., r2>0.9) and the mean difference after accounting for the 
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complex study design (Test of difference=0, p≥0.05). I also expect that a Bland-Altman 
plot will support the observation of agreement of self-reported and measured current 
weight in HCHS/SOL (p<0.05). Similar to previous studies I anticipate that the mean 
difference will vary in direction of mis-reporting across a number of previously reported 
differential predictors of inaccuracy (e.g. age, gender, categories of BMI, language 
preference, nativity, site by background) [46-51]. I hypothesize that multiple imputation of 
covariates will increase our precision, but otherwise will not influence the substantive 
conclusions of the work, thus indicating that predictors of inaccuracy were likely missing 
at random. 
2. Aim 1B 
We then used linear regression models to assess how the accuracy of self-
reported weight varied across strata of potential predictors of inaccuracy (e.g. age, 
gender, categories of BMI, language preference, nativity, site by background) after 
taking all other factors into account.  
Hypothesis: I anticipate that only a subset of the most consistent determinants of 
accuracy (e.g. age, gender, categories of BMI) will be relevant in this study in a 
multivariate prediction model (p<0.05). Again I hypothesize that multiple imputation will 
increase our precision, but otherwise will not influence the conclusions of the work. 
C. Aim 2 
After I having garnered a better understanding of the accuracy of self-reported 
weight in US Hispanic/Latinos, as an alternative measure of body weight for the 
calculation of BMI, I harnessed the rich data available in the PAGE Study to generalize 
and fine-map BMI loci, as captured by measured and self-reported weights and heights, 
in diverse ethnic/racial studies which included 102,514 adults of African (34.7% of total 
sample), Hispanic/Latino (25.4%), Asian (21.9%), European (17.4%) and American 
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Indian/Alaskan Native (0.5%) ancestries. Although several large GWAS of BMI have 
been published to date, no studies have attempted to generalize associations to other 
racial/ethnic groups or fine-map the established BMI loci with dense genotyping within 
these multiple racial/ethnic groups (Aim 2A) or trans-ethnically (Aim 2B). For this reason, 
I have chosen to address this knowledge gap, before continuing research on the other 
components and pathways of our conceptual diagram (Figure 1). The research methods 
for Aim 2 are briefly described below. 
1. Aim 2A  
I utilized the densely-mapped available in the PAGE Study to generalize 170 
previously described and validated SNPs from the GWAS literature (or their proxies, 
r2≥0.8 in the population of discovery). Because these SNPs were identified mostly in 
individuals of non-Hispanic/Latino European ancestry and are likely correlated with the 
‘causal’ variant, I also fine-map the underlying functional SNPs for increased BMI 
(captured using measurements and self-reports) at 36 established BMI loci. Each 
participating study performed linear regression of the natural log of the BMI distribution 
for each single SNPs while adjusting for relevant confounders [age, gender, population 
stratification, field center as appropriate, and the complex sampling design and 
backgrounds of HCHS/SOL in generalized estimating equations (GEEs)]. On the study- 
and racial/ethnic group- (African, Hispanic/Latino, Asian, European and American 
Indian/Alaskan Native ancestry) stratified summary results, I performed an inverse 
variance weighted fixed-effect meta-analysis to generate a single fixed-effect summary 
per racial/ethnic group. I then assessed the effect heterogeneity across studies. Lastly, I 
generated forest plots to investigate SNP-associations with evidence of study 
heterogeneity (p<0.05/166 independent previously reported signals).  
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Hypothesis: I hypothesized that the majority of the risk alleles of ‘index’ 
(previously reported) SNPs would have directionally consistent effects for risk alleles 
comparing the previous reports and racial/ethnic-specific results, and that this would 
surpass what we would expect by chance (binominal p<0.05, 170 tests, 0.5 probably of 
success on each). I anticipated that a smaller proportion (~25%, based on previous 
reports [52]) of the index SNPs would generalize, defined as being both directionally 
consistent and statistically significant considering the number of independent tests 
performed (p<0.05/166), within in each racial/ethnic group. I also anticipated that the 
number of loci generalized would be the least and greatest in our smallest (American 
Indian/Alaskan Native) and largest (African American) samples, respectively. I also 
expected that the additional SNPs available in the 36 fine-mapped BMI loci would 
improve our ability to select the marker with the lowest p-value (‘top’ SNP) and that in 
most cases this top SNP would not be the index SNP (p<0.05/ independent tests per 
locus, r2<0.2 in African Americans). 
2. Aim 2B  
Using the racial/ethnic-specific summary results from meta-analysis of African, 
Hispanic/Latino, Asian and European ancestries estimated in Aim 2A, I performed 
inverse variance weighted fixed-effect meta-analysis to generate a trans-ethnic fixed-
effect summary for each SNP, and then assess the evidence of heterogeneity across 
racial/ethnic groups (p<0.05/166 previously reported independent SNPs). Additionally, I 
implemented a Bayesian trans-ethnic meta-analysis to cluster the racial/ethnic groups by 
their allelic frequency differences [53] and within the 36 densely-genotyped BMI loci to 
construct a 99% credible interval reflective our confidence of observing the causal 
variant within its bounds. Lastly, approximate conditional analyses were performed to 
establish the number of independent signals within each locus, and regional plots were 
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utilized to illustrate the genetic architecture of each of the 36 densely-genotyped loci.  
Hypothesis: Similar to Aim 2A, I hypothesized that the majority of the risk allele of 
the ‘index’ (previously reported) SNPs in our trans-ethnic analyses would be directional 
consistent with the risk allele in the previous reports (binominal p<0.05, 170 tests, 0.5 
probably of success on each). I anticipated that we would see an even greater 
proportion of the loci generalize in the trans-ethnic fixed-effect analyses (>25%, based 
on previous reports [52]; defined as directional consistency and statistically significance, 
p<0.05/166), due to the increased sample size. However, I hypothesized that a handful 
of these loci may have evidence of racial/ethnic group heterogeneity; therefore the 
Bayesian trans-ethnic meta-analysis would relax the assumption of fixed-effects and, at 
times, may note a different ‘top’ trans-ethnic SNP. I expected that the 99% credible set 
would help narrow the interval of putative interest for most loci (>16 loci). Lastly, based 
on previous reports in a large sample of European descent [33], I thought that 
conditional analyses would replicate/reveal a small number of (≤5) secondary or tertiary 
independent associations at these loci (p<0.05/independent tests per locus, r2<0.2 in 
African Americans), providing additional information about the genetic architecture of 
BMI loci in diverse populations.  
D. Public Health Implications 
Several US racial/ethnic groups, including Hispanic/Latinos, are oversimplified 
with respect to their diversity or understudied altogether in public health and genetics 
[40]. In contrast, the above dissertation aims were conceived with diversity in mind. 
Furthermore, my dissertation manuscripts fill two gaps in the epidemiologic literature on 
the implementation of diverse alternative measures of body weight (Aim 1), and diverse 
ancestral populations in genetic obesity research (Aim 2). I describe the public health 
implications of each aim separately below.  
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The diversity of Hispanic/Latino backgrounds captured across the study sites of 
the HCHS/SOL is unprecedented and reflect multiple subgroups based on self-reported 
Hispanic/Latino heritages and country of origin. With regards to Aim 1, this work adds 
novel knowledge to the literature by describing the accuracy of self-reported weight 
among multiple backgrounds of US Hispanic/Latinos, which has not been investigated 
previously. Alternative measures of body weight can be used to calculate BMI, a 
commonly used proxy measure of obesity in epidemiology, or can be used to track 
changes in self-reported weight in epidemiologic studies of dynamic US immigrant 
populations, such as Hispanic/Latinos. For example, the genetic analyses conducted as 
part of Aim 2 included studies of BMI with both measured and self-reported weights. 
Knowledge of the overall direction of misreporting (under versus over) and the predictors 
thereof are imperative for the design of future epidemiologic studies and etiologic 
analyses, such as the one conducted in Aim 2.  
Hispanic/Latinos are now the largest US minority group, but there are limited 
data on their genetic risk factors (addressed in Aim 2) and the environmental origins of 
their obesity disparities.  The generalization and fine-mapping of obesity loci in Aim 2 are 
an important first step towards prioritization of strong candidates SNPs for future 
epidemiologic studies in diverse populations in addition to follow-up and targeted 
functional follow-up. An improved understanding of the genetic architecture and its 
population diversity in complex traits such as BMI will undoubtedly improve our ability to 
tailor interventions for diverse populations such as Hispanic/Latinos, as we attempt to 
translate statistical associations to public health interventions.  
My two dissertation manuscripts provide a strong basis for future research on the 
complex interplay between the sociocultural and genetic determinants of obesity (see 
conceptual diagram in Figure 1) and the future study of how US Hispanic/Latinos 
assimilate to the obesogenic patterns of diet and physical activity in the US, which in turn 
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may have a detrimental effect on their health. In summary it is my hope that this large 
body of work in genetics will result in a deeper understanding of the etiology of obesity, 
how obesogenic environments are embodied, and what might be potential modifiable 
targets for public health interventions for obesity among US Hispanic/Latinos.   
E. Supporting Figure 
 
 
Figure 1. Conceptual diagram of alternative measures (Aim 1) and diverse populations 
(Aim 2) in genomics and epidemiology research on the complex interconnections 
between genetics, acculturation and obesity. 
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CHAPTER III: BACKGROUND AND SIGNIFICANCE 
A. Overview 
In this next chapter I will provide the background and significance for this 
dissertation. First, I will describe the global obesity epidemic in terms of how it is defined, 
its trends, and then in terms of its established risk factors. Second, I will give a brief 
summary of the diversity of US Hispanic/Latinos and their obesity disparities as 
compared to non-Hispanic/Latino European Americans as well as across the varied 
Hispanic/Latino heritages represented in the US. Third, I will describe self-reported 
weight as a measure of obesity commonly available in large epidemiologic studies, and 
its accuracy in Hispanic/Latinos. Fourth, I will focus on how diverse measures and 
populations have been applied to the study of obesity and the common genetic 
determinants. Lastly, I will present our conceptual model supporting future work on the 
complex interactions between the underlying determinants of obesity, genetic and 
environmental, in diverse populations. 
B. The Global Obesity Epidemic 
Obesity is a global health epidemic and major CVD risk factor [1]. As described in 
more detail below, BMI (the ratio of weight to height squared) is a perfect measures of 
body mass, but an imperfect index of body fatness as it unable to differentiate between 
fat-free and fat mass [54]. This index was originally described by Quetelet, a Belgium 
mathematician and astronomer, for its proportional relationship between weight and 
height squared among adults [55]. It then re-emerged in the early 20th century to 
describe to “desirable” body weights for the Metropolitan Life Insurance Company [56]. 
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The limitations of initial recommendations based on these tables are well documented 
(e.g. data collected for these tables utilized both measured and self-reported heights and 
weights, included only non-Hispanic individuals from the United States and Canada 25-
59 years without chronic conditions, and included smokers). However in spite of these 
initial limitations, BMI has since been validated with other more detailed measurements 
of fat mass, mortality, and CVD diseases [55], which I will discuss in more detail below.  
 The components of BMI (weight and height) are easily reported or measured in 
a variety of settings (e.g. home, clinic) as they does not require special equipment. 
Therefore weight and height have been included and BMI calculated in many large and 
nationally representative epidemiologic studies [55]. If the rankings of BMI and other 
measures of body fatness are similar [54], quantitative differences between BMIs of 
individuals at the same time or changes within individual in BMI over time may still be 
informative in studying both trends in the overall obesity epidemic and individual health 
trajectories. For this reason, surveillance of the obesity epidemic has historically been 
conducted by tracking the temporal and geographic trends in the distributions of BMI or 
prevalence of under- (<20kg/m2 among adults, <5th percentile among 
children/adolescents), normal- (20 to <25kg/m2, 5th to <85th percentile), over-weight (25 
to <30kg/m2, 85th to <95th percentile) and obese (≥30kg/m2, ≥95th percentile) individuals, 
which can be further divided into obesity classes of increasing severity  [56, 57]. In order 
to understand the obesity epidemic, both the temporal and geographic trends should be 
reviewed.  
1. Temporal Trends 
The prevalence of obesity remained around 10% in the 1970s and early 1980s, 
but began notably increasing in the US in the mid-1980s [2, 58]. As of 2010 the age-
adjusted prevalence of obesity among US civilian non-institutionalized adults 20 years or 
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older was 36%, with another one-third of the population being overweight. Likewise 
nearly one-third of US children and adolescents (2-19 years) were obese or overweight 
in 2010 [3, 59]. There is some preliminary evidence to support a plateauing of the 
epidemic in some subgroups of the US [2, 3]. Yet other work indicates that the epidemic, 
in particular the most severe forms of obesity, may still be growing among US children 
and adolescents [60, 61]. 
2. Geographic Trends 
As Westernization had been exported across the globe, so too has the obesity 
epidemic. As of 2008, 10% of the world population was obese [62]. Traditionally, 
developed countries like the US have been at the forefront of the epidemic. However, 
more recently, developing countries have undergone transitions from under- to over-
nutrition, especially in urban settings. For example, in 2008, Mexico surpassed the age-
adjusted prevalence of obesity in United States (33% versus 32% among adults 20 
years or older) [45].  
Although globally childhood/adolescent obesity prevalence has historically 
remained lower than adult prevalence, concerning increases have occurred [3, 63], 
especially in developing countries with emerging economies where the prevalence can 
exceed 30% among preschool aged children [62].  
C. Risk Factors for Obesity 
 There is a wealth of CVD literature on the determinants of obesity. Using a broad 
frame of reference, I have grouped risk factors into six categories (age, period and birth 
cohort; energy balance; sex and gender; smoking; genetics; and psychosocial, 
socioeconomic and –cultural factors) to highlight the interconnections between several 
sets of factors. Intentionally I have focused on the obesity risk factors that are most 
relevant to this dissertation. These broad categories relate to both inter- and intra-
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individual characteristics and environments, further indicating how adult obesity is a 
multifactorial public health concern that requires methodologies that can study multiple 
contributors (risk factors) simultaneously.  
1. Age, Period and Birth Cohort Effects 
Excessive weight gain beyond what is required for normal development and 
maturation at any time point in the life course is concerning and can have metabolic 
implications. Weight gain early in life is a public health concern as overweight or obese 
children and adolescents are at extremely heightened increased risk for overweight or 
obese in adulthood and therefore may remain at higher risk for CVD throughout their 
lives [64-67].  
Similarly, weight gain in adulthood may lead to the development of 
overweight/obesity for the first time in adulthood or the intensification of obesity-related 
CVD risk. For example, longitudinal studies of weight gain have shown that it predicts a 
number of CVD risk factors throughout adulthood in a number of populations including 
Mexican Americans [68, 69]. With respect to outcomes, weight gain since 18 years old 
(based on self-report) has been shown to a risk factor for all-cause mortality later in life 
(specifically CVD-related deaths and non-smoking-related cancers) in the Nurses’ Health 
Study [70]. This association was independent of one’s early adulthood body mass (self-
reported BMI at 18 years of age). Importantly, weight gain in adulthood is more likely to 
lead to the deposition of extra weight in the abdomen, where fat is most metabolically 
detrimental [71]. 
Adults have been at the forefront of the obesity epidemic as compared to their 
children/adolescents [58]. Yet in addition to age-related disparities, there have been 
marked period effects in the obesity epidemic since the 1980s. The interaction of these 
two time-related factors (age and period) produces susceptible cohorts. For example, 
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individuals born in the US in the midst of the obesity epidemic (after 1980) carry a larger 
burden of obesity than seen in other cohorts [72]. Although the exact genetic and 
environmental etiologic mechanisms are unclear, weight gain during adulthood may 
exacerbate the public health burden experience by birth cohorts from the obesity 
epidemic [71].  
2. Energy Balance 
 Presumably the current obesity epidemics seen in developed nations like the US 
are due to a continued imbalance between energy intake and expenditure [58]. In 
developing countries transition from a tradition to a Westernized diet, the adaptation of 
an urbanized lifestyle or other cultural practices (‘reverse acculturation’) has been 
associated with a nutrition transition leading to population-level increases in obesity. 
However, on an individual level poor diet or physical activity have been challenging to 
quantify and change in epidemiology and public health.  
3. Sex and Gender 
 Women tend to have higher percentages of body fat than men, which they store 
preferentially in subcutaneous rather than visceral depots. As such at a given BMI (e.g. 
30 kg/m2) women on average have higher percentages body fat and less fat free or bone 
mass than men [58]. Among parous women, both gestational weight gain and post-
partum weight retention are considered risk factors for obesity [73]. Moreover, 
independent of aging effects menopause has been documented to associate with 
increased weight gain and shifts in body composition towards more central adiposity [74, 
75]. 
In addition to evidence of a biological basis of differences in obesity prevalence 
between men and women, women’s weight appears to vary more across SES 
conditions, racial/ethnic groups, and nativity than men’s weight. This indicates that body 
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weight and obesity may also be engendered through complex social processes or 
cultural roles.  
4. Smoking 
Generally current smoking and tobacco use has been associated with lower 
average body weight and therefore less overweight and obesity [58]. Yet this 
generalization does not hold for all current smokers. While it has been demonstrated that 
weight is generally lower among adult smokers (ages 25-44), and higher among former 
adult smokers, this trend has not been found in younger smokers (ages 16-24) [76]. In 
addition, suggested weight control effects of smoking may dissipate over time, as long-
term smokers (20 years and older) have been shown to be heavier than never or former 
smokers, and heavy smokers are more likely to be obese, and have greater abdominal 
obesity, than both other smokers and non-smokers [77, 78]. Additionally, an individual’s 
weight may increase after smoking cessation [58]. Evidence supports the role of nicotine 
in metabolic pathways, although the biologic mechanisms are still unclear.  
5. Psychosocial, Socio-Economic and -Cultural Factors 
Psychosocial stress [79] and depression [80] are risk factors for adult obesity. 
More specifically a variety of sources of perceived psychosocial stressors, such as work 
and caregiving stress, childhood adversity, and financial insecurity have been associated 
with modest increases in obesity over time [81]. Previous reports also describe 
increasing obesity prevalence with lower SES; yet the mechanism is likely complex and 
may be bidirectional in nature (i.e. obesity may influence one’s ability for SES advances 
through the life course) [82]. When studies have jointly assessed the influence of socio-
economic and -cultural factors on BMI and obesity, variability in SES-gradients is evident 
by racial/ethnic group. Furthermore, the differences in BMI across racial/ethnic groups 
are not completely accounted for by SES differences. This observation highlights the 
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distinct role that sociocultural factors may play in determining one’s body image and 
access to health care, which could impact the accuracy of self-reported measures (e.g. 
Aim 1 of body weight), and in determining an individual’s burden of obesity (e.g. gene-
environment interactions).  
Acculturation is a multi-dimensional process of cultural adaptation that begins 
when individuals from more than one culture come into continuous contact with each 
other, which results in the maintenance and development of cultural practices with one 
or both cultures [9, 83, 84]. Work by Berry has outlined four potential strategies during 
the process of acculturation: integration, assimilation, separation and marginalization [9, 
84].  
Yet the role of acculturation in public health disparity research and its 
operationalization has been widely debated [85-89]. The concept of acculturation has 
been criticized in the field of public health for not involving the structural factors that 
might also account for health disparities [90]. Additionally, uni-directional and uni-
dimensional measures of acculturation are based on the assumption that the host 
culture is static and that any observed change in the individual is due to their 
assimilation in the host culture. Such measures therefore have been criticized for their 
ability to differentiate between the varied components of acculturation (e.g. individuals 
that have successfully integrated the cultural influences of both cultures to their benefit, 
and those who have become equally marginalized from both cultures) [84].  
6. Genetics   
Above I have already described some of the environmental risk factors for 
obesity. Yet obesity is a multifactorial disease due to a combination of environmental 
and genetic influences [91, 92]. Estimates of the heritability of obesity range between 40-
70%, with single gene disturbances (monogenic) accounting for less than 5% of severe 
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cases of obesity. Monogenic forms of extreme obesity can be grouped into three main 
etiologic categories [91]. First, several occur in the genes involved in the hypothalamic 
leptin-melanocortin system that regulates energy balance. Second, the genes involved in 
the neurodevelopment of the hypothalamus can also be distributed to produce extreme 
obesity. Lastly, extreme obesity has been associated with a handful of pleiotropic 
syndromes due to the dysfunction of the primary cilium. Given that monogenic forms of 
extreme obesity explain a small portion of the heritability of obesity, most of the 
heritability may be explained by less impactful but more common genetic variations. 
Below I will describe the current state of evidence on the population-level genetic 
influences on obesity, which are the exposures of interest in this dissertation.  
D. United States Hispanic/Latinos 
Hispanic/Latinos comprise the largest US minority group. I will now describe their 
diversity with respect to geographic location, Hispanic/Latino background, immigration 
status, language, culture, and genetic ancestry. Lastly I will summarize how US 
Hispanic/Latinos have been included in epidemiologic research to date and the potential 
for innovation in the field of Hispanic/Latino health. 
i. The Term ‘Hispanic/Latino’ Defined 
The ethnic group Hispanic/Latino can include individuals with ancestry or 
heritage from Latin America or Spain [4]. Whereas ‘Hispanic’ may refer either broadly to 
the peoples from Hispania (or Iberian Peninsula, including both Spain and Portugal) or 
more narrowly to only the Spanish speaking peoples from Spain or Latin America 
(Figure 2, countries highlighted in green in panels C and B, respectively), ‘Latino’ refers 
only to the peoples from Latin America (Figure 2, panel A), regardless of language [93].  
The US government uses ‘Hispanic or Latino’ interchangeably and defines it as a 
descriptor of a person of “Cuban, Mexican, Puerto Rican, South or Central American, or 
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other Spanish culture or origin regardless of race” [4]. Thus as shown in Figure 2, the 
union of these two terms in the US can encompass individuals living in the highlighted 
countries in Panel B, as well as those living in the US in Panel D [93]. Not surprisingly 
peoples from other countries conceptualize the individual terms ‘Hispanic’ and ‘Latino’ as 
well as their union differently [94], and individuals from certain regions of the US may 
prefer one term over another.  
As the US government has defined Hispanic/Latinos, individuals with ancestry or 
heritage from Portugal, Belize, Haiti, Brazil or other predominantly non-Spanish speaking 
countries in Latin America are often not officially considered to be Hispanic/Latino by the 
US government [93]. Yet individuals with ancestry or heritage in these countries may still 
self-identify as Hispanic/Latino in their home countries or in the US even though they 
would be or are not included in government enumerations and initiatives. In spite of the 
debate around the term Hispanic/Latino, in this dissertation I have operationalized it as 
the US government and its funded public health projects have done prior (e.g. 
HCHS/SOL).  
ii. Population Growth 
After nearly a six-fold increase in the Hispanic/Latino population since 1970 [95], 
US Hispanics/Latinos represented 16% of the total population in 2010 [4] and more 
recent US estimates place Hispanic/Latinos at 17% of the US population [96]. According 
to the US Census, the most rapid Hispanic population growth occurred between 2000-
2010, when 43% of the total growth occurred [4]. Although historically the growth in the 
Hispanic/Latino population has been driven by waves of immigration (in particular from 
Mexico), between 2000 and 2012 Hispanic/Latinos US births accounted for 60% of the 
population growth [95]. In some regions of the US the population growth of the 
Hispanic/Latino population is several times that of the general population. The five states 
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with the largest estimated growth of the Hispanic/Latino population are Tennessee, 
South Carolina, Alabama, Kentucky, and South Dakota (163-132% percent change 
2000-2012). It is estimated that nearly one in three Americans will be Hispanic/Latino by 
2060. I will now complete my description US Hispanic/Latinos by acknowledging the 
complexity of the geographical distribution of US Hispanic/Latinos of varying 
backgrounds, their immigration statuses as well as their linguistic, cultural, and ancestral 
heritages.  
1. Diversity 
Just as there are notable regional differences across and within Hispanic/Latino 
Spain and Latin America, so does this diversity resurface in the US in a conglomerate 
ethnic group like Hispanic/Latinos. In light of the global obesity epidemic and the 
potential for disparities in such epidemics, it is important to revisit the intra-ethnic group 
diversity in geographic location, Hispanic/Latino background, immigration status, 
language, culture, and ancestry that characterizes US Hispanic/Latinos. Each aspect will 
be discussed in turn below. 
i. Geographic Location, Immigration Status and Background 
The majority of Hispanic/Latinos reside in the West (41%) and the South (36%). 
The US states of California, Texas and Florida contain 75% of the US Hispanic/Latino 
population, with an additional 6% living in the border states of Arizona and New Mexico 
[4]. However, Hispanic/Latinos can be found in every state with notable pockets of ethnic 
enclaves in Washington, Kansas, Idaho, Oklahoma, Nebraska, Colorado, around 
Chicago, IL, and along the East coast from New York to Virginia. Residential segregation 
has been documented among US Hispanic/Latinos, which may in part explain the origins 
of immigrant enclaves within the US [97, 98]. For example, residential segregation may 
occur [97] as undocumented immigrants settle in regions of US where they have safety 
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nets of family and friends (who may also be undocumented) or easily accessible work 
opportunities [99]. 
The term ‘US Hispanic/Latino’ combines individual of multiple backgrounds. For 
example, the majority of Hispanic/Latinos captured by the 2010 US Census have 
ancestry (or heritage) from Mexico (63%), followed by much smaller populations of 
individuals of Puerto Rican (9%), Central (8%) or South American (6%) ancestries [4]. 
Mexican and Central Americans primarily reside in California, while Cuban and South 
Americans reside mostly in Florida or other states of the US South. Puerto Ricans (not 
living in Puerto Rico) and US Dominicans mostly reside in the areas around New York 
City, NY. Salvadorans were the largest group in and around the nation’s capital.  
Perhaps not surprisingly many communities in Latin America have sister 
communities in the US where a substantial fraction of their former inhabitants now 
reside. For example, as shown in Figure 3 studies of remittances sent from the West 
Coast of the US to Mexico by the World Bank Group shows that most Mexican 
Americans living in US states along the US-Mexico border send remittances to Northern 
Mexico, whereas Mexican Americans living in more northern locations may have ties to 
central and southern Mexico [100]. The same pattern is replicated for Mexican 
Americans residing in other regions of the US and speaks generally to the non-random 
nature of where US Hispanic/Latinos reside in the US. As such there is an inherent 
‘confounding by geography,’ wherein it is difficult to disentangle the influences of 
geography and Hispanic/Latino background [101]. For this reason, community-based 
studies of Hispanic/Latino studies, such as HCHS/SOL, are limited in their ability to 
disentangle the two influences on CVD.  
In addition to geography and background differences in the US, there are notable 
differences across Hispanic/Latinos with respect to immigration status, which can 
determine an individual’s opportunities, resources and therefore their perception of 
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discrimination or individual rights [102]. The Pew Hispanic Center estimates that 
currently there are more than 11 million undocumented immigrants living in the US, the 
majority of whom are from recent waves of immigration from Mexico or other Latin 
American countries [103]. Furthermore, they estimate that a subset of undocumented 
Hispanic/Latinos, perhaps as much as 15%, did not participate in the 2010 US Census 
and therefore the current population estimates are an underestimate. There are a variety 
of ways immigrants can become ‘undocumented’, the majority have either overstayed 
their visas or entered without prior authorization across the US-Mexico or US-Canada 
border [103].  
The US-Mexico border is the most violent border in the world between two 
countries not at war [104]. Every year while trying to cross innumerable undocumented 
immigrants experience trauma or worse and thousands experience death [104] along the 
US-Mexico border from imprisonment, kidnappings, assault, robbery, torture, 
dehydration, snake bites, and exhaustion [105]. Traumatic migratory experiences of 
foreign-born Hispanic/Latinos shape their health and can cause a higher burden of both 
morbidity and mortality after arrival to the US [105]. This potential health gap is further 
widened because undocumented immigrants suffer from a host of constrained choices 
and environments [106]. In addition to residential segregation, undocumented immigrant 
are less likely to have health insurance, obtain/use legal representation, assistance from 
federal or state assistance programs, or pursue a higher education [107, 108]. They tend 
to work in unskilled or manual labor occupations, live in poverty, and experience less 
upward mobility. They are more likely to be paid less for the same work [109] and 
perhaps be exploited by their more permissive employers.  
Migratory experiences of documented or undocumented immigrants, as well as 
Hispanic/Latinos families and communities may shape how Hispanic/Latinos thrive in the 
US and impact the findings of research in Hispanic/Latino health. Given the sensitivity of 
    24 
 
the matter, many large epidemiologic studies of Hispanic/Latinos such as HCHS/SOL 
have opted not to inquire with participants about their immigration status. On an 
aggregate level, undocumented immigration may drive differences between US 
Hispanic/Latino backgrounds groups that are not explained by traditiona CVD risk 
factors, SES, etc. (e.g. Puerto Ricans who are all US citizens versus Mexican 
Americans, many of whom may have immigrated to the US without authorization).  
ii. Linguistic and Cultural Identities 
 As mentioned above the operationalization of the ethnic group Hispanic/Latino in 
the US relies on “Spanish culture or origin” and is thus limited to individuals with heritage 
in one or more Spanish-speaking countries [4]. Based on this operationalization one 
might assume that all Hispanic/Latinos would be linguistically and culturally 
homogenous. Yet US Hispanic/Latinos are very linguistically and culturally diverse.  
With regards to linguistics, not all Hispanic/Latino immigrants may have spoken 
Spanish as their first language in their Latin American home country prior to emigrating. 
For example, the 2010 Mexican Census estimated that 7% of the Mexican population 
spoke one of 60 indigenous languages [110]. Additionally, cultural diversity is a 
byproduct of centuries of mixing of indigenous, Spanish, and other cultures in Latin 
America. According to a survey by the Pew Hispanic Center, less than a third of US 
Hispanic/Latinos consider the designation ‘Hispanic/Latino’ to represent a common 
underlying culture [94]. This can be seen in the creation of mixed identities, such as the 
identity of ‘Mestizo’ in Mexico, which captures both the cultural and ancestral mixing of 
Spanish and native cultures in their history [111].  
iii. Ancestry 
There is a substantial amount of genetic diversity in US Hispanic/Latinos. Three 
primary ancestral groups, American Indian, Europeans, and Africans, are known to 
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contribute to the current genetic diversity seen in Latin American countries [112-116]. 
However, the genetic diversity within each of these three ancestral groups has yet to be 
fully appreciated in studies of Hispanic/Latinos [111, 117]. Although remarkable genetic 
diversity across some American Indian populations has been described [117], no 
systematic survey has informed the breadth of this diversity across the Americas. From 
historical records we know that prior to Columbus’ arrival in the New World in 1492, the 
Iberian Peninsula was very diverse and contained Iberians, Celts, Greeks, Romans, 
Sephardic Jews, Arabs, Gypsies alike [111]. Although African slaves being brought to 
the New World were classified according to their port of departure [111], they likely 
originated from other ancestrally diverse locations in Africa [118]. 
Many Hispanic/Latinos do not identify with a particular race categorization. For 
example, in the 2010 US Census, 31% of Hispanic/Latino respondents identified 
themselves as ‘some other race’ or chose to not respond, resulting in a non-response 
rate for race of 13%, nearly three times that of the general US population [119]. In the 
Multi-Ethnic Study of Atherosclerosis (MESA) study, 29% of self-identified 
Hispanic/Latinos had their self-reported “racial/ethnic classification” reassigned by 
principal component analysis (PCA)-based racial groupings, which were constructed 
using genotypes from 96 ancestry informative markers, Ward’s minimum variance 
method, and K-means clustering algorithm to identify four clusters of ancestrally related 
individuals. Reclassification was highest for Hispanic/Latinos than any of the other 
racial/ethnic group [European (12% of sample reassigned), African (11%), or Chinese 
American (<1%)] [120].  
Although, racial classification into discrete groupings is problematic in general, 
this MESA study and other related data demonstrate the heightened difficulty of racial 
identification in the highly admixed ethnic group designated as ‘Hispanic/Latino’ as one’s 
self-conception of race are often grounded in linguistic and cultural factors in addition to 
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knowledge about their ancestral genetic background. Although the federally funded 
HCHS/SOL had been mandated to collect information on race, similarly to what was 
done on the US Census, HCHS/SOL investigators have subsequently chosen to not 
include race in their descriptive and association analyses of CVD. In the next section I 
will continue to discuss how generally diverse Hispanic/Latinos have been incorporated 
into public health research to date and focus on the opportunities to improve upon the 
current practices in Hispanic/Latino health research. 
iv. Inclusion in Epidemiologic Research 
Future epidemiologic research on Hispanic/Latinos should appropriately 
acknowledge or account for the various origins and/or diversity in US Hispanic/Latinos. 
In spite of the current body of research on Hispanic/Latinos, studies designed to 
investigate and highlight the diversity Hispanic/Latinos will yield the greatest benefit in 
epidemiology [111]. Stratification of results by self-identified Hispanic/Latino background 
group may allow researchers to assess the impact of background on observed 
heterogeneity, but it may only capture portions of the other components of diversity 
described above, which include geographic, immigration, linguistic, cultural and 
ancestral factors. 
In the field of genetic epidemiology, it is important to account for ancestral 
differences given that genetic diversity may be confounded by the aforementioned other 
aspects of diversity and confound observed health associations. Although it is common 
practice in genetic epidemiology to account for this confounding by ancestral diversity 
(population stratification), it is also possible that the other sources of diversity may act as 
potential effect modifiers. With this in mind, this dissertation aims to explore the role that 
diverse ancestry may play in determining genetic susceptibility to increased BMI (Aim 2).  
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2. Disparities in Obesity 
Having described the trends in the obesity epidemic as well as the diversity of US 
Hispanic/Latinos, here I will describe the current disparities in obesity and the current 
understanding of its underlying causes.  
i. Adulthood 
Within the US there are striking disparities in obesity prevalence, which are 
masked by looking at just overall national estimates as I had done in my description of 
the temporal and geographic trends in the obesity epidemic. For example, as of 2010 
non-Hispanic/Latino White adults 20 years or older were estimated to have the lowest 
age-adjusted prevalence of obesity (34%, civilian non-institutionalized) [2]. 
Hispanic/Latinos (39%) and non-Hispanic/Latino Black (50%) adults had a higher burden 
of obesity. The Hispanic Health and Nutritional Examination Survey in 1982-1984 was 
the first to show that the burden of obesity may not be similar across all background 
groups of US Hispanic/Latinos [121, 122]. Restricting the 2010 estimates of obesity 
prevalence to just Mexican Americans demonstrated a slightly higher proportion were 
obese for this background group than overall for Hispanic/Latinos (40%). More recent 
nationally-representative estimates of obesity across the US Hispanic/Latino 
backgrounds are currently lacking.  
In this regard, community-based studies, like HCHS/SOL, may be a helpful 
snapshot of heterogeneity in the burden of obesity in US Hispanic/Latinos. In the 
HCHS/SOL communities a slightly smaller proportion of Hispanic/Latinos were obese 
(37%) than in contemporary national estimates [6]. Yet the burden of obesity across 
Hispanic/Latino backgrounds was indeed highly variable—with South American (27%) 
and Puerto Rican (41%) adults representing the ends of the spectrum in obesity 
prevalence [42, 43]. Nonetheless the causes of heterogeneity remain unclear due, in 
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part, to the confounding by geography mentioned above of Hispanic/Latinos in the US 
[42, 43]. 
ii. Childhood and Adolescence 
Unfortunately obesity disparities are even more pronounced among US 
Hispanic/Latino children and adolescents than in adults [2, 3]. Whereas in 2010 14% of 
non-Hispanic/Latino White children and adolescents (2-19 years) were obese, a higher 
burden of obesity was shouldered by Hispanic/Latino (21%) and non-Hispanic/Latino 
Black (24%) children and adolescents. Although considering all of childhood and 
adolescence it appears that the prevalence of obesity in Mexican Americans is similar to 
the large Hispanic/Latino designation, an alarming trend towards obesity can be seen in 
particular among Mexican American adolescent boys (12-19 years). This observation is 
supported by recent work in the National Longitudinal Study of Adolescent Health, which 
among the Hispanic/Latino backgrounds saw the largest gains in BMI between 12-32 
years in adolescents of Mexican (males) or Puerto Rican (females) ancestry or heritage 
[123]. Adolescents of Central/South American, Cuban or other backgrounds gained body 
mass at or below the non-Hispanic/Latino White adolescents in the study.  
iii. Non-Genetic Determinants of Obesity 
This brings us to the question of what might be key underlying determinants of 
obesity disparities for US Hispanic/Latinos, as well as what are potential sources of 
heterogeneity across this ethnic group’s diverse backgrounds. One possible component 
is the high proportion of Hispanic/Latinos who do not have health insurance and 
therefore affordable access to health care services [124, 125]. Although the Affordable 
Healthcare Act was enacted to equalize access to health care in the US, it does not 
include undocumented immigrants who are estimated to collectively amount to more 
than 11 million individuals [103] and may increase barriers to health care and further 
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marginalize this vulnerable population [105]. In 2010, 34% of all US Hispanics <65 years 
of age did not have health insurance and 45% of US Hispanic/Latinos in families earning 
<200% of the poverty line were uninsured [126]. At the same time 14% of non-Hispanic 
Whites and 21% of non-Hispanic Blacks were uninsured. Lack of insurance varies 
substantially by Hispanic/Latino background groups (e.g. from 50% of Hondurans to 
15% of Puerto Ricans were uninsured in 2010) [127], and tends to be highest among 
background groups that have the highest proportions of undocumented immigrants such 
as immigrants from Mexico (34%) and Central America (41-50%) [103, 127]. When 
lacking adequate clinical monitoring and management in roughly half of all US 
Hispanic/Latinos <65 years old [124, 126], inequitably some individuals may be 
subjected to an array of adverse environmental and lifestyle factors as they assimilate to 
the US resulting in poor population-level health outcomes [44]. A systematic review of 
mortality disparities in US Hispanic/Latinos (as compared to the general US population) 
revealed that although the greatest disparity is seen in diabetes-related mortality, 
Hispanic/Latinos also suffer from mortality disparities in a number of other conditions 
including some cancers, liver disease, HIV, homicide, and work-related injuries [125]. 
Diversity across Hispanic/Latino background groups may related to barriers to health 
care (e.g. citizenship or legal resident requirements for Medicaid/Medicare and 
Affordable Care Act, type and location of employment opportunities, language 
preference) and result in both lower seeking and receipt of healthcare services among 
Hispanic/Latinos. 
Another determinant of the obesity epidemic and the observed disparities relates 
to the social determinants of health, which can include poverty, trauma, stress, 
discrimination, unskilled or unreliable employment [125]. These health determinants 
have been linked to allostatic loads and hypothesized by Marmot to relate to a ‘status 
syndrome’, characterized by lower participation in and sense of control over their 
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surroundings [128]. Low socioeconomic status (SES) has been linked to rates of obesity, 
metabolic syndrome, and mortality [125].  
Additionally, the sociocultural environment and an individual’s strategy of 
acculturation [9, 84] may be key determinants in the patterning of diet, physical activity, 
obesity disparities. In the absence of the time and the resources to measure 
acculturation using detailed scales, proxies of acculturation have become common in 
epidemiologic studies of Hispanic/Latinos [9, 83]. In a systematic review of the public 
health literature by Thomson and Hoffman-Goetz, nearly a third of studies of 
Hispanic/Latinos relied on one or a combination of proxies of acculturation (language 
preference, nativity, time in the US, language preference, etc.). The need to balance 
practicality with validity is important to the study of the effects of acculturation. According 
to their review of the literature when both proxies of acculturation and detailed scales 
have been assessed in the same study, the correlations varied across the scales 
(r=0.17-0.76).  
A number of cross-sectional studies have investigated acculturation and obesity 
among US Hispanics/Latinos and have shown positive associations between 
acculturation and measures of adiposity, which vary by background [122, 129-138]. In 
the cross-sectional literature on this topic, time living in the US is a consistent cross-
sectional predictor of increasing weight status, independent of age, and shows evidence 
of a threshold effect after 10 years in the US [8]. A number of other measures of 
acculturation, such as age at immigration, generational status, language preference at 
examination, nativity, and the Short Acculturation Scale for Hispanics, have previously 
shown the most acculturated Hispanic/Latinos to carry the largest obesity burden; 
however, the results from studies using these measures have generally been less 
consistent [9, 83].  
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These cross-sectional studies have led to a number of competing hypotheses 
about the underlying pathway between acculturation and obesity. Hispanic/Latino 
immigrants have been documented to be healthier than their US-born peers, in what has 
been described as the ‘healthy immigrant effect.’ Explanations of this pattern are similar 
to the ‘Hispanic paradox’ described above [125] and have revolved in part around the 
selective migration of the healthiest individuals from the sending countries as well as 
retention of protective cultural practices such as a healthier diet and physically active 
lifestyle [86, 139]. Others have pointed out that return migration due to immigration 
enforcement, retirement, or health concerns (i.e. ‘salmon bias’) [125] may create a 
reverse selection bias that could mask or accentuate observed differences between 
foreign- and US-born Hispanic/Latinos in cross-sectional and longitudinal studies alike 
[140, 141].  
‘Social adaptation’ provides another alternative explanation of disparities and has 
been cast in both a positive and negative light in the current literature [125]. In contrast 
the ‘unhealthy assimilation’ hypothesis has been posited as an explanation for the cross-
sectional observation of the effect of increasing duration in the US [138, 141, 142]. If 
recent Hispanic/Latino immigrants are exposed to obesogenic environments as they 
assimilate to the US then they would gain weight faster than native-born 
Hispanic/Latinos until their weights converged. In a more positive light, ‘divergence’ 
describes the possibility that more recent immigrants may be more likely to maintain 
cultural practices, which support healthy lifestyles with regards to diet and physical 
activity, as they negotiate the process of establishing new relationships in the US.  
A handful of longitudinal studies [142-145] and repeated cross-sectional studies 
[140, 141] (Table 1) have sought to test the hypotheses of an ‘healthy immigrant effect’ 
followed by ‘unhealthy assimilation’ to the US by testing for baseline differences in 
obesity by generational status and then assessing the rates of weight gain between 
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foreign- and US-born Hispanic/Latinos. However, the findings have been far more mixed 
than seen previously in the cross-sectional literature [122, 129-138]. 
Within the body of literature some studies have noted incomplete mediation of 
the cross-sectional [139, 146, 147] or longitudinal [148] effect of acculturation on obesity 
by diet or physical activity, which may indicate that other sociocultural or environmental 
factors other than diet or physical activity may mediate the influence of acculturation 
(assimilation to US society) on obesity [8, 147]. Specifically, the association may be 
mediated by coping strategies for the stress related to immigration, discrimination, or 
other characteristic of being Hispanic/Latino in the US [149]. Other researchers propose 
that ‘segmented’ (unequal) assimilation [150] or structural factors not captured by the 
individual concept of acculturation [90] may in turn compromise the health of certain 
segments of the Hispanic/Latino population [145]. 
In summary restricted or inconsistent access to health care or SES disadvantage 
may interact with geographic, Hispanic/Latino background, immigration status, linguistic, 
sociocultural and ancestral diversity to determine the patterning of obesogenic 
environments in the US. This could in turn yield the complex picture of Hispanic/Latino 
health and health disparities in obesity we see currently in the US [2, 125].  
E. Classification of Obesity 
In this section I will describe how excess fat mass (or adiposity) is measured in 
obesity research, with a particular focus on self-reported weight and BMI, a proxy 
measure of obesity. For each I will present the current evidence on the validity and 
reliability in Hispanic/Latinos. In the absence of studies in Hispanic/Latinos I will 
summarize what trends in validity and reliability are seen in other US populations. 
Excess fat mass is the hallmark of obesity but can be measured in a variety of 
manners [54, 55]. An individual’s body composition can be measured using costly 
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precise assessments or using more inexpensive proxies [56]. Each type of measurement 
plays an important role in public health research.  
Detailed reference measurements are often performed in small samples as “gold 
standards” for body composition and include densitometry, hydrometry, computed 
tomography, magnetic resonance imagining, dual-energy X-ray absorptiometry, and 
potassium counting [55]. Often the findings from these small samples are used as 
references by which to calibrate and validate how less expensive indexes at capturing 
the components of body composition. Measures based on two-compartment models 
estimate fat mass and fat free mass, whereas multi-compartment models (e.g. computed 
tomography, magnetic resonance imagining, dual-energy X-ray absorptiometry, 
potassium counting) are able to decompose fat-free mass into further subdivisions 
including body water, protein, or bone mineral. Both types of models have been used to 
establish the accuracy of less expensive indexes of obesity to be discussed below. As 
the technological sophistication of these valid and reliable reference methods increases 
it becomes particularly important to consider their limitations. They are more costly, time-
consuming, and often are not easily portable, which impedes their wide-spread use in 
large epidemiologic studies [54, 55].  
On the other hand, there are a number of more accessible anthropometric 
measures and proxies of obesity, which include weight, BMI, waist circumference, waist-
to-hip ratio, skinfold thickness, and bioimpedance [54, 55]. For example, weight changes 
during a period of adulthood when height is not expected to change substantially tracks 
well with changes in fat mass [55]. Weight and height are reported or measured in a 
variety of settings as they do not require additional equipment beyond what is normally 
found in the home or clinic. BMI can then be easily calculated from an individual’s weight 
and height, and given this utility has already been integrated into US public health 
applications [57]. BMI has also been included by many public health researchers in most 
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large or nationally representative epidemiologic studies [55], many of which also 
implement standardized measurement or self-reporting protocols [55, 151]. 
In addition self-reported weight and height have been used in the absence of 
measured indexes, however with additional error discussed further below. Self-reported 
or recalled weights and heights may be particularly helpful when information on obesity 
or its change over time is otherwise unavailable to the researcher. Therefore many large 
epidemiologic studies (e.g. Atherosclerosis Risk in Communities Study or ARIC, 
HCHS/SOL, WHI, MEC, MESA, CHS) also capture self-reported and recalled weights at 
a number of epochs prior to study enrollment in order to capture weight maintenance, 
gain, or loss across an individual’s life course [152]. Yet these self-reported measures 
may have questionable significance across populations or variable measurement in a 
variety of settings, making the study of their validity and reliability particularly relevant for 
epidemiology research.  
I will begin a summary of the validity and reliability of self-reported weight (Aim 
1), and then describe the evidence for the validity and reliability of BMI, calculated using 
measured weights and heights (Aim 2). 
1. Validity of Self-Reported Weight and its Change 
I will first summarize the validity of self-reported weight, which I propose to 
assess in the first aim of this dissertation. The validity of self-reported weight at both a 
single time point and multiple time points has been investigated using four perspectives 
(Table 2). The first two perspectives each isolate two different potential sources of bias 
when self-reported weights are used in place of measured weights by comparing i) 
contemporaneous self-reported and measured weight as an estimate of self-report bias, 
and ii) current self-reported and recalled weight at the same age as an estimate of recall 
bias. The third perspective results in a combination of self-report and recall bias by 
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contrasting iii) measured weight and recalled weight at the same age. The final 
perspective harnesses multiple measures of self-reported and measured weights or 
weight changes to investigate the difference between iv) self-reported and measured 
weight over time. Although each perspective may be informative for informing ‘validity’ in 
particular study designs/datasets and is summarized below, we will focus on the first 
perspective, contemporaneous self-report and measured weight, as our preferred 
approach to isolate the magnitude of self-report bias in diverse US Hispanic/Latinos in 
Aim 1.  
i. Contemporaneous Self-Reported versus Measured Weight  
According to a review on the self-report bias in current self-reported weight 
(Table 2), most studies have described a tendency towards modest under-reporting of 
current weight (0.1 to 1.2 kg), but there is a large amount of variability in individual 
reporting [151]. In samples containing Hispanic/Latinos, categories of body mass index 
[48, 49, 51], aging [47, 49, 51, 153, 154], gender [47, 51], reproductive factors (parity 
and menopause) [75], household income [51], education, employment and nativity [49] 
have been described as predictors of self-reported inaccuracy. Yet an important 
limitation of this literature is that only a handful of validity studies have been completed 
in Hispanic/Latin American countries, or in US among Hispanic/Latinos. I will now focus 
on these studies in an effort to compare and contrast the body of evidence most relevant 
to US Hispanic/Latinos. 
From Latin America, a study of a nationally-representative sample of Mexican 
citizens born before 1951 noted modest over-reporting of weight (0.6kg) and a good 
correlation (r2>0.8) between self-reported and measured weights in Mexican adults 
(r2=0.84) [47]. Another study of Mexican asthma cases and controls noted under-
reporting of weight, but did not describe this observation quantitatively [155]. A 
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population-based study from Spain documented a trend towards under-reporting of 
weight and stronger correlations between self-reported and measured weight (r2=0.96) 
[46].  
In the US, the most recent estimates from the National Health and Nutrition 
Examination Survey (NHANES, 2007-2008) reveal that the difference between 
measured and self-reported current weight among non-institutionalized Hispanic/Latinos 
≥20 years old appears to be more consistent across gender than observed in other 
ethnic/racial groups [156]. Specifically, in NHANES researchers found that both 
Hispanic/Latino men and women tend to under-report their current weight (0.09 and 
0.59kg, men and women) and over-report their current height (0.89 and 1.56 cm, men 
and women). Because men do this to a lesser extent their calculated BMI values are 
less markedly under-reported than for women (0.29 and 0.79 kg/m2, men and women). 
Even though predictors of under-reporting in weight were not directly assessed, 
predictors of under-reporting in BMI included being overweight and obese, elderly (≥60 
years), and college educated, which could distort the population distribution of BMI by 
underestimating the largest BMIs but may not impact the classification of obesity. 
Earlier national estimates among Mexican Americans (1988-1994) indicated that 
the correlation between self-reported and measured weight was generally good (r2=0.96) 
[50] and that there may be more under-reporting of weight among foreign-born as 
compared to US-born Mexican American women [49]. Although Mexican American men 
tended to over-report their weight, this was invariant to their nativity. This observation 
indicates that previous studies of Hispanic/Latino adults in their home countries may not 
entirely represent the accuracy of self-reported weight we would expect to observe in a 
sample of both foreign- and US-born Hispanic/Latinos [47]. This may be due to the 
varying sociocultural influences of diverse Hispanic/Latino backgrounds as well as post-
immigration changes in these influences, which may in turn shape an individual’s body 
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image [157]. For example, Mexican American women describe that they have had to 
transition from Mexican culture that considers a full figure to be desirable to an American 
standard, which they describe as “extremely thin” and questionably healthy.  
Due to the predominance of Mexican Americans in NHANES, the validity of self-
reported weight by other Hispanic/Latino backgrounds is still largely unknown. However, 
another study of post-menopausal women (45-60 years) in Miami-Dade County, Florida 
found that the under-reporting of current weight (mean under-reporting 1.55 kg, 95% 
confidence interval 1.25 to 1.85) [75] was greater than national estimates of under-
reporting from NHANES for Hispanic/Latina women of multiple backgrounds (difference 
in means of 0.59kg) [156], but more similar to under-reporting of weight captured by 
earlier national estimates Mexican American women (mean difference of 1.37kg) [50]. 
This may be due post-menopausal weight fluctuations. Self-reporting bias was also more 
marked among the Hispanic/Latina women in their sample (mean under-reporting of 
weight 1.55 versus 1.51 kg, and of BMI 1.41 versus 1.05 kg/m2, respectively) than 
among non-Hispanic/Latina women due to the greater over-reporting of height in 
Hispanic/Latina women (mean over-reporting of height 2.48 versus 1.62cm, respectively) 
[75]. The investigators did not provide any information about the Hispanic/Latino 
background(s) of these women, but given the Hispanic/Latino background distribution in 
HCHS/SOL [43] one might assume the majority of women were of Cuban heritage. This 
report indicates further that there is the potential for heterogeneity in self-reporting bias 
by diverse Hispanic/Latino backgrounds, which could be masked in previous combined 
estimates of accuracy in Hispanic/Latinos [156]. 
ii. Current Self-Reported Weight versus Recalled Weight at the Same Age 
As a measure of recall bias, the next perspective on the validity of self-reported 
weight comes from the comparison of self-reported current weights and recalled weight 
    38 
 
at the same age (Table 2). Any differences between these two self-reports should be 
due to the fact that one is made with some time lag (e.g. a self-reported current weight 
when an individual was 21 years of age, versus the recalled 21-year old weight of the 
same individual at 40 years old). Estimates of this recall bias are particularly informative 
for studies of self-reported weight histories, which in HCHS/SOL for example could have 
be recalled up to 55 years prior to baseline.  
Not many US-based studies have two self-reported weights (at the same age) 
collected as part of multiple waves of data collection across a long period of time in 
adulthood [158]. I am not aware of any such study that includes samples of 
Hispanic/Latinos. In a large US report from the Adventist Health Study of older non-
Hispanic/Latinos, the correlation of these two self-reports (current weight and recalled 
weight for an age 26 years ago) was good (r≥0.83) for self-reported weights for ages 28-
72 years [158]. This corresponded to an average under-reporting of self-reported weight 
(recall bias) of 0.67 kg over a 26-year period, which for example varied from 0.01 kg 
over-reporting of recalled weights for ages 28-32 years (n=691) to 1.43 kg under-
reported of recalled weight for ages 58-62 years (n=384). Likewise the recalled weights 
for participants 30-64 years old at the second wave of data collection recalled weights 
were over-estimated by 0.16 kg, whereas participants 65-74 years old tended to under-
report their recalled weights by 0.84 kg. Recalled weights were also under-reported 
more substantially among the obese (≥30kg/m2, versus <30kg/m2) and ever smokers 
(versus never smokers). This study from a 26-year period of time indicates that in this 
population the average recall bias was roughly 0.25 kg per decade of recalled time, but 
that recalled weights earlier in the adult life course may be more accurate than those 
later in the adulthood and those made by younger participants may be more precise than 
those for older participants. Based on their results the authors conclude that the 
accuracy of recalled weights 20-28 years prior to the inception of a study (e.g. as part of 
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HCHS/SOL weight histories) may also be minimally biased by recall, but they do 
recommend that future studies of weight histories consider accounting for this potential 
bias.  
iii. Measured Weight versus Recalled Weight at the Same Age 
The third perspective on the validity of self-reported weight compares an 
individual’s actual measured weight and recalled weight for the same age (Table 2). 
Because any differences between these two measurements (measured and recalled 
weight) could be due to either self-report or recall bias, this perspective only roughly 
helps us gauge how much larger these differences are combined than individually 
(described sections i and ii above), i.e. through an interaction of biases. Again this area 
of research has been conducted exclusively among non-Hispanic populations [159-161]. 
In these studies, correlations between measured and self-reported recalled weight at a 
given age were high (r>0.8) and have been reported for recalled weights up to 28 years 
ago [160, 161]. One study in the bi-racial elderly cohort of the Charleston Heart Study 
used two periods of recall (28-years and 4-years in the past) indicates that the accuracy 
of recalled weights as compared to measured weights at the same age may vary across 
populations. For example, African American men under-reported their weights 28-years 
in the past less than White men (difference in means, 1.2 versus 1.5 kg, respectively), 
whereas African American women under-reported these recalled weights more than 
White women (1.8 versus 2.0 kg). Both African American men and women had more 
bias in their weights recalled from 4-years prior as compared to White men and women 
(0.3 and <0.1 kg over-reporting, respectively). However, African American men over-
reported their weights 4-years prior by 0.95 kg and African American women under-
reported their weights 4-years prior by 1.15 kg.  
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 More recent work from the repeated cross-sections in NHANES I Epidemiology 
Follow-Up Study (1982-1992) has indicated that the inaccuracy between measured 
weight and recalled weight at the same age was modest (1.77 kg under-report) over an 
average period of repeated cross-sections of 19 years [159]. These estimates were 
generated based on calculating the mean discrepancy between measured weight and 
estimated recalled weight for the same age based on the predicted recalled weight for 
the same age as the NHANES I examination (1971-1975) and a best fit line per 
individual of the recalled adult (20-65 years) weights prior to and after the NHANES I 
Survey (on average 19 years prior to the follow-up). This report also noted heterogeneity 
by racial groups in the estimated intercept and slope effects of discrepancy between 
measured weight and recalled weight at the same age but did not explore them 
systematically due, which warrants further research in diverse cohorts. Additionally 
across the range of periods of recall in this sample, this combination of self-report and 
recall bias was observed to increase with each additional decade of recalled time by 
approximately 2 kg (estimated range of recall periods, 7-21 years) [159], which is 
substantially larger than previous estimates of recall bias alone of 0.25 kg per decade 
[158]. This indicates that self-report bias may be a stronger influence in the study of self-
reported weight histories in HCHS/SOL.  
iv.  Self-Reported versus Measured Weight over Time 
The final perspective on the validity of self-reported weight allows us to directly 
assess its utility in capturing changes over time; however again it represents a less-
straight forward method to investigate self-report and recall bias. In addition to 
comparing the accuracy of self-reported weights at two waves of data collection, the 
National Longitudinal Study of Adolescent to Adult Health (Add Health) investigators 
used multiple self-reported and measured current weights of adolescents and young 
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adults to calculated weight change over a 5 or 6-year period of time. Calculations of 
weight change based on self-reported weights were on average 1.0-1.3 kg less than the 
calculated weight change based on measured weights (female versus males 
respectively, Waves II, 1996 and III, 2001-2002) [48]. Hispanic/Latino ethnicity and other 
known predictors of true weight change were not related to the discrepancy between 
self-reported and measured weight change (p≥0.07). In contrast with the reports of the 
accuracy of self-reported weight at one-time point, obese participants under-reported 
their individual weights more consistently than non-obese individuals, which resulted in 
more negligible under-estimation using calculated change among this group.  
Additional work including the Add Health Wave IV (2007-2008) indicated that the 
under-estimation of weight increased as adolescent girls transitioned into young 
adulthood, whereas self-reporting bias was not seen among adolescent or young adult 
boys. Race/ethnicity did not predict changes in self-report bias in either gender group 
[162]. This study indicates that with some systematic under-estimation of changes, 
multiple self-reported current weights can be used to capture weight changes in 
adolescence/early adulthood stably over a range of body mass categories. The 
calculation of weight trajectories based on a combination of recalled and self-reported 
current weights, such as in HCHS/SOL, may also underestimate population-level 
weights, but be a useful tool for studying weight trajectories in otherwise hard to study 
dynamic populations of Hispanic/Latinos.   
2. Validity of Measured Body Mass Index 
I will now shift my focus to the validity of measured BMI as a proxy measure of 
obesity and its downstream health consequences.  As previously indicated, BMI is a 
convenient measure of body mass in large epidemiologic studies, and was initially 
described and studied in populations of non-Hispanic European descent [55]. The 
    42 
 
validity of BMI has been studied in primarily non-Hispanic populations (although some 
studies of Hispanic/Latinos exist) and related to reference measurements of overall 
adiposity, mortality, and other outcomes such as CVD. I will describe each line of 
evidence separately below. 
i. Measured BMI versus Obesity 
First, BMI correlates with other proxy measures of obesity in a number of 
populations, but the interpretation varies somewhat by sex, age, and race/ethnicity [55]. 
For example, in the bi-racial ARIC Study, BMI strongly correlated with weight, waist, and 
hip circumferences (r≥0.85) [54]. Separately in a sample of Blacks and Whites from New 
York City, potentially including some individuals that could have had Hispanic/Latino 
ancestry, BMI correlated strongly with percent body fat calculated from a four-
component model including body weight and other measurements from densitometry, 
hydrometry, and dual-energy X-ray absorptiometry in both racial groups and in men and 
women (r≥0.58) [163]. Sex was a significant modifier of the correlation between BMI and 
percent body fat consistently over the life course (at 23kg/m2, 8.7-12.7% difference 
between women and men). Age also modified this association but far less strongly; older 
individuals had a modestly increased percent body fat for the same BMI (e.g. 23 kg/m2) 
than their younger counterparts—estimated to correspond to an average difference of 
0.7 to 1.1 percent per decade.  
A number of validity studies of BMI have also investigated racial/ethnic 
differences in the distribution of percent body fat and fat-free mass [164]. The 
observations that compared to Whites with the same percent body fat, individuals in 
other racial/ethnic groups can on average have a BMI between 4.6kg/m2 lower 
(Ethiopians) to 1.3kg/m2 higher (African Americans) BMI values has questioned the utility 
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of this measure of obesity across diverse populations [165, 166]. Moreover, there is 
substantial variability within racial groups such as Asians.  
It has also been noted that at certain BMI values, US Hispanic/Latinos have 
lower percentages of body fat than European Americans, and at other BMIs they have 
higher percentages of body fat [167, 168]. Nonetheless, most recently the correlation 
between BMI and adiposity was shown in a small but diverse sample from New York 
City to be comparable between US Hispanic/Latinos and Whites (r2=0.48-0.60 versus 
0.46-0.47) [169], the population in which BMI was first described and categorized. 
Therefore in order to avoid potential differences in racial/ethnic groups in the adiposity 
captured by the common categorizations of BMI into overweight (25 to <30kg/m2) and 
obesity (30kg/m2) categories, I have opted to study the continuous variation in BMI 
among Hispanic/Latinos as an indicator of the population-level variability in body mass, a 
useful tool in identifying obesity (Aim 2).  
ii. Measured BMI versus Mortality 
Second, a number of studies of mortality have described a J- or U-shaped dose 
response relationship between BMI and mortality with a nadir around a BMI at 25kg/m2 
[58]. The observation of a non-monotonic dose response curves relates to how BMI 
combines the influences of two components of body composition: fat mass (a risk factor 
at high percentages) and fat-free mass (a risk factor at low percentages) [54, 170]. 
Moreover, the observed dose-response relationship is also sensitive to the age, sex, 
racial/ethnic and smoking distribution of the population being studied. The association of 
BMI, a measure of overall adiposity, on all-cause mortality is independent of a variety of 
measures of central adiposity [171]. The obesity epidemiology literature suggests that 
excess fat mass or obesity, BMI ≥30kg/m2, may be a valid indicator of elevated mortality 
risk due to mechanisms independent of central adiposity [58].  
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In Hispanic/Latinos mortality studies of BMI have been primarily conducted in 
Mexican descent populations. One study has shown that the absolute reduction in life 
expectancy at 60 years of age from severe obesity is slightly larger among Mexicans 
living in Mexico (7.7 years) than among the general US population or among a sample of 
Americans of European descent (6.7 and 5-6 years, respectively) [172]. Yet Mexican 
Americans residing in the US have historically had comparable or less mortality burden 
from obesity as compared to Americans of European descent [173], which has been 
described as part of the ‘Hispanic paradox’ [174]. A recent pooled analysis of 16,798 
Hispanic/Latino adults (primarily samples from Puerto Rico and Mexican Americans 
living in the US Southwest) showed no significant relative increase in mortality with 
overweight or obesity [175]. Although, substantial heterogeneity has been described in 
the obesity-related impacts on mortality across Hispanic/Latino background groups 
[125]. 
The origins of the Hispanic paradox are unclear [125]. Inherent differences in the 
populations (e.g. foreign and US-born Hispanic/Latinos and other US-born racial/ethnic 
groups, SES, age, and/or gender) may mask differences in mortality [176], or the 
average percentage of body fat for a given BMI may be less impactful among 
Hispanic/Latinos [167, 168]. It is also possible that the process of immigration to the US 
selects for a population of healthy immigrants or the improved living conditions in the US 
as compared to the sending country provide a health advantage for the foreign-born 
Hispanic/Latinos as compared their US-born counterparts. Another hypothesis contends 
that reverse selection ('salmon bias') may be the driving factor, wherein US 
Hispanic/Latino immigrants with health concerns may rejoin with family and receive 
health care in their country of origin and are subsequently undercounted. Others have 
pointed out that there may be an under-estimate of mortality rates if Hispanic/Latinos are 
systematically misclassified as non-Hispanic/Latino. Yet no single theory singly or jointly 
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appears to accounts for the differentials in health within Hispanic/Latinos, which appear 
to track with “life-course epidemiologic factors in both sending and receiving nations.” In 
contrast, Vega and colleagues propose [125] that social adaptation, characterized by 
“social learning in contexts that supply opportunities, environmental conditions, and 
psychological reinforcement for health-degrading behaviors that increase in prevalence 
between generations after immigration,” is a useful paradigm to understand 
Hispanic/Latino health disparities and these paradoxical findings. Future studies of 
obesity and mortality in Hispanic/Latinos should consider diverse Hispanic/Latino 
backgrounds and their inherent characteristics of the populations being studied in order 
to determine if the paradox is an artifact of confounding factors, or how it may relate to 
Hispanic/Latino health research [176]. 
iii. Measured BMI versus Cardiovascular Disease 
Lastly, there exists a wealth of literature regarding obesity as a risk factor for 
future CVD [170]. Briefly the influence of obesity on future CVD is dependent on both the 
degree of excess adiposity and the duration [177] and partially mediated by obesity’s 
influence on other CVD risk factors [58]. Given the multiple measurements of BMI, 
researchers have previously inquired if BMI is indeed the best measurement to capture 
future risk of CVD. In a study from the United Kingdom, the strength of association 
between overall (BMI), central (waist circumference, waist-hip ratio) or more direct 
measures of adiposity (bioimpedance, skinfold thickness with either CVD risk factors or 
incident coronary heart disease were similar, indicating that BMI performs at least 
equally well at capturing adiposity-related CVD risk [178].  
The most contemporary and diverse estimates of BMI and CVD risk factors in 
Hispanic/Latinos come from the HCHS/SOL [179]. At the baseline examination BMI 
categorizations of overweight and three subclasses of obesity (25-<30 and ≥30 kg/m2) 
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associated positively with a higher prevalence of CVD risk factors (hypertension, 
diabetes, low high-density lipoprotein cholesterol, high C-reactive protein and 
triglycerides) across a wide age range of diverse Hispanic/Latinos. At high BMI levels 
(≥40kg/m2) men and younger individuals were more likely to have unfavorable CVD risk 
factor profiles, including both traditional CVD risk factors as well as emergent risk factors 
(e.g. C-reactive protein and triglycerides). 
This observation is concerning, given that Hispanic/Latinos have both a high 
burden of obesity and a predisposition to obesity-related disorders, such as diabetes and 
low high-density lipoprotein cholesterol [179]. Recent preliminary research from 
NHANES Mexican Americans indicates that with respect to diabetes this may be due in 
part to the stronger influence of overall adiposity, as measured by BMI, on diabetes as 
compared to other US racial/ethnic groups [180]. Next I will describe the reliability of the 
measures of obesity I propose to use in this dissertation (self-reported weight and its 
change, measured BMI).  
3. Reliability of Self-Reported Weight and its Change 
Above I have described the validity of the measures of obesity I propose to use in 
this dissertation. In contrast, here I will describe the reliability (overall consistency over at 
least two assessments) of weight and its change. With regards to self-reported weight, to 
my knowledge primarily non-Hispanic European studies have investigated the reliability 
of self-reported current or past weight using two time points within one year and found 
that measurement error was generally good [181, 182]. Specially, a study from Potsdam, 
Germany reported that greater than 75% of middle-aged adults reported a weight that 
was ±3kg of their previously reported weight (at either 25 or 40 years of age), regardless 
of gender, education, current age, weight or current BMI [181]. In a large US study of the 
sisters of women with breast cancer (including a small subset of 322 Hispanic/Latina 
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women, 1.8% of sample), the reliability of self-reported weight was found to be high 
(80% of self-reports within 1.36 kg of each other, r=0.99) when it was assessed using 
two different self-reporting methods (computer-assisted telephone interview and 
questionnaire) [183].  
4. Reliability of Measured Body Mass Index 
Now I will discuss the reliability of measured BMI, which I propose to use in Aim 
2 of this dissertation. As mentioned above standardized protocols have been 
recommended for the measurement of weight and height, which are used to calculate 
BMI in large and national epidemiologic studies [55]. For example in HCHS/SOL, 
weights and heights were measured on participants in a scrub suit or examination gown 
without their shoes, using a digital scale (Tanita Body Composition Analyzer, TBF 300A, 
Tanita Corporation) and standiometer (SECA 222, Perspective Enterprises, Inc.) by 
trained staff and following a standardized clinic protocol [43]. Additional efforts were 
made to increase the reliability of the measurements in HCHS/SOL, which resulted in 
reliability estimates of 0.97 and 0.94 for measured weight and height in a random subset 
of participants (n=565 and 570, respectively).  
Under such standardized conditions the reliability of measured weight and height 
is generally considered to be very good [184, 185]. In particular weight is measured with 
less imprecision and technical error than other anthropometric measures such as waist 
circumference and skinfold thickness. In NHANES II the inter-observer reliabilities were 
also highest for weight and height (r≥0.97) than for the other anthropometric measures 
collected [185].  
5. Strengths and Limitations of Current Knowledge 
Here I have presented the various perspectives on validity and reliability of self-
reported weight and its change and measured BMI in Hispanic/Latinos. With respect to 
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the validity of self-reported weight and its change, several important determinants were 
described in Hispanic/Latinos (or in their absence a non-Hispanic/Latino population), and 
include age, sex, overweight/obese status, nativity, and smoking status. The validity of 
measured BMI at capturing the underlying construct of excess adiposity, mortality and 
CVD were sensitive to differences in a number of individual characteristics: age, sex, 
racial/ethnic groups, nativity, and smoking. Reliability estimates for both self-reported 
weight and measured BMI were generally good when standardized protocols were 
followed. I plan to leverage this body of evidence to inform the design of this dissertation 
as well as the interpretation of my findings. 
Even though there is wealth of existent evidence to support the use of these 
measures in obesity research, not all supporting studies included Hispanic/Latinos and if 
they did the diversity in Hispanic/Latino samples were often restricted to one or two 
Hispanic/Latino background groups. This is a limitation of the current literature as the 
ability of BMI to serve as an index of fat mass may vary across racial/ethnic groups [164, 
166] and US Hispanic/Latinos are extremely diverse with respect to a number of factors 
including their ancestral backgrounds. 
6. Opportunities for Research 
This limited data on obesity research in Hispanic/Latinos presents an interesting 
opportunity for future research, which I plan to address in Aim 1 of this dissertation. 
There are a handful of studies in the literature that have assessed the self-report bias of 
current self-reported weight in Hispanic/Latinos. Yet none represent the full diversity of 
US Hispanic/Latinos. In this respect, an assessment of the validity of self-reported and 
measured weight at baseline among across multiple Hispanic/Latino backgrounds could 
contribute to the current literature and my understanding of the self-report and recall 
biases inherent in existing repeated measures of body mass in diverse Hispanic/Latinos, 
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such as in the self-reported weight histories of HCHS/SOL. In light of this future 
opportunity for contribution to the scientific literature, I will next describe the current state 
of the knowledge on the risk factors of adult obesity.  
F. Genetic Epidemiology of Common Complex Obesity 
 Above I have given a brief overview of genetics as a risk factor for obesity, which 
is a multi-factorial trait with heritability estimates that are only partially accounted for by 
rare monogenic forms of extreme obesity [91]. I will devote this next section to reviewing 
the current state of knowledge on the genetic determinants of obesity that are more 
common in the general population (≥1% minor allele frequency) and as such may 
account for some of the remaining heritability of obesity. 
Within the past decade genome-wide association studies (GWAS) have led to 
the discovery of over 100 adult BMI single nucleotide polymorphisms (SNPs), which 
explain less than 3% of the overall variability in the trait [14-33]. Further analyses have 
shown that the genetic architecture of BMI is similar between men and women [186]. In 
summary, these discoveries highlight the importance of genetic pathways in the central 
nervous system, as well as pathways involved in synaptic function, glutamate signaling, 
lipids and insulin, energy metabolism, and adipogenesis [33]. Yet the exact functional 
variants underlying most of these BMI loci or their allelic heterogeneity across diverse 
racial/ethnic populations remain unknown. Furthermore the single-SNP design of genetic 
discovery studies (e.g. GWAS) may preclude the accurate estimation of genetic effects 
in the context of the genome (i.e. jointly). This inaccuracy is exacerbated by the 
‘‘winner’s curse’’ phenomenon, whereby initial assessments of risk may be 
overestimated, rendering subsequent studies of similar sizes underpowered [187].  
As a substantial portion of the overall heritability in obesity has not been yet been 
explained, future studies that search for secondary or rare variant effects in known loci, 
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or contextualize heritable effects (e.g. GxE interactions as shown in our conceptual 
diagram Figure 1, epigenetic modification, etc.) will be useful in accounting for the 
remaining heritability of traits like BMI. For example, a number of loci previously known 
to be involved in monogenic forms of obesity have also been described in agnostic 
GWAS, indicating the potential for a shared underlying mechanisms between monogenic 
obesity disorders and more common etiologies of obesity [92].  
An example of the added value of fine-mapping and conditional analysis comes 
from Yang et al., who used genome-wide complex trait analysis (GCTA) [188] to map 49 
additional signals in 36 established height loci. The additional variants explained 1.3% of 
the heritability, nearly doubling the heritability explained in the initially identified SNPs in 
these 36 loci in a discovery sample of over 133,000 European descent samples [34]. 
The same group performed a similar experiment for BMI (n=123,865), but perhaps due 
to its lower overall accounted heritability no conditional signals were found at the time. 
Yet more recently using a larger sample of up to 322,154 primarily European descent 
individuals, investigators were able to describe two additional independent SNPs in 
MC4R and another independent SNP in BDNF, explaining an estimated 0.5% of the 
phenotype variation (for a total estimated phenotypic variation of 2.7% across 97 loci) 
[33]. Two of the newly identified SNPs had lower frequency compared to the initially 
identified SNPs (minor allele frequency, MAF, in European sample <5%). Therefore, it 
stands to reason that additional signals of varying frequencies (rare; <1%; low 
frequency: 1-5%;) could be identified at these >100 established loci previously tagged by 
more common genetic variants (>5%) given a larger sample size or greater ancestral 
diversity in functional variation. 
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1. Meta-Analysis Methodologies  
In light of the need to combine across multiple studies and provide summary 
genetic results (i.e. distributed data model), meta-analysis is an important tool in the field 
of genetic epidemiology. In particular, because single genetic effects in complex 
diseases are often modest to weak, meta-analysis can improve the validity of the 
findings (i.e. improve power and reduce the false positive rate) [189]. The most common 
meta-analysis method in the field of genetic epidemiology is inverse variance weighted 
fixed-effect analysis. However, random-effects and other implementations along the 
continuum of K=1 to K=number of studies [e.g. Meta-ANalysis of TRansethnic 
Association studies (MANTRA) by Morris [53], a Modified Random-Effects by Han and 
Eskin [190]] are becoming increasingly popular for trans-ethnic analysis. The Bayesian 
implementation of the trans-ethnic meta-analysis approach [53] is described in more 
detail as part of manuscript 2, below. 
Additionally methodologies have been generated to allow for investigators 
working under a distributed data-model to perform approximate conditional (described in 
more detail as part of manuscript 2) or joint additional analyses on study-specific results 
[34], or perform cross-phenotype meta-analyses of interrelated traits of interest [191]. In 
the case of the approximate conditional analysis, this is a substantial improvement over 
exact conditional approaches, which often require several months to request and 
received study-specific conditional results and may thereby limit investigators’ ability to 
test the presence of tertiary or further independent signals [34], such as those seen in 
recent BMI GWAS [33]. 
2. Limited Diversity 
As of 2009, only 4% of current published GWAS involved samples of non-
European populations [40]. Similarly, few non-European descent GWAS studies have 
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been published for obesity [14, 20, 25, 26, 30, 32, 192-195]. Three GWAS of exclusively 
East Asian descent populations have described 9 genome-wide significant loci and 
generalized over 10 additional BMI loci to Asian populations [25, 26, 195]. One recent 
GWAS of African descent populations has described two novel genome-wide significant 
loci and generalized four previously described BMI loci to African descent populations 
[30]. No GWAS have been conducted of exclusively Hispanic/Latinos to date. However, 
two studies included Hispanic/Latinos either in the discovery or replication samples. A 
GWAS has described three genome-wide significant findings at previously known loci 
using a trans-ethnic discovery sample including Hispanic/Latinos [32]. A study of African 
descent populations has included Afro-Caribbean individuals in their replication sample 
[30]. Yet the direct replication of candidate SNPs from previous genetic studies of 
predominantly European descent populations, may be inappropriate given the distinct 
linkage disequilibrium patterns across ancestral populations and the potential for effect 
dilution from less correlated markers, and spurious findings [196, 197]. Furthermore 
genome-wide interaction studies have been criticized for their inability to differentiate 
chance findings from biologic interactions and limited ability to account for all of the 
heritability at previous identified BMI loci or studying GxE interactions [198]. 
The lack of a published Hispanic/Latino GWAS to date can be attributed in part to 
the unavailability of large epidemiologic samples of Hispanic/Latinos, but also 
exacerbated by the current limited understanding of Hispanic/Latino genetic structure. A 
handful of studies have described the broad ancestral populations (i.e. West African, 
European, and American Indian) that contributed to the current genetic diversity in Latin 
American countries [112-116]. Although anthropological geneticists have reconstructed 
the migrations across and peopling of the Americas [199, 200], to date we are aware of 
only one population-based study that has described this important component of 
diversity and its impact on health for US Hispanic/Latinos [201]. Interestingly, in this 
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study the investigators noted that the residual variability in a number of traits, including 
BMI, was substantially decreased if both global measures of ancestry and genetic 
ancestry groupings (which incorporated self-reported Hispanic/Latino backgrounds as 
well as multi-dimensional genetic clustering) in a linear mixed model in HCHS/SOL. 
Similarly, the statistical models (e.g. GEE) used by the PAGE Study have all adjusted for 
self-reported backgrounds in HCHS/SOL [202].  
In light of these challenges it is not surprising that to date most genetic studies of 
BMI among US Hispanic/Latinos are generalization studies [193, 203], which investigate 
the loci discovered and described in other populations (e.g. of European descent) as 
candidates and may also utilize high-dimensional data to narrow in on the underlying 
functional variants. For example, I have participated in two previous projects in the 
PAGE study [204] and its substudies [193] that have indicated that fine-mapping may be 
a useful tool to generalize the established BMI signal and narrow the putative interval of 
interest for future follow up.  
In a subset of the Hispanic/Latino WHI sample, my collaborators and I have 
investigated the generalizability of known BMI genetic loci among 3,587 female US 
Hispanic/Latinas [193]. Of the 32 BMI loci tested using genotyped GWAS data, 9 loci 
showed evidence for generalization at the same previously described signal or at an 
independent signal at the same locus. This study provides some insight that a fine-
mapping approach to investigate known BMI loci among Hispanic/Latinos is valid given 
sufficient sample size and densely genotyped platforms, such as the MetaboChip 
(Illumina, Inc.; San Diego, CA).  
More recent fine-mapping work in a subset of the African American sample in the 
PAGE Study has shown that 8 of 21 established BMI loci at the time and fine-mapped on 
the MetaboChip array generalize to African Americans at p<5.8x10-5 and GNPDA2 
exhibited evidence of an independent signal in exact conditional analyses [204]. To date 
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we are unaware of any published fine-mapping studies that have done this trans-
ethnically or with a Bayesian trans-ethnic mapping approach to appropriately cluster the 
racial/ethnic groups, as we have done in Aim 2. 
3. Opportunities for Research  
Even though many SNPs do not generalize directly to all populations, most loci 
do appear to be relevant to multiple populations and may even contain multiple causal 
variants as marked by multiple independent (‘secondary’) signals [197]. This lack of 
SNP-specific generalization is likely primarily due to differences in linkage disequilibrium 
patterns and genetic architecture between diverse ancestral and admixed populations, 
which if harnessed correctly, can ultimately help identify the underlying functional 
variant. Therefore, it is important to fine-map established loci in ancestrally diverse and 
admixed populations as it can further aid in this localization among these arguably under 
studied racial and ethnic groups. In Aim 2 I address this research gap directly by fine-
mapping 36 BMI Loci on the MetaboChip array (Illumina, Inc., San Diego, CA) in more 
than 100,000 diverse samples of the PAGE Study.  
G. Gene-Environment Interactions 
  GxE interactions are believed to play an important role in CVD, like obesity 
[36, 196]. For example given the pace of the global obesity epidemic [1] and the 
apparent obesity disparities across racial/ethnic groups in the US for example [2, 3], it is 
unlikely that recent changes in population genetics have driven the current obesity 
epidemic. Instead, it is more likely that obesogenic environments are conferring 
susceptibility to obesity—in concert with thrifty genes that evolved to store/preserve fat in 
times of scarcity [39, 205]. Further it is possible that changes in obesogenic 
environments with migration and social adaptation may increase innate genetic 
susceptibility and contribute to the apparent Hispanic/Latino obesity disparity [125, 206]. 
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Given the difficultly in measuring physical activity and dietary changes individually [58], 
GxE interactions using measures of broad social adaptations such as acculturation may 
be particularly helpful in advancing the field of GxE research.  
 Now that I have described the motivating rationale for studying GxE interactions in 
obesity, I will describe the current methods that are commonly applied to the study of 
GxE interactions. Then I will conclude with what I believe are future opportunities for 
contributions to the field of GxE interactions in obesity.  
1. Methodologies 
Currently in the literature there are a number of methods to support meta-
analysis, but only a few designed specifically for GxE interactions. One approach to the 
meta-analysis of GxE studies includes either fixed- or random-effect meta-analysis of the 
estimated GxE coefficient (i.e. a ‘1df’ test).  
A more powerful approach focuses on meta-analyzing the combination of genetic 
and GxE interaction effects (i.e. a ‘2df’ test) [207, 208]. Consortia like the Genetic 
Investigation of Anthropometric Traits (GIANT) Consortium have begun to try to reduce 
residual variation by employing genome-wide GxE models with ‘2df’ tests to account for 
known determinants of the phenotype of study [186]. Although a ‘2df’ test can be derived 
from an interaction model and then meta-analyzed [207], it can alternatively be made by 
stratifying the association models by the environmental variable of interest and then 
meta-analyzing the stratum-specific results [208]. As illustrated by Randall et al. such a 
‘2df’ test corresponds to a joint test of the genetic and GxE interaction effects, or in other 
words the difference in the genetic effect between two or more strata [209].  
Although the two approaches (interaction model and stratified analysis) are 
deemed to be equivalent mathematically and currently the method selection strongly 
depends “on researchers’ prior beliefs regarding the likely form of any true gene-
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environment interaction pattern” [208], no systematic comparison of type I or II error 
between the two methods has been published to date [207, 208]. Future GxE model 
selection will be informed by a simulation study I conducted for the Genetic Analysis 
Workshop 19 (Fernández-Rhodes et al., in press). In this analysis we compared the 
performance of an interaction model incorporating an interaction term to capture the 
gene-medication interaction on systolic blood pressure and the stratified analysis by 
medication status for both ‘1df and 2df tests’ of GxE effects [207-209]. In this specific 
simulation I observed more stable false positive proportions (Figure 4) and slightly more 
conservative true positive estimation (Figure 5A-I) across a range of minor allele 
frequencies using the stratified analysis as compared to the interaction term model. As 
the SNP of interest becomes less common, the performance of both methods 
deteriorated.  
2. Previous Applications and Limitations  
Despite the recent methodological innovations to support GxE studies, they 
continue to face challenges to the fulfillment of their public health relevance for CVD [35, 
36, 196]. According to a recent review, there are >200 GxE studies in the literature, but 
usually are subject to concerns about data quality (environmental and phenotypic), are 
not significant after multiple testing penalties, or do not include independent replication 
[196]. Moreover, few include diverse racial/ethnic groups.  
There is a large and growing body of GxE literature [196], which may elucidate 
how “common diseases result from common exposures to which I are all susceptible, 
albeit in varying degrees” [206]. Additionally, GxE studies can help explain some of the 
missing heritability and contextualize estimates of genetic effects, which previously were 
estimated without respect the impact of the environments. However, according to a 
recent review, many of these studies are limited due to concerns about data quality 
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(environmental and phenotypic), are not significant after multiple testing penalties, or do 
not include independent replication [196]. Furthermore, the generalizability of current 
GxE studies is hampered when few include diverse populations. For example, between 
2011-2014 I identified 18 published GxE studies on BMI/obesity [102, 205, 210-225]. 
Only three of these studies reported findings from cohorts with Hispanic/Latino 
individuals (Add Health, the WHI-SNP Health Association Resource) [210, 213, 218], 
now the largest US ethnic minority [4]. In addition only five of these studies included 
upstream environmental or psychosocial characteristics to capture aspects of the obesity 
epidemic, which are more contextual [205, 213, 219-221].  
As the state of the science moves from a priori hypotheses to agnostic 
interrogation of genome-wide GxE effects, concerns remain for GxE studies around their 
multiple testing burden and the distinction between statistical and biologic interactions 
[198, 226]. Arguably an ideal GxE investigation would be ancestrally diverse and utilize a 
design, which could 1- integrate a priori information to inform the environmental factor of 
interest, 2- limit the number of associations tested (using an ’a priori genetic profile’ 
[198]) or explore independent replication, 3- involve intensive variable harmonization 
across multiple studies, and 4- test for the presence of multiplicative interactions more 
likely to be biologic in nature.  
3. Future Promise in Epidemiology 
GxE interaction studies are considered to be integral to the future of genetic 
epidemiology and its public health applications for the following three reasons. First, 
many environmental risk factors for common, complex human diseases such as CVD 
have been revealed by epidemiologic studies, but how variants at specific loci modulate 
the effect of environmental risk factors is largely unknown [36]. The use of GxE 
methodologies in epidemiologic studies may decrease the residual variation in traits like 
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BMI and may thereby account of unexplained heritability. The majority of GWAS have 
not included environmental information to account for this ‘missing heritability.’ This 
integrative approach may inform the impact of future interventions for obesity and its 
CVD consequences, in a way that cannot be studied using experimental designs.  
Second, the design of genetic discovery studies (e.g. GWAS) generally 
precludes the accurate estimation of genetic effect size. This inaccuracy is due to the 
‘‘winner’s curse’’ phenomenon, whereby initial assessments of risk may be 
overestimated, rendering subsequent studies of similar sizes underpowered [187]. One 
could counteract this by estimating the effects of associations discovered in GWAS in a 
diverse population. Moreover, such a study could reveal the true population impact of 
genetic variants by assessing their interaction with environmental factors. Yet as the 
genetic architecture of obesity to be complex, a constellation of SNPs may explain 
varying amounts of heritability in adiposity depending on the particular population or 
environment of study. 
Lastly, hypotheses about social and cultural environments and genetic 
susceptibility cannot be interrogated using animal models or experimental designs. For 
example, acculturation is a complex social phenomenon unique to humans, which 
among other things is hypothesized to capture exposure to obesogenic behavioral and 
lifestyle factors [8, 86] for which experimental designs may be unethical. By integrating 
sociocultural information into an analysis of the genetic determinants of obesity among 
US Hispanic/Latinos, such findings would gain real world applicability, which could not 
be obtained without using an observational study design. 
I am confident that as more reference samples are included in the 1000 
Genomes project [227] or sequenced as part of the second phase of the PAGE Study, 
as genome-wide discovery efforts like the Hispanic/Latino Anthropometry (HISLA) 
Consortium or the fine-mapping of established BMI loci in diverse populations (Aim 2) 
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are completed, the basis for future research on the genetic architecture of diverse US 
populations, such as Hispanic/Latinos, and gene-environment interactions in obesity will 
be dramatically strengthen (see conceptual diagram, Figure 1). Although few genetic 
studies have been conducted among US Hispanics/Latinos, an ethnic group with roughly 
half of the foreign-born immigrants and notable obesity disparities [125], they hold great 
promise in genetic epidemiology in particular with regards to their multiple aspects of 
diversity and their unique migratory and sociocultural histories [125, 206]. 
With respect to the components of an ideal GxE study design, as described 
above there is a wealth of longitudinal information on acculturation and obesity risk in 
public health (Table 1), as well as cross-sectional studies in HCHS/SOL [138]. Moreover, 
the fine-mapping of established BMI loci in the PAGE Study would be the perfect 
supporting work for a targeted gene-acculturation study in HCHS/SOL of the best 
marker, or functional, SNPs on BMI (untransformed, in order to interrogate multiplicative 
interactions). Through my work with the HISLA Consortium of studies of 
Hispanic/Latinos from across the US and Latin America, I have already identified several 
independent studies with acculturation, genetic and obesity information for possible 
replication. 
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H. Supporting Tables and Figures 
Table 1. Summary of the longitudinal or repeated cross-sectional literature on acculturation and measures of obesity. 
First 
Author, 
Year (Ref) 
Study  
(Total N) 
Exposure Outcome Model Follow Up Age Baseline 
Differences by 
Exposure? 
Evidence of 
change over 
time by 
Exposure? 
Additional 
Analyses/Considerations? 
Diversity? 
LONGITUDINAL 
Balistreri, 
2009  
[143] 
ECLS-K (n=12,696) Generation 
(Children of 
immigrants v 
natives) 
Measured BMI  GC ~5.5 years ~5-10 
years 
Yes (S, children of 
immigrants higher 
than of natives) 
Divergence 
(faster BMI 
growth among 
children of 
immigrants) 
SES Gradients, Sampling 
weights 
Hispanic/Latino (majority 
Mexican), non-
Hispanic/Latino White 
Harris, 
2009 
[144] 
Add Health 
(n<=20,745 Waves I-
III) 
Generation (1st, 
2nd, or 3rd or native) 
SR (Wave I) and 
measured (Waves 
II,III) BMI 
GC ~7-9 years 11-28 
years old 
Yes (S) Divergence Sampling weights Hispanic/Latino, non-
Hispanic/Latino Asian, 
Black, and White 
Jackson, 
2011 
[142] 
Add Health (n= 
15,601, Waves I-III)  
Generation (1st, 
2nd, or 3rd or native) 
SR (Wave I) and 
measured (Waves 
II,III) BMI 
GC ~7-9 years 11-28 
years 
Yes (S) Divergence Sampling Weights Hispanic (Mexican, Non-
Mexican), East Asian, 
Other Asian, non-
Hispanic/Latino Black and 
White 
Albrecht, 
2014 
[145] 
Add Health 
(n=13,701, Waves I 
and IV) 
SES/Generation 
(1st, 2nd, 3rd plus)  
Measured BMI (Wave 
IV) 
Linear 
models 
~12 years 12-33 
years old 
Yes (S) Divergence Sampling Weights,  
M (IN): language spoken at 
home (Wave I, English or 
other) 
Hispanic/Latino, non-
Hispanic/Latino Asian, 
Black and White 
Albrecht, 
2013 
[148] 
MESA (n=2,288) Nativity (US, F 
born)/Time in US 
(<15, 15-30, >30 
years) 
Measured WC, BMI LMM 5 years 45-84 
years old 
Yes (S) Convergence 
(Mexican), 
Stability (Non-
Mexican, 
Chinese) 
M (IN, NS): smoking, alcohol, 
physical activity, diet 
Mexican, Non-Mexican, 
Chinese 
Ullmann, 
2013 
[228] 
L.A. FANS (n=975) Generation (1st v 
2nd plus) 
Annual SR weight 
change 
LMM 5-8 years 18-85 
years old 
No (NS) Divergence (S 
total and 
women only) 
Environment using 2000 
census-tract information 
(primarily NS): Population 
density, composition, foreign-
born %, and average BMI, 
socioeconomic disadvantage, 
collective efficacy (S in women 
only), neighborhood safety 
Adjusted for baseline weight 
and height 
Hispanic/Latino (majority 
Mexican), White, Black, 
Asian/Pacific Islander 
REPEATED CROSS-SECTIONS  
Antecol, 
2006 [10] 
NHIS (n=47,006, 
1986-1996) 
Nativity (US, 
F)/Time in US (0-4, 
5-9, 10-14, 
>14years)/Arrival 
cohort (>1981, 
1981-1985, 1986-
1990, 1991-1995) 
Regression calibrated 
SR weight and height 
(based on NHANES III 
data) used to calculate 
BMI, overweight and 
obesity (yes, no) 
 NA, Panel 
study 
20-64 
years 
Yes Convergence 
(BMI most 
strongly) 
Arrival cohorts assessed 
separately 
Hispanic/Latino (majority 
Mexican although not 
stated) 
Park,  
2009 
[141] 
NHIS (n=17,300, 
1994-1996 and 
2004-2006) 
Nativity (US, 
F)/Time in US (<5 
years in 1995, 10-
14 years in 2005) 
SR weight and height 
used to calculate 
obesity (yes, no) 
Logistic 
models  
NA, Panel 
study 
18+ years Yes (S 18-54 year 
olds only) 
Divergence Decomposition of age, period, 
cohort, and duration of time in 
US effects. 
Hispanic/Latino (majority 
Mexican although not 
stated) 
Albrecht, 
2013 
[140] 
NHANES (pooled 
NHANES III 1988-
1994 n=3,175 and 
continuous 1999-
2004 n=3,037 and 
2005-2008 n=1,937) 
Nativity (US, F 
born)/Time in US 
(<10, ≥10 years) 
Measured WC, BMI Linear 
models  
NA, Panel 
study 
20-64 
years 
Yes (S all outcomes 
among men, S only 
with WC 2005-2008 
among women) 
NA  Sampling Weights,  
No Secular trends (NS) in 
nativity/time in US differentials 
on WC or BMI 
Mexican American  
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Abbreviations: Add Health=National Longitudinal Study of Adolescent to Adult Health, AIC=Alkaike Information Criterion, BMI=body mass index, 
ECLS-K=Early Childhood Longitudinal Study, Kindergarten Class of 1998-1999, GC=Growth curves implemented using mixed models, 
IN=Incomplete mediation, L.A. FANS=Los Angeles Family and Neighborhood Survey, LMM=Linear mixed model, M=Mediation analysis through 
adjustment in model, MESA=Multi-ethnic Study of Atherosclerosis, NA=Not applicable, NHANES=National Health and Nutrition Survey, 
NHIS=National Health Interview Survey, NS=Non-significant p≥0.05, Ref=Reference, S=Significant p<0.05, SES=Socieconomic Status, SR=Self-
reported, WC=waist circumference 
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Table 2. Summary of literature on accuracy of self-reported weight and weight change in 
Hispanic/Latinos (when available). 
First Author, Year 
(Ref) 
Study  
(Total N) 
Age Measure Timing of 
Comparison 
Bias Tested 
(Estimate**) 
Hispanic/Latino 
Samples Noted 
(Diversity) 
Comparison of 
Accuracy to non-
Hispanic/Latinos 
SELF-REPORTED VERSUS MEASURED CURRENT WEIGHT FOR THE SAME AGE 
Alvarez-Torices, 
1993 [46]* 
León, Spain 
Study (n=572) 
18-? 
years 
Weight Current SR Bias  
(-0.6kg) 
Yes (Spanish 
Nationals) 
NA 
Santillan, 2003 
[155]* 
Monterrey, 
Mexico Asthma 
Case-Control 
Study (n=961) 
18-? 
years  
Weight Current  SR Bias  
(-?kg) 
Yes (Mexican 
Nationals) 
NA 
Avila-Funes, 2004 
[47]* 
Mexican 
National Health 
and Aging Study 
(n=1,707) 
24-95 
years 
Weight Current  SR Bias  
(0.6kg) 
Yes (Mexican 
Nationals) 
NA 
Merrill, 2009 [51] NHANES 
Continuous 
2001-20006 
(n=16,814) 
16-? 
years 
Weight Current  SR Bias  
(0.10 to -1.16kg) 
Yes (Combined 
across background 
groups) 
NA 
Griebeler, 2011 [75] Soy 
Phytoestrogens 
as Replacement 
Estrogen Study 
(n=428) 
45-60 
years 
Weight Current  SR Bias  
(-1.55kg) 
Yes (Combined 
across background 
groups) 
Yes, Hispanic/Latino NS 
predictor 
Wen, 2012 [156] NHANES 
Continuous 
2007-2008 
(n=5,343) 
20-? 
years 
Weight Current  SR Bias  
(-0.1 to -0.6kg) 
Yes (Combined 
across background 
groups) 
Yes, Hispanic/Latino 
ethnicity NS predictor 
after covariate 
adjustments 
SELF-REPORTED CURRENT WEIGHT VERSUS RECALLED WEIGHT FOR THE SAME AGE 
Kyulo, 2012 [158] Adventist Health 
Study 2 
(n=2,727) 
48-100 
years? 
Weight Past (20-28 years 
prior) 
Recall Bias  
(-0.67kg) 
No NA 
MEASURED CURRENT WEIGHT VERSUS RECALLED WEIGHT FOR THE SAME AGE 
Stevens, 1990 [160] Charleston Heart 
Study (n=703) 
62-100 
years 
Weight Past (4 and 28 
years prior) 
SR and Recall 
Bias  
(-1.2 to 0.3kg at 4 
years, -1.2 to -
2.0kg at 28 years) 
No NA 
Troy, 1995 [161] Nurses’ Health 
Study II (n=118) 
25-42 
years 
Weight Past (at 18 years) SR and Recall 
Bias  
(-1.4kg) 
No NA 
Kovalchik, 2009 
[159] 
NHANES I 
Epidemiological 
Follow-Up Study 
(n=6,101) 
20-65 
years 
Weight Past (Recalled 
Weight at 
NHANES I Exam 
Imputed from 
Linear Change 
Across SR Weight 
History) 
SR and Recall 
Bias  
(-1.77kg) 
No (Nationally 
representative 
sample from 1971-
1975 may have 
included) 
NA 
SELF-REPORTED VERSUS MEASURED WEIGHT OVER TIME 
Field, 2007 [48] Add Health 
Wave II-III (n=?) 
16-26 
years 
across 
waves 
Weight 
change 
Past versus 
Current (5-6 years 
after)  
Recall Bias, Under 
assumptions about 
SR bias stability 
over time  
(-1.0 to -1.3kg) 
Yes (Combined 
across background 
groups) 
Yes, Hispanic/Latino 
ethnicity NS predictor 
Clarke, 2014 [162]  Add Health 
Waves II-IV 
(n=19,238 with 
at least Wave II 
and another 
wave) 
13-32 
years 
across 
waves 
Weight Current SR Bias, between 
13-32 years of age  
(-0.86kg 
adolescent girls at 
13 years, 
increased with 
aging, Boys NS at 
all time-points) 
Yes (Combined 
across background 
groups) 
Yes, Hispanic/Latino 
ethnicity NS predictor of 
SR bias change over 
time 
Abbreviations: Add Health=National Longitudinal Study of Adolescent to Adult Health, NA=not 
applicable, NHANES=National Health and Nutrition Examination Survey, NS=Non-significant, 
Ref=Reference, SR=Self-report. 
*These three studies of Hispanic/Latino samples were referenced as part of the review by Connor 
Gorber et al. [151].  
**Estimate given as mean difference (=self-report minus measurement). 
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Figure 2. Definitions for “Hispanic” and “Latino.” One definition for the term Latino refers 
to persons whose origin or ancestries are from countries of Latin America (A). The US 
Office of Management and Budget uses the terms Hispanic and Latino interchangeably 
to refer to persons who indicated that their origin is Mexican, Puerto Rican, Cuban, 
Central and South American, or other Spanish culture or Spanish-speaking country or 
origin, regardless of race (B). Other definitions for the term Hispanic include individuals 
whose origin or ancestry comes from Hispania, the former name for the Iberian 
Peninsula (C), and Spanish-speaking persons of Latin American descent living in the 
United States (D).1 
 
  
                                               
1Figure and legend reproduced with permission from JAMA Dermatology. 2013;149(3):274-275. 
doi:10.1001/jamadermatol.2013.1304. Copyright © (2013) American Medical Association. All 
rights reserved. [93] 
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Figure 3. Illustration of Inverted Remittance Corridors from the West Coast of the US to 
Mexico, 1999-2003.2  
                                               
2Figure adapted from Hernández-Coss, Raúl. 2005. The U.S.–Mexico Remittance Corridor: 
Lessons on Shifting from Informal to Formal Transfer Systems. World Bank Working Paper No. 
47. © World Bank. https://openknowledge.worldbank.org/handle/10986/7322 License: Creative 
Commons Attribution License (CC BY 3.0 IGO). [100] 
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Figure 4. Comparison of the false positive proportions (FPP) at the CYP3A43 locus 
(chr7:98957518-99957518) and 95% confidence intervals for the interaction model (solid 
line) and med-diff approaches (dashed line) and 200 replicates of true negative findings 
on the odd-numbered chromosomes using the 1 degrees of freedom, df (gray), and 2df 
tests (black) and their variability across bins of minor allele frequency (>0.1% to 50%).3 
 
  
                                               
3Reproduced from Fernández-Rhodes et al., in press with BMC Proceedings. License: Creative 
Commons Attribution License 4.0. 
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Figure 5A-I. Comparison of the estimated effects (A-C), standard errors (D-F), and –log 
of the 1f p-values (G-I) on SBP from the interaction model (X-axis) and med-diff (Y-axis) 
approaches in up to 200 replicates of simulated gene-medication interactions at three 
SNPs at CYP3A43 (6.2mmHg, dashed line in A-C) of varying minor allele frequencies 
(MAF).4 
  
                                               
4Reproduced from Fernández-Rhodes et al., in press with BMC Proceedings. License: Creative 
Commons Attribution License 4.0. 
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CHAPTER IV: METHODS 
A. Overview 
In this chapter I will attempt to outline the specific steps required to conduct my 
dissertation research. First, I will begin by summarizing the study design and available 
data in HCHS/SOL and the PAGE Study for a secondary-analysis (Sections B-C). Then I 
will describe the data analyses to address each aim in turn: definition of pertinent 
variables, statistical analyses, power calculations, as well as the strengths and 
limitations. Lastly, I will describe my compliance with the guidelines on ethical human 
subjects research from the Internal Review Board in the Office of Human Research 
Ethics at the University of North Carolina at Chapel Hill. 
B. Hispanic Community Health Study/Study of Latinos (HCHS/SOL) 
The HCHS/SOL is the first population-based cohort study of CVD to recruit more 
than 16,000 self-identified Hispanic/Latino adults (18-74 years at screening) from diverse 
Hispanic/Latino backgrounds (Central American, Cuban, Dominican, Mexican, South 
American, and Puerto Rican), resident in four US urban communities (Bronx, NY; 
Chicago, IL; Miami, FL; San Diego, CA) between 2008-2011 [42, 43]. The two main 
analytic objectives of HCHS/SOL were to 1- collect data that could support estimates of 
prevalence of CVD risk factors in the HCHS/SOL communities at baseline (2008-2011), 
and 2- estimate the association between CVD risk factors and disease outcomes over 
the course of follow-up (2009 to present).  
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1. Study Design 
 Due to limited time and resources allocated to the tasks of studying the 
prevalence and CVD incidence in Hispanic/Latino residents of the four HCHS/SOL study 
sites, it was identified early in the design of HCHS/SOL that probability sampling would 
be necessary [42]. First, census block groups were sampled within strata of SES 
(percent of population 25 years or older with at least a high school education) and 
concentration of Hispanic/Latino households as per the 2000 US Census, in order to 
proportionately sample low and high SES areas and disproportionately select census 
block groups with a high concentration of Hispanic/Latino households. Second, using 
lists of postal addresses and Hispanic surnames within the selected census block 
groups (primary sampling units), households with Hispanic surnames were over-selected 
within block groups. Third, once contact with a household member was made (in either 
Spanish or English) a roster of household members was taken and a digital hand-held 
device [229] was used to determine eligibility and the probability of individual selection in 
one of two ways [42]. The first method sampled whole households, where households 
with all Hispanic/Latino adult household members 45-74 years of age are selected with 
certainty (=1) and all other households are selected with a lower probability (<1), but was 
only implemented in the first 6 months of the study due to its low proportion of selected 
households. The second method implemented after the first 6 months of recruitment 
divided each household into sub-clusters: Hispanic/Latino adults 45-76 years selected 
with certainly (=1), and 18-44 years selected with a lower probability (<1). Furthermore 
during screening individuals were deemed ineligible for the HCHS/SOL examination if 
they were on active military duty, not currently living at home, unable to give informed 
consent, travel to the field center, complete the study questionnaires, or had plans to 
move from area in the next 3 years. Pregnant women were rescheduled for baseline 
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interviews ~3 months postpartum as physiologic changes in cardiometabolic risk factors 
may change during and immediately after pregnancy.  
Even though all HCHS/SOL study materials were available in Spanish or English 
and the study engaged Hispanic community partners at each study site, the sample of 
Hispanic/Latinos who attended the baseline examination may not be fully representative 
of all Hispanic/Latino adults living in these communities. For example, the US Census 
was used to inform the sampling procedures but may be an imperfect tool for identifying 
the location of marginalized populations in community-based studies. The Pew Hispanic 
Center estimates that perhaps as much as 15% of undocumented Hispanic/Latino adults 
did not participate in the 2010 US Census, which could result in an inaccurate estimate 
of the true distribution of Hispanic/Latinos in the US [103]. This bias could vary across 
the four communities in HCHS/SOL (e.g. San Diego, CA may have a higher population 
of undocumented Hispanic/Latinos due to its proximity to the US/Mexico border), by 
Hispanic/Latino background group, or other characteristics. For example, despite study-
wide efforts to engender trust with their participants, to exclude the discussion of 
sensitive information (e.g. legal status) or to minimize the length of the baseline exam to 
under 8 hours, it is still possible that consenting and eligible participants were more likely 
to be US legal residents or citizens or to work in the formal sector or have flexible work 
schedules.  
Throughout this dissertation I applied the sampling weights recommended by the 
HCHS/SOL Coordinating Center (CC). The use of sampling weights yields appropriate 
estimates of population characteristics and the corresponding standard errors using a 
sandwich variance estimator [230-232]. Failure to account for the sampling in this study 
could produce biased parameter estimation. Specifically, these weights are inverse 
participant selection probabilities that were adjusted for non-response (at both the 
household and individual level), windsorized within each field center, calibrated to 2010 
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US Census population estimates with respect to the Hispanic/Latino background and 
age/gender distributions and then normalized based on the mean and standard deviation 
of the resulting weights of the entire HCHS/SOL sample. Although it is impossible to 
determine the effect that selection bias could have on the generalizability of the results, 
the use of non-response adjusted sampling weights is an important step towards 
minimizing this potential bias while increasing the generalizability of inferences to the 
HCHS/SOL communities. 
In addition to their primary analytic objectives mentioned above, HCHS/SOL 
investigators wanted to collect information that would inform secondary analyses of less 
commonly studied aspects of CVD. Therefore, they also collected detailed information 
on anthropometrics (including self-reported weight histories), sociocultural factors, and 
genetics in a culturally- and linguistically-appropriate manner, which is described in more 
detail below. 
 In general, trained HCHS/SOL study personnel assisted participants during the 
baseline exam in the language of their preference (Spanish or English, noted at the 
beginning of the exam) with filling out the various study questionnaires. Participants 
could choose not to respond to any question as part of the examination. If participants 
were unable to complete the entire exam in one day, in an effort to minimize missing 
data, they were encouraged to complete the missing portions at a later date and this was 
noted.  
2. Genetic Data 
Consent for participation in the HCHS/SOL baseline examination was obtained 
separately from the consent for genetic testing and the sharing of this data on dbGap 
(n=12,472). Genomic characterization in HCHS/SOL occurred in the context of the 
PAGE Study; using the MetaboChip genotyping array (Illumina, Inc., San Diego, CA) 
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[41]. The 196,725 SNPS genotyped on the MetaboChip were chosen to fine-map 257 
loci that had been validated with cardiometabolic traits as of 2009 [233]. After excluding 
duplicates, individuals with <95% call rates or reporting a sex that was discordant 
(phenotype) with the genotypic sex (n=355), 12,117 individuals (74% of total HCHS/SOL 
cohort) had available genotype information for analysis. More information about the 
MetaboChip genotyping completed as part of the PAGE Study and derived genetic 
variables considered as part of this dissertation is presented in the following section 
about the PAGE Study. 
3. Anthropometric Data 
The HCHS/SOL anthropometric data were collected from two sources: the 
Anthropometry (ANTA) and Weight History (WHEA) Questionnaires (English versions in 
Appendices). In general, both the absolute number completed and completion rate were 
higher for the ANTA (n≤16,388) than the WHEA Questionnaire (n≤15,279), Whereas the 
WHEA Questionnaire relied exclusively on recalled self-reports of individuals at least 21 
years of age, the ANTA Questionnaire was a combination of self-reported and measured 
anthropometric information on the entire cohort. Importantly the ANTA Questionnaire 
asked participants about their weight before measurements were made, to ensure that 
the self-reports (ANTA3A, to the whole kilogram, kg, or pound, lb) were made without 
the knowledge of the actual measured value from a digital scale (ANTA4, Tanita Body 
Composition Analyzer, TBF 300, Japan), which then transcribing it into an electronic 
data entry system by the study personnel. The ANTA questionnaire and measurements 
were collected during the fasting block of time immediately after a urine collection [43] on 
participants who were able to stand on both feet while wearing a scrub suit or 
examination gown and no shoes [179].  
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In HCHS/SOL great efforts were made to minimize the measurement error of the 
anthropometrics captured by the ANTA Questionnaire. First, during the measurements 
participants wore a scrub suit or examination gown without shoes [234]. Weight in kg 
was measured using a scale and height in centimeters using a stadiometer. Second, 
quality control measures were put into place by the HCHS/SOL study to ensure that all 
personnel were collecting data in a similar manner such as the provision of trainings, 
certifications (requiring a minimum of 5 practice subjects with 0.5 kg weight and 0.5 cm 
height agreement between a trainee and expert), and periodic observations. Third, 
HCHS/SOL anthropometric equipment was calibrated frequently to ensure quality 
measurements (e.g. scales zero balanced daily and calibrated weekly, and stadiometer 
inspected daily). Lastly, HCHS/SOL assessed inter-technician agreeability in HCHS/SOL 
by randomly selecting 3-5% of baseline participants for retest and the HCHS/SOL 
Quality Control Committee then analyzed and uses these agreements during the 
recertification process. Additionally, inter-rater reliability was assessed by randomly 
selecting 3-5% of participants for retest by a second trained technician immediately after 
the initial anthropometric exam during the same baseline visit. Self-reported and 
measured weights (n=565) differed on average between two technicians by 0.46 kg 
(95% confidence interval, CI: -0.12, 1.03 kg) and 0.16 kg (95% CI: -0.18, 0.50 kg), 
respectively. This resulted in good reliabilities of 0.93 and 0.97 and relatively low 
coefficients of variation (the within-specimen variation expressed as a percentage of the 
mean) of 6.3 and 3.7%.  
C. Population Architecture using Genomics and Epidemiology (PAGE) Study 
Since the start of the obesity epidemic, a number of consortia of observational 
studies have been created to facilitate the study the population-level changes in CVD 
risk factors. For example the PAGE Study offers a unique opportunity to investigate the 
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genetic and environmental contributors to obesity in minority US populations such as 
African, Hispanic/Latinos, Asian, and Alaskan Natives/American Indians [41]. 
1. Consortium Design 
The Population Architecture using Genomics and Epidemiology (PAGE) Study 
has a coordinating center and four large study sites/consortia that include a number of 
diverse observational studies including: the ARIC Study, the Epidemiologic Architecture 
for Genes Linked to Environment (EAGLE) Study accessing the Vanderbilt University 
BioBank (BioVU), Coronary Artery Risk Development in Young Adults (CARDIA), 
Cardiovascular Health Study (CHS), the Hispanic Community Health Study/Study of 
Latinos (HCHS/SOL), Multiethnic Cohort (MEC), the Women’s Health Initiative (WHI) 
[41]. Additional studies collaborating in this analysis also included: The GenNet Network 
(GenNet), the Hypertension Genetic Epidemiology Network (HyperGEN) Study, the 
MEC-Slim Initiative in Genomic Medicine for the Americas Type 2 Diabetes Consortium 
(SIGMA) Type 2 Diabetes Consortium, the Mount Sinai School of Medicine’s Biobank 
(BioME), and the Taiwan-MetaboChip Study for Cardiovascular Disease (TaiChi) study. 
A detailed description of each study can be found in our Appendices (Supplemental 
Materials for Manuscript 2). 
2. Genetic Data 
 The MetaboChip was designed to fine-map 257 loci with 196,725 genotyped 
SNPs. These loci had been validated with cardiometabolic traits as of 2009 [233] and 
include 36 validated BMI loci [14-33]. The genotyping of the MetaboChip was performed 
for the PAGE Study at certified research genomics laboratories: the Human Genetics 
Center of the University of Texas-Houston (Houston, TX), University of Southern 
California Genomics Core (Los Angeles, CA), Translational Genomics Research Institute 
(Phoenix, AZ), and Vanderbilt Technologies for Advanced Genomics (Nashville, TN) 
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[235]. HapMap control samples were also genotyped independently by each site to allow 
for an internal control and both used Illumnia GenomeStudio with the GenCall 2.0 
algorithm to make genotypic calls. SNPs with a Gentrain score <0.6, cluster separation 
<0.4, more than 1 Mendelian inconsistency, discordant duplicate calls, GenoSNP score 
>3.3%, call rate <95%, ambiguous mapping to the genome, or that were discordant with 
GWAS SNP in PAGE pilot studies were excluded by the PAGE Study CC at Rutgers 
University (n=13,808). There were then 182,917 SNPs left in final set of SNPs in the 
analytic set provided by the PAGE Study CC, and an additional 2,646 SNPs were 
excluded for ambiguous intensity plots in later quality control analyses. Intentional and 
unintentional duplicates, individuals with low call rates (<95%), excess heterozygozity, 
phenotype-genotype sex discordance, or ancestry outliers were also excluded from the 
quality controlled data set as potential sample errors [235]. Any samples with an 
inbreeding coefficient (F) >0.15 were also excluded [236]. 
Given the potential for population stratification in ancestrally diverse 
Hispanic/Latinos, the PAGE Study CC did not apply an overall Hardy-Weinberg 
Equilibrium filter for Hispanic/Latinos, but instead have chosen to perform this test 
stratified by Hispanic/Latino background in the sub-study with the most diversity, 
HCHS/SOL. If a SNP had a Hardy-Weinberg Equilibrium p-value<1x10-6 in at least one 
background group as well as in the overall sample, the PAGE Study CC recommends its 
flagging/exclusion as a potential genotyping error. 
Imputation of MetaboChip SNPs was conducted in MEC-SIGMA 
(Hispanic/Latinos only), BioME (African and Hispanic/Latino American), and WHI 
(representing 54% of WHI African American women, and all of the WHI European 
descent women) [237] using 1000 Genomes phase 1 reference samples and filtered on 
imputation quality.  
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 Due the design of HCHS/SOL, the cohort included related individuals and 
unequal sampling probabilities that must be accounted for in genetic analyses [238]. 
This influences the sample selection, statistical models and adjustments for ancestry 
that have been recommended for genetic analyses in HCHS/SOL as compared to the 
other three studies. I will describe each below. 
First, in most population-based genetic epidemiologic studies the member of 
each first degree related pair based on identity-by-descent statistics (e.g. probability of 
sharing 0, 1, or 2 alleles at a given marker [239]) with the lowest call rate is excluded 
from statistical models that assume independence. The PAGE Study CC assessed 
relatedness within and across the studies with Hispanic/Latinos using PLINK to generate 
identity-by-descent statistics [240], and all duplicate or 1st degree relative pairs with other 
studies than HCHS/SOL were broken by preferentially including the pair from 
HCHS/SOL.  
Second, within the HCHS/SOL cohort there is large variability in the number of 
participants per household in HCHS/SOL and the distribution is skewed to the right 
(range of 1-14, median of 1, mean of 1.7) [238]. Although most population-based genetic 
analyses exclude 1st degree relatives to obtain an ‘independent’ set of observations, 
alternatives exists to account for empirical estimates of relatedness between individuals 
and retain all observations in the statistical modeling. Given the variability in shared 
households and the potential for relatedness, the PAGE Study CC recommends 
modeling shared household and estimates of relatedness in all analyses. As such flags 
have been distributed to cluster individuals in the subset of HCHS/SOL with 
MetabocChip data into groupings based on shared households or high amounts of 
identity-by-descent relatedness (defined as a 1st degree relatives with 0.35<Φ<0.98 
estimated identity-by-descent allele sharing). These flags result in 6,899, 761, 96, and 
35 extended families of sizes 1-2, 3-4, 5-6, and ≥ 7, respectively. Although variance-
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component models [241-245] perform well in instances of cryptic relatedness (i.e. 3rd or 
more degrees) and can be used for binary, ordinal, and age-at onset traits [246-248], 
GEEs provide a more robust and less computational intensive alternative to 
appropriately account for the complex sampling design of HCHS/SOL [230]. GEEs are 
also applicable to binary, ordinal, age-of-onset and quantitative traits, such as many 
CVD traits [249]. For this reason the PAGE Study CC recommends the use of GEEs in 
HCHS/SOL to account for both relatedness, aspects of the study design, and 
Hispanic/Latino backgrounds and have provided a statistical package, SUGEN, in C++ 
to facilitate this analysis [238].  
Lastly, given that the frequency of various genetic markers and the trait of 
interest may both depend on an individual’s ancestral background, a great deal of 
attention in genetic epidemiology has been given to controlling for this potential source 
of confounding (i.e. population stratification) [250, 251]. PCA is commonly used in 
genetic epidemiology to condense the multiple marker observations within a given study 
into their ancestral components, but PCA is not valid in samples with relatedness due to 
their inter-dependence. Imputation can be used to infer the global ancestry of one 
relative based on the estimates of the other, but this is not appropriate in samples with 
substantial amounts of relatedness. Therefore, HCHS/SOL investigators have chosen an 
alternative strategy that allows for the estimation of global ancestry in the entire sample. 
Briefly, this was accomplished by using the 1000 Genomes publically available reference 
populations (CEU, YRI, MXL, PUR, CLM, CHB) to train the principal component space 
(i.e. create 20 eigenvectors of genotypes) and then project the entire HCHS/SOL sample 
along each of these components based on their observed genotypes. These analyses 
have been performed in Eigensoft software and have been shared across the PAGE 
Study for investigators doing genetic association studies [250, 252]. 
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Unlike HCHS/SOL, the other participating PAGE Study studies with 
Hispanic/Latino samples include far smaller proportions of related individuals. Therefore 
the decisions regarding sample selection, statistical models, and ancestry adjustments 
are more straightforward. After estimating relatedness using PLINK [240], all duplicate or 
1st degree relative pairs were broken across studies by either including the pair with the 
highest call rate [235] (unless one pair was from HCHS/SOL). Within-study 1st degree 
relative pairs were broken between the PAGE studies by including the pair with the 
highest call rate. Linear regression was then performed using PLINK [240]. The PAGE 
Study CC has distributed PCA estimates calculated separately in an unrelated subset 
(as defined as 2nd degree relatives or beyond, ≤0.35 estimated identity-by-descent allele 
sharing) for use in genetic association analyses.  
3. Anthropometric Data 
One of the advantages to a consortium such as the PAGE is that the data is 
cleaned and harmonized centrally (Rutgers University, Piscataway, NJ) before it is 
distributed to the investigators of the participating sub-studies [41]. The harmonization of 
the anthropometric variables such as BMI in the PAGE Study has been described 
previously [203, 204]. Both weight and height were measured in HCHS/SOL [43] and 
WHI at examination by trained staff following a standardized protocol [253]. However, in 
MEC these anthropometric values were self-reported [203, 254]. In EAGLE BioVU and 
BioME, biobanks of electronic medical records, height and weight were measured in the 
clinic as part of a patient’s examination [30, 33, 255, 256].   
D. Research Plan  
In this section I will briefly describe my methodological approach to establish the 
accuracy of self-reported weight as a tool for future studies of trajectories of self-reported 
weight in HCHS/SOL (Aim 1). Then I will outline the approaches I took to study the 
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generalization and fine-mapping of BMI loci to diverse populations in the PAGE Study 
(Aim 2). Additionally information on the methods of each manuscript can be located in 
the Results sections below.  
1. Aim 1 
I will now describe the approach I took to examine the accuracy of self-reported 
weight in HCHS/SOL before and after adjustment for potential predictors of inaccuracy 
(Aims 1A and 1B, respectively). I next describe how I constructed a quality controlled 
analytic dataset of self-reported and measured weight among the 16,119 non-pregnant 
participants 18-74 years at screening, without a limb amputation at the baseline 
examination, and without extreme self-reported (or BMI values, calculated using 
measured height at baseline).  
i. Data Quality Control 
Further details on my data cleaning and exclusions protocol for the self-reported 
and measured weights are provided in Manuscript 1 (below). Based on a priori 
knowledge of Hispanic/Latino migratory patterns and exploratory analyses of the data, 
we were concerned about the potential for unit confusion in the self-report (kg or lb) and 
sought to compare our range of difference between self-reported and measured weight 
with previous reports. As such we flagged absolute differences between self-reported 
and measured weight ≥15kg as possible data errors based on a previous study from 
Mexico [47]. 
We then applied a detailed data quality control protocol (described in detail in 
manuscript 1), to all 16,203 participants with data on both self-reported weight and 
measured weight (98.7% of entire sample) to: 1) address the flagged calculated 
differences between self-reported and measured weight as potential data errors (42 
individuals excluded), and 2) exclude currently pregnant women (who reported not being 
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pregnant during the screening but reported being pregnant as part of their medical 
history), or individuals with limb amputations (≥45 years, not otherwise affecting their 
ability to stand on both feet), or a body mass index <16 or >70 kg/m2 (42 individuals 
excluded). Unless indicated otherwise, all results presented below pertain to the sample 
with both self-reported and measured weight that remained after applying this quality 
control protocol (n=16,119).  
ii. Statistical Analyses 
In Aim 1A I first described the frequency of unit (kg or lb) and end digit 
preference. This description culminated in the calculation of an End Digit Preference 
Score (DPS) [257]. Using an a priori criterion for end digit preference, we interpreted 
DPS>20 as supportive of digit preference (i.e. heterogeneity across end digits). Second, 
we described 1) the mean difference between contemporaneous self-reported and 
measured weights, 2) the mean percentage difference relative to mean measured 
weight, and 3) then stratified the mean differences by factors hypothesized to influence 
the accuracy of self-reported weight. Because persons from specific Hispanic/Latino 
backgrounds tend to concentrate in specific geographic areas, not all Hispanic/Latino 
backgrounds were represented at each study center, creating confounding between 
background and center. Therefore we considered the cross-classification of 
Hispanic/Latino background by field site to construct meaningful contrasts of the 
differences within either background groups or sites. All Hispanic/Latino backgrounds 
with <100 participants at a given study site were pooled with individuals at the same site 
self-identifying as being of ‘Mixed’ or ‘Other’ backgrounds. Third, we used an unadjusted 
linear regression of measured weight on self-reported weight to estimate the overall 
correlation coefficient (r2) using a priori criteria of good model fit of r2>0.9.  
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Given that stratified means and correlation coefficients do not capture the 
complex differential sources of under- or over-reporting, in Aim1B I applied multivariate 
linear models to assess the joint influence of potential predictors of inaccuracy on the 
differences between self-report and measured weights using disjoint indicator variables. 
Whereas stratified mean differences between self-reported and measured weight reflect 
the observed misreporting (kg) for all individuals in a given stratum, multivariate effect 
estimates represent the estimated change (kg) in the difference between self-report and 
measured weight (henceforth referred to as ‘change in difference’) for a given stratum 
compared to the difference observed for the referent, after holding all other potential 
predictors constant.  
In both Aims 1A and 1B I performed multiple imputation [258] to fill in missing 
predictor information (8.5% of the sample missing ≥1 predictors) and generate 25 
stacked datasets for use in the multivariate analyses (20 burn in period). All statistical 
analyses accounted for the complex sampling design and sampling weights of 
HCHS/SOL in SAS 9.4 (SAS Institute, Research Triangle Park, NC).  
iii. Strengths and Limitations  
This current work was strengthened by our data quality control protocol. In 
contrast data quality control approaches that are based on a single criterion (e.g. >4 
standard deviations), although straightforward, may compromise the representativeness 
of the analytic sample and artificially inflate estimates of accuracy. As such our approach 
to data quality control may be useful for future accuracy studies. This analysis 
constitutes the largest and most diverse accuracy study of Hispanic/Latinos to date. 
Additionally we utilized multiple imputation to account for missing predictors of 
inaccuracy and retain the full data set (n=16,119) in our stratified estimates (Aim 1A) and 
in our multivariate models (Aim 1B).  
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This work was not without limitations, however. Although the assessment of 
contemporaneous self-reported and measured weight isolates the impact of self-report 
bias, it does not shed light on the magnitude of recall bias or its interaction with self-
report bias in the HCHS/SOL weight history data.  Nonetheless good accuracy of current 
self-report weight in HCHS/SOL suggests that self-reported weight histories could be a 
valid tool for studying dynamic immigrant populations, if recall bias were to also be 
minimal.  As discussed previously, there is an inherent confounding by geography in the 
design of HCHS/SOL, which relates to the non-random distribution of varied 
Hispanic/Latino backgrounds across the US. Therefore we assessed the cross-
classification of background and site and created contrasts both within background and 
site for strata with ≥100 individuals to assure positivity. Yet we were unable to fully 
decompose the effects of site and background in our predictive modeling, given that both 
components had within group variability. Although the HCHS/SOL baseline design and 
data collection were extensive, we were unable to fully explore all conditions that might 
lead to large weight fluctuations in adulthood or frequent doctor visits (e.g. Auto-Immune 
Deficiency Syndrome, Bariatric Surgery, etc.). Lastly our results are not generalizable 
beyond the communities sampled in HCHS/SOL. Yet these communities give us 
important insights into the range of misreporting of self-reported weight that we might 
see in similarly diverse samples of US Hispanic/Latino adults. 
2. Aim 2 
To fully describe the components of a fine-mapping study of diverse populations 
in the PAGE Study I will begin by defining my exposures and outcome. Then I will 
describe the statistical analyses and present my power calculations to support this 
analysis, and conclude with a discussion of the strengths and limitations of Aim 2.  
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i. Exposure Measurement 
The approximately 195,000 SNPS genotyped on the MetaboChip were chosen to 
fine-map 257 loci that had been validated with cardiometabolic traits as of 2009 and 
capture a low coverage genome-wide backbone [233]. Because the MetaboChip 
contains finely mapped 21 adult BMI loci known at the time of design and an additional 
13 densely-genotyped loci implicated with BMI since 2009 [14-33], Metabochip data are 
well suited to investigate of the genetic architecture of obesity among US 
Hispanic/Latinos and inform how acculturation and genetic susceptibility may jointly 
influence BMI. SNPs with a Gentrain score <0.6, cluster separation <0.4, more than 1 
Mendelian inconsistency, discordant duplicate calls, GenoSNP score >3.3%, call rate 
<95%, ambiguous mapping to the genome, or that were discordant with GWAS SNP in 
PAGE pilot studies or had ambiguous intensity plots were excluded by the PAGE Study 
CC (n=16,454) [235]. This analysis was restricted to the SNPs that passed the PAGE 
quality control filters (n=180,271) and were within the physical bounds of the 36 fine-
mapped BMI loci defined as part of the MetaboChip design. I only reported on 
association results for low frequency and common SNPs (≥1% minor allele frequency). 
Additionally I excluded the 747 SNPs that failed Hardy Weinberg Equilibrium (p<1x10-6) 
overall and in at least one background group in HCHS/SOL (not including individuals 
reporting backgrounds inconsistent with their parents, or individuals of other or multiple 
backgrounds).  
ii. Outcome Measurements 
As described above both weight and height were measured at examination by 
trained staff following a standardized protocol in HCHS/SOL [43] and WHI [253]. 
However, in MEC these anthropometric values were self-reported [203, 254] and in 
EAGLE BioVU and BioME height and weight were measured in the clinic as part of a 
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patient’s examination [30, 33, 255, 256]. BMI was then calculated as the ratio of an 
individual’s weight (kg) to their height (m) squared.  
iv. Statistical Analyses 
As has been in done in previous analyses of BMI in adults [204], I excluded 
individuals 20 years of age or younger as their BMI values may not be comparable (e.g. 
due to their potential for ongoing physical maturation) to individuals older than 20 years. 
Two exceptions are that in CARDIA this exclusion was not applied and in HCHS/SOL we 
also excluded individuals 20 years of age. Individuals with extreme BMIs (<18.5 and >70 
kg/m2) were excluded from the analytic sample for Aim 2 due to the possibility of data 
coding errors, an underlying illness or syndrome, or rare genetic mutations as has 
implemented in previous PAGE Study projects [203, 204].  
The distribution of BMI is commonly skewed to the right [58] and this is also the 
case in the studies of the PAGE Study (e.g. in WHI-SHARe women, Figure 6). As 
compared to other practices to adjust for skewness, such as inverse ranked 
normalization, the natural log transformation results in parameters that are easier to 
interpret (i.e. as percent increase in BMI between an individual with one risk allele 
versus no risk alleles) and have been used in previous PAGE Study analyses [203, 204]. 
Yet the natural log transformation imposes the assumption linearity on the natural log 
scale when a variable contains more than two categories. In other words, genetic effects 
would be assumed to be linear or additive on the natural log scale across the observed 
genotypes (e.g. AA, AG, GG). 
Throughout Aim 2 I assumed an additive genetic model (e.g. a SNP with a coded 
allele of G and non-coded allele of A would result in three possible genotypes: AA=0, 
AG=1, GG=2) and as per my directed acyclic graphic analysis (Figure 7) controlling for 
age, gender, principal components, and study center/region (as appropriate) were 
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sufficient to control for all anticipated sources of confounding, regardless of the unclear 
directionality between acculturation and socioeconomic factors. In HCHS/SOL we also 
adjusted for Hispanic/Latino backgrounds. Single SNP-BMI associations were modeled 
to determine the SNP with the strongest evidence of association as measured by the p-
value (i.e. the ‘top’ SNP). I anticipated that the majority of these top SNPs will be 
common (>5% minor allele frequency), because the previously validated BMI loci were 
described as part of GWAS of common variation.  
Due to the relatedness in HCHS/SOL principal components were calculated 
using an unrelated sample of six distinct 1000 Genomes reference sample populations 
(CEU, YRI, MXL, PUR, CLM and CHB) using a panel of 44,883 SNPs in low linkage 
disequilibrium and then principal component values were projected onto the entire 
HCHS/SOL sample [238]. Other studies calculated their principal components among an 
unrelated study sample (as defined as 2nd degree relatives or beyond, ≤0.35 estimated 
identity-by-descent allele sharing) and projected to their full sample. Ancestral outliers of 
the resulting principal components were excluded from further analysis [235]. A 
minimum of the top three principal components were included in all models to capture 
the three main ancestral groups contributing to the diversity in Hispanic/Latinos: African, 
European, and American Indian [112-116].  
In HCHS/SOL GEEs were used to adjust for the complex sampling design and 
relatedness (clusters defined as 1st degree relatives or individuals sampled from the 
same household) using an optimized Horvitz-Thompson estimator in SUGEN based on 
selection probabilities adjusted for household- and individual-level non-response, and 
trimmed marginal inclusion probabilities [238]. In other studies with family structure 
(GenNet, HyperGen) linear mixed models were used in GWAF [259]. Standard linear 
regression models for the other studies were run using PLINK [240] or R (https://cran.r-
project.org). Regression modeling based on less than 100 individuals were excluded 
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from all analyses. All SNP results were flipped to the positive strand and risk allele prior 
to the reporting of the final results.  
We created a Bonferroni threshold of significance for the 170 index SNPs (or if 
unavailable on the MetaboChip, their highest LD proxy, r2≥0.8 in the discovery 
population 1000 Genomes pilot CEU, YRI, or CHB+JPT) from previous GWAS or 
Metabochip-wide studies after accounting for the 4 loci with more than one racial/ethnic-
specific finding in tight linkage disequilibrium (LD, r2≥0.8 in CEU, YRI and CHB+JPT). 
Replication (i.e. in the same population of discovery) or generalization (i.e. to another 
population) was declared if an index SNP was: 1) Bonferroni significant at this threshold 
and 2) had a consistent direction of effect as the previous report. This same threshold 
was applied to any index SNP within the 36 fine-mapped BMI loci.  
For the other SNPs in the fine-mapped regions, we generated a locus-specific 
Bonferroni correction for multiple comparisons based on the number of independent 
(r2≤0.2) SNPs with n a 50-SNP window, which was shifted by 5 SNPs each iteration, in 
the ARIC Study African American sample with MetaboChip data (n=3,399). This served 
as a worst-case scenario of the maximum number of independent tests in our population 
with the smallest LD blocks.  
Among the subset of the 28,573 SNPs passing quality control and located in the 
36 densely-genotyped loci, we conducted inverse variance fixed-effect meta-analysis 
across studies (>100 observations each) in METAL (version 2011-03-25) [260] when the 
SNP was >0.1% MAF in the racial/ethnic group and was informed by more than half of 
the maximum racial/ethnic-specific sample size. Any SNP-association with evidence of 
heterogeneity (defined as p<0.05 at the top SNP) was further investigated using forest 
plots, or if a trans-ethnic finding, using Bayesian fine-mapping and conditional analyses 
of fixed-effect estimates. As described above, MEC assessed BMI through self-reported 
weight and height and EAGLE BioVU and BioME utilized measurements of weight and 
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height from the medical record. I was careful to review the evidence of heterogeneity 
across studies in Aim 2A, given that self-report inaccuracy (assessed in Hispanic/Latinos 
as part of Aim 1) or inconsistent measurement protocols across the PAGE Study could 
induce heterogeneity across studies.  
Similarly, in Aim 2B we generated trans-ethnic meta-analyses for SNPs >0.1% 
MAF in each racial/ethnic group and informed by more than half of the maximum trans-
ethnic sample size (n=101,979) from at least two populations. We excluded the Alaskan 
Natives/American Indians from WHI from our trans-ethnic fixed-effect estimates due to 
small sample size (n=535).  
Finally the fine-mapping of causal variants was informed by estimates of 
population-specific allele frequencies and LD correlation (r2, 500 Kb sliding windows) in 
PLINK [261] using genotypes from the ARIC (African American), HCHS/SOL 
(Hispanic/Latino), and WHI studies (Asian, European and American Indian/Alaskan 
Native). Trans-ethnic LD estimates were generated from a sample of 17,437 individuals 
from HCHS/SOL, and WHI, which was proportionate to the racial/ethnic groups of our 
trans-ethnic meta-analysis. Regional plots were generated using LocusZoom to visualize 
trans-ethnic association differences as well as across the LD of various racial/ethnic 
groups [262]. 
We further investigated all of the 36 fine-mapped loci for second independent 
signals using GCTA (version 64) [34, 188]. We included the top SNP (i.e. marker with 
the lowest p-value within each region) in an approximate conditional model and 
contrasted the conditional effect estimates and P-values of the surrounding SNPs with 
their unconditional estimates, to ascertain if additional SNPs arise after we adjust for the 
top SNPs. We repeated this approach for any additional significant lead SNPs in low LD 
(r2<0.2) with the previous top SNPs until no additional independent significant SNPs 
were identified.  
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Lastly, I relaxed the assumption of a fixed-effect across diverse racial/ethnic 
groups using an empirical Bayesian trans-ethnic meta-analysis in MANTRA [53]. I 
estimated mean effect allele frequency differences from our trans-ethnic results. Then I 
allowed MANTRA to empirically calculate the number of ancestral groups, or for 
comparison purposes force it to K=1 or K=N (number of study-, acculturation- and 
background-specific strata) to implement either a Bayesian fixed- or random-effects 
meta-analysis, respectively [53]. Significance in MANTRA analyses was determined 
using a threshold of a log10 Bayes Factor (BF)>5. I anticipated that no significant 
heterogeneous effects would remain after adjustments for ancestral differences across 
racial/ethnic groups using MANTRA. Furthermore we also calculated the posterior 
probability 𝜙𝑗  that the jth SNP in the kth independent signal is causal, and then ranked 
all SNPs by their BF’s and summed their cumulative posterior probabilities until it 
exceeded 99%. Assuming that each independent signal contained only one causal 
variant genotyped on the MetaboChip, the resulting set of SNPs constitutes the 99% 
credible set and defines a genomic region where there is a 99% probability of containing 
the causal SNP.  
v. Power Calculations 
Prior to analyses I had anticipated having genotype and BMI information on a 
maximum analytic sample of 35,606 African, 26,048 Hispanic/Latino, 22,466 Asian and 
535 American Indian/Alaskan Native descent adults. Therefore, at the time I calculated 
my expected power to detect a range of fixed-effect genetic estimates in Aim 2 using 
Quanto 1.2.4 (Figure 8). I had assumed an additive genetic model with a Bonferroni 
correction for the number of BMI loci I anticipated to test (p<0.05/33). Based on 
preliminary observations in HCHS/SOL as a representation of the outcome distribution in 
the other studies, I assumed a mean BMI (standard deviation) of 28.5 (1.22) kg/m2. I had 
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decreased the maximum available sample size by 15% to account for the non-
independence of the HCHS/SOL observations with respect to household and/or 
relatedness, the potential loss in power from conducting a weighted GEE model in 
HCHS/SOL, or missing person-level data. Thus, an effective sample size of 19,000 
would correspond to this worst-case scenario for Asian Americans, our smallest 
racial/ethnic group >1000 observation and of non-European descent. 
As shown in Figure 8, my power to detect SNP effects under a worst-case 
scenario for racial/ethnic-specific estimates (Aim 2A) would be ≥80% power for common 
variants (≥5%) of small genetic effect sizes (>0.1kg/m2) and rare variants of (1 to <5%) 
of moderate effect sizes (>0.25kg/m2). As minor allele frequency increases so would my 
power to detect smaller genetic effects. Our power to detect effects in the African, 
Hispanic/Latino American samples, and the trans-ethnic meta-analyses (Aim 2B) would 
be far greater. 
vi. Strengths and Limitations  
Even though it is possible that many of the BMI loci discovered after 2009 may 
not be fine-mapped on the MetaboChip, this analysis benefits from the large sample 
sizes available in the PAGE Study and the ability to capture 13 additional 
cardiometabolic loci that have been described with BMI since 2009. I propose a 
Bonferroni correction for the number of independent tests performed in each analysis as 
a way of limiting my type I error rate to declare generalization to 5% across all 
independent tests. Additionally several efforts have been made in the PAGE Study to 
harmonize the exposure, outcome, and effect measure modifier measurements of 
interest. This proposed analysis builds off of the best practices of several previous 
PAGE Study analyses that have used centralized genotyping and quality control, as well 
as harmonization protocols [203, 204].  
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In light of the strengths of this work, there are a few notable limitations. I was 
cautious when presenting fixed-effect meta-analyses in the presence of effect 
heterogeneity by study or race/ethnicity. Although Aim 2B incorporated a trans-ethnic to 
account for ancestral sources of heterogeneity (as captured by mean allele frequency 
differences in the results), outcome ascertainment or key environmental sources of 
heterogeneity may still remain (such as how acculturation captures changes in the 
obesogenic environment by gender, linguistic or cultural groups). My current analysis 
was not able to interrogate these sources of heterogeneity, but I plan to consider this in 
future studies of how obesogenic sociocultural environments can influence obesity and 
genetic susceptibility. Therefore, the loci implicated from Aim 2 will be targeted for 
follow-up study as key components of my overarching conceptual diagram (Figure 1). 
E. Human Subjects 
The PAGE Study CC, participating studies, and their study-sites all received 
Institutional Review Board approval prior to the initiation of each study. Although the 
specific forms differ slightly in wording and format, written and informed consent was 
obtained for the above outlined research activities, as well as the collection of data and 
genotyping. All investigators and staff associated with this proposal have received 
ongoing ethics and data security training/certification. The Institutional Review Board at 
the University of North Carolina at Chapel Hill has deemed that the secondary-data 
analyses of this dissertation do not require a full Institutional Review Board approval and 
are in accordance with the Institutional Review Board principles for ethical human 
subjects research. The HCHS/SOL Publications Committee has reviewed, approved of 
the research activities, and verified the data analysis (Aim 1 only) of this dissertation. In 
addition, the PAGE Publications Committee and its sub-studies have reviewed and 
approved the statistical analyses for Aim 2.   
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F. Supporting Figures  
 
Figure 6A-B. Comparison of distributions of BMI (kg/m2) in entire WHI sample of self-
identified Hispanic/Latinas (n=5,337) before (A) and after natural log (ln) transformation 
(B). 
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Figure 7. Directed Acyclic Graph of relationship between genetic variation and body 
mass index (BMI) with unclear directionality between acculturation and socioeconomic 
measures. 
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Figure 8. Power analysis of genetic effects across a range of minor allele frequencies 
(blue=1%, red=5%, green=10%, purple=20%) assuming an additive genetic model, a 
mean (SD) BMI 28.5 (1.22) kg/m2, an alpha of 0.05/33 genetic loci, and a maximum 
effective sample size of n=19,000 (Quanto 1.2.4). 
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CHAPTER V: RESULTS 
A. Manuscript 1: The Accuracy of Self-Reported Weight in a Diverse 
Population-Based Sample of Hispanic/Latino Adults from Four Urban United 
States Communities: The Hispanic Community Health Study/Study of Latinos 
(HCHS/SOL) 
1. Overview 
 Background: Previous United States (U.S.) population-based studies have found that 
body weight may be underestimated when self-reported by individuals. However, this 
research may not apply to all U.S. Hispanics/Latinos, many of whom are immigrants with 
distinct cultural orientations to ideal body size.  We assessed the data quality and 
accuracy of self-reported current weight in a population-based sample of U.S. 
Hispanics/Latino adults from various Hispanic/Latino backgrounds (or heritages). 
Methods: Using baseline data (2008-2011) from the Hispanic Community Health 
Study/Study of Latinos (HCHS/SOL), we described the difference between 
contemporaneous self-reported and measured weight overall and across potential 
predictors of inaccuracy (n=16,119). Multivariate adjusted models were used to establish 
whether the observed trends in misreporting in a given predictor persisted after 
adjustment for all other potential predictors.   
Results: Self-reported current body weight was well correlated with measured weight 
(r2=0.95), and on average was 0.23 kg greater than measured weight. However, the 
following factors were associated with differential misreporting of weight: age group, 
gender, body mass index categories, nativity, study site by background, unit of self-
report (kg or lb), and end digit preference. 
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Conclusions: We found slight over-reporting of weight in a diverse cohort of 
Hispanic/Latino adults from four U.S. urban centers, which may be due in part to 
characteristics of the HCHS/SOL cohort, such as its high proportion of immigrants. The 
direction of misreporting in self-reported weight, and thus the anticipated bias in obesity 
prevalence estimates based on self-reported weights, may differ in U.S. Hispanic/Latinos 
from that found in prior U.S. population-based studies. 
2. Background 
  In spite of the potential for misreporting of body weight and biases associated 
with self-report, self-reported weight is often used in epidemiological studies when 
information on an individual’s weight status is otherwise unavailable [151]. Previous 
population-based studies of the accuracy of self-reported weight indicate a tendency for 
participants to under-report their current weight as compared to their measured weight 
(with self-reported weight lower than measured weight by 0.1 kg [263] to 1.2 kg [264, 
265]) with consistent differential misreporting across age, gender, and body mass index 
categories [151]. Yet this finding differs from a study of Mexican adults, which found that 
weight was over-reported by an average of 0.6 kg, indicating that the direction of 
misreporting may vary across cultures [47] due to the social desirability of body weight 
[157, 266].  
Hispanic/Latinos comprise the largest United States (U.S.) minority group, 
representing 17% of the adult population in 2013 [96] at least half of whom were born 
outside of the U.S.[95] Among Hispanic/Latinos in the U.S. and abroad body mass index 
(BMI) categories [48, 49, 51], age [47, 49, 51, 153, 154], gender [47, 51], reproductive 
factors [75], household income [51], education, employment and nativity[49] have all 
been described as predictors of weight misreporting. Despite the recommendation to 
report the range of differences between self-reported and measured weight [151], we are 
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only aware of one study in Hispanic/Latino populations that has published this 
information [47]. Although U.S. Hispanic/Latinos represent diverse ancestries, cultural 
practices, languages and migration histories and have been documented to have 
variability in perceptions towards ideal body size [267], to our knowledge no previous 
study has compared the accuracy of self-reported weight across more than one 
Hispanic/Latino background (or heritage) in a predominantly foreign-born population-
based cohort [47-49, 51, 75, 153, 154]. As new population-based studies collect more 
data on diverse U.S. Hispanic/Latinos, there is a need to reassess the data quality and 
accuracy of self-reports made in multiple languages or units.  
Therefore using data from the Hispanic Community Health Study/Study of 
Latinos (HCHS/SOL), we describe the accuracy of self-reported body weight and factors 
associated with misreporting in a predominantly foreign-born population-based sample 
of U.S. Hispanic/Latino adults from various Hispanic/Latino backgrounds, including 
Central or South American, Cuban, Dominican, Mexican, and Puerto Rican.  
3. Methods 
i. Population 
  The HCHS/SOL is population-based cohort of 16,415 self-identified 
Hispanic/Latino adults (18-76 years at examination) of diverse Hispanic/Latino 
backgrounds (Central or South American, Cuban, Dominican, Mexican, and Puerto 
Rican) who were sampled using a probability study design from four U.S. urban 
communities (Bronx, NY; Chicago, IL; Miami, FL; San Diego, CA) between 2008-2011 
[42, 43]. Centrally trained HCHS/SOL study personnel conducted the screening and 
baseline examinations in the participant’s preferred language (English or Spanish). 
Women who reported being pregnant during screening were rescheduled for 
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examination ~3 months postpartum. Institutional Review Boards at all study sites 
approved the study procedures.  All participants gave their informed written consent.  
ii. Weight Measures 
 The baseline HCHS/SOL weight and height data were collected on participants 
who were able to stand on both feet while wearing a scrub suit or examination gown and 
no shoes [179] during the fasting block of the examination and immediately after a urine 
collection [43]. Trained and certified study personnel asked participants to self-report 
their body weight (to the whole kilogram, kg, or pound, lb) before measuring their weight 
to a tenth of a kg using a digital scale (Tanita Body Componsition Analyzer, TBF 300, 
Japan) and then transcribing it into an electronic data entry system. We converted self-
reported weights in lb to kg and calculated the difference in kg (=self-reported weight – 
measured weight) between the self-reported and measured weights (“gold standard”) as 
well as the percentage difference relative to measured weight [=(self-reported weight – 
measured weight)/measured weight * 100%]. 
iii. Data Quality Control 
 Quality control measures were implemented to ensure that all personnel were 
measuring anthropometrics with precision and included daily zero-balancing and weekly 
calibration of scales, centralized two day-personnel trainings that culminated with a 
certification that confirmed ≤0.5 kg weight agreement between a trainee and certified 
expert on ≥5 individuals, as well as periodic observations. Study personnel initialed each 
form and monthly the HCHS/SOL Coordinating Center notified the clinic managers of 
data points were beyond an expected error range, which resulted in refresher training(s) 
for the study personnel who collected those data points. With the consent of study 
participants, each study personnel audio recorded three baseline interviews (one per 
recruitment year) and were then randomly invited to share these recordings with study 
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personnel from others sites with the aim of determining if all sites and interviewers were 
implementing the study protocols and interviewing techniques consistently across the 
four HCHS/SOL sites.   
Additionally, inter-rater reliability was assessed by randomly selecting 3-5% of 
participants for retest by a second certified assessor immediately after the initial 
anthropometric exam during the same baseline examination visit. Self-reported weights 
(n=565) differed between the two study personnel (=original – replicate) by 0.46 kg (95% 
confidence interval, CI: -0.12, 1.03 kg); whereas, measured weights (n=565) differed by 
0.16 kg (95% CI: -0.18, 0.50 kg).  This resulted in good reliability coefficients for self-
reported and measured weight of 0.93 and 0.97 and relatively low coefficients of 
variation (the within-specimen variation expressed as a percentage of the mean) of 6.3 
and 3.7%.   
Given the large number of foreign-born Hispanic/Latino adults in the U.S. [95], 
we were concerned about unit confusion in the self-report (kg or lb) and sought to 
compare our range of difference between self-reported and measured weight with 
previous reports.  One study from Mexico (where metric units are used) reported that 
among individuals ages >75 years, the differences between self-reported and measured 
weight ranged from -14.8 to 16.6 kg in males, and -8.6 to 14.7 kg in females [47]. As 
such we flagged absolute differences between self-reported and measured weight ≥15kg 
as possible data errors.  
We then applied a data quality control protocol shown in Figure 9 and described 
in more detail in Appendix A to all 16,203 participants with data on both self-reported 
weight and measured weight (98.7% of entire sample) to: 1) address the flagged 
calculated differences between self-reported and measured weight as potential data 
errors, and 2) exclude currently pregnant women (who reported not being pregnant 
during the study screening but later reported being pregnant as part of their medical 
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history), or individuals with limb amputations (≥45 years, not otherwise affecting their 
ability to stand on both feet), or a body mass index <16 or >70 kg/m2. Unless indicated 
otherwise, all results presented below pertain to the sample with both self-reported and 
measured weight that remained after applying this quality control protocol (n=16,119).    
iv. Analysis 
First, across and within each unit of self-report (kg or lb) we stratified self-
reported and measured weights by their end digit and then compared the observed 
frequency with the expected frequency of 10% for each digit (i.e. under a uniform 
distribution of digits between 0-9).  We assessed how much self-reported and measured 
weights deviated from homogeneity of end digit using the End Digit Preference Scores 
(DPS)[257] as described below: 
𝐷𝑃𝑆 = 100 ∗ √
𝜒2
𝑑𝑓 ∗ 𝑁𝑤𝑒𝑖𝑔ℎ𝑡𝑒𝑑
 
where df represents the degrees of freedom (= number of strata - 1) for the Rao-Scott 
Chi-square.  
Using an a priori criterion for end digit preference, we interpreted DPS>20 as supportive 
of digit preference (i.e. heterogeneity across end digits). 
Second, we described 1) the mean difference between self-reported and 
measured weights, 2) the mean percentage difference relative to mean measured 
weight, and 3) then stratified the mean differences by factors hypothesized to influence 
the accuracy of self-reported weight, which included demographic characteristics (age, 
field site, Hispanic/Latino background, gender), health behaviors, and factors relevant to 
weight gain/loss (body mass index categories, health insurance, smoking status, 
diabetes, history of cancer/malignant tumor or heart failure, menopausal status), 
socioeconomic and sociocultural factors (education, household income, language 
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preference at examination, nativity), and characteristics of self-reported weight (units of 
report, end digit preference).  Because persons from specific Hispanic/Latino 
backgrounds tend to concentrate in specific geographic areas, not all Hispanic/Latino 
backgrounds were represented at each study center, creating confounding between 
background and center. In particular, participants of Cuban background were 
predominantly recruited in Miami, those of Dominican backgrounds were predominantly 
selected in the Bronx, and participants from San Diego were predominantly of Mexican 
background [43].  Therefore we considered the cross-classification of Hispanic/Latino 
background by field site to construct meaningful contrasts of the differences within either 
background groups or sites. All Hispanic/Latino backgrounds with <100 participants at a 
given study site were pooled with individuals at the same site self-identifying as being of 
‘Mixed’ or ‘Other’ backgrounds.   
As has been reported previously [46, 47, 50, 268], third, we used an unadjusted 
linear regression of measured weight on self-reported weight to estimate the overall 
correlation coefficient (r2) using a priori criteria of good model fit of r2>0.9.   
Given that stratified means and correlation coefficients do not capture the 
complex differential sources of under- or over-reporting, we last applied multivariate 
linear models to assess the joint influence of potential predictors of inaccuracy on the 
differences between self-report and measured weights using disjoint indicator variables. 
Whereas stratified mean differences between self-reported and measured weight reflect 
the observed misreporting (kg) for all individuals in a given stratum, multivariate effect 
estimates represent the estimated difference (kg) in misreporting, as captured by the 
difference between an individual’s self-report and measured weight and henceforth 
referred to as ‘difference in misreporting’, for a given stratum compared to the difference 
observed for the referent, after holding all other potential predictors constant. In addition 
to a complete case analysis, we also used multiple imputation [258] to fill in missing 
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predictor information (8.5% of the sample missing ≥1 predictors) and generate 25 
stacked datasets for use in the multivariate analyses (20 burn in period). All statistical 
analyses accounted for the complex sampling design and sampling weights of 
HCHS/SOL in SAS 9.4 (SAS Institute, Research Triangle Park, NC).   
4. Results 
i. Unit and End Digit Preference 
   The majority of HCHS/SOL participants self-reported their body weight in pounds 
(96% weighted frequency). However, this varied across the four study sites. For 
example, 89% of individuals in San Diego and 99% of individuals in the Bronx preferred 
to self-report in pounds.  
Over half of the participants (56%) self-reported weights ending in zero or five, 
which is above our expectation if interviewers or participants had no digit preference 
(20%, zeros and fives). Digit preference was evident for self-reported weights (DPS=23), 
but was the strongest for self-reports ending in zeros compared to all other digits 
(DPS=62). More self-reports ended in zeros and fives when the self-report was made in 
lb as compared to kg (58% versus 42% weighted frequencies; Appendix B) and similar 
trends were seen for end digit preference for even versus odd digits (Appendix C). No 
end digit preference was evident in the measured weights (DPS=5.8), which were 
transcribed by study personnel from the scale to the electronic data entry system.  
ii. Raw Mean Difference 
Prior to data quality control the calculated difference ranged from 74.5 kg under 
to 51.6 kg over-reporting, resulting in a mean difference of 0.26 kg (95% CI: 0.14, 0.37 
kg; confidence limit difference, CLD: 0.23 kg) and coefficient of determination (r2) of 0.94 
(n=16,203). Although self-reported and measured weights were similar for most 
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individuals (i.e. most observations lay along the line of unity in Figure 11A), calculated 
differences were beyond four standard deviations from the mean for 129 individuals 
(gray lines in Figure 11C). We flagged 229 (1.4%) extreme absolute differences (15 kg) 
between self-reported and measured weight as possible instances of unit confusion.      
iii. Quality Controlled Mean Difference 
 After data quality control, 48 of these extreme absolute differences between self-
reported and measured weight were resolved reducing the number of flagged self-
reported weights to 1% of the final analytic sample (181 of 16,119, Appendix A).  The 
range of calculated differences decreased from 74.5 kg under to 51.6 kg over-reporting 
before quality control to 52.8 kg under to 35.4 kg over-reporting after quality control. This 
resulted in an attenuated mean difference (0.23 kg) and increased precision (95% CI: 
0.12, 0.34 kg; CLD: 0.22 kg; Figure 11A-D). The difference between an individual’s self-
reported and measured weight as a percentage of their measured weights was on 
average 0.53% (95% CI: 0.40, 0.66%). As compared to the raw data, the quality-
controlled data represent a tighter correlation between self-reported and measured 
weight (r2=0.95). In a hexagonal binning plot the majority of data were placed into a few 
bins along the best-fit line (Appendix D). Yet differential self-reporting across measured 
weight was more evident after data quality control, as we observed a stronger tendency 
towards over-reporting among individuals with measured weight below the mean (78.8 
kg) than above the mean, and a stronger tendency towards under-reporting among 
individuals with measured weight above the mean than below the mean (Figure 11C-D). 
Based on these findings all subsequent analyses were conducted using the quality-
controlled data. 
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iv. Predictors of Misreporting 
 The magnitude and direction of the difference between self-reported and 
measured weight varied across strata of a number of potential predictors of inaccuracy 
including: age, categories of BMI, nativity, background by study site, unit and digit 
preference (Appendix E).  Similar patterns were seen in both the stratified (Appendix E) 
and adjusted analyses (Appendix F and Table 3) of complete case and multiply imputed 
datasets, and therefore the results from the multiply imputed dataset are presented 
below. Age, categories of BMI, background by study site, digit preference, and 
gender/menopausal status each had at least one stratum where the multivariate 
adjusted difference between self-reported and measured weight and corresponding 95% 
CI did not contain the null, indicating that these predictors of misreporting were 
statistically independent of each other (Table 3).   
v. Demographic Factors 
 There was a positive relationship between increasing categories of age and 
over-reporting of weight (Table 3), in which on average adults ages 18-29 years under-
reported and those adults ages ≥30 years over-reported their weights (Appendix E). 
Although over-reporting of weight was generally observed in all strata of 
gender/menopausal status (Appendix E), when other predictor of misreporting were 
taken in account both pre-menopausal (-0.35 kg adjusted difference in misreporting) and 
post-menopausal (-0.43 kg) females tended to over-report their weight less than males 
(Table 3).  
Overall individuals from all Hispanic/Latino background groups in the Bronx, and 
those of Puerto Rican and ‘Other’ backgrounds in Chicago under-reported their weight; 
by contrast those from all other site-background groups over-reported their weight 
(Appendix E). In Figure 10 we observed differential patterns of under-reporting among 
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the Hispanic/Latino backgrounds at the Bronx (Mexicans and Puerto Ricans under-
reported their weights less than Central Americans; Appendix E), but these trends were 
not replicated at any other study site (Figure 10). Within the four Hispanic/Latino 
backgrounds that were represented at more than one study site, all adjusted contrasts 
contained the null except for the comparisons of Central and South Americans from the 
Bronx to their counterparts in Miami (Appendix G). 
vi. Health-Related and Sociocultural Factors 
  When all other factors were held constant, underweight individuals were more 
likely to over-report their weight (1.58 kg adjusted difference in misreporting) as 
compared to normal-weight individuals, whereas over-weight and obese individuals were 
more likely to under-report their weights by -0.75 and -1.78 kg, respectively (Table 3). 
U.S.-born adults were more likely to under-report and foreign-born adults were more 
likely to over-report their weight (Appendix E).  Although the 95% CI for the adjusted 
difference between self-reported and measured weight comparing U.S.-born and 
foreign-born individuals contained the null (-0.31 kg, 95% CI: -0.69, 0.08 kg; Table 3), 
the direction of misreporting was consistent with unadjusted findings [-0.41kg, difference 
between US-born (-0.09 kg) and Foreign-born adults (0.32 kg); Appendix E].  
vii. Characteristics of Self-Reporting 
 On average, individuals who elected to report their weight in kg or used end 
digits of zeros and fives under-reported their weight, whereas those who chose to report 
in lb or used other end digits over-reported their weight (Appendix E). Adjusted 
estimates of difference in misreporting also supported the observation that individuals 
who used either larger units (i.e. kg, equivalent to roughly 2.2 lb), or end digits of zeros 
and fives to report weight were less likely to over-report their weight (Table 3). 
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5. Discussion 
 Given the diversity and recent population growth of Hispanic/Latinos residing in 
the U.S., there is a need to reassess the data quality and accuracy of self-reported 
weight, which is commonly used in obesity surveillance and epidemiologic 
investigations.  This study is the first to our knowledge to describe the accuracy of self-
reported weight in a large population-based sample of multiple Hispanic/Latino 
backgrounds—each with unique cultural, linguistic, and migration histories. We observed 
a strong correlation between self-reported and measured weight as well as slight over-
reporting of weight on average after quality control (r2=0.95, mean difference of 0.2 kg). 
This is consistent with good correlation described previously (r2≥0.9) [46, 50, 268] and 
over-reporting in a nationally representative sample of Mexican citizens (mean difference 
of 0.6 kg) [47]. Yet the finding of over-reporting is contrary to the under-reporting noted 
in nationally representative samples of U.S. Hispanic/Latinos[156] and two convenience 
samples of women in the U.S. and Guatemala [75, 268].  For example, estimates from 
the U.S. National Health and Nutrition Examination Survey (continuous 2007-2008 
NHANES) indicated that Hispanic/Latino adults under-reported their current weight on 
average (-0.35 kg), but the magnitude of under-reporting was less than half as much as 
observed among non-Hispanic/Latino Whites (-0.75 kg) [156].  To date the NHANES 
Hispanic/Latino samples have been primarily of Mexican heritage and US-born (foreign-
born: 39% of females and 48% of males in NHANES III [49]); whereas, HCHS/SOL is a 
diverse sample of predominantly foreign-birth (foreign-born: 84% of females and 81% of 
males, Appendix A).  
Although the mean difference between self-reported and measured weight did 
not contain the null, the magnitude of over-reporting observed in our study was 
considerably less than previous estimates of adult diurnal variability in weight, which 
have been reported to be up to 2 kg (4.4 lb) across a day [152].   We posit that the slight 
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over-reporting of weight may, in part, be attributable to the fact that the anthropometric 
assessment was conducted immediately following a urine collection within the fasting 
procedural block of time [43].  
We are further reassured by the observation that several established predictors 
of inaccuracy[47-49, 51, 75] were also predicted differential self-reporting in our study 
both before and after applying multivariate adjustments to account for other potential 
predictors. However, there are some interesting differences in the magnitude and 
directionality of misreporting by gender in our diverse sample of Hispanic/Latino self-
identified women and men. For example, in contrast to previous national estimates that 
described distinct effects of age by gender [153], we observed a similar tendency 
towards more over-reporting with increasing age in both females and males (data not 
shown).  The magnitude of over-reporting observed in our sample of women (Appendix 
E) was less than the magnitude of under-reporting reported in recent national estimates 
of self-reported weight inaccuracy for all U.S. women (-1.38 kg) and Hispanic/Latinas (-
0.59 kg) [156]. Even though the magnitude of over-reporting for males in our study was 
larger than these national estimates of all men and Hispanic/Latinos, the gender gap in 
self-report bias was narrower in our study than previous national estimates.  
Given that half of the current adult U.S. Hispanic/Latino population are foreign-
born,[95] previous studies from Latin America [47, 268] may inform the cultural origins of 
over-reporting of weight in samples like HCHS/SOL. In HCHS/SOL foreign-born adults 
on average over-reported their weight and their U.S.-born counterparts under-reported 
weight. This may be due in part to the cultural factors that influence body image and the 
complex process of acculturation to the dominant culture of the U.S. [157, 266, 267]. For 
example, qualitative studies of U.S. Hispanic/Latinas have documented a perception that 
their culture of origin considers a full figure to be desirable and healthy due to its 
connection with “wealth, affluence, and tranquility” [266], whereas in the U.S. they 
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perceive that it is desirable for women to be “extremely thin” [157]. Similarly in previous 
national estimates of Mexican Americans (NHANES III 1988-1994), foreign-born women 
and men (39% and 48% of sample) under-reported less and over-reported more than 
their U.S.-born counterparts [49].  
This current work is strengthened by a transparent discussion of our data quality 
concerns and control procedures. In sum our efforts resulted in <1% altered 
observations (16 recoded and 84 excluded; Appendix A), yet interestingly we noted that 
the extreme observations in the raw data set obscured the differential misreporting 
across measured weights (Figure 11C-D). Data quality control approaches to identify 
data errors that are based on a single criterion (e.g. >4 standard deviations), although 
straightforward, may compromise the representativeness of the analytic sample and 
artificially inflate estimates of accuracy. As such our approach to data quality control may 
be useful for future accuracy studies.   
In our sample 80% of participants preferred Spanish to complete the interview, 
but only 4% preferred to report their weight in kg, perhaps due to their participation in the 
U.S. medical system and its monitoring of weight in lb.  This is supported by the 
observation that the majority of individuals who reported their weight in kg did not have 
current health insurance (65%), whereas less than half of individuals who reported in lb 
did not have current health insurance (48%).  Although language preference did not 
appear to influence the accuracy of self-reported weight, self-reports made in kg were 
more accurate than those made in lb. This indicates that even though multiple units may 
necessitate additional quality control it may increase accuracy in future studies of U.S. 
Hispanic/Latinos.  Additionally predictors were missing in <10% of the sample and we 
successfully retained these observations in our multivariate models using multiple 
imputation.  
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Our work, however, is not without limitations. First, there is an inherent 
confounding by study site (geography) in the design of HCHS/SOL. Therefore we 
assessed the cross-classification of background and site and created contrasts both 
within background and site for strata with ≥100 individuals to assure positivity.  Although 
we were unable to fully decompose the effects of site and background, a predictive 
model including study site fit better than one with Hispanic/Latino background alone in 
exploratory analyses (data not shown). Our final multivariate model showed that within 
the Bronx there was more over-reporting of weight by Mexicans and Puerto Ricans, as 
compared to Central Americans (Figure 10). There was less over-reporting of weight by 
Central and South Americans living in the Bronx versus those living Miami and this 
pattern of less over-reporting in the Bronx was also consistent for Mexicans living in the 
Bronx versus those in San Diego (Appendix G). In light of the rigorous centralized 
coordination of the procedures and interviewing techniques of the HCHS/SOL baseline 
examination and the preference for self-reporting weights in lb at the Bronx (99%), future 
studies may want to examine if there is something unique about living in the Bronx that 
leads to Hispanic/Latino background groups to be more receptive to the U.S. cultural 
norms related to body size as they acculturate to the U.S.   
Second, although the HCHS/SOL baseline design and data collection were 
extensive, we were unable to fully explore all chronic conditions that might lead to large 
weight fluctuations in adulthood or frequent doctor visits.  However, we were able to 
assess prevalent diabetes, cancer, and health failure and they did not predict differential 
misreporting in our study.  
Lastly our results are not generalizable beyond the communities sampled in 
HCHS/SOL.  As such the slight over-reporting of weight observed in our sample of 
predominantly foreign-born Hispanic/Latino adults with a preference for Spanish may not 
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necessarily reflect the ever-increasing proportion of U.S.-born Hispanic/Latino adults [95] 
who may be more familiar with English and U.S. cultural biases around weight.  
 In summary, we observed a slight tendency towards over-reporting of weight 
(<0.3kg) in a community-based sample of adults from four U.S. urban centers, which 
was associated with demographic characteristics (age, gender, study site by 
background), health status (BMI categories), and self-report preferences (unit and digit 
preference). Etiologic analyses using self-reported weights in HCHS/SOL or similar 
samples of Hispanic/Latinos may need to account for the key sources of differential 
misreporting. Future studies of U.S. Hispanic/Latinos may increase their accuracy of 
self-reported weight by accommodating a participant’s language or unit preferences. As 
such this study provides insights into the potential for a distinct pattern of social 
desirability towards weight among U.S. Hispanic/Latinos and serves as a model for 
future studies in populations of diverse backgrounds.   
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6. Main Tables and Figures 
Table 3.  Regression beta coefficients of predictors of accuracy of self-reported weight 
as compared to measured weight (kg) in Hispanic/Latino adults 18-76 years of age in 
HCHS/SOL (2008-2011) (n=16,119).  
 SR-M* SE  95% CI  
Age (years) 
 
 
18-22  0 (ref)   
23-29  0.20 0.24 -0.27, 0.67 
30-44  0.48 0.20  0.08, 0.88 
45-59  0.76 0.20  0.37, 1.14 
60-76  
 0.82 0.24  0.36, 1.29 
Background by 
Site 
Dominicans- Bronx  0 (ref)   
Central American- Bronx -0.32 0.29 -0.88, 0.24 
Central American- Chicago  0.97 0.26  0.45, 1.48 
Central American- Miami  1.10 0.24  0.63, 1.57 
Cubans- Miami  1.01 0.19  0.64, 1.38 
Mexicans- Bronx  0.81 0.45 -0.07, 1.69 
Mexicans- Chicago  1.15 0.20  0.75, 1.54 
Mexican- San Diego  1.49 0.22  1.07, 1.91 
Puerto Ricans- Bronx  0.42 0.26 -0.09, 0.92 
Puerto Ricans- Chicago  0.61 0.32 -0.02, 1.24 
South American- Bronx -0.07 0.33 -0.73, 0.58 
South American- Chicago  0.80 0.28  0.24, 1.35  
South American- Miami  1.00 0.29  0.44, 1.56 
Other- Bronx -0.12 0.43 -0.96, 0.72 
Other- Chicago  0.33 0.52 -0.68, 1.34 
Other- Miami  1.16 0.39  0.40, 1.92 
Other- San Diego  1.58 0.41  0.79, 2.38 
Body Mass Index 
Categories 
Underweight (<18.5 kg/m2) 
 1.88 0.41  1.07, 2.69 
 Normal Weight (18.5-24.9 kg/m2)  0 (ref)   
 Overweight (25.0-29.9 kg/m2) -0.75 0.10 -0.95, -0.56 
 Obese (≥30.0 kg/m2) -1.78 0.13 -2.04, -1.52 
Cancer History Yes  -0.11 0.35 -0.79, 0.57 
 No  0 (ref)   
Diabetic Status** Normal Glucose Regulation  0 (ref)   
 Impaired Glucose Tolerance -0.18 0.12 -0.42, 0.05 
 Diabetes  0.17 0.16 -0.13, 0.48 
Education  Less than high school or a GED  0.01 0.13 -0.23, 0.26 
 At most high school or a GED  -0.10 0.12 -0.33, 0.13 
 More than high school or a GED  0 (ref)   
End Digit 
Preference 
5 or 10 -0.84 0.09 -1.02, -0.66 
1-4, 6-9  0 (ref)   
Gender Female, pre-, peri-menopausal*** -0.35 0.13 -0.60, -0.10 
 Female, post-menopausal -0.43 0.13 -0.69, 0.17 
 Male  0 (ref)   
Heart Failure 
History 
Yes  0.12 0.35 -0.56, 0.80 
No  0 (ref)   
Health Insurance Yes  0.09 0.12 -0.14, 0.33 
 No  0 (ref)   
Language 
Preference 
English  0.30 0.18 -0.06, 0.66 
Spanish  0 (ref)   
Nativity Born in the United States****  -0.31 0.20 -0.69, 0.08 
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Abbreviations: CI=Confidence interval, GED=General Education Development Equivalent of a 
High School Diploma, M=Measured weight, ref=Referent, SE=Standard error, SR=Self-reported 
weight, USD=United States Dollars.  
*Difference=self-reported minus measured weight (kg). Multivariate difference was calculated 
from a multivariate linear regression model of mean difference on the above possible 
determinants of validity (independent variables). 
**As defined by the American Diabetes Association [269]. 
***Women reporting not reporting ‘yes’ to having reached menopause (change of life) were 
assumed to be pre- or peri-menopausal. 
****As defined as being born in one of the 50 United States, not including United States 
Territories such as Puerto Rico. 
*****As defined in the 2008 Physical Activity Guidelines for adults [270]. 
 
 
  
 Foreign Born   0 (ref)   
Physical Activity 
Level***** 
Inactive  0.03 0.12 -0.22, 0.27 
Low Activity  0.03 0.13 -0.23, 0.29 
Medium Activity  0.29 0.16 -0.02, 0.60 
High Activity  0 (ref)   
Smoking Status Never  0 (ref)   
 Former  0.24 0.14 -0.03, 0.51 
 Current  0.13 0.13 -0.13, 0.38 
Socioeconomic 
Status 
Less than $30,000 USD  0.14 0.10 -0.06, 0.35 
$30,000 or more USD  0 (ref)   
Unit of Self-Report Kg -1.09 0.30 -1.67, -0.51 
 Lb  0 (ref)   
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Figure 9. Flow chart of staged quality control on 16,203 adult Hispanic/Latino 
participants (18-76 years) with both self-reported (SR) and measured (M) weight at the 
baseline examination (2008-2011) of the Hispanic Community Health Study/Study of 
Latinos (HCHS/SOL), resulting in 16 self-reported weights recoded due to unit 
confusion, 84 individuals excluded, and a final analytic sample of 16,119 participants. 
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Figure 10. Multivariate estimated differences in misreporting (defined as the difference 
between self-reported and measured weights) and 95% confidence intervals comparing 
the seven Hispanic/Latino backgrounds (CA=Central Americans, referent for all sites but 
San Diego; C=Cubans; D=Dominicans; M=Mexicans, referent for San Diego; PR=Puerto 
Ricans; SA=South Americans; O=Other) within the study sites (The Bronx, NY; Chicago, 
IL; Miami, FL; San Diego, CA; ≥100 participants of a given background per site). 
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Figure 11A-D. Change in scatterplots of self-reported (SR) weight (Panel A and B, unity 
shown by gray line) and the difference between SR and measured (M) weight as a 
function of M weight (Panel C and D, mean difference and ± 4 standard deviations 
shown by gray lines; 129 versus 137 observations beyond 4 standard deviations from 
the mean, respectively) in raw (Panels A,C; n=16,203 observations in black) and quality 
controlled datasets (Panels B,D; n=16,119 observations in black and recoded values in 
gray). 
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B. Manuscript 2: Trans-Ethnic Fine-Mapping of Genetic Loci for Body Mass 
Index in the Diverse Populations of the Population Architecture using Genomics 
and Epidemiology (PAGE) Study 
1. Overview 
Most body mass index (BMI) genetic loci have been identified in studies of 
primarily non-Hispanic/Latino European ancestries. The effect of these loci in other 
racial/ethnic groups is less clear. Thus we aimed to characterize the allelic heterogeneity 
at 170 established BMI variants, or their proxies, to diverse US populations and trans-
ethnically fine-map 36 BMI loci using a sample of >102,000 adults of African, 
Hispanic/Latino, Asian, European and American Indian/Alaskan Native descent from the 
Population Architecture using Genomics and Epidemiology Study. 
We restricted our analytic sample to adults with BMI between 18.5-70kg/m2 and 
performed linear regression of additive single nucleotide polymorphisms (SNPs) of the 
MetaboChip (Illumina, Inc.) on natural log-BMI, adjusting for age, sex, population 
stratification, study site or relatedness. We then performed fixed-effect meta-analyses 
and a Bayesian trans-ethnic meta-analysis to empirically cluster by allele frequency 
differences.  Lastly, we approximated conditional and joint associations to test for the 
presence of secondary signals. 
We noted directional consistency with the previously reported risk alleles beyond 
what would have been expected by chance (binomial p<0.05).  Nearly a quarter of the 
previously described BMI index SNPs and 29 of 36 densely-genotyped BMI loci on the 
MetaboChip replicated/generalized in trans-ethnic analyses. We observed multiple 
signals at 9 loci, including the description of seven loci with novel multiple signals. 
This study supports the generalization of most common genetic loci to diverse 
ancestral populations and emphasizes the importance of dense multi-ethnic genomic 
data in refining the functional variation at genetic loci of interest and describing allelic 
heterogeneity. 
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2. Introduction 
Obesity is a global epidemic and has become a top public health concern given 
its downstream effects on cardiovascular disease, diabetes, cancer, and other diseases 
[1]. In the United States (US), there are marked racial/ethnic differences in obesity 
prevalence among adults [2]. For example, the US National Health and Nutrition 
Examination Survey estimated that in 2009-2010, non-Hispanic/Latino African descent 
(50%) and Hispanic/Latino (39%) adults had the highest burden of obesity; whereas 
adults of non-Hispanic/Latino European descent had the lowest (34%). Studies of Asian 
descent subpopulations indicate that they may have an even lower prevalence of obesity 
between 4-10% [271].  Given that non-European ancestries and Hispanic/Latinos 
collectively make up more than one third of the US population and are experiencing 
some of the fastest population growth [272], future public health research on the 
determinants of obesity in US must be relevant to these racial/ethnic minorities.  
Body mass index (BMI, kg/m2) is commonly used to classify obesity in 
epidemiologic studies and has been shown to be a polygenic trait with heritability 
estimates ranging between 40-70% [12, 13].  As numerous genome-wide association 
studies (GWAS) of predominantly non-Hispanic/Latino European descent populations 
have identified more than 100 BMI loci [21, 24-26, 29, 33, 186, 195], little is known about 
the effect of these loci in non-European ancestries. Therefore, the study of diverse 
populations can inform the generalizability and allelic heterogeneity of established loci 
and aid the identification of causal variants through trans-ethnic fine-mapping.   
To this aim the Population Architecture using Genomics and Epidemiology 
(PAGE) Study was designed to extend the current body of knowledge on the genetic 
determinants of complex chronic diseases from studies of primarily non-Hispanic/Latino 
European descent populations to African, Hispanic/Latino, Asian and American 
Indian/Alaskan Native ancestries [41], which within the US are differentially affected by 
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the obesity epidemic [59, 271]. In this study of approximately 102,000 adults from 
diverse ancestries, we aimed to generalize a total of 170 previously described BMI index 
single nucleotide polymorphisms (SNPs), or their available proxies, located within 166 
loci and to fine-map 36 of these BMI loci with dense genotyping on the MetaboChip 
(Illumina, Inc.) using trans-ethnic meta-analytic methods to narrow the putative interval 
for future biologic study. 
3. Methods 
i. Study Population 
  The Population Architecture using Genomics and Epidemiology (PAGE) Study is 
comprised of several large study sites/consortia and a coordinating center bringing 
together samples of diverse populations including those included in this analysis: the 
Atherosclerosis Risk in Communities (ARIC) Study, the Epidemiologic Architecture for 
Genes Linked to Environment study accessing BioVU (EAGLE BioVU), Coronary Artery 
Risk Development in Young Adults (CARDIA), Cardiovascular Health Study (CHS), the 
Hispanic Community Health Study/Study of Latinos (HCHS/SOL), Multiethnic Cohort 
(MEC), the Women’s Health Initiative (WHI) [41]. Additional studies collaborating in this 
analysis also included: the GenNet Network (GenNet), the Hypertension Genetic 
Epidemiology Network (HyperGEN) Study, the MEC-Slim Initiative in Genomic Medicine 
for the Americas Type 2 Diabetes Consortium (MEC-SIGMA), the Mount Sinai School of 
Medicine BioBank (BioME), and the Taiwan-MetaboChip Study for Cardiovascular 
Disease (TaiChi) study.  A detailed description of each study can be found in our 
Supplemental Materials. 
Racial/ethnicity was self-reported in most studies except for EAGLE BioVU 
where racial/ethnicity is observer-reported [273, 274].  MEC-SIGMA sample included 
Type 2 Diabetes cases and controls from Los Angeles, CA [275]. The TaiChi Consortium 
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substudies were conducted in Taiwan, the San Francisco Bay Area, and Hawaii and 
represent East Asian ancestry [276]. The PAGE MEC and WHI Hispanic/Latino samples 
predominantly represent individuals of Mexican origin [277], whereas the HCHS/SOL [6] 
and BioME Hispanic/Latino samples were more diverse with respect to Hispnaic/Latino 
backgrounds and admixture (e.g. African, European and American Indian) [278]. The 
majority of WHI Asian American samples were of Chinese and Japanese descent, but 
also included smaller samples of other backgrounds (e.g. Hawaiian, Filipino, Korean, 
and Vietnamese). MEC represents both Japanese and Hawaiian ancestries, which were 
analyzed separately based on their self-reported Asian background. Only WHI recruited 
American Indians/Alaskan Natives.  Each study obtained approval from their Institutional 
Review Boards and written consent from all participants with the exception of EAGLE 
BioVU, which followed an opt-out program [255, 279].  
ii. Genotyping and Imputation  
The MetaboChip was a custom Illumina iSELECT array that contained 
approximately 195,000 SNPs and was designed to support large scale follow up of 
putative associations for cardiovascular and metabolic traits, including BMI [233]. 
Approximately 33% of the MetaboChip SNPs were included as replication targets and 
62% were included for fine-mapping within 257 targeted densely-genotyped loci, which 
included 21 loci associated with BMI as of 2009 [233] and 15 additional loci (i.e. 
originally included on the MetaboChip for other cardiometabolic traits) associated with 
BMI since 2009 [21, 25, 26, 33, 186, 195]. Collectively, these 36 densely-genotyped BMI 
MetaboChip loci include 37,900 SNPs (Appendix I), represent 20% of all BMI loci 
identified as of June 2016, and contain more than a third of all BMI index SNPs, or their 
proxies, on the MetaboChip.  We define a locus as was done as part of the design of the 
MetaboChip [233].  Therefore as shown in Appendix I the number of SNPs per locus, 
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which varied widely as a function of the base pair range of the putative region of interest 
(133 to 3,494 SNPs across 38 kb to 1.9Mb, respectively) and the tiered-prioritization of 
11 dense-genotyping for cardiometabolic phenotypes of interest (e.g. BMI) [233]. 
As part of the PAGE Study, the genotyping of the MetaboChip was performed at 
research genomics laboratories: the Human Genetics Center of the University of Texas-
Houston (Houston, TX), the Vanderbilt University Center for Human Genetics Research 
(CHGR) DNA Resources Core (Nashville, TN), University of Southern California 
Genomics Core (Los Angeles, CA), and the Translational Genomics Research Institute 
(Phoenix, AZ) [235].  Each genotyping center genotyped the same 90 HapMap YRI 
(Yoruba in Ibadan, Nigeria) samples and 2-3% study-specific blinded replicates to 
facilitate genotyping quality control. The study-specific SNP- and person-level quality 
control measures are summarized in Appendix J.  
Imputation of MetaboChip SNPs was conducted in MEC-SIGMA 
(Hispanic/Latinos only), BioME (African and Hispanic/Latino ancestries), and WHI 
(representing 54% of WHI African descent women, and all of the WHI European descent 
women) using 1000 Genomes phase 1 reference populations, or in the case of WHI 
using study-specific reference samples [237], and then filtered on imputation quality 
(Appendix J). Less than a third of the final analytic sample genotypes were imputed. 
Within each racial/ethnic group, related participants were identified within and 
across studies in PAGE using PLINK [261] to estimate identical-by-descent statistics. 
When apparent first-degree relative pairs were identified, the member from each pair 
with the lower call rate was excluded from further analysis with the exception of GenNet, 
HCHS/SOL, and HyperGen (Appendix J).  In these studies the family structure was 
either accounted for using a linear mixed models (GenNet, HyperGen) or a generalized 
estimating equation incorporating clusters of 1st degree relative pairs/household 
members (HCHS/SOL) [202]. Any samples from studies without extensive relatedness 
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identified by an inbreeding coefficient (F) >0.15 were excluded [236]. Principal 
components of ancestry were calculated using the Eigensoft software [280, 281] and 
determined either among the unrelated subset, or in the 1000 Genomes reference 
populations, and then projected to the study sample [202]. Ancestral outliers of the 
resulting principal components were excluded by the PAGE Coordinating Center from 
further analysis [235]. 
iii. Ascertainment of BMI 
 GenNet, HCHS/SOL, HyperGen, WHI and TaiChi studies. In EAGLE BioVU, the 
median weight and height were calculated across the complete medical histories [282]. 
For BioMe, height and weight measures were obtained from participants’ medical 
records at the time of enrollment [30, 33]. In MEC weight and height were self-reported 
by questionnaire with good validity [283, 284].  
BMI was then calculated as the ratio of weight to height squared.  Following 
previous PAGE study recommendations to remove extreme outliers [203, 204], BMI 
values <18.5 or >70 kg/m2 are excluded from most studies due to the potential for these 
extremes to be coding errors, reflect underlying illnesses or rare genetic mutations. 
However, due to the young age of CARDIA participants, individuals <18.5kg/m2 were 
retained in the analytic sample. To reduce the influence of growth and development on 
quantitative variation in BMI, we limited our analytic samples to adults >19 years of age 
in EAGLE BioVU, CARDIA, and BioME, and >20 years of age in HCHS/SOL. Across the 
PAGE studies we had genotype and BMI information available on a resulting analytic 
sample of 35,606 African, 26,048 Hispanic/Latino, 22,466 Asian and 535 American 
Indian/Alaskan Native descent adults (Appendices K-N).   
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iv. Statistical Analysis 
 As described previously [203, 204] the distribution of BMI was naturally log (ln) 
transformed to minimize the influence of outliers. All regression models were adjusted 
for age, sex, the top 2 to top 10 principal components, and study site, as appropriate for 
the racial/ethnic group and study (Appendix J). Study- and racial/ethnic-specific linear 
regression models were implemented in PLINK [261], R (WHI, https://cran.r-project.org), 
SNPTEST (BioME), GWAF (GenNet, HyperGen) [259], or a weighted version of a 
generalized estimating equation in SUGEN (HCHS/SOL) [202].  
v. Generalization of Established SNP-Associations with BMI in Diverse 
Populations  
 We created a Bonferroni corrected threshold of significance for the 170 index 
SNPs (or if unavailable on the MetaboChip, their highest LD proxy, r2≥0.8 in the 
discovery population 1000 Genomes pilot CEU, YRI, or CHB+JPT) from previous GWAS 
or MetaboChip-wide studies after accounting for the four loci with more than one 
racial/ethnic specific finding in strong linkage disequilibrium (LD, r2≥0.8 in CEU, YRI and 
CHB+JPT). Replication (i.e. in the same population of discovery) or generalization (i.e. to 
another racial/ethnic group) was declared if an index SNP was: 1) Bonferroni significant 
for 166 independent tests at this threshold and 2) had a consistent direction of effect as 
the previous report. This same threshold was applied to any index SNP within the 36 
densely-genotyped BMI loci.  Using a binomial distribution, we tested if the number of 
observed SNPs with directional consistency between the risk allele observed in this 
study and prior studies was greater than would be expected by chance (50% expected 
allele consistency by chance, p<0.05 significant).  
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vi. Replication/Generalization of 36 Densely-Genotyped BMI Loci in Diverse 
Populations 
 To identify independent signals in the fine-mapped regions, we generated a 
locus-specific Bonferroni correction for multiple comparisons based on the number of 
independent SNPs (r2≤0.2, pruned in PLINK using a 50-SNP window that was shifted by 
five SNPs each iteration) in the African descent samples with MetaboChip data from the 
ARIC Study (n=3,399). This served as a worst-case scenario of the maximum number of 
independent tests in the present study’s populations with the least LD. The resulting p-
value thresholds for statistical significance ranged from 6.31x10-5 to 1.39x10-3 (Appendix 
I).   
Among the subset of the 28,573 SNPs passing quality control and located in the 
36 densely-genotyped loci (range per locus: 110 to 2,785; Appendix I), we conducted 
inverse variance fixed-effect meta-analysis across studies (>100 observations each) in 
METAL (version 2011-03-25) [260] when the SNP was >0.1% minor allele frequency 
(MAF) in the racial/ethnic group and was informed by more than half of the maximum 
racial/ethnic-specific sample size.  
vii. Trans-Ethnic Meta-Analyses to Narrow the Putative Interval 
Similarly, we generated trans-ethnic meta-analyses for SNPs >0.1% MAF in each 
racial/ethnic group and informed by at least two populations and more than half of the 
maximum trans-ethnic sample size (n=101,979). We excluded American Indians/Alaskan 
Natives from our trans-ethnic fixed-effect estimates due to their small sample size and 
apparent extensive allelic heterogeneity given their recruitment across all nation-wide 
WHI recruitment centers (n=535). 
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Linkage Disequilibrium: Finally the fine-mapping of causal variants was informed 
by estimates of population-specific allele frequencies and LD correlation (r2, 500 Kb 
sliding windows) in PLINK [261] using genotypes from the ARIC (African descent), 
HCHS/SOL (Hispanic/Latino), and WHI studies (Asian, European, and American 
Indian/Alaskan Native ancestries). Trans-ethnic LD estimates were generated from a 
sample of 17,437 individuals from HCHS/SOL and WHI, which was proportionate to the 
racial/ethnic groups of our trans-ethnic meta-analysis. Regional plots were generated 
using LocusZoom to visualize trans-ethnic association differences as well as across the 
LD of various racial/ethnic groups [262]. 
 
Bayesian Trans-Ethnic Meta-Analysis: Lastly, the assumption of fixed-effects 
across racial/ethnic groups was relaxed in a Bayesian trans-ethnic meta-analysis in 
MANTRA, which allows for the empirical estimation of mean allele frequency differences 
between racial/ethnic groups as prior information in the clustering of the observed 
genetic effects across defined racial/ethnic groups [53]—in our case African, 
Hispanic/Latino, Asian and European ancestries. We adjusted for multiple comparisons 
in this Bayesian analysis by defining strong evidence in favor of association to have a 
Bayes Factor (BF)>5. Furthermore we also calculated the posterior probability 𝜙𝑗 that 
the jth SNP in the kth independent signal is causal as: 
𝜑𝑗 =
𝐵𝐹𝑗
∑ 𝐵𝐹𝑘𝑘
 
We then ranked all SNPs by their BFs and summed their cumulative posterior 
probabilities until it exceeded 99%. The resulting set of SNPs constitutes the 99% 
credible set and defines a genomic region where there is a 99% probability of containing 
the causal SNP, if the assumption holds that each region of interest contained only one 
causal variant. 
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Established and Novel Secondary Signals at Known Loci: We further investigated 
our trans-ethnic fixed-effect meta-analysis results at the 36 densely-genotyped loci for 
second independent signals using Genome-wide Complex Trait Analysis (GCTA, version 
64) [34, 188]. To inform our approximations we used the same trans-ethnic genotypes of 
17,437 individuals from HCHS/SOL, and WHI, which were used to calculate trans-ethnic 
LD above and were proportionate to the racial/ethnic groups of our trans-ethnic meta-
analysis.  Then we included the ‘lead SNP’ (i.e. the marker with the smallest p-value 
within each region) in an approximate conditional model and contrasted the conditional 
effect estimates and p-values of the surrounding SNPs with their unconditional estimates 
to ascertain if any additional SNPs that were at least associated unconditionally with BMI 
at p<0.05 arose as ‘independent’ after we adjusted for the lead SNPs. We repeated this 
approach including any additional significant lead conditional SNPs in the region until no 
additional independent significant SNPs were identified.   
Then we entered these potentially independent SNP markers into an 
approximate joint model in GCTA, which also included all of the lead SNPs in the 36 
densely-genotyped loci as well as the index SNPs outside of these regions.  Joint 
analyses were repeated dropping out the SNPs with non-significant joint p-values, until a 
final joint model included only significant joint SNP associations. As a sensitivity analysis 
of a subset of loci with evidence of two independent signals in the approximate GCTA 
analyses, we performed a single round of exact conditional analyses using statistical 
analysis software and performed fixed-effect meta-analysis in METAL as described 
above. In this round we adjusted for the lead fixed-effect trans-ethnic SNP and queried 
the significance of the remaining SNPs within the densely-genotyped region.  
The percent variance explained for a given SNP association (β) and frequency (f) 
was estimated for the significant joint SNP associations as previously described [33]:  
𝑉𝑎𝑟𝐸𝑥𝑝 = 𝛽2(1 − 𝑓)2𝑓 
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Additionally these significantly joint SNPs were queried for functional annotation in 
HaploReg (version 4.1) [285]. Both GERP and SiPhy conservation, as well as 
GENCODE and RefSeq genetic annotations were queried on each lead SNP.  
viii. Statistical Power 
  In Quanto version 1.2.4 [286] we calculated power to detect genetic effects on 
BMI.  Previous PAGE meta-analyses using this transformation have estimated that 
genetic effects for risk variants at FTO could be as much as 1% change in BMI per risk 
allele (or 0.0119 on the natural ln scale) [204].  Using information available on the worst-
case locus-specific Bonferroni correction from Appendix I (6.31x10-5), the varying BMI 
distributions and sample sizes of the race/ethnic specific and trans-ethnic meta-analyses 
we calculated power to detect effects up to as large as 1% change in BMI per risk allele.  
As shown in Appendix O, power was expected to be greatest in the trans-ethnic 
meta-analysis, which would allow for the identification of moderate genetic effects 
(>0.6% change per risk allele) at 80% power for low frequency variants (1%). Despite 
the smaller size of the Asian descent sample, we estimated that we generally would 
have better power in the analysis than in the African and Hispanic/Latino (>13,000 and 
>3,000 samples larger, respectively) descent analyses, which would allow us to describe 
large genetic effects at 80% for both low frequency and common variants (1%). In 
contrast, the African, Hispanic/Latino, and European descent analyses were expected 
not have sufficient power (<80%) to describe low frequency variants (e.g. 1%), and only 
had sufficient power (80%) to describe moderate effects (>0.6% change per risk allele) 
that were common (5%) in that specific race/ethnic group.    
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4. Results 
 Our study was comprised of 102,514 individuals from five racial/ethnic groups, 
with a mean age spanning from 27 years old (range: 20-37 years) in CARDIA to 73 
years (65-93 years) in CHS (data not shown).  The biobank studies (EAGLE BioVU, 
BioME), HCHS/SOL, HyperGen, and TaiChi each represented ages from more than 5 
decades across the life course. Women comprised the majority (or entirety, as in the 
WHI) of all studies, except for the TaiChi sample, which was only 39% female. Within 
sex obesity prevalence varied substantially across studies (26-64% of females and 19-
46% of males were obese at the time of examination/self-report). Yet obesity prevalence 
was higher in women and men of African, Hispanic/Latino and American Indian/Alaskan 
Native ancestry compared to women and men of Asian and European ancestry.  
i. Generalization of SNP-Associations to BMI in Diverse Populations 
  Overall, 135 of 165 SNPs, or their proxies (r2≥0.8), were previously shown to 
associate with BMI, passed quality control filters in at least two racial/ethnic groups, and 
displayed consistent directions of effect in the trans-ethnic fixed-effect meta-analysis 
(Appendix P). This is more concordant than would be expected by chance (binomial p, 
pbin=1.63x10-17).  Of all 170 index SNPs, or their proxies, that passed quality control 
filters in at least one racial/ethnic group, 42 were significantly associated with BMI in 
either the trans-ethnic analyses or in at least one racial/ethnic group (Appendices K-N, 
P, O). For example, we replicated two African descent-specific associations at GALNT10 
(rs4569924 p=4.79x10-5 [30]) and DHX34 (rs4802349, p=3.79x10-8 [204]), and 
demonstrated generalization of associations from previous studies of European descent 
populations for two SNPs at 8p12 (rs7844647, r2=0.96 in CEU, p=2.03x10-4 [186]) at 
AGBL4 (rs657452, p=5.52x10-6 [33]) to African and Hispanic/Latino descent individuals, 
respectively.  
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Eighteen of the 42 significant index SNP associations were only significant in the 
trans-ethnic sample, perhaps due to its larger sample size (Appendices K-N, P). Three 
SNPs exhibited significant heterogeneity across the racial/ethnic groups in the trans-
ethnic fixed effect meta-analysis, yet only one of these SNPs (rs116612809 the index 
SNP at BRE and the most significant (‘top’) SNP in the African descent and trans-ethnic 
fixed-effect analyses) persisted to have evidence in favor of association after accounting 
for the ancestral heterogeneity in a Bayesian meta-analysis.  One index SNP at TRAF3 
(rs7143963; [186]) was nominally significant and directionally consistent in both the 
African descent and trans-ethnic analyses, but only exhibited significant heterogeneity 
across the studies of African descent individuals (Appendix Q), wherein the effect 
estimates from two studies with <1,200 individuals were the most extreme (HyperGen 
n=1171, Risk Allele Frequency=66.9; MEC pilot n=433, 59.2%).  
ii. Replication/Generalization of 36 Densely-Genotyped BMI Loci in Diverse 
Populations 
 In 35,606 African descent individuals, 31 of 35 index SNPs (or their proxies) that 
passed quality controls and were located within one of the 36 densely-genotyped BMI 
loci showed an association that was directionally consistent with the previously reported 
risk allele (pbin=1.52x10-6). We observed no significant heterogeneity within the studies 
contributing samples of African descent individuals at either the index or lead SNPs. Our 
analysis of the dense genotypes of African descent individuals led to the generalization 
of 14 BMI loci (Table 4), including six loci (COBLL1, FLJ35779, SLC22A3, TCF7L2, 
MAP2K5, SH2B1) not previously associated and eight loci that were previously 
generalized to African descent individuals [204]: SEC16B, ETV5, TFAP2B, FTO and 
MC4R with the same lead SNP, and TMEM18, GNPDA2, and BDNF with a different top 
marker (r2 of 0.86, 0.98, 0.11, respectively).  Additionally as described previously [204], 
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rs116612809 at BRE replicated as the most significant SNP for BMI in our expanded 
African descent sample (Table 4). Thus our findings resulted in a total of 15 BMI loci with 
significant evidence of association in African descent individuals, six of which were best 
represented by the index SNP from GWAS of European [21, 33], and non-European 
populations [30, 32, 204].  
In a sample of 26,048 Hispanic/Latinos, 32 of 36 index SNPs in the densely-
genotyped BMI loci had associations that were directionally consistent with previous 
reports (pbin=8.57x10-7). We also observed no significant heterogeneity within the 
Hispanic/Latinos studies at either the index or lead SNPs. Using the dense-genotyping 
at 36 BMI loci, we were able to generalize 13 BMI loci to Hispanic/Latinos (Table 5), 
including 8 loci that were generalized to African descent individuals (SEC16B TMEM18, 
COBLL1, GNPDA2, TCF7L2, MAP2K5, FTO and MC4R) plus an additional 5 loci 
(LYPLAL1, IGF2BP2, SLC39A8, KCNQ1, MTCH2) that only generalized to 
Hispanic/Latinos.   
In the entire Asian descent sample (n= 22,466), 29 of 34 available index SNPs 
were directionally consistent (pbin=4.76x10-6). At MAP2K5 we did observe evidence of 
heterogeneity across the Asian descent studies at one nominally significant SNP 
(rs182297248, p=4.5x10-4, phet=2.7x10-4, Appendix R). Excluding the Hawaiian sample 
from the MEC (n=2,586) did diminish the effect heterogeneity (phet=2.3x10-3) and 
decreased the p-value, but it remained nominally significant (p=1.7x10-4). When we 
included the Hawaiian samples from the MEC we were able to generalize to Asian 
descent adults at eight BMI loci, including loci that were previously generalized to African 
descent individuals (FLJ35779, TFAP2B, BDNF), Hispanic/Latinos (MTCH2), or both 
racial/ethnic groups (GNPDA2, TCF7L2, FTO, MC4R) (Table 6). The lead SNP at MC4R 
was the index SNP from GWAS of European/trans-ethnic populations [21, 32]. In 
addition, we replicated three loci (CDKAL1, KCNQ1, QPCTL) that were previously 
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described in only Asian populations using lead SNPs that were in strong LD (r2>0.8) with 
the previously reported index SNPs [25, 195], or were the Asian index SNP itself [25, 26, 
195]. In summary a total of 11 BMI loci replicated or generalized to our sample of Asian 
Americans. We noted that MTCH2 and MC4R were no longer Bonferroni significant 
when we excluded the Hawaiian samples from the MEC in our exploratory analyses 
(p<3x10-4), and therefore carried forward the full Asian descent sample in our trans-
ethnic meta-analyses, below. 
In the European descent sample (n=17,859), 30 of 35 available index SNPs were 
directionally consistent (pbin=9.45x10-6). We observed no significant heterogeneity across 
studies at either the index or lead SNPs. Additionally, we replicated associations at nine 
BMI loci, including five loci that previously had not been associated with any other 
racial/ethnic group (NEGR1, LRPN6C, PRKD1, KCNJ2, KCTD15).  
Lastly, in the small sample of 535 American Indian/Alaskan Native women 22 of 
35 available BMI index SNPs were directionally consistent (pbin=4.30x10-2).  We were 
able to generalize the lead SNP (rs73012297, 6.55% change in BMI per C allele, 
p=2.2x10-4) at SLC22A3 to American Indian/Alaskan Native women, at a different lead 
SNP than had generalized to African descent individuals (rs116859471, in ARIC r2<0.01 
with top American Indian/Alaskan Native SNP; Table 4). 
iii. Trans-Ethnic Meta-Analyses to Narrow the Putative Interval 
 Across the ancestries carried forward to trans-ethnic analyses (African, 
Hispanic/Latino, Asian and European descent), we saw greater variability in risk allele 
frequencies than effect sizes at index BMI SNPs of the densely-genotyped BMI regions 
on the MetaboChip (Figure 12). Trans-ethnic fixed-effect meta-analysis in up to 101,979 
individuals generalized 29 of 36 BMI loci (Table 7). Most of these loci were already 
replicated/generalized to at least one racial/ethnic group (Figure 13).  
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The Bayesian trans-ethnic meta-analysis did not reveal additional loci strongly 
associated with BMI, as defined as log10 Bayes Factor>5 (Table 7). However, after 
accounting for ancestral heterogeneity 22 loci had strong evidence in favor of 
association and only three of these were noted to have a different lead SNP as seen in 
the fixed-effect analysis.  For example, at BRE the Bayesian approach resulted in a 
top/index SNP, which had significant heterogeneity across the African descent studies 
(Table 4) and across the racial/ethnic groups (Table 7); whereas, the fixed-effect meta-
analysis resulted in a lead SNP that was located ~300kb towards FOSL2 (Appendix S).  
The other two loci (IGF2BP2, QPCTL) with top significant SNPs that differed between 
the two trans-ethnic approaches appeared to be capturing the same signal across the 
range of LD (e.g. African to European descent) represented in our trans-ethnic meta-
analysis.  
 Using the physical location of the top fixed-effect racial/ethnic specific results, we 
compared our results to the initial range of the fine-mapped region (Appendix I) and 
calculated a percentage reduction of our putative interval of interest (Table 8).  Across 
the 29 loci with significant trans-ethnic fixed-effect estimates the reduction in base pairs 
and percentage narrowed ranged from 14,099 (37% of region) to 930,200 (72%).   
Using a Bayesian approach to account for ancestral heterogeneity, we used the 
physical bounds of the 99% credible set to reduce the putative interval by 52,690 base 
pairs (bp) at ETV5 (46% of region) to 764,979 bp at CDKAL1 (96% of region; Table 8). 
Figures 12-13 illustrate the trans-ethnic fixed-effect estimates of 12 loci where the 
Bayesian approach narrowed the putative interval to ≤12 SNPs.  The remaining 24 fine-
mapped regions are plotted in the Supplement (Appendices S-V). At three of these loci 
(SEC16B, TFAP2B, MC4R) the 99% credible set reduced the interval of interest by 
between from 182,749-566,266 bp to a single SNP (Figure 14).  
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iv. Established and Novel Secondary Signals at Known Loci 
 First, we sought to determine if previously reported secondary signals in studies 
of European descent individuals (BDNF, MC4R; [33]) were independently associated 
with BMI in our trans-ethnic sample. Consistent with previous reports we observed 
nominally significant evidence that rs10835210 (pc=4.22x10-2) at BDNF was independent 
of rs11030104. Two MC4R SNPs (rs9944545 pc=6.19x10-3, rs17066842 pc=1.48x10-2) 
were nominally independent of the index/lead SNP, rs6567160, in our trans-ethnic 
sample. Additionally we noted that rs2331841, originally reported in Asian populations 
[26], was also nominally independent of our top finding in the region (pc=4.10x10-2). All 
other conditional p-values were >0.24 or were not estimable.  
However, given that these index SNPs may not be the best markers of the BMI 
signals in our trans-ethnic sample, we then performed conditional analyses of the trans-
ethnic fixed-effect estimates in the 36 densely-genotyped BMI loci after adjusting for the 
top trans-ethnic fixed-effect SNP. Then in an approximate joint analysis (Table 9), we 
confirmed the presence of Bonferroni significant secondary signals at BDNF and MC4R, 
which were in low LD (r2<0.3) with our top trans-ethnic findings. Additionally, our 
conditional and joint analysis of GPRC5B (lead SNP, rs67501351; joint p, pj=7.70x10-19) 
and GP2 (index SNP, rs11074446; pj=1.69x10-7) indicated their independent 
associations with BMI. 
Similar to the previous observation of a secondary signal at FTO with Type 2 
diabetes [287], we also noted three additional independent signals in our trans-ethnic 
sample with BMI in conditional (not shown) and joint analyses (Table 9), which had 
varying degrees of LD in our trans-ethnic sample with our lead SNP (r2=0.05-0.41). We 
also observed evidence for 6 additional novel secondary signals at LYPLAL1, COBLL1, 
LOC646736, SLC39A8, TFAP2B, OVCH2 (Table 9). Incidentally 2 of these 10 loci had 
99% credible intervals that included 1-6 SNPs (TFAP2B and FTO; Figures 10-11). 
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Whereas, the 99% credible intervals for the other loci with novel conditional signals were 
less refined including ≥15 SNPs (Table 8).  
Interestingly the top/index SNP at BRE was significant in the single-variant model 
but not statistically significant in the joint model of the most significant SNPs 
representing each signal, which included a variant >3 Mb upstream at ADCY3 
(rs10182181, pj=2.42x10-10).  Conditional analyses adjusting for rs10182181 at ADCY3 
confirmed that the top fixed-effect and Bayesian SNPs in the region were no longer 
Bonferroni significant (pc=2.02x10-3 and 9.94x10-3, respectively), suggesting that this 
association may in part be related to long-range LD patterns.   
We also conducted an exact conditional sensitivity analysis in a subset (6 of 8 
loci) of the densely-genotyped BMI loci with evidence of two independent signals in the 
conditional and joint GCTA analyses.  At these six loci we noted at four loci locus-
specific Bonferroni significant conditional p-values (COBLL1, TFAP2B, BDNF, MC4R; pc 
exact≤1.4x10-5) and at two loci nominally significant conditional p-values (LYPLAL1 and 
SLC39A8; pc exact≤1.6x10-3). 
 Collectively the lead SNPs representing multiple signals within 9 densely-
genotyped regions varied dramatically in risk allele frequencies across the racial/ethnic 
groups (Appendix X) and explained an additional 0.025% of the variance (Table 9).  This 
was more than a third (38%) of the variance explained by all of the 35 SNPs that 
remained significant in the joint model (28 lead SNPs from the densely-genotyped 
regions plus 7 additional index SNPs located outside of these regions).  
v. Functional Annotation 
Of the 39 trans-ethnic lead SNPs within 28 loci, two were annotated to be non-
synonymous SNPs (SLC39A8, GIPR) and 19 were intronic SNPs (Appendix Y). Among 
the loci where we were able to fine-map the putative casual variant(s) there were several 
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interesting functional consequences. For example, the lead and index SNP 8.8kb 3’ of 
SEC16B and 3.6kb 3’ of RP4-798P15.2 was conserved across species, and from 
histone modification assessment was predicted to be an enhancer in muscle tissue. The 
lead SNPs 43kb 3' of TMEM18 was predicted to change BCL and TR4 motifs, and within 
C10orf32-AS3MT was identified as an eQTL. The lead and index SNP within TCF7L2 
was found to be a promoter in pancreas; an enhancer in fat, muscle, and five other 
tissues; and changed several binding motifs. The non-synonymous lead SNP at the 
QPCTL locus was located within GIPR, which is conserved across species, was an 
enhancer, promoter, DNAse sensitive region in several tissues including fat, muscle, and 
pancreas, found to bind with and change the CTCF and several other binding motifs, as 
well as bind to CMYC.  
Similarly, for the loci with multiple signals we noted varied functional 
consequences at several SNPs.  For example, both lead SNPs upstream of the 3' of 
LYPLAL1 and 287kb 5' of RNU5F were predicted to be enhancers in fat and a number of 
other tissues, and modify motifs of a number of binding factors. Whereas the lead SNP 
for the primary signal at 1.7kb 3' of COBLL1 alters the binding site for MAFK, the lead 
SNP for the secondary signal located intronic at COBLL1. Between AC068138.1 (>40kb 
5’) and IRS1 (>400kb 3’) lead SNPs for multiple signals were predicted to alter binding 
motifs and the the lead SNP for the secondary signal was also an enhancer in brain 
tissue. Whereas the lead and index SNP for the primary signal at SLC39A8 was a non-
synonymous mutation and conserved across species, the secondary signal was located 
38kb 3' of SLC39A8 and predicted to alter a number of binding motifs. At the primary 
signal lead SNP 1.6kb 5' of TFAP2B was predicted to modify both TATA and GAGA bind 
motifs, and the secondary signal was predicted to modify three other motifs. The primary 
and secondary signals intronic at TRIM66 and STK33 both were predicted to change 
HDAC2 sites, but the secondary site was conserved across species and was also an 
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enhancer in fat and skin. Both the lead SNPs of the multiple BDNF-AS1 and BDNF 
signals were conserved across species, were predicted to be enhancer in brain and 
other tissues, and were DNAse sensitive regions; however, the primary signal was 
intronic to BDNF antisense RNA, which binds to GATA2 and YY1. All of the multiple 
signals were intronic at FTO andpredicted to be enhancers in at least muscle as well as 
either fat or brain and lead/index SNPs representing two of the four regions were DNAse 
sensitive in brain tissue. The primary and tertiary signals at FTO were conserved across 
species, but the tertiary signal was also predicted to be a promoter in fat and change a 
binding motif for FOXA1 and FOXA2 binding. Lastly, the lead and index SNP for the 
primary signal 209kb 3' of MC4R and 1.7kb 5' of U4, a small nucleor RNA, was 
conserved across species and DNAse sensitive in muscle, whereas the lead SNP for the 
secondary signal was located 44kb 5' of MC4R and was in high LD (r2>0.8 in 1000 
Genomes AFR) with a highly conserved non-synonymous SNP (rs2229616) 44kb 
upstream within MC4R, which alters a GATA binding motif and has histone markers 
consistent with promoter and enhancer in brain. 
5. Discussion 
 In this analysis we find that nearly a quarter of the previously described BMI 
index SNPs and >80% of the densely-genotyped BMI loci on the MetaboChip (29 of 36) 
met our definition for generalization in our trans-ethnic sample of 101,979 adults. The 
trans-ethnic meta-analyses, which are better powered than racial/ethnic specific 
analyses (Appendix O) for genetic loci that are shared across ancestral groups [288], 
demonstrate the similarity in the genetic underpinnings of obesity and transferability of 
common genetic loci to diverse populations.  
The results show that while much of the genetic architecture underlying these 
adiposity-related traits is shared across ancestral groups, we also found evidence for 
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allelic heterogeneity and therefore unique functional variation at established loci in non-
European descent populations. However, some of the BMI loci assessed in this study (7 
of 36) were not significant in the trans-ethnic fixed-effect meta-analysis. Three of these 
replicated in European Americans only (NEGR1, PRKD1, KCNJ2).  One locus 
(SLC22A3) generalized to African and American Indian/Alaskan Native descents, and 
two more were significant but were directionally inconsistent with the index report that 
was in low LD in European Americans from WHI with the top trans-ethnic SNP (KCNJ11 
and TRAFD1, r2<0.01; Appendices K-N, P), suggesting that it may either be a spurious 
finding or represent a distinct haplotype at this locus. Overall these observations are 
consistent with the hypothesis that the majority of common genetic loci for complex traits 
like BMI will generalize to diverse populations given sufficient statistical power (a 
function of allele frequency, effect size and sample size, etc.) and that spurious findings 
and effect dilution can be avoided through the consideration of directional consistency as 
well as fine-mapping techniques [52]. 
The majority of the current literature on the genetic epidemiology of BMI comes 
from European descent populations [40]. Consistent with a recent study of BMI [33], we 
also observed evidence in support of multiple signals at BDNF, MC4R and 
GPRC5B/GP2. Yet due to the allelic heterogeneity of our diverse sample, we were able 
to describe novel independent signals at 7 BMI loci with at least two independent signals 
with varying risk allele frequencies across African, Hispanic/Latino, Asian and European 
ancestries of our study (LYPLAL1, COBLL1, LOC646736, SLC39A8, TRAP2B, OVCH2, 
and FTO). Additional sensitivity analysis of exact conditional analysis at a subset of 
these loci support the presence of multiple signals in our data. In previous work we 
noted a possible secondary signal in Hispanic/Latina women at TRAP2B [193], which 
was supported by this analysis. Interestingly, we noted the presence of four independent 
signals at FTO and three of the four FTO signals were within the physical bounds of the 
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putative interval of interest in African descent individuals of the PAGE Study [289]. Yet 
no secondary signals were observed at FTO in this previous study and others with less 
diverse samples [33, 34, 204].  
Collectively the 11 secondary (or beyond) variants within 9 established BMI loci 
on the MetaboChip account for more than a third of the total variance explained by all of 
the SNPs in the joint model, which further illustrates the added value of diverse 
populations in mapping allelic heterogeneity. Eleven of the 20 independent primary and 
secondary (or beyond) SNPs at the 9 loci with multiple signals had a range of risk alleles 
>20% across the racial/ethnic populations included in our trans-ethnic meta-analysis 
(Appendix X). One such SNP at FTO (rs7206790) also exhibited significant evidence of 
heterogeneity across race/ethnicities (Table 9). However, future independent effect 
estimation and replication is needed to accurately describe the variance explained and 
the true genetic effects in similar diverse populations.  
A strength of this work is that it addresses a knowledge gap on the genetic 
architecture of BMI [40] in populations with distinct burdens of obesity [2, 271] by 
expanding on previous fine-mapping efforts conducted by the PAGE Study [204], which 
generalized 8 of 21 BMI loci known at the time to African descent individuals. Since then 
the tally of BMI loci densely covered on the MetaboChip has grown to 36 and a recent 
large meta-analysis of >322,000 predominantly European descent samples illustrated 
the potential benefit for fine-mapping (at 26 of the known BMI loci at the time) [33].  
Moreover, recently a handful of non-European BMI signals have been published in 
African descent and Asian GWAS and we were able to incorporate several of these non-
European or trans-ethnic reports [25, 26, 30, 32, 195], while including almost 67,000 
more Hispanic/Latino, Asian, European and American Indian/Alaskan Native descent 
adults than previous PAGE fine-mapping endeavors [204]. 
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In the current study, we note the same lead SNP (e.g. SEC16B, LOC646736, 
SLC39A8, FAIM2, TCF7L2, MC4R) as previously reported in a much larger but less 
diverse [33] analysis using an approximate Bayesian fine-mapping approach [290]. 
Compared to these previous works, using a Bayesian trans-ethnic fine-mapping 
approach we are able to narrow the putative region of interest (in base pairs) equally 
well or better than these previous reports at 9 of 20 loci reported on previously that also 
exhibited strong evidence of association with BMI at the lead SNP in our study 
(SEC16B, TMEM18, LOC646736, TFAP2B, NT5C2, TCF7L2, BDNF, MC4R, QPCTL), 
and then determine if the assumption of one underlying signal held (e.g. SEC16B, 
TMEM18, NT5C2, TCF7L2, QPCTL) to interpret our 99% credible intervals as the 
probability of containing the underlying functional SNP at these narrowed loci.   
In order to relax the assumption of fixed genetic effects in all of the racial/ethnic 
groups, we have also strengthened our analysis by performing a trans-ethnic Bayesian 
analysis, wherein we applied empirical estimates of the mean allele frequency 
differences to appropriately cluster the racial/ethnic groups and construct credible 
intervals, representing our confidence that the causal SNP lies within its bounds. We 
acknowledge that our findings and credible intervals are limited by the presence of 
multiple signals within a locus (e.g. at TFAP2B, MC4R). Although approximate 
conditional and joint analyses of fixed-effect estimates ruled out the presence of 
statistically significant secondary signals at 27 densely-genotyped loci, future work 
should focus on all aspects of genetic variation that lie within the physical bounds of the 
99% credible interval and continue to test the assumption of no secondary signals at 
these loci or their impact on fine-mapping. 
Fine-mapping resolutions depend on many factors, such as the extent of LD 
within the locus, allele frequencies and sample sizes of populations. Not surprisingly in 
this study the narrowing of the interval in trans-ethnic meta-analyses varied from one 
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locus to another (Table 8). Furthermore, the additional improvement in resolution offered 
by a Bayesian trans-ethnic meta-analysis related to the ancestral heterogeneity at a 
given locus, the extent to which the estimated allele frequency differences across 
populations captured this heterogeneity, the number of independent signals, and their 
allele frequencies. 
 Overall herein we find that nearly a quarter of the previously described BMI index 
SNPs and >80% of the densely-genotyped BMI loci generalize trans-ethnically. Thus 
study represents an important step towards prioritizing strong candidates for future 
epidemiologic study and targeted functional follow-up to identify causal variants for 
etiologic research and drug development. An improved understanding of the genetic 
architecture and the population diversity of complex traits such as BMI will in turn 
improve our ability to tailor both interventions to populations and to the individuals within 
them. Our systematic interrogation of the dense-genotyping at 36 BMI loci for their 
generalization to diverse populations further refines the regions of putative interest, and 
illustrates the importance of dense multi-ethnic genomic data in describing the allelic 
heterogeneity of diverse ancestral populations. 
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6. Main Tables and Figures 
Table 4. Replication or generalization of 15 of the fine-mapped 36 BMI loci on the MetaboChip to 35,606 African descent adults. 
Gene SNP rsID Chr Bp37 A1 A2 Freq β (%) SE (%) P*** I2 HetP N r2 range**** in 
ARIC 
r2 range**** 
in WHI 
SEC16B Index rs543874 1 177,889,480 g a 0.249 1.37 0.17 6.0E-15 44.5 4.2E-02 35,604   
 Top rs543874 1 177,889,480 g a 0.249 1.37 0.17 6.0E-15 44.5 4.2E-02 35,604 0.32-1 (same) 0.96-1 (same) 
TMEM18 Index rs13021737 2 632,348 g a 0.883 1.36 0.23 8.9E-09 26.8 1.7E-01 35,541   
 Top rs10865549 2 631,759 a g 0.883 1.52 0.24 6.4E-10 0 5.0E-01 33,352 0.42-1.00 1.00 
BRE*,** Index rs116612809 2 28,301,171 g a 0.097 1.39 0.25 6.4E-08 0 6.3E-01 35,583   
 Top rs116612809 2 28,301,171 g a 0.097 1.39 0.25 6.4E-08 0 6.3E-01 35,583 1 (same) 1 (same) 
COBLL1* Index rs10184004 2 165,508,389 t c 0.719 0.72 0.17 2.1E-05 32.2 1.2E-01 35,598   
 Top rs10184004 2 165,508,389 t c 0.719 0.72 0.17 2.1E-05 32.2 1.2E-01 35,598 1 (same) 1 (same) 
ETV5 Index rs1516725 3 185,824,004 c t 0.817 0.64 0.20 1.2E-03 6.9 3.8E-01 35,485   
 Top rs7647305 3 185,834,290 c t 0.594 0.68 0.15 1.1E-05 0 5.3E-01 35,602 0.18 0.57 
GNPDA2 Index rs10938397 4 45,182,527 g a 0.250 0.77 0.17 8.4E-06 51.9 1.5E-02 35,517   
 Top rs181153926 4 45,165,656 t c 0.249 0.87 0.18 1.6E-06 44.5 4.8E-02 32,146 0.22-0.98 - 
FLJ35779 Index rs2112347 5 75,015,242 t g 0.495 0.09 0.15 5.5E-01 0 8.9E-01 35,604   
 Top rs984976 5 74,910,870 a g 0.150 0.88 0.22 5.4E-05 0 5.2E-01 35,595 0.09 0.36 
TFAP2B Index rs2207139 6 50,845,490 g a 0.096 0.79 0.26 2.0E-03 44.7 4.1E-02 35,605   
 Top rs2744475 6 50,784,880 g c 0.331 0.84 0.16 2.0E-07 7.5 3.7E-01 35,513 0.19 0.47 
SLC22A3* Index rs3127574 6 160,791,370 c g 0.587 0.03 0.15 8.3E-01 4 4.1E-01 35,597   
 Top rs116859471 6 160,736,564 t a 0.002 7.37 1.95 2.4E-04 53.3 1.8E-02 33,916 <0.01 <0.01 
TCF7L2* Index rs7903146 10 114,758,349 c t 0.706 0.66 0.17 6.1E-05 26.7 1.8E-01 35,604   
 Top rs7903146 10 114,758,349 c t 0.706 0.66 0.17 6.1E-05 26.7 1.8E-01 35,604 1 (same) 1 (same) 
BDNF Index rs11030104 11 27,684,517 a g 0.951 1.28 0.36 3.8E-04 14.6 3.0E-01 35,606   
 Top rs7929344 11 27,743,495 a g 0.245 0.78 0.18 1.1E-05 28.5 1.6E-01 35,586 0.02-0.05 <0.01 
MAP2K5 Index rs16951275 15 68,077,168 t c 0.610 0.57 0.15 2.7E-04 0 5.7E-01 35,605   
 Top rs3784718 15 68,098,004 c t 0.630 0.61 0.16 1.2E-04 0 5.9E-01 34,268 0.52-0.93 0.53-0.99 
SH2B1 Index rs2650492 16 28,333,411 a g 0.064 0.70 0.33 3.5E-02 0 5.3E-01 35,590   
 Top rs8061590 16 28,895,130 g a 0.312 0.69 0.16 2.5E-05 29.8 1.5E-01 35,592 0.82 1.00 
FTO Index rs17817964 16 53,828,066 t c 0.118 1.05 0.24 1.2E-05 33 1.2E-01 35,606   
 Top rs62048402 16 53,803,223 a g 0.114 1.19 0.24 1.1E-06 23 2.1E-01 35,603 0.91-0.98 0.94-1.00 
MC4R Index rs6567160 18 57,829,135 c t 0.189 1.08 0.19 2.8E-08 58.9 3.7E-03 35,599   
 Top rs6567160 18 57,829,135 c t 0.189 1.08 0.19 2.8E-08 58.9 3.7E-03 35,599 <0.01-1 
(same) 
<0.01-1 
(same) 
Abbreviations: A1=coded allele, A2=non-coded allele, β=Effect Size, Bp37=base pair Build 37, Chr=chromosome, Freq=coded allele frequency, 
HetP=heterogeneity p-value, P=p-value, SE=standard Error, SNPs=single nucleotide polymorphisms. 
*Note: Starred genes represent fine-mapped loci, which were associated with BMI after the design of the MetaboChip in 2009. 
**PAGE trans-ethnic discovery signal (Gong et al., submitted to Nature Communications).  
***For GWAS SNPs a Bonferroni correction for multiple tests reflected the number of independent previously-reported signals tested (=0.05/166; 
Appendices K-N, P). For all other SNPs in the fine-mapped BMI regions, we performed a Bonferroni correction for the number of independent 
SNPs per region (r2<0.2 in ARIC African-Americans; Appendix I). 
****The range of linkage disequilibrium captures any SNP within the fine-mapped loci (Appendices K-N, P) that represents the index BMI signal or 
secondary signal (described in European descent populations), or race/ethnic population specific marker. ARIC and WHI samples were used to 
represent the linkage disequilibrium for the PAGE African and European descent samples. 
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Table 5. Generalization of 13 of the fine-mapped 36 BMI loci on the MetaboChip to 26,048 Hispanic/Latino descent adults. 
Gene SNP rsID Chr Bp37 A1 A2 Freq β (%) SE (%) P*** I2 HetP N 
r2 range**** 
in HCHS/SOL 
r2 range**** 
in WHI 
SEC16B Index rs543874 1 177,889,480 g a 0.202 0.76 0.20 1.8E-04 0 4.4E-01 26,045   
 Top rs543874 1 177,889,480 g a 0.202 0.76 0.20 1.8E-04 0 4.4E-01 26,045 0.81-1 (same) 0.96-1 (same) 
LYPLAL1** Index rs2820436 1 219,640,680 a c 0.439 0.63 0.17 1.6E-04 0 4.8E-01 26,046   
 Top rs2820446 1 219,748,818 g c 0.414 0.89 0.17 1.3E-07 50.8 5.8E-02 25,991 0.33 0.55 
TMEM18 Index rs13021737 2 632,348 g a 0.867 1.14 0.24 3.6E-06 29.5 2.0E-01 26,016   
 Top rs6744653 2 628,524 g a 0.849 1.25 0.23 8.5E-08 43.9 9.8E-02 26,047 0.82-0.88 1.00 
COBLL1* Index rs10184004 2 165,508,389 t c 0.326 0.39 0.18 3.2E-02 44 9.7E-02 26,045   
 Top rs12692738 2 165,558,252 c t 0.252 0.77 0.20 1.1E-04 33 1.8E-01 26,045 0.67 0.45 
IGF2BP2** Index rs11927381 3 185,508,591 t c 0.673 0.52 0.18 3.9E-03 23.6 2.5E-01 25,976   
 Top rs6778126 3 185,405,781 g a 0.515 0.63 0.17 1.5E-04 43.9 9.8E-02 26,043 0.14 0.05 
GNPDA2 Index rs10938397 4 45,182,527 g a 0.372 0.70 0.17 4.7E-05 49.1 6.7E-02 26,020   
 Top rs10938398 4 45,186,139 a g 0.371 0.72 0.17 2.9E-05 44.5 9.4E-02 26,048 0.45-0.99 0.55-0.99 
SLC39A8* Index rs13107325 4 103,188,709 t c 0.046 1.03 0.39 9.5E-03 55.2 3.7E-02 26,048   
 Top rs63519 4 103,202,914 a c 0.142 0.85 0.24 3.4E-04 31.6 1.9E-01 26,048 0.29 0.26 
TCF7L2* Index rs7903146 10 114,758,349 c t 0.739 0.79 0.19 3.3E-05 63.8 1.1E-02 26,047   
 Top rs7903146 10 114,758,349 c t 0.739 0.79 0.19 3.3E-05 63.8 1.1E-02 26,047 1 (same) 1 (same) 
KCNQ1* Index rs2237897 11 2,858,546 t c 0.200 0.82 0.22 1.4E-04 0 9.1E-01 26,044   
 Top rs60808706 11 2,857,233 a g 0.217 0.90 0.21 1.6E-05 0 6.2E-01 26,045 0.83 0.60 
MTCH2 Index rs3817334 11 47,650,993 t c 0.397 0.51 0.17 2.5E-03 0 6.1E-01 26,040   
 Top rs11039448 11 47,918,416 t g 0.653 0.88 0.17 4.0E-07 0 4.7E-01 26,048 0.25 0.47 
MAP2K5 Index rs16951275 15 68,077,168 t c 0.531 0.37 0.17 3.4E-02 25.4 2.4E-01 26,046   
 Top rs76616765 15 68,003,745 g c 0.010 3.95 0.91 1.9E-05 0 6.4E-01 24,207 <0.01 <0.01 
FTO Index rs17817964 16 53,828,066 t c 0.253 1.37 0.19 2.1E-12 47.2 7.8E-02 26,046   
 Top rs7187250 16 53,810,546 a c 0.300 1.34 0.18 2.6E-13 47.8 7.4E-02 26,044 0.69-0.73 0.94-0.98 
MC4R Index rs6567160 18 57,829,135 c t 0.146 1.12 0.24 3.3E-06 53 4.7E-02 26,047   
 Top rs72982988 18 57,802,714 a g 0.151 1.22 0.24 2.8E-07 16.8 3.0E-01 26,048 <0.01-0.79 <0.01-0.75 
Abbreviations: A1=coded allele, A2=non-coded allele, β=Effect Size, Bp37=base pair Build 37, Chr=chromosome, Freq=coded allele frequency, 
HetP=heterogeneity p-value, P=p-value, SE=standard Error, SNPs=single nucleotide polymorphisms. 
**PAGE trans-ethnic discovery signal (Gong et al., submitted to Nature Communications).  
***For GWAS SNPs a Bonferroni correction for multiple tests reflected the number of independent previously-reported signals tested (=0.05/166; 
Appendices K-N, P). For all other SNPs in the fine-mapped BMI regions, we performed a Bonferroni correction for the number of independent 
SNPs per region (r2<0.2 in ARIC African-Americans; Appendix I). 
****The range of linkage disequilibrium captures any SNP within the fine-mapped loci (Appendices K-N, P) that represents the index BMI signal or 
secondary signal (described in European descent populations), or race/ethnic population specific marker. HCHS/SOL and WHI samples were 
used to represent the linkage disequilibrium for the PAGE Hispanic/Latino and European descent samples. 
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Table 6. Replication or generalization of 11 of the fine-mapped 36 BMI loci on the MetaboChip to 22,465 Asian descent adults. 
Gene SNP rsID Chr Bp37 A1 A2 Freq β (%) SE (%) P*** I2 HetP N 
r2 range**** 
in HCHS/SOL 
r2 range**** in 
WHI 
GNPDA2 Index rs10938397 4 45,182,527 g a 0.279 0.55 0.15 2.6E-04 24 2.3E-01 22,386   
 Top rs10938398 4 45,186,139 a g 0.281 0.57 0.15 1.6E-04 20.5 2.6E-01 22,464 0.81-1 (same) 0.96-1 (same) 
FLJ35779 Index rs2112347 5 75,015,242 t g 0.443 0.45 0.14 9.0E-04 10.3 3.5E-01 22,464   
 Top rs56912706 5 75,037,086 a g 0.517 0.57 0.13 2.2E-05 0.4 4.3E-01 22,464 0.33 0.55 
CDKAL1*,** Index rs9356744 6 20,685,486 t c 0.595 0.86 0.14 5.3E-10 42.6 8.4E-02 22,461   
 Top rs9368222 6 20,686,996 c a 0.597 0.88 0.14 2.0E-10 38.9 1.1E-01 22,393 0.82-0.88 1.00 
TFAP2B Index rs2207139 6 50,845,490 g a 0.210 0.29 0.17 8.5E-02 0 6.0E-01 22,464   
 Top rs2076308 6 50,791,640 c g 0.270 0.61 0.15 6.3E-05 0 8.0E-01 22,461 0.67 0.45 
TCF7L2* Index rs7903146 10 114,758,349 c t 0.934 1.49 0.32 4.6E-06 50.6 4.0E-02 22,465   
 Top rs4506565 10 114,756,041 a t 0.931 1.50 0.32 3.7E-06 49.5 4.5E-02 22,465 0.14 0.05 
KCNQ1* Index rs2237897 11 2,858,546 t c 0.353 0.73 0.18 3.5E-05 62.1 9.9E-03 14,181   
 Top rs2299620 11 2,858,295 t c 0.389 0.85 0.17 6.8E-07 42.8 9.3E-02 14,182 0.45-0.99 0.55-0.99 
BDNF Index rs11030104 11 27,684,517 a g 0.566 0.10 0.14 4.5E-01 61.9 7.2E-03 22,465   
 Top rs11030100 11 27,677,586 g t 0.570 0.53 0.14 1.1E-04 49.9 4.3E-02 22,465 0.29 0.26 
MTCH2 Index rs3817334 11 47,650,993 t c 0.312 0.23 0.14 1.2E-01 0 8.7E-01 22,447   
 Top rs76229852 11 47,258,369 g a 0.958 1.48 0.34 2.0E-05 20.9 2.6E-01 22,465 1 (same) 1 (same) 
FTO Index rs17817964 16 53,828,066 t c 0.223 1.28 0.17 2.2E-14 0 4.9E-01 22,465   
 Top rs3751812 16 53,818,460 t g 0.185 1.56 0.17 5.5E-19 0 5.4E-01 22,463 0.83 0.60 
MC4R Index rs6567160 18 57,829,135 c t 0.197 0.67 0.17 9.0E-05 0 5.8E-01 22,461   
 Top rs6567160 18 57,829,135 c t 0.197 0.67 0.17 9.0E-05 0 5.8E-01 22,461 0.25 0.47 
QPCTL* Index rs11671664 19 46,172,278 g a 0.531 0.57 0.14 4.2E-05 0 8.4E-01 22,460   
 Top rs11671664 19 46,172,278 g a 0.531 0.57 0.14 4.2E-05 0 8.4E-01 22,460 <0.01 <0.01 
Abbreviations: A1=coded allele, A2=non-coded allele, β=Effect Size, Bp37=base pair Build 37, Chr=chromosome, Freq=coded allele frequency, 
HetP=heterogeneity p-value, P=p-value, SE=standard Error, SNPs=single nucleotide polymorphisms. 
**PAGE trans-ethnic discovery signal (Gong et al., submitted to Nature Communications).  
***For GWAS SNPs a Bonferroni correction for multiple tests reflected the number of independent previously-reported signals tested (=0.05/166; 
Appendices K-N, P). For all other SNPs in the fine-mapped BMI regions, we performed a Bonferroni correction for the number of independent 
SNPs per region (r2<0.2 in ARIC African-Americans; Appendix I). 
****The range of linkage disequilibrium captures any SNP within the fine-mapped loci (Appendices K-N, P) that represents the index BMI signal or 
secondary signal (described in European descent populations), or race/ethnic population specific marker. WHI samples were used to represent 
the linkage disequilibrium for the PAGE Asian and European descent samples. 
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Table 7. Trans-ethnic fixed-effect and meta-analysis of 36 BMI loci and Bayesian fine-mapping in up to 101,979 individuals. 
  TOP FIXED-EFFECT TOP MANTRA 
Gene  rsID Chr Bp37 Ref. 
Risk 
Allele 
A
1 
A
2 
Freq  β  
(%) 
SE 
(%) 
P*** I2 HetP**** N r2 
range****
* in TE 
Sample 
rsID Bp37 log
10 
BF 
Post 
prob. 
Het 
N r2 
range****
* in TE 
Sample 
NEGR1 Ind. rs3101336 1 72,751,185 C c t 0.655 0.17 0.09 6.8E-02 69.4 2.0E-02 101,969        
 Top rs1460939 1 72,861,567  t a 0.868 0.47 0.13 4.3E-04 0.6 3.9E-01 101,976 0.18 rs1460939 72,861,567 2.3 0.022 101,976 0.18 
TNNI3K Ind. rs12566985 1 75,002,193 G g a 0.719 0.42 0.11 2.8E-04 0 5.2E-01 75,627               
  Top rs12566985 1 75,002,193   g a 0.719 0.42 0.11 2.8E-04 0 5.2E-01 75,627 1 (s) rs76514352 75,011,423 2.1 0.107 51,874 <0.01 
SEC16B Ind. rs543874 1 177,889,480 G g a 0.213 0.90 0.10 3.5E-21 72.9 1.1E-02 101,972               
  Top rs543874 1 177,889,480   g a 0.213 0.90 0.10 3.5E-21 72.9 1.1E-02 101,972 0.62-
1 (s) 
rs543874 177,889,480 19.
1 
0.252 101,972 0.62-
1 (s) 
LYPLAL1** Ind. rs2820436 1 219,640,680 A a c 0.388 0.50 0.09 3.2E-08 0 4.7E-01 93,721               
  Top rs2820436 1 219,640,680   a c 0.388 0.50 0.09 3.2E-08 0 4.7E-01 93,721 1 (s) rs2820436 219,640,680 6.0 0.006 93,721 1 (s) 
TMEM18 Ind. rs13021737 2 632,348 G g a 0.873 1.05 0.12 3.0E-18 42 1.6E-01 101,832               
  Top rs6731872 2 624,205   g t 0.877 1.09 0.12 8.3E-19 45.3 1.4E-01 101,832 0.61-
0.92 
rs6731872 624,205 16.
6 
0.037 101,832 0.61-
0.92 
BRE* Ind. rs116612809 2 28,301,171 G g a 0.088 1.05 0.23 8.8E-06 87.9 2.6E-04 68,016               
  Top rs58154175 2 28,604,833   t c 0.315 0.53 0.12 8.8E-06 12.6 3.3E-01 93,669 0.07 rs116612809 28,301,171 5.1 0.937 68,016 1 (s) 
COBLL1* Ind. rs10184004 2 165,508,389 T t c 0.452 0.52 0.10 1.3E-07 0 5.5E-01 93,726               
  Top rs10184004 2 165,508,389   t c 0.452 0.52 0.10 1.3E-07 0 5.5E-01 93,726 1 (s) rs10184004 165,508,389 5.6 0.011 93,726 1 (s) 
LOC646736
* 
Ind. rs2176040 2 227092802 A a g 0.274
6 
0.50 0.10 4.0E-07 0 5.5E-01 93,732               
  Top rs2176040 2 227092802   a g 0.274
6 
0.50 0.10 4.0E-07 0 5.5E-01 93,732 1 (s) rs2176040 227,092,802 5.1 0.006 93,732 1 (s) 
CADM2 Ind. rs13078960 3 85,807,590 G t g 0.857 0.00 0.15 9.8E-01 0 8.2E-01 101,976        
 Top rs115299727 3 85,843,586  g t 0.009 2.91 0.79 2.6E-04 0 1.0E+00 51,162 <0.01 rs115299727 85,843,586 2.5 0.049 51,162 <0.01 
IGF2BP2** Ind. rs11927381 3 185,508,591 T t c 0.563 0.49 0.09 1.3E-07 0 8.4E-01 93,626               
  Top rs11927381 3 185,508,591   t c 0.563 0.49 0.09 1.3E-07 0 8.4E-01 93,626 1 (s) rs4481184 185,505,787 5.6 0.005 93,647 0.81 
ETV5 Ind. rs1516725 3 185,824,004 C c t 0.864 0.69 0.13 1.0E-07 0 8.7E-01 101,811               
  Top rs7647305 3 185,834,290   c t 0.720 0.59 0.10 3.7E-09 0 5.2E-01 101,974 0.34 rs7647305 185,834,290 7.0 0.017 101,974 0.34 
GNPDA2 Ind. rs10938397 4 45,182,527 G g a 0.325 0.60 0.08 7.3E-13 1.7 3.8E-01 101,782               
  Top rs12507026 4 45,181,334   t a 0.325 0.61 0.08 5.3E-13 6.7 3.6E-01 101,974 0.38-
0.98 
rs12507026 45,181,334 10.
8 
0.011 101,974 0.38-
1.00 
SLC39A8* Ind. rs13107325 4 103,188,709 T t c 0.053 1.05 0.25 3.4E-05 0 8.7E-01 79,090               
  Top rs13107325 4 103,188,709   t c 0.053 1.05 0.25 3.4E-05 0 8.7E-01 79,090 1 (s) rs13107325 103,188,709 3.2 0.015 79,090 1 (s) 
FLJ35779 Ind. rs2112347 5 75,015,242 T t g 0.531 0.28 0.08 4.3E-04 3.3 3.8E-01 101,972               
  Top rs60493905 5 75,038,426   c t 0.630 0.48 0.09 1.9E-08 0 7.8E-01 101,968 0.17 rs60493905 75,038,426 6.4 0.008 101,968 0.17 
CDKAL1* Ind. rs9356744 6 20,685,486 T t c 0.562 0.42 0.08 2.6E-07 81.2 1.2E-03 101,966               
  Top rs67131976 6 20,686,878   c t 0.729 0.60 0.10 4.0E-10 61.6 5.0E-02 101,973 0.24 rs67131976 20,686,878 8.1 0.092 101,973 0.24 
TFAP2B Ind. rs2207139 6 50,845,490 G g a 0.211 0.41 0.10 1.0E-04 2 3.8E-01 101,973               
  Top rs2744475 6 50,784,880   g c 0.352 0.56 0.08 9.9E-12 39.1 1.8E-01 101,763 0.33 rs2744475 50,784,880 9.7 0.015 101,763 0.33 
SLC22A3* Ind. rs3127574 6 160,791,370 C c g 0.497 0.13 0.08 1.2E-01 51.7 1.0E-01 93,727        
 Top rs78739765 6 160,868,121  g a 0.979 1.34 0.43 1.9E-03 0 6.4E-01 72,083 0.01 rs73589298 160,804,090 1.9 0.952 57,992 0.03 
LRPN6C Ind. rs10968576 9 28,414,339 G g a 0.217 0.52 0.10 1.1E-07 0 5.9E-01 101,976               
  Top rs17770336 9 28,414,625   t c 0.223 0.52 0.10 9.6E-08 0 6.3E-01 101,930 0.95 rs17770336 28,414,625 5.8 0.013 101,930 0.95 
NT5C2* Ind. rs11191560 10 104,869,038 C c t 0.204 0.54 0.11 1.8E-06 0 7.8E-01 101,966               
  Top rs11191447 10 104,652,323   t c 0.193 0.56 0.11 3.8E-07 0 8.4E-01 101,919 0.86 rs11191447 104,652,323 5.2 0.008 101,919 0.86 
TCF7L2* Ind. rs7903146 10 114,758,349 C c t 0.739 0.75 0.10 2.2E-13 54 8.9E-02 101,975               
  Top rs7903146 10 114,758,349   c t 0.739 0.75 0.10 2.2E-13 54 8.9E-02 101,975 1 (s) rs7903146 114,758,349 11.
2 
0.063 101,975 1 (s) 
KCNQ1* Ind. rs2237897 11 2,858,546 T t c 0.237 0.66 0.12 3.3E-08 0 4.0E-01 93,516               
  Top rs2237896 11 2,858,440   a g 0.272 0.73 0.13 3.0E-08 0 4.6E-01 93,196 0.76 rs2237896 2,858,440 6.2 0.014 93,196 0.76 
OVCH2 Ind. rs4256980 11 8,673,939 G g c 0.509 0.22 0.08 5.2E-03 0 5.4E-01 101,492               
  Top rs76876925 11 8,650,183   g a 0.512 0.36 0.10 1.4E-04 0 8.7E-01 72,292 0.80 rs76876925 8,650,183 2.7 0.008 72,292 0.80 
NCR3LG1/
KCNJ11* 
Ind. rs1557765 11 17,403,639 T c t 0.686 0.31 0.10 1.5E-03 0 5.0E-01 93,268        
 Top rs7949405 11 17,085,192  a c 0.568 0.32 0.09 4.8E-04 0 5.8E-01 86,446 0.08- rs214933 17,194,584 2.2 0.005 93,270 0.20-
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0.09 0.21 
BDNF Ind. rs11030104 11 27,684,517 A a g 0.694 0.40 0.10 7.3E-05 79.5 2.2E-03 101,516               
  Top rs1519480 11 27,675,712   c t 0.444 0.59 0.09 1.2E-11 44.3 1.5E-01 101,510 0.28-
0.40 
rs1519480 27,675,712 9.5 0.006 101,510 0.28-
0.40 
MTCH2 Ind. rs3817334 11 47,650,993 T t c 0.338 0.28 0.08 6.3E-04 0 5.0E-01 101,940               
  Top rs896817 11 47,394,305   c t 0.713 0.46 0.09 4.3E-07 0 7.9E-01 101,965 0.03 rs896817 47,394,305 5.1 0.006 101,965 0.03 
FAIM2 Ind. rs7138803 12 50,247,468 A a g 0.285 0.35 0.09 9.0E-05 0 4.8E-01 101,969               
  Top rs7138803 12 50,247,468   a g 0.285 0.35 0.09 9.0E-05 0 4.8E-01 101,969 1 (s) rs7138803 50,247,468 2.9 0.003 101,969 1 (s) 
TRAFD1* Ind. rs11065987 12 112,072,424 A a g 0.716 0.21 0.12 8.8E-02 17.8 3.0E-01 93,730        
 Top rs10774631 12 112,023,001  a g 0.219 0.25 0.10 1.2E-02 46.6 1.3E-01 93,498 <0.01
-0.06 
rs10774631 112,023,001 0.9 0.024 93,498 <0.01
-0.06 
PRKD1 Ind. rs11847697 14 30,515,112 T t c 0.258 0.01 0.14 9.3E-01 0 9.5E-01 93,490        
 Top rs1957347 14 30,483,129  t g 0.303 0.27 0.09 3.4E-03 0 5.4E-01 101,505 0.02 rs1957347 30,483,129 1.4 0.016 101,505 0.02 
MAP2K5 Ind. rs16951275 15 68,077,168 T t c 0.542 0.35 0.08 2.5E-05 27.3 2.5E-01 101,972               
  Top rs4776970 15 68,080,886   a t 0.422 0.38 0.08 6.1E-06 0 9.0E-01 101,972 0.56-
1 (s) 
rs4776970 68,080,886 4.1 0.004 101,972 0.56-
1 (s) 
GPRC5B/ 
GP2 
Ind. rs12446632 16 19,935,389 G                                 
  Top rs67501351 16 20,006,745   g c 0.372 0.36 0.08 1.5E-05 28.8 2.4E-01 101,506 0.02 rs28461566 19,998,311 3.5 0.021 101,498 0.03 
SH2B1 Ind. rs2650492 16 28,333,411 A a g 0.146 0.54 0.14 9.5E-05 26.1 2.5E-01 99,770               
  Top rs8061590 16 28,895,130   g a 0.307 0.52 0.10 2.9E-07 0 3.7E-01 84,081 0.92 rs8061590 28,895,130 5.2 0.011 84,081 0.92 
FTO Ind. rs17817964 16 53,828,066 T t c 0.256 1.23 0.10 7.1E-36 0 7.1E-01 101,976               
  Top rs3751812 16 53,818,460   t g 0.242 1.34 0.10 2.3E-42 15.6 3.1E-01 101,974 0.94-
0.95 
rs3751812 53,818,460 39.
9 
0.010 101,974 0.94-
0.95 
KCNJ2* Ind. rs312750 17 68,343,539 A a g 0.638 0.09 0.09 3.4E-01 0 8.9E-01 93,734        
 Top rs72868947 17 68494065  t a 0.006
5 
2.60 0.78 9.2E-04 52.5 1.2E-01 74,163 <0.01  rs72868947 68,494,065 1.7 0.105 74,163 <0.01 
MC4R Ind. rs6567160 18 57,829,135 C c t 0.193 0.89 0.10 9.4E-19 13.8 3.2E-01 101,966               
  Top rs6567160 18 57,829,135   c t 0.193 0.89 0.10 9.4E-19 13.8 3.2E-01 101,966 0.01-
1 (s) 
rs6567160 57,829,135 16.
2 
0.011 101,966 0.01-
1 (s) 
KCTD15 Ind. rs29941 19 34,309,532 G g a 0.562 0.26 0.09 3.9E-03 0 6.2E-01 101,951               
  Top rs368794 19 34,320,452   a t 0.537 0.32 0.08 1.4E-04 0 4.0E-01 99,796 0.49 rs368794 34,320,452 2.7 0.012 99,796 0.49 
QPCTL* Ind. rs11671664 19 46,172,278 G g a 0.688 0.40 0.11 1.5E-04 79.9 1.9E-03 101,500               
  Top rs1800437 19 46,181,392   g c 0.817 0.64 0.11 1.6E-09 0 8.2E-01 101,488 0.09-
0.88 
rs11672660 46,180,184 7.0 0.007 101,501 0.09-
0.88 
Abbreviations: A1=coded allele, A2=non-coded allele, β=Effect Size, BF=Bayes Factor, Bp37=base pair Build 37, Chr=chromosome, Freq=coded 
allele frequency, HetP=heterogeneity p-value, Ind.=Index, MANTRA=Meta-ANalysis of Trans-Ethnic Association studies, P=p-value, s=same, 
SE=standard error, SNPs=single nucleotide polymorphisms, TE=Trans-ethnic. 
*Note: Starred genes represent fine-mapped loci, which were associated with BMI after the design of the Metabochip in 2009. 
**PAGE trans-ethnic discovery signal (Gong et al., submitted to Nature Communications).  
***For GWAS SNPs a Bonferroni correction for multiple tests reflected the number of independent previously-reported signals tested (=0.05/166; 
Appendices K-N, P). For all other SNPs in the fine-mapped BMI regions, we performed a Bonferroni correction for the number of independent 
SNPs per region (r2<0.2 in ARIC African-Americans; Appendix I). 
****The range of linkage disequilibrium captures any SNP within the fine-mapped loci (Appendices K-N, P) that represents the index BMI signal or 
secondary signal (described in European descent populations), or race/ethnic population specific marker. ARIC, HCHS/SOL, and WHI samples 
were used to represent the linkage disequilibrium for the PAGE trans-ethnic and European descent samples.  
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Table 8. Trans-ethnic meta-analyses to narrow the putative interval of interest at 36 BMI 
loci. 
 TOP FE SNPS MANTRA 99% CREDIBLE INTERVAL 
Gene 
Range 
(bp) 
Reduction 
% 
Reduced 
N SNPs 
Range 
(bp) 
Reduction 
% 
Reduced 
NEGR1 290,988 154,230 35 791 445,217 1 0 
TNNI3K 101,051 16,107 14 224 117,158 0 0 
SEC16B 16,575 166,174 91 1 0 182,749 100 
LYPLAL1** 167,016 107,141 39 30 128,966 145,191 53 
TMEM18 43,013 205,740 83 21 16,729 232,024 93 
BRE* 353,982 930,200 72 26 879,946 404,236 31 
COBLL1* 126,262 106,608 46 15 56,403 176,467 76 
LOC646736* 54,967 128,106 70 32 87,419 95,654 52 
CADM2 179,274 219,755 55 445 398,619 410 0 
IGF2BP2** 204,453 53,206 21 13 38,588 219,071 85 
ETV5 48,250 67,301 58 12 62,861 52,690 46 
GNPDA2 22,002 66,280 75 5 10,448 77,834 88 
SLC39A8* 78,859 17,861 18 141 94,766 1,954 2 
FLJ35779 260,885 299,794 53 29 372,409 188,270 34 
CDKAL1* 221,440 576,581 72 6 33,042 764,979 96 
TFAP2B 272,303 293,963 52 1 0 566,266 100 
SLC22A3* 238,014 32,672 12 720 270,605 81 0 
LRPN6C 28,519 67,137 70 4 3,722 91,934 96 
NT5C2* 418,829 362,996 46 22 261,330 520,495 67 
TCF7L2* 52,861 23,298 31 2 4,261 71,898 94 
KCNQ1* 331,607 167,414 34 7 18,885 480,136 96 
OVCH2 190,703 122,255 39 368 312,450 508 0 
NCR3LG1/KCN
J11* 
235,612 149,042 39 295 383,901 753 0 
BDNF 71,243 225,776 76 2 1,874 295,145 99 
MTCH2 753,051 420,187 36 88 543,139 630,099 54 
FAIM2 42,290 79,577 65 152 121,090 777 1 
TRAFD1* 1,332,934 582,773 30 93 1,889,612 26,095 1 
PRKD1 30,716 76,520 71 168 106,079 1,157 1 
MAP2K5 408,882 156,440 28 122 493,712 71,610 13 
GPRC5B/GP2 118,750 196,458 62 155 315,118 90 0 
SH2B1 431,490 262,983 38 74 413,702 280,771 40 
FTO 15,237 631,041 98 6 20,171 626,107 97 
MC4R 73,513 293,976 80 1 0 367,489 100 
KCNJ2 149,440 107,131 42 790 256,456 115 0 
KCTD15 24,124 14,099 37 70 38,223 0 0 
QPCTL* 197,022 73,189 27 3 21,988 248,223 92 
Abbreviations: bp=base pairs, FE=Fixed-Effect, MANTRA=Meta-ANalysis of Trans-Ethnic 
Association studies, SNPs=single nucleotide polymorphisms.  
*Note: Starred genes represent fine-mapped loci, which were associated with BMI after the 
design of the Metabochip in 2009. 
**PAGE trans-ethnic discovery signal (Gong et al., submitted to Nature Communications).  
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Table 9. Single variant and joint trans-ethnic fixed-effect estimates for the Bonferroni significant top signals at the 36 densely-
genotyped BMI loci, after accounting for index SNPs (r2<0.9 with each other, included in the trans-ethnic analyses) outside of these 
regions. 
      SINGLE VARIANT MODEL JOINT MODEL 
Gene rsID Chr Bp37 A
1 
A
2 
Freq  β  
(%) 
SE 
(%) 
P*** I2 HetP***
* 
Actual N Aprrox 
Freq 
 βj  
(%) 
SEj 
(%) 
Pj*** Effective 
N 
% VarExp 
TNNI3K rs12566985 1 75,002,193 g a 0.719 0.42 0.11 2.8E-04 0 5.2E-01 75,627 0.697 0.42 0.11 1.4E-04 85,877 0.0007 
SEC16B rs543874 1 177,889,480 g a 0.213 0.90 0.10 3.5E-21 72.9 1.1E-02 101,972 0.217 0.90 0.10 2.3E-19 125,180 0.0028 
LYPLAL1** rs2820436 1 219,640,680 a c 0.388 0.50 0.09 3.2E-08 0 4.7E-01 93,721 0.387 0.50 0.09 3.5E-08 109,170 0.0012 
LYPLAL1** rs4445477 1 219,759,481 a g 0.621 0.38 0.10 2.5E-04 0 6.3E-01 89,078 0.639 0.37 0.10 1.8E-04 89,156 0.0006 
TMEM18 rs6731872 2 624,205 g t 0.877 1.09 0.12 8.3E-19 45.3 1.4E-01 101,832 0.877 1.09 0.12 2.3E-19 135,002 0.0025 
COBLL1* rs10184004 2 165,508,389 t c 0.452 0.52 0.10 1.3E-07 0 5.5E-01 93,726 0.444 0.53 0.11 4.0E-07 84,752 0.0014 
COBLL1* rs17244444 2 165,548,415 g a 0.911 0.41 0.16 1.3E-02 58.6 6.4E-02 93,731 0.927 0.64 0.17 1.0E-04 101,259 0.0006 
LOC646736* rs2176040 2 227,092,802 a g 0.275 0.50 0.10 4.0E-07 0 5.5E-01 93,732 0.259 0.75 0.11 5.2E-11 105,388 0.0021 
LOC646736* rs2673147 2 227,177,202 c g 0.466 0.15 0.09 9.9E-02 0 8.6E-01 93,727 0.418 0.47 0.10 4.9E-06 104,177 0.0011 
IGF2BP2** rs11927381 3 185,508,591 t c 0.563 0.49 0.09 1.3E-07 0 8.4E-01 93,626 0.523 0.38 0.09 4.6E-05 105,325 0.0007 
ETV5 rs7647305 3 185,834,290 c t 0.720 0.59 0.10 3.7E-09 0 5.2E-01 101,974 0.744 0.48 0.10 3.1E-06 104,120 0.0009 
GNPDA2 rs12507026 4 45,181,334 t a 0.325 0.61 0.08 5.3E-13 6.7 3.6E-01 101,974 0.317 0.61 0.08 2.5E-14 149,522 0.0016 
SLC39A8* rs28392891 4 103,134,678 a t 0.891 0.52 0.15 4.8E-04 62.3 4.7E-02 95,585 0.913 0.51 0.15 6.9E-04 95,771 0.0004 
SLC39A8* rs13107325 4 103,188,709 t c 0.053 1.05 0.25 3.4E-05 0 8.7E-01 79,090 0.030 1.03 0.25 4.2E-05 67,039 0.0006 
FLJ35779 rs60493905 5 75,038,426 c t 0.630 0.48 0.09 1.9E-08 0 7.8E-01 101,968 0.606 0.48 0.09 9.7E-08 111,182 0.0011 
CDKAL1* rs67131976 6 20,686,878 c t 0.729 0.60 0.10 4.0E-10 61.6 5.0E-02 101,973 0.798 0.60 0.10 2.0E-09 106,176 0.0012 
TFAP2B rs2744475 6 50,784,880 g c 0.352 0.56 0.08 9.9E-12 39.1 1.8E-01 101,763 0.349 0.54 0.08 2.1E-11 143,714 0.0013 
TFAP2B rs2397016 6 50,929,066 a g 0.806 0.76 0.17 6.8E-06 39.6 1.9E-01 79,510 0.909 0.68 0.17 6.8E-05 46,410 0.0008 
LRPN6C rs17770336 9 28,414,625 t c 0.223 0.52 0.10 9.6E-08 0 6.3E-01 101,930 0.217 0.52 0.10 2.0E-07 121,118 0.0009 
NT5C2* rs11191447 10 104,652,323 t c 0.193 0.56 0.11 3.8E-07 0 8.4E-01 101,919 0.127 0.56 0.11 3.6E-07 111,260 0.0007 
TCF7L2* rs7903146 10 114,758,349 c t 0.739 0.75 0.10 2.2E-13 54 8.9E-02 101,975 0.765 0.75 0.10 6.5E-14 108,781 0.0020 
KCNQ1* rs2237896 11 2,858,440 a g 0.272 0.73 0.13 3.0E-08 0 4.6E-01 93,196 0.133 0.82 0.13 5.5E-10 62,758 0.0015 
OVCH2 rs76633799 11 8,599,566 a g 0.037 1.38 0.37 2.6E-04 0 7.1E-01 57,988 0.017 1.45 0.37 1.1E-04 42,922 0.0007 
OVCH2 rs76876925 11 8,650,183 g a 0.512 0.36 0.10 1.4E-04 0 8.7E-01 72,292 0.556 0.41 0.10 5.7E-05 84,029 0.0008 
BDNF rs1519480 11 27,675,712 c t 0.444 0.59 0.09 1.2E-11 44.3 1.5E-01 101,510 0.513 0.64 0.09 1.6E-12 104,967 0.0020 
BDNF rs190666912 11 27,737,969 g c 0.496 0.35 0.09 1.9E-04 16.9 3.0E-01 72,303 0.502 0.43 0.09 2.6E-06 103,685 0.0009 
MTCH2 rs896817 11 47,394,305 c t 0.713 0.46 0.09 4.3E-07 0 7.9E-01 101,965 0.735 0.46 0.09 3.2E-07 126,735 0.0008 
FAIM2 rs7138803 12 50,247,468 a g 0.285 0.35 0.09 9.0E-05 0 4.8E-01 101,969 0.254 0.35 0.09 1.0E-04 127,226 0.0005 
MAP2K5 rs4776970 15 68,080,886 a t 0.422 0.38 0.08 6.1E-06 0 9.0E-01 101,972 0.440 0.38 0.08 2.0E-06 134,469 0.0007 
GPRC5B/ 
GP2 
rs67501351 16 20,006,745 g c 0.372 0.36 0.08 1.5E-05 28.8 2.4E-01 101,506 0.327 0.40 0.08 4.8E-07 140,434 0.0007 
SH2B1 rs8061590 16 28,895,130 g a 0.307 0.52 0.10 2.9E-07 0 3.7E-01 84,081 0.318 0.56 0.10 3.2E-08 98,598 0.0013 
FTO rs7206790 16 53,797,908 g c 0.424 0.30 0.09 5.1E-04 94.7 3.3E-12 101,974 0.437 -1.14 0.14 5.6E-16 106,167 0.0064 
FTO rs73612011 16 53,809,861 t c 0.858 0.40 0.14 3.1E-03 58.4 6.6E-02 101,978 0.879 -0.95 0.18 1.3E-07 87,717 0.0020 
FTO rs3751812 16 53,818,460 t g 0.242 1.34 0.10 2.4E-42 15.6 3.1E-01 101,974 0.213 1.31 0.13 1.8E-24 114,260 0.0057 
FTO rs9936385 16 53,819,169 c t 0.289 1.34 0.11 7.5E-37 6.9 3.4E-01 66,366 0.366 1.51 0.16 1.2E-20 84,239 0.0104 
MC4R rs6567160 18 57,829,135 c t 0.193 0.89 0.10 9.4E-19 13.8 3.2E-01 101,966 0.184 0.89 0.10 7.7E-19 134,789 0.0024 
MC4R rs77901086 18 58,083,923 a c 0.985 1.84 0.43 2.6E-05 0 4.5E-01 88,060 0.989 1.81 0.43 3.2E-05 77,866 0.0007 
KCTD15 rs368794 19 34,320,452 a t 0.537 0.32 0.08 1.4E-04 0 4.0E-01 99,796 0.581 0.32 0.08 6.3E-05 131,938 0.0005 
QPCTL* rs1800437 19 46,181,392 g c 0.817 0.64 0.11 1.6E-09 0 8.2E-01 101,488 0.842 0.64 0.11 6.0E-09 116,182 0.0011 
Abbreviations: Approx=approximate, A1=coded allele, A2=non-coded allele, β=Effect Size, βj=Joint effect Size, BF=Bayes Factor, Bp37=base pair 
Build 37, Chr=chromosome, Freq=coded allele frequency, HetP=heterogeneity p-value, MANTRA=Meta-ANalysis of Trans-Ethnic Association 
studies, P=p-value, Pj=joint p-value, SE=standard error, SEj=joint standard error, SNPs=single nucleotide polymorphisms, TE=Trans-ethnic, 
VarExp=Variance Explained. 
*Note: Starred genes represent fine-mapped loci, which were associated with BMI after the design of the MetaboChip in 2009. 
**PAGE trans-ethnic discovery signal (Gong et al., submitted to Nature Communications).  
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***For GWAS SNPs a Bonferroni correction for multiple tests reflected the number of independent previously-reported signals tested (=0.05/166; 
Appendices K-N, P). For all other SNPs in the fine-mapped BMI regions, we performed a Bonferroni correction for the number of independent 
SNPs per region (r2<0.2 in ARIC African-Americans; Appendix I). 
****Locus-specific Bonferroni significant heterogeneity p-values shown in italics. 
*****The range of linkage disequilibrium captures any SNP within the fine-mapped loci (Appendices K-N, P) that represents the index BMI signal or 
secondary signal (described in European descent populations), or race/ethnic population specific marker. ARIC, HCHS/SOL, and WHI samples 
were used to represent the linkage disequilibrium for the PAGE trans-ethnic and European descent samples. 
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Figure 12. The comparison of the statistical significance (-log10 of the p-value), effect 
size (% change in BMI per risk allele) and coded allele frequencies (oriented to the risk 
allele in the trans-ethnic meta-analysis) across African, Hispanic/Latino, Asian and 
European ancestries for the lead SNPs (position noted for build 36) within the 36 
densely-genotyped BMI regions on the MetaboChip with either locus-specific Bonferroni 
significant associations (rsid in black) or non-significant (rsid in gray).   
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Figure 13. Venn diagram of overlap in significant lead SNP findings at each of 36 
densely-genotyped BMI loci across the racial/ethnic populations [African (AfA), 
Hispanic/Latino (HA), Asian (AsA), European (EA), American Indian/Alaskan Native 
descent (NA, in parentheses)] and in the trans-ethnic fixed-effect meta-analysis of 
African, Hispanic/Latino, Asian and European descent adults (noted with asterisk).  
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Figure 14. Regional plots of trans-ethnic fixed-effect estimates (I, index SNPs; FE, top 
finding) and Bayesian fine-mapping of 6 significant BMI loci to select the SNP with the 
highest posterior probability (M, shown in purple and reference for trans-ethnic linkage 
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disequilibrium) and narrow the putative interval of interest to <4 SNPs (SNPs in 99% 
credible interval shown in diamonds) in a sample of up to 101,979 individuals. 
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Figure 15. Regional plots of trans-ethnic fixed-effect estimates (I, index SNPs in black; 
FE, top finding) and Bayesian fine-mapping of 6 significant BMI loci to select the SNP 
with the highest posterior probability (M, shown in purple and reference for trans-ethnic 
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linkage disequilibrium) and narrow the putative interval of interest to 4-12 SNPs (SNPs in 
99% credible interval shown in diamonds) in a sample of up to 101,979 individuals. 
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CHAPTER VI: CONCLUSIONS 
A. Recapitulation of Aims 
The disconnect between the current body of genetic epidemiology research [40] 
and the disparate burden of obesity and its downstream consequences in US 
racial/ethnic minorities, such as Hispanic/Latinos [44], has inspired me to organize my 
dissertation aims within a larger conceptual model (Figure 1). Specifically, as part this 
dissertation I performed secondary data analyses of the HCHS/SOL and the other PAGE 
collaborating studies to address what I determined were important gaps in the public 
health literature surrounding the application of alternative measures (Aim 1) and diverse 
populations (Aim 2) in genomics and epidemiologic research. This was done in order to 
inform our understanding of and future studies on the complex etiologic origins of obesity 
and its population-level disparities.   
This conceptual model strengthened my dissertation by nesting the research 
aims within the broader study of genomics and epidemiology. As shown in Figure 1 my 
dissertation research provides two entrance points into a broader research agenda on 
the complex origins of racial and ethnic disparities. Specifically, Aim 1 represents an 
advancement of current knowledge on the accuracy of diverse measures of obesity, 
such as self-reported weight (Figure 1; top corner) in populations with otherwise 
unavailable weight data, e.g. US Hispanic/Latinos many of whom are transnational 
immigrants. Next, Aim 2 advanced our understanding of what are the particular genetic 
determinants of obesity in populations of diverse ancestries (Figure 1; right hand corner). 
Collectively these works provide a strong basis for the successful application of diverse 
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measures and populations in research on the complex mixture of genetic and non-
genetic determinants of obesity, such as in the etiologic interaction between genetics 
and sociocultural environments (Figure 1; center set of arrows). Specifically, future gene-
acculturation studies will be able to use both self-reported and measured weights and 
heights to calculate BMI (Aim 1), as well as decrease the burden of multiple testing by 
focusing on the just putative functional genetic risk factors for increased BMI (Aim 2).  
B. Main Findings  
In Aim 1 I established the accuracy of self-reported weight in HCHS/SOL, as a 
component of BMI, a useful metric for classifying obesity (Figure 1; upper corner). In Aim 
1A I investigated the unadjusted difference between self-reported and measured weight 
at the HCHS/SOL baseline examination, and then in Aim 1B I extended this investigation 
to model the differences in a multivariate model including a number of potential 
predictors of self-reported weight inaccuracy. 
Overall Findings: I found that self-reported weight was an accurate proxy of 
measured weight at baseline across Hispanic/Latino backgrounds, as measured by both 
the correlation and the mean difference. I noted in a modified Bland-Altman plot that 
current self-reported weights were most imprecise at the extremes of measured weight 
in HCHS/SOL. Similar to previous studies I noted that the mean difference varied in the 
direction of effect across a number of key predictors of inaccuracy in a multiply imputed 
dataset, both in unadjusted and mutually-adjusted multivariate prediction models: age, 
gender, categories of BMI, nativity, study site by Hispanic/Latino background, self-report 
and end digit preference. 
In Aim 2 I utilized the fine-mapped MetaboChip data of >100,000 samples of the 
PAGE Study to generalize previously described SNPs and narrow the putative interval 
around the underlying functional SNPs at 36 established BMI loci. In Aim 2A I performed 
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the generalization and fine-mapping within each racial/ethnic group. Then in Aim 2B I 
extended this work through two trans-ethnic meta-analyses and approximate conditional 
and joint estimations of genetic effects. 
Overall Findings: I found that the majority of the risk alleles of the previous 
reported (‘index’) SNPs were directionally consistent with the risk alleles of previous 
reports, surpassing what we would expect by chance. I noted that a smaller proportion of 
the index SNPs generalized to a racial/ethnic group, which I defined as a SNP 
association being both directionally consistent and statistically significant. I observed that 
the additional genotypes available in the 36 fine-mapped BMI loci improved my ability to 
select the strongest associated SNPs (‘top’) and that in most cases this top SNP was not 
the index SNP from the discovery report. A handful of these loci had evidence of 
heterogeneity across racial/ethnic groups and therefore the Bayesian trans-ethnic meta-
analysis was a useful way to relax the assumption of fixed-effects to bolster the evidence 
for the observed fixed-effect findings across multiple racial/ethnic groups. I found that the 
99% credible set allowed me to fine-map the interval of putative interest for the subset of 
loci without independent signals.  Lastly, conditional and joint analyses helped me 
describe allelic heterogeneity at several established BMI loci, 7 of which for the first time 
with BMI.  
1. Strengths 
Given the ubiquitous use of proxy measures in obesity surveillance and 
epidemiology as well as the recent population growth of US Hispanic/Latinos, there is a 
clear need to reassess the data quality and accuracy of self-reported weight in this group 
due to the potential for differential migratory histories, or sociocultural, linguistic, etc. 
characteristics than in previous accuracy studies of US Hispanic/Latinos. Aim 1 
represents the first study to my knowledge to describe the accuracy of self-reported 
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weight in a large population-based sample of multiple Hispanic/Latino backgrounds—
each with unique cultural, linguistic, and migration histories. Previous accuracy studies in 
NHANES Hispanic/Latino samples have primarily been of Mexican heritage and US-born 
[49]. In contrast HCHS/SOL is more reflective of nativity status of the current adult US 
Hispanic/Latino population (i.e. the majority is foreign-born) [95]. Unlike most accuracy 
studies available in the current literature, I presented a transparent discussion of my 
data quality concerns and control, including reporting of the range of observed 
differences between self-reported and measured weight. Data quality control 
approaches based on a single criterion, although straightforward, could have 
compromised the representativeness of our analytic sample and artificially inflated 
estimates of accuracy. Although language preference did not appear to influence the 
accuracy of self-reported weight, self-reports made in kilograms were more accurate 
than those made in pounds. This indicates that even though multiple units may 
necessitate additional quality control measures, it may increase accuracy in future 
studies of US Hispanic/Latinos. As such the HCHS/SOL protocol for requesting self-
reported weights in multiple languages or units and our approach to data quality control 
may be a useful model for future public health research design. 
In Aim 2 of this dissertation we purposively utilized measures of BMI derived from 
both self-reported and measured weight, to obtain a maximum available sample of 
diverse populations (African, Hispanic/Latino, Asian, European and American 
Indian/Alaskan Native descent) with fine-mapping data from the MetaboChip as part of 
the PAGE Study. Given that the majority of the current literature on the genetic 
epidemiology of BMI comes from non-Hispanic/Latino European descent populations 
[40], this study was strengthened by its inclusion of ~67,000 additional diverse samples 
to expand on the previous fine-mapping efforts conducted by the PAGE Study [204]. 
Thus this study is the first to our knowledge to systematically generalize and fine-map 
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established BMI loci to diverse populations. Moreover, when the index SNP was not 
located in a fine-mapped BMI region (or was unavailable), we individually investigated 
this index SNP or its best proxy on the MetaboChip. Since the design of the 
MetaboChip, a handful of African- and Asian-descent GWAS [25, 26, 30, 195] or trans-
ethnic reports [32] (Gong et al., submitted to Nature Communications) have been 
completed, increasing the tally of fine-mapped BMI loci to 36, which is nearly a third of 
all currently known BMI loci. We were able to interrogate these non-European-descent 
index SNPs as potential population-specific markers in our diverse study samples. 
Lastly, I relaxed the assumption of fixed genetic effects in all of the racial/ethnic groups 
by using a Bayesian analysis to appropriately cluster the racial/ethnic groups by their 
allele frequency differences and construct credible intervals that would reflect my 
confidence that the underlying functional variants were located within the intervals’ 
bounds. Overall this study represents an important first step towards prioritizing strong 
candidates for future epidemiologic study and targeted functional follow-up, in the hope 
of identifying the exact causal variants of obesity risk. 
2. Limitations 
 This body of work is not within limitations, however. With respect to the analyses 
of HCHS/SOL baseline data in Aim 1, there is an inherent confounding by geography. 
Even though we utilized a cross-classification of site and background, this obscured 
interpretability and still we could not fully decompose the complex effects of site and 
background. Furthermore, even if there were notable site differences across the sites of 
HCHS/SOL, these may have also been conflated by disparate interviewing practices 
despite the CC’s efforts to coordinate study procedures across the sites. Lastly even 
though our sample of predominantly foreign-born Hispanic/Latino adults may more 
closely reflect the national profile of Hispanic/Latinos [95], than in reflected in previous 
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studies such as NHANES, our conclusions cannot generalized broadly due to its reliance 
on four urban US Hispanic/Latino communities (or immigrant enclaves). Yet the 
HCHS/SOL study is unique in its remarkable community engagement, which allows it to 
have stronger internal validity than previous studies like NHANES that may have poor 
interval validity (i.e. selection bias from immigrant non-participation) but less external 
validity concerns (i.e. nationally-based sampling design).  
 In Aim 2, we were also limited by the inability to independently contrast my 
results with previous fine-mapping work by the PAGE Study in African Americans (82% 
overlap with current analytic sample, which includes 6,455 additional individuals) [204]. It 
is reassuring, however, that I saw similar conclusions with respect to directional 
consistency, magnitude of effect, and statistical significance, even when top SNP 
changed in the expanded African descent and trans-ethnic meta-analyses. As well my 
ability to narrow the putative interval of around functional variant of interests at the 36 
fine-mapped BMI loci may have violated a key assumption of the Bayesian trans-ethnic 
[53]. Missing SNP information on the MetaboChip, resulting from the strict SNP-level 
quality control measures throughout the work, may have further perturbed the Bayesian 
modeling. Although approximate conditional analyses of fixed-effect meta-analysis 
estimates ruled out the presence of secondary signals at most of the densely-genotyped 
loci, future work should focus on all aspects of genetic variation within the bounds of the 
credible interval and test the assumption of no secondary signals at these loci or their 
impact on fine-mapping initiatives. 
C. Overall Conclusions 
Future studies of US Hispanic/Latinos may increase their accuracy of self-
reported weight by accommodating a participant’s preference for both language and 
units of measurement. Even though this may an intuitive approach to studying diverse 
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individuals, it poses particular challenges to data quality. The data cleaning protocol and 
findings of Aim 1 provide support for the use of self-reported weight as a reasonably 
good proxy for measured weight, albeit with differential error, in diverse backgrounds of 
US Hispanic/Latinos.  My findings indicate that there may be a distinct pattern of social 
desirability of weight among US Hispanic/Latinos, as compared to other racial/ethnic 
groups predominantly studied in the public health literature [151]. Awareness of this 
distinct patterning of self-report bias will be important to future etiologic obesity research 
in US Hispanic/Latinos. 
Etiologic analyses using self-reported weights in HCHS/SOL or similar samples 
of Hispanic/Latinos should consider these sources of differential misreporting. For 
example, the bias in association results from measurement error in self-reported weight 
(exposure) may be corrected under certain assumptions by calibrating the regression 
coefficients [291]. Alternatively, in descriptive analysis of self-reported weight histories in 
HCHS/SOL these variables may be included as covariates in descriptive or predictive 
models.  
The majority of the current literature on the genetic epidemiology of obesity relies 
on the study of BMI in non-Hispanic/Latino European-descent populations [40]. 
Consistent with recent reports from >300,000 European-descent samples [33], in Aim 2 
we also observed evidence in support of multiple signals at BDNF and MC4R. Yet due to 
the allelic heterogeneity of our innovatively diverse sample, we were able to discover 7 
additional BMI loci with multiples signals (TNNI3K, LYPLAL1, COBLL1, SLC39A8, 
TRAP2B, OVCH2, and FTO).  
Targeted functional studies and drug development for obesity will benefit from 
our description of allelic heterogeneity in BMI. Ancestral diversity is needed to elucidate 
the complex biologic machinery that regulates human body mass and to determine how 
obesogenic environmental cues interact with these pathways. Moreover, the process by 
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which disparate environments become embodied to create racial/ethnic health 
disparities will remain unclear until we are able to document the underlying functional 
variants in diverse populations (i.e. minimize our multiple testing burden and increase 
our power to detect effects). Thus Aim 2 represents an important first step towards 
prioritizing strong candidates for future epidemiologic studies in GxE interactions. Overall 
an improved understanding of the genetic architecture and the population diversity of 
complex traits such as BMI, and its component parts based on either self-reported or 
measured anthropometrics, will in turn bolster our ability to tailor public health 
interventions to both diverse populations and the individuals within them.  
D. Fulfillment of Doctoral Research Requirements 
 The Department of Epidemiology at the University of North Carolina at Chapel 
Hill requires that a dissertation be of appropriate scope and rigor to fulfill the goals of 
doctoral research. Although the committee is ultimately responsible for determining if I 
have met this goal through the research described herein, I can attest that since 2011 I 
have collaborated in the numerous methodological [201, 238] and substantive [193, 203, 
204, 238, 277, 292] manuscripts that have supported the methods and analyses of this 
dissertation. Under the guidance of Kari E. North, I have led the concept, design, 
analysis, and writing of the two above scientific manuscripts.  
 This dissertation has benefited greatly from the input provided by the Committee 
Chair and its members, as well as peer-review from my coauthors and the HCHS/SOL 
Publications Committee. At each of the interim meetings, all members reached the 
consensus that the scope of the research was appropriate. Collectively the proposal 
defense, research preparation, and final defense fully address the specific goals of the 
Epidemiology Academic Policies Manual: originality, depth, scholarship, and writing 
skills. Thus I feel that this dissertation clearly demonstrates my ability as a public health 
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professional to execute epidemiologic research that integrates the methodological and 
substantive objectives outlined by the Department’s core curriculum and requirements.   
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APPENDIX A: RESULTS OF STAGED DATA QUALITY CONTROL PROTOCOL ON 
16,203 ADULT HISPANIC/LATINO PARTICIPANTS (18-76 YEARS) WITH BOTH 
SELF-REPORTED AND MEASURED WEIGHT AT THE BASELINE EXAMINATION 
(2008-2011) OF THE HISPANIC COMMUNITY HEALTH STUDY/STUDY OF LATINOS 
(HCHS/SOL). 
Action Measure(s) Criteria Number of 
Individuals 
(Number  
Affected) 
Number of 
Remaining 
Individuals  
 Stage 1- Data Cleaning of Flagged SR Current Weights (≥15kg change)a  
Recodedb Current SR weight ≥15kg drop in difference 
between SR and M 
current weight 
16,203            
(16 recodedb) 
16,203 
Excluded Current SR weight >2 SDc, ≥15kg 
difference between SR 
and M current weight 
16,203 (41) 16,162 
 Current SR weight <34.5kgd 16,162 (1) 16,161 
  >200.8kgd 16,161 (2) 16,159 
Stage 2- Exclusions  
Excluded Current SR, M weights Current pregnancye 16,159 (14) 16,145 
 Current SR, M weights Limb amputatione 16,145 (12) 16,133 
 BMI for current SR, M 
weight 
<16.0kg/m2 f 16,133 (14) 16,119 
 >70.0kg/m2 f - - 
Final Analytic Sample with both SR and M Current Weights  16,119 
Abbreviations: BMI=Body mass index, M=Measured, SD=Standard deviation, SR=Self-reported 
aAt the beginning of the first stage, 229 current SR weights were flagged for being ≥15kg from the 
M weight at the same time point.  After completing Stage 1, the number of flagged SR weights 
decreased to 183. After Stage 2, the number of flagged SR weights decreased to 181. 
bThe two possible scenarios of kg/lb SR were assessed (1- true SRs in kg were recorded as lb, 2- 
true SR in lb were recorded as kg) and the weight was recoded if one of the scenarios were 
favored according to the listed criteria.  
cBeyond 2 standard deviations from the gender and age-specific mean of any self-reported 
weight in HCHS/SOL (categories of age: 18-21, 22-29, 30-39, 40-49, 50-59, 60-69, 70-76 years). 
dThe criteria <34.5 and >200.8 were obtained from the range of M weights at the same time point.  
If social desirability were to differentially bias SR weights at the same away from extreme 
weights, we would expect that anything beyond the range of M weights might be a data error. 
eBoth current SR and M weights were excluded for women reporting to be currently pregnant 
(noted on Medical History Questionnaire Form) and for individuals with a limb amputation (noted 
on Ankle Arm Blood Pressure Procedure Form) who were otherwise able to stand on both feet 
(noted on Anthropometric Procedure Form) at the baseline examination.   
fBMI was calculated for all SR and M weights using an individual’s M adult height at the baseline 
examination under the assumption that this would be static across adulthood. 
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APPENDIX B: HISTOGRAMS OF THE DISTRIBUTION OF SELF-REPORTED 
WEIGHTS STRATIFIED BY UNITS OF SELF-REPORT AND END DIGIT 
PREFERENCE FOR ZEROS AND FIVES (PANEL A: KG, 1-4 AND 6-9 END DIGITS, 
B: LB, 1-4 AND 6-9 END DIGITS, C: KG, 0 AND 5 END DIGITS, D: LB, 0 AND 5 END 
DIGITS) PRIOR TO DATA QUALITY CONTROL (N=16,203). 
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APPENDIX C: FREQUENCY PRIOR AND AFTER WEIGHTED FOR SAMPLING DESIGN AND DISTRIBUTION (BOX AND 
WHISKER PLOTS, WHERE THE BOX REPRESENTS THE INTERQUARTILE RANGE AND THE MEDIAN, THE DIAMOND 
REPRESENTS THE MEAN, THE WHISKERS REPRESENT THE MINIMUM AND MAXIMUM) OF SELF-REPORTED WEIGHTS 
(N=16,203) BY UNITS OF SELF-REPORT AND END DIGIT PREFERENCE. 
Ending 
Digit 
Expected 
Frequency 
(n=16,203) 
Frequency (unweighted/weighted) with box and 
whisker plots of self-reported weights given in kg 
(n=710) 
Frequency (unweighted/weighted) with box and 
whisker plots of self-reported weights given in lb 
(n=15,493) 
0 0.10  0.25/0.24 
 
Self-Reported Weight (kg) 
0.37/0.38 
 Self-Reported Weight (kg) 
1 0.10  0.04/0.04  0.02/0.02 
2 0.10  0.10/0.12  0.07/0.07 
3 0.10  0.07/0.07  0.05/0.05 
4 0.10  0.09/0.09 0.06/0.06 
5 0.10  0.16/0.17 0.20/0.20 
6 0.10 0.08/0.08  0.06/0.05 
7 0.10 0.05/0.05  0.05/0.05 
8 0.10 0.10/0.10  0.08/0.08 
9 0.10 0.05/0.04 
 
0.03/0.03 
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APPENDIX D: HEXAGONAL BINNING OF QUALITY CONTROLLED SELF-
REPORTED WEIGHT AND MEASURED WEIGHTS AT BASELINE EXAMINATION 
(18-76 YEARS OF AGE) USING 60 BINS, A BEST FIT REGRESSION LINE, AND 
COLORED BY EITHER THE SAMPLING WEIGHT (PANEL A, ADJUSTED FOR 
COMPLEX SAMPLING DESIGN) OR THE OBSERVATION COUNT (PANEL B, 
UNWEIGHTED). 
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APPENDIX E: STRATIFIED MEAN DIFFERENCES BETWEEN SELF-REPORTED AND MEASURED WEIGHT DURING 
BASELINE EXAMINATION OF HISPANIC/LATINO ADULTS 18-76 YEARS OF AGE IN THE HISPANIC COMMUNITY HEALTH 
STUDY/STUDY OF LATINOS (HCHS/SOL) ACROSS STRATA OF KEY COVARIATES BEFORE AND AFTER ASSIGNING 1,366 
INDIVIDUALS (8.5% OF SAMPLE) WITH MISSING COVARIATES TO A SPECIFIC STRATUM IN MULTIPLE IMPUTATIONS (25 
STACKED DATASETS OF N=16,119). 
  Before Multiple Imputation  
(n=15139 to 16119) 
After Multiple Imputation,  
If Missing Covariates  
(n=16119) 
  N Mean 
Diff. 
(kg)* 
 95% CI (kg) Range of N Mean 
Diff. 
(kg)* 
95% CI (kg) 
Age at 
Examinatio
n (years) 
 
 
18-22 1236 -0.04 -0.40, 0.32    
23-29 1385 -0.01 -0.34, 0.32    
30-44 3954  0.12 -0.07, 0.31      
45-59 6796  0.41  0.26, 0.56     
60-76 2748  0.63  0.45, 0.81     
Back-
ground by 
Site 
Dominicans- Bronx 1362 -0.64 -0.96, -0.31 1367-1374 -0.64 -0.96, -0.32 
Central American- Bronx 217 -0.97 -1.51, -0.43 217-222 -0.97 -1.51, -0.43 
Central American- Chicago 416  0.38 -0.05, 0.82 416-419  0.38 -0.05, 0.82 
Central American- Miami 1017  0.36  0.02, 0.71 1019-1022  0.37  0.02, 0.71 
Cubans- Miami 2229  0.52  0.36, 0.68 2233-2235  0.52  0.36, 0.68 
Mexicans- Bronx 203 -0.21 -1.12, 0.71 205-207 -0.08 -0.99, 0.83 
Mexicans- Chicago 2342  0.33  0.12, 0.53 2346-2351  0.33  0.12, 0.53 
Mexican- San Diego 3771  0.66  0.40, 0.92 3790-3795  0.66  0.40, 0.93 
Puerto Ricans- Bronx 1793 -0.15 -0.48, 0.18 1797-1805 -0.15 -0.48, 0.18 
Puerto Ricans- Chicago 764 -0.14 -0.69, 0.42 764-767 -0.13 -0.68, 0.42 
South American- Bronx 186 -0.58 -1.14, -0.01 186-191 -0.58 -1.14, -0.01 
South American- Chicago 366  0.20 -0.35, -0.75 366-369  0.20 -0.34, -0.75 
South American- Miami 461  0.44 -0.05, 0.92 461-463  0.44 -0.04, 0.92 
Other- Bronx 241 -0.84 -1.69, 0.01 241-244 -0.84 -1.69, 0.01 
Other- Chicago 150 -0.49 -1.51, 0.53 150-151 -0.49 -1.50, 0.53 
Other- Miami 290  0.44 -0.23, 1.11 290-293  0.44 -0.23, 1.11 
Other- San Diego 244  0.84  0.18, 1.50 244-249  0.84  0.19, 1.50 
 Missing 67   0   
Body Mass 
Categories 
Underweight (<18.5 kg/m2) 117  2.76  1.94, 3.58 117-118  2.76  1.94, 3.57 
Normal Weight (18.5-24.9 kg/m2) 3153  1.09  0.94, 1.24 3153-3158  1.09  0.94, 1.24 
Overweight (25.0-29.9 kg/m2) 6058  0.52  0.39, 0.64 6059-6063  0.52  0.39, 0.64 
Obese (≥30.0 kg/m2) 6782 -0.59 -0.79, -0.39 6783-6788 -0.59 -0.79, -0.39 
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Missing 9   0   
Cancer 
History 
Yes 633  0.26 -0.44, 0.95 634-640  0.26 -0.43, 0.95 
No 15414  0.22  0.11, 0.33 15479-15485  0.23  0.12, 0.33 
Missing 72   0   
Diabetic 
Status** 
Normal Glucose Regulation 6752  0.30  0.15, 0.44 6753-6759  0.30  0.15, 0.44 
Impaired Glucose Tolerance 6224  0.05 -0.12, 0.22 6226-6234  0.05 -0.12, 0.22 
Diabetes 3130  0.42  0.18, 0.66 3130-3136  0.42  0.18, 0.66 
Missing 13   0   
Education  Less than high school or a GED 6078  0.25  0.05, 0.45 6099-6119  0.26  0.06, 0.46 
 At most high school or a GED  4102  0.10 -0.10, 0.29 4114-4127  0.11 -0.09, 0.30 
 More than high school or a GED 5868  0.29  0.14, 0.44 5882-5895  0.29  0.14, 0.44 
 Missing 71   0   
End Digit 
Preference 
5, 10s 9029 -0.13 -0.29, 0.04    
1-4s, 6-9s 7090  0.72  0.61, 0.82     
Gender Female, pre-, peri-
menopausal*** 
5784  0.03 -0.14, 0.20    
 Female, post-menopausal 3874  0.24  0.06, 0.43    
 Male 6461  0.38  0.21, 0.54    
Heart 
Failure 
History 
Yes 297  0.30 -0.35, 0.95 297-305  0.31 -0.34, 0.96 
No 15743  0.22  0.11, 0.33 15814-15822  0.23  0.12, 0.34 
N Missing 79   0   
Health 
Insurance 
Yes 8035  0.21  0.05, 0.38 8210-8233  0.20  0.03, 0.36 
No 7793  0.26  0.12, 0.40 7886-7909  0.26  0.12, 0.40 
N Missing 291   0   
Language 
Preference 
English 3242  0.04 -0.21, 0.28     
Spanish 12877  0.29  0.18, 0.41     
Nativity Born in the United States**** 2819 -0.09 -0.38, 0.21 2821-2830 -0.09 -0.38, 0.21 
 Foreign Born 13247  0.31  0.21, 0.42 13289-13298  0.32  0.22, 0.43 
 Missing 53   0   
Physical 
Activity 
Level***** 
Inactive 3623  0.22  0.02, 0.41 3640-3659  0.23  0.03, 0.42 
Low Activity 2152  0.16 -0.06, 0.37 2161-2172  0.17 -0.04, 0.39 
Medium Activity 1776  0.47  0.19, 0.74 1780-1794  0.47  0.20, 0.75 
High Activity 8450  0.19  0.04, 0.34 8507-8525  0.20  0.04, 0.35 
 Missing 118   0   
Smoking 
Status 
Never 9759  0.11 -0.02, 0.25 9794-9812  0.12 -0.02, 0.25 
Former 3174  0.48  0.25, 0.71 3186-3195  0.49  0.26, 0.72 
Current 3112  0.33  0.13, 0.54 3120-3131  0.34  0.13, 0.54 
Missing 74   0   
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Abbreviations: CI=Confidence interval, Diff.=Difference, GED=General Education Development Equivalent of a High School Diploma, 
ref=Referent, SE=Standard error, USD=United States Dollars.  
*Mean difference=self-reported minus measured weight (kg).  
**As defined by the American Diabetes Association [269]. 
***Women reporting not reporting ‘yes’ to having reached menopause (change of life) were assumed to be pre- or peri-menopausal. 
****As defined as being born in one of the 50 United States, not including United States Territories such as Puerto Rico. 
*****As defined in the 2008 Physical Activity Guidelines for adults [270]. 
Socioecono
mic Status 
Less than $30,000 USD 10315  0.23  0.09, 0.36 11031-11087  0.23  0.10, 0.36 
$30,000 or more USD 4824  0.24  0.07, 0.41 5032-5088  0.23  0.05, 0.40 
 Missing 980   0   
Unit of Self-
Report 
Kg 704 -0.03 -0.59, 0.52    
Lb 15415  0.24  0.13, 0.35     
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APPENDIX F: REGRESSION BETA COEFFICIENTS OF PREDICTORS OF ACCURACY 
OF SELF-REPORTED WEIGHT AS COMPARED TO MEASURED WEIGHT (KG) IN THE 
HISPANIC/LATINO ADULTS 18-76 YEARS OF AGE IN HCHS/SOL (2008-2011) 
INCLUDED IN A COMPLETE CASE ANALYSIS (N=14,753). 
                                                            SR-M*        SE  95% CI (kg) 
Age at 
Examination 
(years) 
 
 
18-22  0 (ref)   
23-29  0.22 0.28 -0.32, 0.76 
30-44  0.50 0.23  0.05, 0.95 
45-59  0.73 0.22  0.29, 1.17 
60-76  0.76 0.27  0.23, 1.28 
Background by 
Site 
Dominicans- Bronx  0 (ref)   
Central American- Bronx -0.29 0.33 -0.94, 0.36 
Central American- Chicago  1.07 0.28  0.53, 1.61 
Central American- Miami  1.34 0.26  0.84, 1.85 
Cubans- Miami  1.22 0.20  0.82, 1.61 
Mexicans- Bronx  0.77 0.50 -0.21, 1.76 
Mexicans- Chicago  1.27 0.22  0.84, 1.70 
Mexican- San Diego  1.62 0.23  1.16, 2.07 
Puerto Ricans- Bronx  0.57 0.29  0.01, 1.14 
Puerto Ricans- Chicago  0.76 0.34  0.08, 1.43 
South American- Bronx  0.17 0.37 -0.56, 0.90 
South American- Chicago  0.99 0.30  0.41, 1.57 
South American- Miami  1.11 0.30  0.52, 1.70 
Other- Bronx  0.38 0.36 -0.33, 1.09 
Other- Chicago  0.65 0.51 -0.35, 1.66 
Other- Miami  1.18 0.41  0.38, 1.98 
Other- San Diego  1.70 0.42  0.88, 2.52 
Body Mass 
Categories 
Underweight (<18.5 kg/m2)  1.81 0.49  0.85, 2.76 
 Normal Weight (18.5-24.9 kg/m2)   0 (ref)   
 Overweight (25.0-29.9 kg/m2)  -0.77 0.10 -0.97, -0.57 
 Obese (≥30.0 kg/m2)  -1.84 0.14 -2.10, -1.57 
Cancer History Yes  -0.20 0.36 -0.91, 0.52 
 No  0 (ref)   
Diabetic Status** Normal Glucose Regulation  0 (ref)   
 Impaired Glucose Tolerance -0.16 0.12 -0.40, 0.07 
 Diabetes  0.24 0.16 -0.08, 0.56 
Education  Less than high school or a GED  0.04 0.13 -0.22, 0.31 
 At most high school or a GED  -0.08 0.12 -0.33, 0.16 
 More than high school or a GED  0 (ref)   
End Digit 
Preference 
5, 10s -0.84 0.10 -1.03, -0.65 
1-4s, 6-9s  0 (ref)   
Gender Female, pre-, peri-menopausal*** -0.36 0.13 -0.62, -0.10 
 Female, post-menopausal -0.38 0.14 -0.65, -0.11 
 Male  0 (ref)   
Heart Failure 
History 
Yes  0.33 0.32 -0.31, 0.96 
No  0 (ref)   
Health Insurance Yes  0.13 0.13 -0.11, 0.38 
 No  0 (ref)   
Language 
Preference 
English  0.29 0.19 -0.09, 0.67 
Spanish  0 (ref)   
Nativity Born in the United States****  -0.32 0.21 -0.73, 0.08 
 Foreign Born   0 (ref)   
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Abbreviations: CI=Confidence interval, GED=General Education Development Equivalent of a High 
School Diploma, M=Measured weight, ref=Referent, SE=Standard error, SR=Self-reported weight, 
USD=United States Dollars.  
*Difference=self-reported minus measured weight (kg). Multivariate difference was calculated from a 
multivariate linear regression model of mean difference on the above possible determinants of validity 
(independent variables).  
**As defined by the American Diabetes Association [269]. 
***Women reporting not reporting ‘yes’ to having reached menopause (change of life) were assumed 
to be pre- or peri-menopausal. 
****As defined as being born in one of the 50 United States, not including United States Territories 
such as Puerto Rico. 
*****As defined in the 2008 Physical Activity Guidelines for adults [270]. 
  
Physical Activity 
Level***** 
Inactive -0.03 0.13 -0.28, 0.23 
Low Activity  0.02 0.13 -0.24, 0.29 
Medium Activity  0.38 0.16  0.07, 0.68 
High Activity  0 (ref)   
Smoking Status Never  0 (ref)   
 Former  0.23 0.14 -0.05, 0.52 
 Current  0.19 0.14 -0.08, 0.45 
Socioeconomic 
Status 
Less than $30,000 USD  0.14 0.10 -0.06, 0.34 
$30,000 or more USD  0 (ref)   
Unit of Self-Report Kg -0.99 0.27 -1.52, -0.46 
 Lb  0 (ref)   
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APPENDIX G: MULTIVARIATE ESTIMATED DIFFERENCES IN MISREPORTING 
(DEFINED AS THE DIFFERENCE BETWEEN SELF-REPORTED AND MEASURED 
WEIGHTS) AND 95% CONFIDENCE INTERVALS COMPARING THE STUDY SITES 
(B=THE BRONX, NY; C=CHICAGO, IL; M=MIAMI, FL; S=SAN DIEGO, CA; THE 
LARGEST SITE FOR A GIVEN BACKGROUND WAS USED AS REFERENT) WITHIN 
THE FOUR HISPANIC/LATINO BACKGROUNDS SAMPLED AT MORE THAN ONE SITE 
(≥100 PARTICIPANTS OF A GIVEN BACKGROUND PER SITE). 
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APPENDIX H: SUPPLEMENTAL DESCRIPTION OF STUDIES PARTICIPATING IN 
MANUSCRIPT 2. 
The Population Architecture using Genomics and Epidemiology (PAGE) study is 
funded by the National Human Genome Research Institute to examine the epidemiologic 
architecture of common genetic variants that have been reproducibly associated with human 
diseases and traits (https://www.pagestudy.org) [41]. The PAGE study consists of a 
coordinating center and four sub-consortia, representing one or more US racial/ethnic 
groups, and includes the Atherosclerosis Risk in Communities Study (ARIC), the Vanderbilt 
University Medical Center's DNA biobank (EAGLE BioVU), the Coronary Artery Risk 
Disease in Young Adults study (CARDIA), the Cardiovascular Health Study (CHS), the 
Hispanic Community Health Study/Study of Latinos (HCHS/SOL), the Multiethnic Cohort 
(MEC), Mount Sinai Biobank Program (BioME), and the Women’s Health Initiative (WHI). 
Additionally, for this analysis the PAGE study also reached out to additional studies, such as 
the GenNet Network, the Hypertension Genetic Epidemiology Network (HyperGen), Slim 
Initiative in Genomic Medicine for the Americas Type 2 Diabetes Consortium (SIGMA), and 
the Taiwan-MetaboChip Study for Cardiovascular Disease (TaiChi) Study to expand the 
sample size. 
The Atherosclerosis Risk in Communities Study (ARIC) 
ARIC is a prospective population-based study of four U.S. communities [293]. It was 
designed to investigate the causes of atherosclerosis and its clinical outcomes, as well as 
the key components (e.g. race, gender, geographic location, time period) of variation in CVD 
burden, and health care utilization. The larger ARIC study includes two separate parts: The 
Cohort Component and the Community Surveillance Component. The Cohort Component 
started in 1987 when the ARIC field centers randomly selected, recruited approximately 
4,000 individuals aged 45-64 years from each center, and began regular telephone follow-
up of the cohort for health status updates. Weight and height were measured as part of the 
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ARIC cohort examinations. The Community Surveillance Component monitors the ARIC 
communities to determine the long-term trends in hospitalized myocardial infarction and 
coronary heart disease (CHD) deaths in approximately 470,000 community-dwelling men 
and women aged 35-84 years, but these participants were not included in the current study. 
All ARIC cohort study participants provided written informed consent. Only the consenting 
African American subjects of the ARIC cohort were genotyped on the MetaboChip. 
Epidemiologic Architecture for Genes Linked to Environment study accessing BioVU 
(EAGLE BioVU) 
BioVU is Vanderbilt University's biorepository of DNA extracted from discarded blood 
that was collected during routine clinical testing and then linked to de-identified health 
records available in the Synthetic Derivative, which contains highly detailed longitudinal 
clinical data for approximately one million patients, and is updated regularly to include new 
patients and append new data [255, 279]. Planning for BioVU began in mid-2004 under the 
goal of providing a resources to investigators for studies of genotype-phenotype 
associations and the first BioVU samples were collected in February 2007 at an accrual rate 
of ~500-700 samples per week. BioVU uses an "opt out" model, which was informed by an 
opinion from the federal Office of Human Research Protection (OHRP) that discarded 
biologic samples could be used and linked to de-identified clinical data for biomedical 
research without having to obtain prospective consenting of each individual [255, 279]. The 
Epidemiologic Architecture for Genes Linked to Environment (EAGLE) study accessed all 
non-European descent patients as of 2011 [282]. The Vanderbilt University Center for 
Human Genetics Research (CHGR) DNA Resources Core genotyped these samples along 
with 360 HapMap samples on the MetaboChip [294]. Body mass index was calculated from 
the median height (centimeters) and weight (kilograms), by year and then by patient [282]. 
The median age of clinical visits per patient was included as a covariate. Race/ethnicity was 
administratively in BioVU assigned as previously described [273, 274]. 
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The Coronary Artery Risk Development in Young Adults Study (CARDIA)  
CARDIA began in 1985-1986 with a group of 5115 black and white men and women 
aged 18-30 years to examine the determinants of CVD and its risk factors [295]. The 
CARDIA participants were selected to equally represent a number of subgroups of race, 
gender, education (high school or less and more than high school) and age (18-24 and 25-
30) across four centers: Birmingham, AL; Chicago, IL; Minneapolis, MN; and Oakland, CA. 
Participants were invited to participate in follow-up examinations during 1987-1988 (Year 2), 
1990-1991 (Year 5), 1992-1993 (Year 7), 1995-1996 (Year 10), 2000-2001 (Year 15), and 
2005-2006 (Year 20), yielding retention rates from 72-90% across all follow-ups. The 
CARDIA examinations have collected medical and family histories, several CVD risk factors 
and anthropometrics, including weight, height, and skinfold fat. The participants in the 
CARDIA cohort were born between 1955-1968 and provide a unique avenue to investigate 
the mechanisms linking obesity to derangements in CVD in individuals earlier in the life 
course. All CARDIA study participants provided written informed consent. 
The Cardiovascular Health Study (CHS) 
The CHS is an observational study of risk factors for cardiovascular disease in adults 
65 years or older, which began in 1989 and continued through 1999 [296]. As part of 
extensive clinical examinations measurements of several CVD risk factors were taken, 
including traditional risk factors such as blood pressure and lipids as well as measures of 
subclinical disease, including echocardiography of the heart, carotid ultrasound, and cranial 
magnetic-resonance imaging (MRI). At six month intervals between clinic visits, and once 
clinic visits ended, participants were followed-up by phone (ongoing) to ascertain their 
hospitalizations and health status, including several outcomes: coronary heart disease, 
angina, heart failure (HF), stroke, transient ischemic attack (TIA), claudication, and mortality.  
 
 
  
174 
The GenNet Network (GenNet) 
Between 1995-2003 GenNet recruited African-American (n=1101) and European-
American participants (n=1497) at two field centers. Non-Hispanic/Latino European 
American subjects were recruited from Tecumseh, Michigan, and African-American subjects 
were recruited from Maywood, Illinois. First, individuals aged 18–50 years with blood 
pressures in the upper 20th to 25th percentile of the age/gender-specific blood pressure 
distribution were identified, and then second, an attempt was made to enroll all siblings and 
parents of the proband, irrespective of their blood pressure or hypertension treatment status 
[297]. All study participants provided their written informed consent. All hypertensive African-
American individuals were genotyped on the MetaboChip and included in the analysis. 
The Hispanic Community Health Study / Study of Latinos (HCHS/SOL) 
The Hispanic Community Health Study/Study of Latinos (HCHS/SOL) is a 
population-based study of four urban Hispanic/Latino communities that was designed to 
identify CVD risk factors playing a protective or harmful role in Hispanics/Latinos, including 
acculturation [43]. The target population of HCHS/SOL included 16,000 adults (18-74 years 
at screening) of Hispanic/Latino origin, specifically of Cuban, Puerto Rican, Mexican, and 
Central/South American heritage, who were living at one of four field centers affiliated with 
San Diego State University, Northwestern University in Chicago, Albert Einstein College of 
Medicine in the Bronx area of New York, and the University of Miami. Seven additional 
academic centers serve as scientific and logistical support centers, including the HCHS/SOL 
CC at the University of North Carolina at Chapel Hill. The HCHS/SOL participants 
underwent an extensive baseline clinic exam between 2008-2011, follow-up examination 
(ongoing), and annual follow-up interviews are ongoing to determine health outcomes of 
interest.  
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Hypertension Genetic Epidemiology Network (HyperGEN)  
HyperGEN is part of the Family Blood Pressure Program designed to study the 
genetics underpinnings of hypertension and other related conditions. Participants were 
recruited from multiply-affected hypertensive sib-ships, which were ascertained through 
population-based cohorts or from the community-at-large. The study was later extended to 
include siblings and offspring of the original sibling pair. Hypertensive individuals were 
identified as those developing hypertension before age 60 and the presence of at least one 
additional hypertensive sibling who was willing to participate. Participants with type 1 
diabetes or advanced renal disease (defined as serum creatinine level >2 mg/dL) were 
excluded. By 2003 two of four centers (AL, NC) recruited 1,264 African Americans, while 
three centers (NC, MN, and UT) recruited European Americans [298]. All study participants 
provided written informed consent, and all African American participants were genotyped on 
the MetaboChip for this analysis. 
The Multiethnic Cohort Study of Diet and Cancer (MEC)  
The MEC was established in 1993 to examine lifestyle risk factors and genetic 
susceptibility for cancer and CVD in five racial/ethnic groups at the University of Hawai‘i 
Cancer Center, in Honolulu, HI, and the Keck School of Medicine, University of Southern 
California (USC) in Los Angeles, CA [283, 299]. The MEC cohort is comprised of more than 
215,000 men and women primarily of African American, Japanese, Latino, Native Hawaiian 
and European ancestry. Every cohort member completed a self-administered 26-page 
baseline questionnaire at entry to the MEC Study (1993-1996), which included an extensive 
diet history, demographics, medical, medication, physical activity and female reproductive 
histories. Incident cancer cases are identified through cancer registries that have been 
established by state statute in Hawai‘i and California. In addition to the baseline 
questionnaire, two additional questionnaires were mailed to MEC participants including a 4-
page questionnaire that was sent in 1999-2001 and another 26-page questionnaire that was 
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sent in 2003-2008. Biological specimens were collected from selected members of the 
cohort, starting in 1996, but more concertedly from 2001-2006. Subjects were selected for 
MetaboChip genotyping based on their availability of biomarker for CVD risk factors or as 
described previously, Type 2 diabetes cases and controls were genotyped as part of the 
Slim Initiative in Genomic Medicine for the Americas Type 2 Diabetes Consortium (SIGMA) 
[275]. 
Mount Sinai Biobank Program (BioME) 
The BioMe Biobank is an ongoing, prospective, hospital- and outpatient- based 
population research program operated by The Charles Bronfman Institute for Personalized 
Medicine (IPM) at Mount Sinai and has enrolled over 33,000 participants since September 
2007 [278]. BioMe is an Electronic Medical Record (EMR)-linked biobank that integrates 
research data and clinical care information for consented patients at The Mount Sinai 
Medical Center, which serves diverse local communities of upper Manhattan with broad 
health disparities. BioMe populations include 25% of African Ancestry, 36% of 
Hispanic/Latino ancestry, 30% of European Ancestry, and 9% of other ancestry. The BioMe 
disease burden is reflective of health disparities in the local communities. BioMe operations 
are fully integrated in clinical care processes, including direct recruitment from clinical sites 
waiting areas and phlebotomy stations by dedicated recruiters independent of clinical care 
providers, prior to or following a clinician standard of care visit. Recruitment currently occurs 
at a broad spectrum of over 30 clinical care sites.  
The Taiwan-MetaboChip Study for Cardiovascular Disease (TaiChi) study  
The TaiChi study was formed through a collaborative effort between investigators 
based in the US and Taiwan, with the goal of identifying the genetic determinants of 
atherosclerosis and diabetes related traits in East Asians [276].  Several US academic sites 
participate in the TaiChi consortium: Stanford University School of Medicine in Stanford, 
California; Hudson-Alpha Biotechnology Institute in Huntsville, Alabama; and Cedars-Sinai 
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Medical Center in Los Angeles, California. The main academic sites in Taiwan include 
National Health Research Institutes (NHRI); National Taiwan University Hospital (NTUH); 
Taipei and Taichung Veteran’s General Hospitals (VGH) and Tri-Service General Hospital 
(TSGH).  To reach TaiChi’s goal, a well-phenotyped East Asian sample of ~13,500 Han 
Chinese subjects living in Taiwan was assembled. Relevant qualitative and quantitative 
traits are available in either a subset or in all cohorts, and seven cohorts comprise the 
current TaiChi bio-resource and have information on body mass index. Each cohort is 
described in more detail below.   
HALST (Healthy Aging Longitudinal Study in Taiwan) is a NHRI-established 
population-based study of older adults living in Taiwan, where more than 5,000 subjects 
were recruited over a four-year period from seven recruitment sites across the country.   
SAPPHIRe (Stanford-Asian Pacific Program in Hypertension and Insulin Resistance) 
is a family-based study established in 1995 to pinpoint the major genetic loci underlying 
hypertension and insulin resistance through linkage analysis in East Asian populations.  At 
the outset, SAPPHIRe involved recruitment sites in the San Francisco Bay Area, Hawaii, as 
well as in Taiwan.  Many metabolic variables were examined in baseline and regular follow-
up visits by a programmatic collaboration between the NHLBI in the US and NHRI in 
Taiwan.  
TCAGEN (Taiwan Coronary Artery Disease GENetic) study is an ongoing cohort 
study that has been enrolling patients undergoing coronary angiography or other 
percutaneous intervention at the National Taiwan University Hospital (NTUH), when either 
stable angina pectoris or prior myocardial infarction has been identified. Participants are 
from the north of Taiwan, where the main NTU medical school/hospital is located, and from 
the Yulin branch of NTUH, which is located in south/central Taiwan.  Peripheral blood was 
collected in the catheter lab specifically for buffy coat isolation and DNA extraction.  
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TACT (TAiwan Coronary and Transcatheter intervention) cohort study enrolled 
patients with angina pectoris and objective documentation of myocardial ischemia, who then 
underwent diagnostic coronary angiography and/or revascularization at NTUH after October 
2000. Participants provided clinically relevant information including use of CVD-related 
medication, which is supplemented by a comprehensive electronic medical records 
database that includes information on drug use and surgical interventions.  
Taiwan DRAGON (Taiwan Diabetes and RelAted Genetic COmplicatioN) study is a 
cohort study with Type 2 diabetes at the Veteran’s General Hospital in Taichung, Taiwan 
(Taichung VGH).  Participants were either newly diagnosed or known to have prevalent 
diabetes and sought care at an outpatient clinic. Subjects with hyperglycemia, but not 
diabetic, were excluded from participating in a health examination at Taichung VGH. 
TUDR (Taiwan USA Diabetes Retinopathy) enrolled subjects with Type 2 diabetes 
receiving care at Taichung VGH or TSGH, and invited TUDR participants to complete 
fundoscopic examination to document the presence and extent of diabetic retinopathy, as 
well as a variety of other clinical phenotypes, including BMI.  A total of 2,222 unrelated Type 
2 diabetes subjects have consented to and undergone the MetaboChip genotyping as part 
of the Taiwan Dragon Study. In addition to DNA and buffy coats, fasting blood for future 
measurement of serum/plasma biomarkers has also been banked. 
TCAD (Taichung CAD study) includes patients with a variety of CVD receiving care 
at the Taichung VGH.  Specifically, individuals who were hospitalized for diagnostic and 
interventional coronary angiography examinations and treatment, or those with a history of 
myocardial or revascularization were included.  
After acquiring appropriate IRB and Taiwan Department of Health permissions for 
the TaiChi Study, ~11,000 of the total 13,500 subjects included in this sample set had their 
buffy coat or DNA transferred to Cedars Sinai and HudsonAlpha, which was followed by 
careful DNA extraction, plating, and genotyping on the MetaboChip at HudsonAlpha.   
  
 
179 
The Women’s Health Initiative (WHI) 
 The WHI is a large study of postmenopausal women’s health investigating risk 
factors for cancer, CVD, age-related fractures and chronic disease [300]. It began in 1993 
as a set of randomized controlled clinical trials (CT) and an observational study (OS). 
Specifically, the CT (n=68,132) included three overlapping components: The Hormone 
Therapy (HT) Trials (n=27,347), Dietary Modification (DM) Trial (n=48,835), and Calcium 
and Vitamin D (CaD) Trial (n=36,282). Eligible women could be randomized into as many as 
all three CTs components. Women who were ineligible or unwilling to join the CT were then 
invited to join the OS (n=93,676). All WHI pariticaipnt provided informed consent to submit 
their genotype data to dbGaP and were either directly genotyped on the MetaboChip or had 
previously-collected genome-wide data (Affymetrix 6.0 array) available for imputation 
(details, see Methods above). 
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APPENDIX I: CHARACTERIZATION OF 36 FINE-MAPPED REGIONS ON THE METABOCHIP WITH EVIDENCE OF GENOME-
WIDE OR ARRAY-WIDE SIGNIFICANCE WITH BMI. 
Gene Chr Bp37 start Bp37 stop Range 
Total 
N 
SNPs 
SNPs 
Passing 
QC*** 
Indepen-
dent 
SNPs*** 
PBonferroni
*** 
Associated Trait(s) 
NEGR1 1 72,513,687 72,958,905 445,218 1377 1,076 284 1.76E-04 BMI; Weight 
TNNI3K 1 74,961,817 75,078,975 117,158 368 311 95 5.26E-04 BMI 
SEC16B 1 177,753,776 177,936,525 182,749 767 662 164 3.05E-04 BMI; Menarche; Weight 
LYPLAL1** 1 219,533,817 219,807,974 274,157 980 767 218 2.29E-04 
BMI**; Adiponectin levels; Adiposity; Fasting 
insulin-related traits (interaction with BMI); Height; 
Osteoarthritis; Visceral adipose 
tissue/subcutaneous adipose tissue ratio; Waist-hip 
ratio; Visceral to adipose tissue ratio 
TMEM18 2 471,136 719,889 248,753 1126 862 257 1.95E-04 BMI; Menarche; Weight 
BRE* 2 27,386,799 28,670,981 1,284,182 
2702 
 
2,157 669 7.47E-05 
BMI*; Cardiovascular disease risk factors; Chronic 
kidney disease; Crohn's disease; Fasting glucose-
related traits; Hypertriglyceridemia; Inflammatory 
bowel disease; LDL cholesterol; Lipoprotein-
associated phospholipase A2 activity and mass; 
Liver enzyme levels (gamma-glutamyl transferase); 
Menopause (age at onset); Metabolic syndrome; 
Metabolic traits; Metabolite levels; Non-albumin 
protein levels ; Phospholipid levels (plasma); 
Platelet counts; Serum albumin level; Serum total 
protein level; Sex hormone-binding globulin levels; 
Triglycerides; Triglycerides-Blood Pressure (TG-
BP); Two-hour glucose challenge; Type 1 diabetes; 
Urate levels; Uric acid levels; Waist Circumference 
- Triglycerides (WC-TG); Waist circumference and 
related phenotypes 
COBLL1* 2 165,499,548 165,732,418 232,870 549 429 135 3.70E-04 
BMI*; Fasting insulin-related traits (interaction with 
BMI); HDL cholesterol; Triglycerides; Type 2 
diabetes; Waist-hip ratio 
LOC646736* 2 227,007,600 227,190,673 183,073 718 592 148 3.38E-04 
BMI*; Adiponectin levels; Adiposity; Coronary heart 
disease; Fasting insulin-related traits (interaction 
with BMI); HDL cholesterol; Triglycerides; Type 2 
diabetes 
CADM2 3 85,651,797 86,050,826 399,029 792 631 218 2.29E-04 BMI 
IGF2BP2** 3 185,339,119 185,596,778 257,659 516 398 154 3.25E-04 
BMI**; Diabetes (gestational); Fasting glucose-
related traits (interaction with BMI); Height; Type 2 
diabetes 
ETV5 3 185,747,042 185,862,593 115,551 371 298 90 5.56E-04 BMI; Weight 
GNPDA2 4 45,099,376 45,187,658 88,282 344 255 55 9.09E-04 BMI 
SLC39A8* 4 103,121,726 103,218,446 96,720 306 254 64 7.81E-04 BMI*; Diastolic and systolic blood pressure; HDL 
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cholesterol 
FLJ35779 5 74,562,373 75,123,052 560,679 1129 891 244 2.05E-04 BMI; Total and LDL cholesterol; Metabolite levels 
CDKAL1* 6 20,393,907 21,191,928 798,021 2372 1,957 580 8.62E-05 
BMI*; Type 2 and gestational diabetes; Birth weight; 
Inflammatory bowel disease; Ileal carcinoids; 
Glycated hemoglobin levels 
TFAP2B 6 50,534,485 51,100,751 566,266 1689 1,389 340 1.47E-04 
BMI; Adiposity; Metabolic syndrome; Obesity; 
Renal function 
SLC22A3* 6 160,704,943 160,975,629 270,686 1185 839 198 2.53E-04 
BMI*; Colorectal cancer; Coronary heart disease; 
Lp (a) levels; Monocyte early outgrowth colony 
forming units; Prostate cancer 
LRPN6C 9 28,403,443 28,499,099 95,656 344 278 66 7.58E-04 BMI 
NT5C2* 10 104,217,441 104,999,266 781,825 1727 1,358 344 1.45E-04 
BMI*; Blood pressure; Coronary heart disease; 
Intracranial aneurysm; Parkinson's disease; 
Schizophrenia; Systolic blood pressure 
TCF7L2* 10 114,746,580 114,822,739 76,159 259 233 78 6.41E-04 
BMI*: Coronary heart disease; Fasting glucose-
related traits; Fasting glucose-related traits 
(interaction with BMI); Fasting insulin-related traits 
(interaction with BMI); Glycated hemoglobin levels; 
Metabolic syndrome; Proinsulin levels; Two-hour 
glucose challenge; Type 2 diabetes; Type 2 
diabetes and other traits 
KCNQ1* 11 2,444,094 2,943,115 499,021 2083 1,681 661 7.56E-05 
BMI*; Bilirubin levels; Electrocardiographic traits; 
Height; Protein quantitative trait loci; QT interval; 
Type 2 diabetes 
OVCH2 11 8,394,189 8,707,147 312,958 672 542 161 3.11E-04 BMI; Menarche 
NCR3LG1/K
CNJ11* 
11 17,039,079 17,423,733 384,654 559 422 121 4.13E-04 BMI*: Height; Schizophrenia; Type 2 diabetes 
BDNF 11 27,452,706 27,749,725 297,019 691 547 164 3.05E-04 
BMI; Bone mineral density; Obesity; Smoking 
behavior, Weight 
MTCH2 11 46,921,641 48,094,879 1,173,238 2401 1,873 566 8.83E-05 
BMI; Fasting glucose; HDL cholesterol; Metabolic 
syndrome; Proinsulin levels; Serum albumin levels 
FAIM2 12 50,168,189 50,290,056 121,867 343 260 84 5.95E-04 BMI; Waist circumference; Weight 
TRAFD1* 12 111,290,599 113,206,306 1,915,707 3494 2,785 792 6.31E-05 
BMI*: Alcohol consumption; Biomedical quantitative 
traits; Blood pressure; Celiac disease; Celiac 
disease and Rheumatoid arthritis; Cholesterol, total; 
Chronic kidney disease; Coronary heart disease; 
Diastolic blood pressure; Drinking behavior; 
Eosinophil counts; Esophageal cancer; Gamma 
glutamyl transpeptidase; HDL cholesterol; 
Hematocrit; Hematological parameters; 
Hemoglobin; Hypothyroidism; Intracranial 
aneurysm; LDL cholesterol; Mean platelet volume; 
Metabolite levels; Platelet counts; Red blood cell 
traits; Renal function-related traits (BUN); Renal 
function-related traits (sCR); Retinal vascular 
caliber; Rheumatoid arthritis; Stroke (ischemic); 
Systolic blood pressure; Tetralogy of Fallot; 
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Abbreviations: Bp37=base pair Build 37, Chr=chromosome, SNPs=single nucleotide polymorphisms, QC=quality control. 
*Note: Starred genes represent fine-mapped loci, which were associated with BMI after the design of the MetaboChip in 2009. 
**PAGE trans-ethnic discovery signal (Gong et al., submitted to Nature Communications).  
Triglycerides; Type 1 diabetes; Type 1 diabetes 
autoantibodies; Upper aerodigestive tract cancers; 
Urate levels; Vitiligo 
PRKD1 14 30,436,558 30,543,794 107,236 251 203 76 6.58E-04 BMI 
MAP2K5 15 67,649,978 68,215,300 565,322 1304 1,032 313 1.60E-04 BMI; Restless leg syndrome 
GPRC5B/GP
2 
16 19,704,224 20,019,432 315,208 764 562 174 2.87E-04 BMI 
SH2B1 16 28,306,987 29,001,460 694,473 795 501 177 2.82E-04 
BMI; Inflammatory bowel disease; Type 1 diabetes; 
Weight 
FTO 16 53,539,509 54,185,787 646,278 1817 1,501 490 1.02E-04 
BMI; Waist circumference; Menarche; Adiposity; 
Obesity; Type 2 diabetes; Weight 
KCNJ2* 17 68,259,822 68,516,393 256,571 1,096 944 229 2.18E-04 
BMI*; QT interval; Thyrotoxic hypokalemic periodic 
paralysis 
MC4R 18 57,727,147 58,094,636 367,489 1278 1,064 271 1.85E-04 BMI; Waist circumference; Height; Obesity; Weight 
KCTD15 19 34,295,278 34,333,501 38,223 133 110 36 1.39E-03 BMI; Major depressive disorder; Weight 
QPCTL* 19 46,136,487 46,406,698 270,211 598 445 155 3.23E-04 BMI*; 2 Hour glucose challenge; Adiposity 
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APPENDIX J: GENOTYPING AND ANALYTICAL CHARACTERISTICS OF THE STUDIES COLLABORATING AS PART OF THE 
POPULATION ARCHITECTURE USING GENOMICS AND EPIDEMIOLOGY (PAGE) STUDY. 
 Genotyping Statistical Analysis 
  Metabochip 
genotype 
calling 
Imputation HWE p-value 
threshold 
SNP 
call 
rate* 
Additional SNP QC Sample 
success 
rate 
Duplicate 
Concord-
ance rate  
Softwar
e  
Covar-
iates 
ARIC GenomeStudio 
with the GenCall 
2.0 algorithm 
NA African American: 
p<1 x 10-6 
≥95% GenTrain score<0.6 or 
cluster separation 
score<0.4 excluded; 
Mendelian 
errors;GenoSNP > 3.3% 
or PAGE consensus vs. 
HapMap 
≥95% ≥99% PLINK age, sex, 
PCs: 1-
10, 
center 
EAGLE 
BioVU 
GenomeStudio 
with the GenCall 
2.0 algorithm 
NA Asian and African: 
p<1 x 10-6; 
Hispanic/Latino: 
Exclusions 
Identified in 
HCHS/SOL 
≥95% GenTrain score<0.6 or 
cluster separation 
score<0.4 excluded; 
Mendelian 
errors;GenoSNP > 3.3% 
or PAGE consensus vs. 
HapMap 
≥95% ≥99% PLINK age, sex, 
PCs: 1-
10 
CARDIA GenomeStudio 
with the GenCall 
2.0 algorithm 
NA African American: 
p<1 x 10-6 
≥95% GenTrain score<0.6 or 
cluster separation 
score<0.4 excluded; 
Mendelian errors; 
GenoSNP > 3.3% or 
PAGE consensus vs. 
HapMap 
≥95% ≥99% PLINK age, sex, 
PCs: 1-4, 
center 
CHS GenomeStudio 
with the GenCall 
2.0 algorithm 
NA African American: 
p<1 x 10-6 
≥95% GenTrain score<0.6 or 
cluster separation 
score<0.4 excluded; 
Mendelian 
errors;GenoSNP > 3.3% 
or PAGE consensus vs. 
HapMap 
≥95% ≥99% PLINK age, sex, 
PCs: 1-
10, 
center 
GenNet GenomeStudio 
with the GenCall 
2.0 algorithm 
NA African American: 
p<1 x 10-6 
≥95% GenTrain score<0.6 or 
cluster separation 
score<0.4 excluded; 
Mendelian errors; 
GenoSNP > 3.3% or 
PAGE consensus vs. 
HapMap 
≥95% ≥99% GWAF age, sex, 
PCs: 1-
10, 
center 
HCHS/SOL GenomeStudio 
with the GenCall 
2.0 algorithm 
NA Hispanic/Latino: 
p<1 x 10-6 in 
HCHS/SOL both 
≥95% GenTrain score<0.6 or 
cluster separation 
score<0.4 excluded; 
≥95% ≥99% SUGEN 
4.0 
age, sex,  
PCs: 1-4, 
center, 
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within and across 
self-identified 
background groups 
(n=747) 
Mendelian errors; 
GenoSNP > 3.3% or 
PAGE consensus vs. 
HapMap 
Hispanic/
Latino 
backgrou
nd 
HyperGen GenomeStudio 
with the GenCall 
2.0 algorithm 
NA African American: 
p<1 x 10-6 
≥95% GenTrain score<0.6 or 
cluster separation 
score<0.4 excluded; 
Mendelian errors; 
GenoSNP > 3.3% or 
PAGE consensus vs. 
HapMap 
≥95% ≥99% GWAF age, sex, 
PCs: 1-
10, 
center 
MEC-
Metabochip 
GenomeStudio 
with the GenCall 
2.0 algorithm 
NA Asian, African and 
European 
American: p<1 x 
10-6 
≥95% GenTrain score<0.6 or 
cluster separation 
score<0.4 excluded; 
Mendelian 
errors;GenoSNP > 3.3% 
or PAGE consensus vs. 
HapMap 
≥95% ≥99% PLINK age, sex, 
PCs: 1-
10 
MEC- 
Imputed 
NA Illumina 
HumanOmni 
2.5 
(Genome 
Studio) and 
1000 
Genome 
haplotype 
panel 
imputation 
Hispanic/Latino: 
Exclusions 
Identified in 
HCHS/SOL 
≥99% Imputation (INFO) ≥ 0.6 ≥95% ≥99% PLINK age, sex, 
PCs: 1-
10 
BioME NA Illumina 
HumanOmni
ExpressExo
me 
(Genome 
Studio) and 
1000 
Genome 
haplotype 
panel 
imputation 
African American: 
p<5 x 10-5; 
Hispanic/Latino: 
Identified in 
HCHS/SOL, or in 
BioME p<5 x 10-5  
≥95% Proper_info ≥ 0.4 ≥95% ≥99% SNPTE
ST 
age, sex, 
PCs: 1-2 
for 
African 
American
s and 1-5 
in 
Hispanic
s 
TaiChi GenomeStudio 
with the GenCall 
2.0 algorithm 
NA Asian: p<1 x 10-3 ≥95% Replication errors (1 or 
more) 
≥98.5% ≥99% PLINK age, sex, 
PCs: 1-
10, study 
cohort 
WHI-
Metabochip 
    NA Asian, African, 
American 
≥95% GenTrain score<0.6 or 
cluster separation 
≥95% ≥99% R age, 
PCs: 1-
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Indian/Alaskan 
Native: p<1 x 10-6; 
Hispanic/Latino: 
Exclusions 
Identified in 
HCHS/SOL 
score<0.4 excluded; 
Mendelian errors; 
GenoSNP > 3.3% or 
PAGE consensus vs. 
HapMap 
10 
WHI- 
Imputed 
NA Affymetrix 
Genome-
wide Human 
SNP Array 
6.0 and 
1000 
Genome 
haplotype 
panel 
imputation 
African and 
European 
American: p<1 x 
10-6 
≥95% Imputation (Rsq)>0.3 ≥95% ≥99% R age, sex, 
PCs: 1-4, 
center 
Abbreviations: GWAS=Genome-wide association study, HWE=Hardy Weinberg Equilibrium, NA=Not applicable, PCs=Principal components, 
SNP=Single nucleotide polymorphism, QC=Quality Control 
*An additional 2,646 SNPs across the MetaboChip were excluded due to poor call differentiation in quality control analyses. 
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APPENDIX K: AFRICAN DESCENT GENETIC EFFECT ESTIMATES FOR 170 BMI 
INDEX SNPS FROM GWAS, INCLUDING SECONDARY SIGNALS IN EUROPEAN 
DESCENT POPULATIONS AND/OR POPULATION-SPECIFIC MARKERS. 
rsID*                Chr Bp37 Gene Ref. First 
Author 
Ref. 
Risk 
Allel
e 
A1 A
2 
Freq β 
(%) 
SE 
(%) 
P*** I2 HetP N 
rs2803328 1 1,874,326 KIAA1751 Winkler C c g 0.804 0.21 0.20 2.9E-01 34.7 1.1E-01 35589 
rs2271928 1 32,127,953 COL16A1 Winkler A a g 0.485 0.08 0.15 5.9E-01 0 5.7E-01 35597 
rs2275426 1 46,487,552 MAST2 Winkler A a g 0.416 0.03 0.15 8.3E-01 59.1 3.5E-03 35598 
rs977747 1 47,684,677 TAL1 Locke T t g 0.663 0.02 0.16 9.0E-01 0 8.9E-01 35598 
rs657452 1 49,589,847 AGBL4 Locke A          
rs11583200 1 50,559,820 ELAVL4 Locke C c t 0.712 0.30 0.17 7.5E-02 6.7 3.8E-01 35606 
rs3101336 1 72,751,185 NEGR1 Speliotes C t c 0.459 0.05 0.15 7.3E-01 0 4.6E-01 35603 
rs12566985 1 75,002,193 FPGT-TNNI3K Speliotes G g a 0.790 0.57 0.19 2.6E-03 0 5.7E-01 35485 
rs12401738 1 78,446,761 FUBP1 Locke** A a g 0.117 0.48 0.24 4.3E-02 0 5.4E-01 35603 
rs11165643 1 96,924,097 PTBP2 Speliotes T t c 0.220 0.49 0.18 8.2E-03 10 3.5E-01 35598 
rs17024393 1 110,154,688 GNAT2 Locke** C t c 0.917 0.01 0.27 9.7E-01 48.3 2.6E-02 35603 
rs4357530* 1 151,103,153 SEMA6C Winkler G a g 0.281 0.19 0.17 2.6E-01 56.6 6.3E-03 35597 
rs10913118 1 175,954,755 RFWD2 Winkler A c a 0.150 0.28 0.21 1.9E-01 0 8.2E-01 35600 
rs574367*** 1 177,873,210 SEC16B Wen 2014 T t g 0.110 0.98 0.24 4.6E-05 0 7.7E-01 35559 
rs543874*** 1 177,889,480 SEC16B Speliotes, 
Monda 
G g a 0.249 1.37 0.17 6.0E-15 44.5 4.2E-02 35604 
rs10920678 1 190,239,907 FAM5C Winkler A a g 0.412 0.26 0.15 9.4E-02 0 4.9E-01 35422 
rs2820292 1 201,784,287 NAV1 Locke C c a 0.364 0.08 0.16 6.0E-01 0 5.4E-01 35598 
rs2820436 1 219,640,680 LYPLAL1 Gong 
(sub.) 
A a c 0.478 0.51 0.15 8.4E-04 0 5.3E-01 35606 
rs12463617*** 2 629,244 TMEM18 Wen 2014 C          
rs13021737*** 2 632,348 TMEM18 Speliotes G g a 0.883 1.36 0.23 8.9E-09 26.8 1.7E-01 35541 
rs11676272*,*** 2 25,141,538 ADCY3 Wen 2014 G g a 0.833 0.94 0.21 6.5E-06 0 4.5E-01 35600 
rs10182181*** 2 25,150,296 ADCY3 Speliotes G g a 0.830 0.89 0.21 1.5E-05 0 6.2E-01 35587 
rs11126666 2 26,928,811 KCNK3 Locke A g a 0.805 0.17 0.19 3.6E-01 20.3 2.4E-01 35597 
rs116612809 2 28,301,171 BRE Gong 
2013 
G g a 0.097 1.39 0.25 6.4E-08 0 6.3E-01 35583 
rs1016287 2 59,305,625 FLJ30838 Speliotes T t c 0.215 0.22 0.18 2.2E-01 15.8 2.9E-01 35600 
rs11688816 2 63,053,048 EHBP1 Locke G a g 0.379 0.13 0.15 4.1E-01 40.1 6.6E-02 35600 
rs12622013* 2 79,501,362 REG3A Winkler G g a 0.200 0.62 0.19 1.1E-03 28.1 1.6E-01 35593 
rs7570971 2 135,837,906 RAB3GAP1 Winkler A a c 0.856 0.20 0.23 3.8E-01 5.3 3.9E-01 35579 
rs4988235 2 136,608,646 MCM6 Winkler A g a 0.851 0.20 0.22 3.7E-01 4.4 4.0E-01 35602 
rs2121279 2 143,043,285 LRP1B Speliotes T t c 0.032 0.00 0.44 9.9E-01 0 7.5E-01 35577 
rs1460676 2 164,567,689 FIGN Locke C c t 0.247 0.38 0.18 2.9E-02 41.1 6.0E-02 35603 
rs10184004 2 165,508,389 GRB14/COBL
L1 
Gong 
(sub.) 
T t c 0.719 0.72 0.17 2.1E-05 32.2 1.2E-01 35598 
rs10930502 2 172,890,588 METAP1D Gong 
(sub.) 
A a g 0.700 0.40 0.17 1.6E-02 19.4 2.5E-01 35599 
rs1528435 2 181,550,962 UBE2E3 Locke T t c 0.612 0.16 0.16 3.0E-01 0 4.9E-01 35606 
rs972540 2 207,244,783 ADAM23 Winkler A g a 0.175 0.09 0.20 6.4E-01 6.7 3.8E-01 35605 
rs17203016 2 208,255,518 CREB1 Locke G g a 0.041 0.59 0.39 1.3E-01 0 8.8E-01 35590 
rs7599312 2 213,413,231 ERBB4 Locke G g a 0.623 0.09 0.16 5.7E-01 30.1 1.4E-01 35575 
rs492400 2 219,349,752 USP37 Locke C          
rs2176040 2 227,092,802 LOC646736 Speliotes A a g 0.307 0.52 0.16 1.4E-03 1 4.4E-01 35602 
rs9845966 3 13,433,158 NUP210 Winkler T t g 0.232 0.03 0.20 8.6E-01 6.8 3.8E-01 29845 
rs6804842 3 25,106,437 RARB Locke G g a 0.412 0.05 0.15 7.4E-01 0 8.3E-01 35595 
rs7613875 3 49,971,514 MON1A Winkler A a c 0.674 0.18 0.18 3.3E-01 0 6.5E-01 27843 
rs2365389 3 61,236,462 FHIT Locke C c t 0.203 0.22 0.19 2.5E-01 5.3 3.9E-01 35602 
rs333495* 3 78,834,343 ROBO1 Winkler G t g 0.510 0.08 0.15 5.9E-01 0 6.1E-01 35605 
rs13078960 3 85,807,590 CADM2 Speliotes G t g 0.935 0.02 0.31 9.6E-01 8.5 3.6E-01 35605 
rs1720825 3 138,108,083 MRAS Graff 
(prep.) 
A g a 0.908 0.14 0.26 5.8E-01 11.4 3.3E-01 35606 
rs2640017* 3 141,335,121 RASA2 Locke G g a 0.018 0.34 0.57 5.5E-01 0 5.9E-01 35481 
rs11927381 3 185,508,591 IGF2BP2 Gong 
(sub.) 
T t c 0.255 0.59 0.18 7.7E-04 0 8.5E-01 35592 
rs1516725 3 185,824,004 ETV5 Speliotes C c t 0.817 0.64 0.20 1.2E-03 6.9 3.8E-01 35485 
rs16992647 4 36,813,105 KIAA1239 Winkler T c t 0.869 0.09 0.23 6.9E-01 0 5.0E-01 35478 
rs16858082 4 45,175,804 GNPDA2 Wen 2014 T t c 0.599 0.39 0.15 1.1E-02 14.4 3.0E-01 35539 
rs10938397 4 45,182,527 GNPDA2 Speliotes G g a 0.250 0.77 0.17 8.4E-06 51.9 1.5E-02 35517 
rs348495 4 45,184,442 GNPDA2 Monda G          
rs13107325 4 103,188,709 SLC39A8 Speliotes T t c 0.019 0.79 0.59 1.8E-01 6.6 3.8E-01 35183 
rs11727676 4 145,659,064 HHIP Locke T t c 0.980 0.53 0.55 3.3E-01 0.4 4.4E-01 35596 
rs2112347 5 75,015,242 POC5 Speliotes T t g 0.495 0.09 0.15 5.5E-01 0 8.9E-01 35604 
rs6870983 5 87,697,533 TMEM161B−A
S1 
Winkler T c t 0.554 0.17 0.15 2.6E-01 39.9 6.8E-02 35601 
rs11951673* 5 95,861,012 PCSK1 Wen 2014 C c t 0.593 0.48 0.15 1.6E-03 21 2.3E-01 35595 
rs6864049 5 124,330,522 ZNF608 Winkler A g a 0.803 0.31 0.19 1.1E-01 22.9 2.1E-01 35567 
rs13174863 5 139,080,745 CXXC5 Winkler A g a 0.060 0.27 0.32 4.0E-01 17.4 2.7E-01 35602 
rs4569924* 5 153,540,025 GALNT10 Monda T t c 0.355 0.65 0.16 4.8E-05 0 9.5E-01 35604 
rs2228213 6 12,124,855 HIVEP1 Winkler A g a 0.891 0.38 0.25 1.2E-01 25.6 1.9E-01 35606 
rs9356744 6 20,685,486 CDKAL1 Wen 2014 T t c 0.374 0.15 0.16 3.4E-01 0 9.9E-01 35598 
rs943466 6 33,731,787 LEMD2 Winkler A g a 0.707 0.14 0.16 4.0E-01 12.9 3.2E-01 35602 
rs205262 6 34,563,164 C6orf106 Speliotes G g a 0.630 0.33 0.16 3.6E-02 0 4.9E-01 35603 
rs2033529 6 40,348,653 TDRG1 Locke G a g 0.835 0.15 0.20 4.6E-01 13.7 3.1E-01 35602 
rs2207139 6 50,845,490 TFAP2B Speliotes G g a 0.096 0.79 0.26 2.0E-03 44.7 4.1E-02 35605 
rs9400239 6 108,977,663 FOXO3 Locke C c t 0.255 0.05 0.18 7.9E-01 0 9.8E-01 35600 
rs9374842 6 120,185,665 LOC285762 Locke T c t 0.228 0.03 0.18 8.5E-01 36.2 9.3E-02 35570 
rs13201877 6 137,675,541 IFNGR1 Locke G g a 0.033 0.32 0.43 4.6E-01 0 5.7E-01 35606 
rs1281962 6 153,431,376 RGS17 Winkler C g c 0.264 0.01 0.17 9.5E-01 38.8 7.5E-02 35599 
rs3127574 6 160,791,370 SLC22A3 Winkler C c g 0.587 0.03 0.15 8.3E-01 4 4.1E-01 35597 
rs13191362 6 163,033,350 PARK2 Locke A a g 0.947 0.97 0.34 4.1E-03 40.8 6.2E-02 35593 
rs10499694* 7 50,614,173 DDC Winkler G a g 0.641 0.12 0.16 4.4E-01 0 8.8E-01 35598 
rs1167827 7 75,163,169 HIP1 Locke G g a 0.870 0.20 0.23 4.0E-01 0 5.1E-01 35598 
rs6465468 7 95,169,514 ASB4 Locke T g t 0.838 0.36 0.21 8.5E-02 23.8 2.0E-01 35573 
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rs6990042 8 14,173,974 SGCZ Winkler T t g 0.634 0.17 0.16 2.7E-01 0 5.5E-01 35602 
rs7844647* 8 34,503,776 Intergenic Winkler T t c 0.285 0.63 0.17 2.0E-04 4.9 4.0E-01 35604 
rs17405819 8 76,806,584 HNF4G Locke** T t c 0.917 0.13 0.28 6.3E-01 0 5.9E-01 35602 
rs16907751 8 81,375,457 ZBTB10 Locke C c t 0.921 0.13 0.28 6.5E-01 11.2 3.3E-01 35605 
rs2033732 8 85,079,709 RALYL Locke C t c 0.119 0.79 0.23 7.2E-04 5.6 3.9E-01 35556 
rs4740619 9 15,634,326 C9orf93 Locke T c t 0.448 0.15 0.15 3.1E-01 48.7 2.5E-02 35575 
rs10968576 9 28,414,339 LINGO2 Speliotes G g a 0.170 0.63 0.20 1.8E-03 0 8.3E-01 35604 
rs6477694 9 111,932,342 EPB41L4B Locke C c t 0.419 0.07 0.15 6.5E-01 0 6.9E-01 35603 
rs1928295 9 120,378,483 TLR4 Locke T c t 0.436 0.09 0.15 5.6E-01 0 4.7E-01 35594 
rs10733682 9 129,460,914 LMX1B Locke A a g 0.288 0.39 0.17 1.9E-02 15.8 2.8E-01 35586 
rs2270204 9 131,042,734 SWI5  Winkler T g t 0.690 0.35 0.17 3.7E-02 33.3 1.2E-01 35527 
rs7899106 10 87,410,904 GRID1 Locke G g a 0.122 0.20 0.23 3.9E-01 55.3 8.2E-03 35596 
rs17094222 10 102,395,440 HIF1AN Locke C c t 0.055 0.18 0.34 6.0E-01 0 8.7E-01 35597 
rs11191560 10 104,869,038 NT5C2 Locke, 
Wen 2012 
C c t 0.042 0.78 0.38 3.9E-02 0 7.6E-01 35601 
rs7903146 10 114,758,349 TCF7L2 Locke C c t 0.706 0.66 0.17 6.1E-05 26.7 1.8E-01 35604 
rs10886017 10 118,672,531 KIAA1598 Winkler A a c 0.462 0.28 0.15 6.3E-02 0 7.1E-01 35565 
rs2237897 11 2,858,546 KCNQ1 Wen 2014 T t c 0.088 0.48 0.27 8.0E-02 3 4.2E-01 35432 
rs4256980 11 8,673,939 TRIM66 Speliotes G g c 0.515 0.26 0.15 8.8E-02 0 5.4E-01 35594 
rs7928810 11 17,372,443 NCR3LG1 Winkler A a c 0.915 0.70 0.28 1.2E-02 40.1 6.7E-02 35603 
rs1557765 11 17,403,639 KCNJ11 Winkler T c t 0.893 0.50 0.25 4.1E-02 27.6 1.7E-01 35605 
rs11030104 11 27,684,517 BDNF Speliotes, 
Wen 2014 
A a g 0.951 1.28 0.36 3.8E-04 14.6 3.0E-01 35606 
rs10835210 11 27,695,910 BDNF Locke C c a 0.868 0.22 0.25 3.8E-01 31 1.6E-01 29676 
rs652722 11 31,905,534 PAX6 Wen 2012 C          
rs2176598 11 43,864,278 HSD17B12 Locke T t c 0.363 0.02 0.16 9.0E-01 0 1.0E+00 35602 
rs3817334 11 47,650,993 MTCH2 Speliotes T t c 0.266 0.19 0.17 2.7E-01 0 7.1E-01 35594 
rs1865732* 11 112,960,722 NCAM1 Winkler C t c 0.668 0.12 0.16 4.5E-01 0 7.9E-01 35601 
rs12286929 11 115,022,404 CADM1 Locke G g a 0.570 0.05 0.15 7.4E-01 0 6.6E-01 34809 
rs11611246 12 939,480 WNK1 Winkler T          
rs7970953 12 24,075,508 SOX5 Winkler A a g 0.236 0.07 0.18 7.1E-01 25.7 1.8E-01 35574 
rs1405552 12 41,746,673 PDZRN4 Winkler A a g 0.102 0.27 0.26 2.9E-01 0 4.5E-01 35606 
rs11181001 12 41,948,196 PDZRN4 Winkler A g a 0.419 0.07 0.15 6.4E-01 0 6.9E-01 35603 
rs7138803 12 50,247,468 BCDIN3D Speliotes A a g 0.179 0.16 0.20 4.2E-01 32.9 1.2E-01 35600 
rs1438994* 12 90,594,389 Intergenic Winkler T t c 0.112 0.43 0.24 7.4E-02 0 8.1E-01 35603 
rs11065987 12 112,072,424 BRAP Winkler A a g 0.919 0.38 0.29 1.8E-01 0 5.7E-01 35602 
rs17630235 12 112,591,686 TRAFD1 Winkler A g a 0.920 0.43 0.29 1.4E-01 0 5.4E-01 35574 
rs11057405 12 122,781,897 CLIP1 Locke G          
rs1885988* 13 28,010,262 MTIF3 Speliotes C c t 0.040 0.55 0.40 1.6E-01 40.1 6.6E-02 35605 
rs12429545 13 54,102,206 OLFM4 Speliotes A a g 0.049 0.65 0.35 6.6E-02 23.4 2.1E-01 35591 
rs9540493 13 66,205,704 MIR548X2 Locke A a g 0.610 0.37 0.15 1.5E-02 50.8 1.8E-02 35547 
rs1441264 13 79,580,919 MIR548A2 Locke A a g 0.693 0.06 0.16 7.3E-01 0 4.6E-01 35577 
rs9634489 13 97,049,004 HS6ST3 Winkler A g a 0.619 0.05 0.16 7.7E-01 0 8.9E-01 35603 
rs10132280 14 25,928,179 STXBP6 Locke C c a 0.475 0.17 0.15 2.6E-01 0 8.5E-01 35561 
rs12885454 14 29,736,838 PRKD1 Locke C c a 0.866 0.14 0.22 5.3E-01 0 1.0E+00 35585 
rs11847697 14 30,515,112 PRKD1 Speliotes T t c 0.331 0.03 0.16 8.4E-01 0 9.9E-01 35603 
rs17522122 14 33,302,882 AKAP6 Winkler T          
rs7141420 14 79,899,454 NRXN3 Speliotes T t c 0.593 0.52 0.15 7.5E-04 14.4 3.0E-01 35592 
rs3783890 14 93,790,276 BTBD7 Winkler T t c 0.902 0.51 0.25 4.5E-02 0 8.9E-01 35606 
rs7143963 14 103,304,425 TRAF3 Winkler T t c 0.618 0.33 0.16 3.7E-02 69 1.2E-04 35602 
rs709400 14 104,149,475 KLC1 Winkler A g a 0.219 0.03 0.18 8.6E-01 11.8 3.3E-01 35605 
rs3736485 15 51,748,610 DMXL2 Locke A a g 0.579 0.14 0.15 3.7E-01 0 5.6E-01 35573 
rs16951275 15 68,077,168 MAP2K5 Speliotes T t c 0.610 0.57 0.15 2.7E-04 0 5.7E-01 35605 
rs4776970 15 68,080,886 MAP2K5 Wen 2012 A a t 0.463 0.47 0.15 1.9E-03 24.5 2.0E-01 35602 
rs7164727 15 73,093,991 LOC10028755
9 
Locke T c t 0.646 0.04 0.16 8.1E-01 0 5.0E-01 35600 
rs7181659 15 95,267,483 MCTP2 Winkler A g a 0.353 0.01 0.16 9.5E-01 35.3 1.0E-01 35602 
rs11866815 16 387,867 AXIN1 Winkler T t c 0.417 0.17 0.15 2.6E-01 39 7.4E-02 35540 
rs12446632 16 19,935,389 GPRC5B Speliotes G          
rs11074446 16 20,255,123 GP2 Locke T t c 0.678 0.49 0.16 2.4E-03 25.6 1.9E-01 35583 
rs2650492 16 28,333,411 SBK1 Locke A a g 0.064 0.70 0.33 3.5E-02 0 5.3E-01 35590 
rs3888190 16 28,889,486 ATP2A1 speliotes A a c 0.271 0.62 0.17 2.8E-04 25.4 1.9E-01 35587 
rs4787491 16 30,015,337 INO80E Locke G g a 0.533 0.31 0.15 4.2E-02 2.9 4.2E-01 35602 
rs9925964 16 31,129,895 KAT8 Locke A a g 0.867 0.24 0.23 2.8E-01 22.1 2.3E-01 34839 
rs2080454 16 49,062,590 CBLN1 Locke C c a 0.654 0.27 0.16 8.4E-02 0 7.1E-01 35604 
rs1558902*** 16 53,803,574 FTO Speliotes, 
Wen 2014 
A          
rs17817964*** 16 53,828,066 FTO Monda T t c 0.118 1.05 0.24 1.2E-05 33 1.2E-01 35606 
rs889398 16 69,556,715 NFAT5 Winkler T c t 0.718 0.02 0.17 8.9E-01 52.6 1.3E-02 35585 
rs9914578 17 2,005,136 SMG6 Locke G c g 0.473 0.02 0.15 8.9E-01 37.5 8.4E-02 35587 
rs1000940 17 5,283,252 RABEP1 Locke G g a 0.237 0.24 0.18 1.7E-01 0 7.8E-01 35599 
rs4986044 17 21,261,560 KCNJ12 Winkler T t c 0.654 0.07 0.16 6.8E-01 24.1 2.1E-01 34843 
rs12150665 17 34,914,787 GGNBP2 Winkler T c t 0.125 0.07 0.23 7.7E-01 42.7 5.1E-02 35601 
rs11652097 17 45,316,717 ITGB3  Winkler T c t 0.639 0.17 0.16 2.9E-01 0 7.4E-01 35559 
rs6504108 17 46,292,923 SKAP1 Winkler T c t 0.302 0.16 0.16 3.3E-01 0 6.4E-01 35599 
rs8075273* 17 61,728,881 unknown Winkler C c a 0.635 0.02 0.16 8.9E-01 0 7.9E-01 35365 
rs312750 17 68,343,539 KCNJ2 Winkler A a g 0.810 0.06 0.19 7.6E-01 0 8.6E-01 35604 
rs12940622 17 78,615,571 RPTOR Locke** G g a 0.446 0.25 0.15 1.0E-01 0 8.6E-01 35603 
rs1808579 18 21,104,888 C18orf8 Speliotes C c t 0.548 0.08 0.15 5.9E-01 21.1 2.3E-01 35597 
rs7239883 18 40,147,671 LOC284260 Locke G a g 0.568 0.00 0.15 9.8E-01 10.2 3.4E-01 35396 
rs7243357 18 56,883,319 GRP Locke T t g 0.872 0.59 0.23 8.4E-03 0 9.6E-01 35606 
rs2331841 18 57,828,637 MC4R Okada A a g 0.486 0.70 0.15 4.1E-06 0 7.5E-01 35586 
rs6567160 18 57,829,135 MC4R Speliotes, 
Pei 
C c t 0.189 1.08 0.19 2.8E-08 58.9 3.7E-03 35599 
rs591166 18 57,841,589 MC4R Wen 2014 A a t 0.742 0.28 0.17 1.1E-01 0 7.5E-01 35594 
rs9944545 18 57,958,244 MC4R Locke T t c 0.543 0.20 0.15 1.9E-01 0 4.5E-01 35603 
rs17066842 18 58,040,624 MC4R Locke G g a 0.827 0.34 0.20 8.6E-02 30.2 1.4E-01 35570 
rs17724992 19 18,454,825 PGPEP1 Locke A a g 0.887 0.67 0.24 5.7E-03 15.2 2.9E-01 35599 
rs17513613 19 30,286,822 CCNE1 Winkler T t c 0.889 0.17 0.24 4.8E-01 0 9.8E-01 35605 
rs29941 19 34,309,532 KCTD15 Speliotes G g a 0.818 0.24 0.19 2.1E-01 0 7.9E-01 35593 
rs2075650 19 45,395,619 TOMM40 Speliotes A g a 0.125 0.01 0.24 9.6E-01 3.5 4.1E-01 35602 
rs11671664 19 46,172,278 GIPR, QPCTL Wen 2014 G a g 0.116 0.41 0.24 8.9E-02 0 7.5E-01 35596 
rs2287019 19 46,202,172 QPCTL Speliotes C          
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rs3810291 19 47,569,003 ZC3H4 Speliotes A a g 0.210 0.47 0.25 5.8E-02 0 5.2E-01 20961 
rs4802349 19 47,874,510 DHX34 Gong 
2013 
G g t 0.519 0.84 0.15 3.8E-08 0 5.1E-01 35507 
rs8123881* 20 15,819,495 MACROD2 Winkler G g a 0.357 0.29 0.16 6.9E-02 26.9 1.7E-01 35604 
rs6091540 20 51,087,862 ZFP64 Locke** C c t 0.775 0.22 0.18 2.2E-01 0 6.9E-01 35604 
rs2836754 21 40,291,740 ETS2 Locke C c t 0.372 0.23 0.16 1.5E-01 0 5.7E-01 35601 
rs4820408 22 40,604,945 TNRC6B Winkler T g t 0.893 0.02 0.25 9.5E-01 10.9 3.4E-01 35606 
Abbreviations: A1=coded allele, A2=non-coded allele, Bp37=base pair Build 37, Chr=chromosome, 
FE=Fixed-Effect, HetP=heterogeneity p-value, P=p-value, Prep=prepared reference, Ref=reference, 
Sub=submitted reference, SNPs=single nucleotide polymorphisms. 
*When the index SNP was not genotyped on the MetaboChip, the proxy SNP in tight linkage 
disequilibrium (r2≥0.8 in 1000 Genomes pilot 1 CEU, YRI, CHB+JPT depending on the population of 
discovery) with the lowest p-value in the African American sample was chosen to represent the index 
signal. The decreasing and increasing alleles for proxies were assigned assuming that the risk index 
SNP would have a similar allele frequency in the 1000 Genomes population (EUR, AFR, or EAS 
depending on the discovery population) as the risk proxy SNP. 
**These loci were also described by Berndt et al. for obesity (maximum sample size of 263,407) [29].  
The most recent BMI references per racial/ethnic group are noted above by their first author and 
publication year, if applicable [21, 25, 26, 30, 32, 33, 186, 195, 204]. 
***For GWAS SNPs a Bonferroni correction for multiple tests in the fixed-effect analyses reflected the 
number of independent previously-reported signals tested (=0.05/166). The 4 noted SNP pairs above 
were in tight linkage disequilibrium [r2≥0.8 in non-European 1000 genomes pilot populations(s)] with 
each other, but because they were reports from distinct discovery populations we retained them in 
this inventory in case they were population-specific variants. Therefore, our Bonferroni correction was 
penalized for only 166 (=170-4) tests. 
****Bonferroni significant heterogeneity p-values shown in italics. 
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APPENDIX L: HISPANIC/LATINO DESCENT GENETIC EFFECT ESTIMATES FOR 170 
BMI INDEX SNPS FROM GWAS, INCLUDING SECONDARY SIGNALS IN EUROPEAN 
DESCENT POPULATIONS AND/OR POPULATION-SPECIFIC MARKERS. 
rsID* C
hr 
Bp37 Gene Ref. First 
Author 
Ref. 
Risk 
Allele 
A
1 
A
2 
Freq β 
(%) 
SE 
(%) 
P*** I2 HetP N 
rs2803328 1 1,874,326 KIAA1751 Winkler C g c 0.515 0.03 0.17 8.6E-01 19.9 2.8E-01 26044 
rs2271928 1 32,127,953 COL16A1 Winkler A g a 0.550 0.07 0.16 6.9E-01 0 6.7E-01 26040 
rs2275426 1 46,487,552 MAST2 Winkler A a g 0.495 0.26 0.17 1.2E-01 23.6 2.5E-01 26046 
rs977747 1 47,684,677 TAL1 Locke T t g 0.550 0.00 0.17 1.0E+00 0 6.4E-01 26046 
rs657452 1 49,589,847 AGBL4 Locke A a g 0.437 0.79 0.17 5.5E-06 0 9.8E-01 24479 
rs11583200 1 50,559,820 ELAVL4 Locke C c t 0.509 0.53 0.17 1.2E-03 42.7 1.1E-01 26045 
rs3101336 1 72,751,185 NEGR1 Speliotes C t c 0.299 0.04 0.18 8.3E-01 17.9 2.9E-01 26045 
rs12566985 1 75,002,193 FPGT-
TNNI3K 
Speliotes G 
g a 0.604 0.28 0.17 1.0E-01 2.4 4.1E-01 25968 
rs12401738 1 78,446,761 FUBP1 Locke** A g a 0.716 0.09 0.18 6.2E-01 11.1 3.4E-01 26045 
rs11165643 1 96,924,097 PTBP2 Speliotes T t c 0.582 0.46 0.17 6.0E-03 4.3 3.9E-01 26031 
rs17024393 1 110,154,688 GNAT2 Locke** C t c 0.976 0.04 0.64 9.5E-01 0 6.2E-01 24225 
rs4357530* 1 151,103,153 SEMA6C Winkler G g a 0.274 0.07 0.21 7.3E-01 18.9 2.9E-01 21396 
rs10913118 1 175,954,755 RFWD2 Winkler A a c 0.762 0.27 0.20 1.7E-01 0 8.9E-01 26042 
rs574367*** 1 177,873,210 SEC16B Wen 2014 T t g 0.183 0.61 0.21 3.9E-03 0 6.0E-01 26044 
rs543874*** 1 177,889,480 SEC16B Speliotes, 
Monda 
G 
g a 0.202 0.76 0.20 1.8E-04 0 4.4E-01 26045 
rs10920678 1 190,239,907 FAM5C Winkler A a g 0.296 0.36 0.18 5.3E-02 38.2 1.4E-01 25997 
rs2820292 1 201,784,287 NAV1 Locke C c a 0.429 0.15 0.17 3.6E-01 0 5.6E-01 26045 
rs2820436 1 219,640,680 LYPLAL1 Gong (sub.) A a c 0.439 0.63 0.17 1.6E-04 0 4.8E-01 26046 
rs12463617*** 2 629,244 TMEM18 Wen 2014 C c a 0.851 1.17 0.23 6.1E-07 46.5 8.2E-02 26046 
rs13021737*** 2 632,348 TMEM18 Speliotes G g a 0.867 1.14 0.24 3.6E-06 29.5 2.0E-01 26016 
rs11676272*,*** 2 25,141,538 ADCY3 Wen 2014 G g a 0.414 0.48 0.17 4.7E-03 0 7.3E-01 26046 
rs10182181*** 2 25,150,296 ADCY3 Speliotes G g a 0.414 0.47 0.17 6.1E-03 0 8.4E-01 26045 
rs11126666 2 26,928,811 KCNK3 Locke A a g 0.194 0.21 0.21 3.0E-01 4.9 3.9E-01 26047 
rs116612809 2 28,301,171 BRE Gong 2013 G a g 0.979 1.35 0.70 5.7E-02 0 5.6E-01 22385 
rs1016287 2 59,305,625 FLJ30838 Speliotes T t c 0.272 0.10 0.19 5.7E-01 0 8.4E-01 26044 
rs11688816 2 63,053,048 EHBP1 Locke G a g 0.446 0.13 0.17 4.3E-01 69.3 3.4E-03 26044 
rs12622013* 2 79,501,362 REG3A Winkler G g a 0.163 0.06 0.22 8.0E-01 0 5.3E-01 26015 
rs7570971 2 135,837,906 RAB3GAP
1 
Winkler A 
c a 0.221 0.21 0.20 3.0E-01 8.8 3.6E-01 26045 
rs4988235 2 136,608,646 MCM6 Winkler A a g 0.226 0.31 0.20 1.3E-01 0.5 4.2E-01 26044 
rs2121279 2 143,043,285 LRP1B Speliotes T t c 0.062 0.01 0.34 9.7E-01 25.3 2.4E-01 26033 
rs1460676 2 164,567,689 FIGN Locke C c t 0.134 0.24 0.25 3.3E-01 0 9.0E-01 26048 
rs10184004 2 165,508,389 GRB14/C
OBLL1 
Gong (sub.) T 
t c 0.326 0.39 0.18 3.2E-02 44 9.7E-02 26045 
rs10930502 2 172,890,588 METAP1D Gong (sub.) A a g 0.656 0.43 0.18 1.4E-02 0 5.2E-01 26043 
rs1528435 2 181,550,962 UBE2E3 Locke T t c 0.653 0.45 0.18 9.8E-03 47.2 7.8E-02 26048 
rs972540 2 207,244,783 ADAM23 Winkler A g a 0.191 0.63 0.21 2.9E-03 0 5.7E-01 26047 
rs17203016 2 208,255,518 CREB1 Locke G g a 0.130 0.12 0.25 6.2E-01 0 8.9E-01 26038 
rs7599312 2 213,413,231 ERBB4 Locke G g a 0.780 0.38 0.20 6.1E-02 41.4 1.2E-01 26046 
rs492400 2 219,349,752 USP37 Locke C c t 0.419 0.37 0.18 3.5E-02 0 5.3E-01 24446 
rs2176040 2 227,092,802 LOC64673
6 
Speliotes A 
a g 0.241 0.67 0.19 6.2E-04 0 4.8E-01 26045 
rs9845966 3 13,433,158 NUP210 Winkler T t g 0.536 0.26 0.17 1.2E-01 0 5.2E-01 26044 
rs6804842 3 25,106,437 RARB Locke G g a 0.552 0.12 0.16 4.5E-01 0 9.4E-01 26046 
rs7613875 3 49,971,514 MON1A Winkler A a c 0.412 0.07 0.17 7.0E-01 0 7.2E-01 25991 
rs2365389 3 61,236,462 FHIT Locke C c t 0.379 0.36 0.17 3.9E-02 0 4.7E-01 26047 
rs333495* 3 78,834,343 ROBO1 Winkler G t g 0.499 0.06 0.17 7.3E-01 0 5.5E-01 26048 
rs13078960 3 85,807,590 CADM2 Speliotes G g t 0.136 0.02 0.24 9.4E-01 0 7.5E-01 26046 
rs1720825 3 138,108,083 MRAS Graff (prep.) A g a 0.867 0.10 0.24 6.9E-01 46.3 8.3E-02 26048 
rs2640017* 3 141,335,121 RASA2 Locke G g a 0.192 0.53 0.22 1.6E-02 38.4 1.4E-01 26046 
rs11927381 3 185,508,591 IGF2BP2 Gong (sub.) T t c 0.673 0.52 0.18 3.9E-03 23.6 2.5E-01 25976 
rs1516725 3 185,824,004 ETV5 Speliotes C c t 0.900 0.84 0.28 3.1E-03 0 1.0E+00 26021 
rs16992647 4 36,813,105 KIAA1239 Winkler T t c 0.155 0.25 0.23 2.7E-01 0 7.5E-01 26047 
rs16858082 4 45,175,804 GNPDA2 Wen 2014 T t c 0.559 0.46 0.17 5.5E-03 47.5 7.6E-02 26035 
rs10938397 4 45,182,527 GNPDA2 Speliotes G g a 0.372 0.70 0.17 4.7E-05 49.1 6.7E-02 26020 
rs348495 4 45,184,442 GNPDA2 Monda G g a 0.523 0.44 0.17 8.4E-03 45.9 8.5E-02 25944 
rs13107325 4 103,188,709 SLC39A8 Speliotes T t c 0.046 1.03 0.39 9.5E-03 55.2 3.7E-02 26048 
rs11727676 4 145,659,064 HHIP Locke T c t 0.056 0.71 0.36 4.9E-02 25.8 2.3E-01 26048 
rs2112347 5 75,015,242 POC5 Speliotes T t g 0.629 0.30 0.17 8.1E-02 0 5.6E-01 26045 
rs6870983 5 87,697,533 TMEM161
B−AS1 
Winkler T 
c t 0.778 0.37 0.21 7.1E-02 48.4 7.1E-02 26048 
rs11951673* 5 95,861,012 PCSK1 Wen 2014 C c t 0.614 0.41 0.17 1.5E-02 0 5.9E-01 26042 
rs6864049 5 124,330,522 ZNF608 Winkler A a g 0.296 0.12 0.18 5.1E-01 0 6.1E-01 26044 
rs13174863 5 139,080,745 CXXC5 Winkler A g a 0.131 0.37 0.25 1.3E-01 0 9.9E-01 26047 
rs4569924* 5 153,540,025 GALNT10 Monda T t c 0.598 0.15 0.17 3.8E-01 53.7 4.4E-02 26044 
rs2228213 6 12,124,855 HIVEP1 Winkler A g a 0.741 0.01 0.19 9.6E-01 29.8 2.0E-01 26048 
rs9356744 6 20,685,486 CDKAL1 Wen 2014 T t c 0.641 0.33 0.17 5.4E-02 6.2 3.8E-01 26048 
rs943466 6 33,731,787 LEMD2 Winkler A g a 0.676 0.06 0.18 7.5E-01 0 9.9E-01 26048 
rs205262 6 34,563,164 C6orf106 Speliotes G g a 0.284 0.25 0.19 1.8E-01 0 7.2E-01 26045 
rs2033529 6 40,348,653 TDRG1 Locke G g a 0.184 0.04 0.22 8.6E-01 1.5 4.1E-01 26046 
rs2207139 6 50,845,490 TFAP2B Speliotes G g a 0.294 0.30 0.19 1.0E-01 0 9.7E-01 26045 
rs9400239 6 108,977,663 FOXO3 Locke C c t 0.586 0.03 0.17 8.4E-01 0 4.5E-01 26044 
rs9374842 6 120,185,665 LOC28576
2 
Locke T 
t c 0.793 0.06 0.20 7.6E-01 0 6.6E-01 26009 
rs13201877 6 137,675,541 IFNGR1 Locke G a g 0.891 0.02 0.27 9.4E-01 0 9.0E-01 26048 
rs1281962 6 153,431,376 RGS17 Winkler C c g 0.615 0.12 0.17 4.9E-01 50.3 6.0E-02 26038 
rs3127574 6 160,791,370 SLC22A3 Winkler C c g 0.456 0.49 0.17 2.9E-03 0 7.1E-01 26048 
rs13191362 6 163,033,350 PARK2 Locke A g a 0.085 0.12 0.30 7.0E-01 0 4.9E-01 26040 
rs10499694* 7 50,614,173 DDC Winkler G g a 0.437 0.07 0.17 6.7E-01 0 9.0E-01 26048 
rs1167827 7 75,163,169 HIP1 Locke G g a 0.452 0.45 0.18 1.1E-02 45.5 8.8E-02 26044 
rs6465468 7 95,169,514 ASB4 Locke T t g 0.229 0.04 0.20 8.3E-01 56.9 3.1E-02 26046 
rs6990042 8 14,173,974 SGCZ Winkler T g t 0.514 0.35 0.17 3.7E-02 0 9.7E-01 26043 
rs7844647* 8 34,503,776 Intergenic Winkler T c t 0.390 0.05 0.17 7.7E-01 16.7 3.0E-01 26047 
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rs17405819 8 76,806,584 HNF4G Locke** T t c 0.739 0.06 0.19 7.5E-01 0 7.9E-01 26043 
rs16907751 8 81,375,457 ZBTB10 Locke C c t 0.925 0.13 0.32 6.8E-01 0 7.0E-01 26047 
rs2033732 8 85,079,709 RALYL Locke C c t 0.784 0.23 0.20 2.5E-01 18 2.9E-01 26033 
rs4740619 9 15,634,326 C9orf93 Locke T t c 0.398 0.07 0.17 6.8E-01 30.8 1.9E-01 26044 
rs10968576 9 28,414,339 LINGO2 Speliotes G g a 0.231 0.64 0.20 1.1E-03 19.8 2.8E-01 26048 
rs6477694 9 111,932,342 EPB41L4B Locke C c t 0.402 0.17 0.17 3.2E-01 43.7 9.9E-02 26047 
rs1928295 9 120,378,483 TLR4 Locke T t c 0.560 0.24 0.16 1.5E-01 0 8.7E-01 26045 
rs10733682 9 129,460,914 LMX1B Locke A a g 0.571 0.34 0.17 4.3E-02 53.5 4.5E-02 26048 
rs2270204 9 131,042,734 SWI5  Winkler T g t 0.391 0.12 0.17 4.9E-01 10.4 3.5E-01 26027 
rs7899106 10 87,410,904 GRID1 Locke G a g 0.947 0.02 0.38 9.5E-01 0 5.5E-01 26048 
rs17094222 10 102,395,440 HIF1AN Locke C c t 0.219 0.30 0.20 1.3E-01 20.1 2.8E-01 26047 
rs11191560 10 104,869,038 NT5C2 Locke, Wen 
2012 
C 
c t 0.157 0.58 0.23 1.2E-02 0 7.1E-01 26048 
rs7903146 10 114,758,349 TCF7L2 Locke C c t 0.739 0.79 0.19 3.3E-05 63.8 1.1E-02 26047 
rs10886017 10 118,672,531 KIAA1598 Winkler A c a 0.683 0.19 0.18 2.8E-01 0 4.4E-01 26047 
rs2237897 11 2,858,546 KCNQ1 Wen 2014 T t c 0.200 0.82 0.22 1.4E-04 0 9.1E-01 26044 
rs4256980 11 8,673,939 TRIM66 Speliotes G g c 0.570 0.04 0.17 8.1E-01 13.4 3.3E-01 26039 
rs7928810 11 17,372,443 NCR3LG1 Winkler A a c 0.654 0.10 0.18 5.8E-01 45.1 9.1E-02 26045 
rs1557765 11 17,403,639 KCNJ11 Winkler T c t 0.653 0.12 0.18 4.8E-01 38.6 1.3E-01 26043 
rs11030104 11 27,684,517 BDNF Speliotes, 
Wen 2014 
A 
a g 0.831 0.42 0.22 5.4E-02 49.6 6.4E-02 26047 
rs10835210 11 27,695,910 BDNF Locke C c a 0.709 0.17 0.18 3.4E-01 0 8.0E-01 25824 
rs652722 11 31,905,534 PAX6 Wen 2012 C c t 0.685 0.18 0.18 3.2E-01 0 7.3E-01 26022 
rs2176598 11 43,864,278 HSD17B1
2 
Locke T 
t c 0.405 0.05 0.17 7.8E-01 14.8 3.2E-01 26045 
rs3817334 11 47,650,993 MTCH2 Speliotes T t c 0.397 0.51 0.17 2.5E-03 0 6.1E-01 26040 
rs1865732* 11 112,960,722 NCAM1 Winkler C t c 0.579 0.05 0.17 7.7E-01 0 8.3E-01 26044 
rs12286929 11 115,022,404 CADM1 Locke G g a 0.526 0.28 0.17 9.2E-02 0 9.1E-01 26044 
rs11611246 12 939,480 WNK1 Winkler T t g 0.266 0.55 0.19 3.7E-03 28 2.1E-01 25991 
rs7970953 12 24,075,508 SOX5 Winkler A a g 0.441 0.13 0.17 4.5E-01 63.9 1.1E-02 26041 
rs1405552 12 41,746,673 PDZRN4 Winkler A g a 0.545 0.14 0.17 4.0E-01 21.4 2.7E-01 26047 
rs11181001 12 41,948,196 PDZRN4 Winkler A a g 0.450 0.24 0.17 1.4E-01 0 5.4E-01 26045 
rs7138803 12 50,247,468 BCDIN3D Speliotes A a g 0.259 0.50 0.19 7.9E-03 12.4 3.3E-01 26047 
rs1438994* 12 90,594,389 Intergenic Winkler T t c 0.235 0.04 0.20 8.3E-01 15.8 3.1E-01 26046 
rs11065987 12 112,072,424 BRAP Winkler A a g 0.743 0.03 0.19 8.9E-01 10.1 3.5E-01 26045 
rs17630235 12 112,591,686 TRAFD1 Winkler A g a 0.745 0.02 0.20 9.1E-01 0 4.8E-01 26045 
rs11057405 12 122,781,897 CLIP1 Locke G g a 0.926 0.25 0.32 4.4E-01 38.3 1.4E-01 25991 
rs1885988* 13 28,010,262 MTIF3 Speliotes C c t 0.106 0.31 0.27 2.5E-01 40.1 1.2E-01 26048 
rs12429545 13 54,102,206 OLFM4 Speliotes A a g 0.273 0.84 0.19 1.1E-05 0 8.2E-01 26048 
rs9540493 13 66,205,704 MIR548X2 Locke A a g 0.485 0.46 0.17 5.5E-03 32.5 1.8E-01 26040 
rs1441264 13 79,580,919 MIR548A2 Locke A a g 0.678 0.26 0.18 1.4E-01 64.2 1.0E-02 26039 
rs9634489 13 97,049,004 HS6ST3 Winkler A g a 0.399 0.12 0.17 5.1E-01 0 9.7E-01 26048 
rs10132280 14 25,928,179 STXBP6 Locke C c a 0.682 0.62 0.18 4.7E-04 10.7 3.5E-01 26043 
rs12885454 14 29,736,838 PRKD1 Locke C c a 0.736 0.19 0.19 3.2E-01 0 4.7E-01 26047 
rs11847697 14 30,515,112 PRKD1 Speliotes T c t 0.906 0.05 0.31 8.6E-01 16.1 3.1E-01 26045 
rs17522122 14 33,302,882 AKAP6 Winkler T t g 0.396 0.25 0.17 1.4E-01 0 6.5E-01 25973 
rs7141420 14 79,899,454 NRXN3 Speliotes T t c 0.626 0.30 0.17 7.5E-02 37.7 1.4E-01 26047 
rs3783890 14 93,790,276 BTBD7 Winkler T c t 0.207 0.13 0.20 5.3E-01 19.9 2.8E-01 26048 
rs7143963 14 103,304,425 TRAF3 Winkler T t c 0.349 0.07 0.17 6.8E-01 0 7.5E-01 26048 
rs709400 14 104,149,475 KLC1 Winkler A a g 0.751 0.12 0.19 5.5E-01 0 4.4E-01 26044 
rs3736485 15 51,748,610 DMXL2 Locke A a g 0.484 0.10 0.17 5.3E-01 43.7 1.0E-01 26037 
rs16951275 15 68,077,168 MAP2K5 Speliotes T t c 0.531 0.37 0.17 3.4E-02 25.4 2.4E-01 26046 
rs4776970 15 68,080,886 MAP2K5 Wen 2012 A a t 0.428 0.33 0.17 5.9E-02 4.8 3.9E-01 26047 
rs7164727 15 73,093,991 LOC10028
7559 
Locke T 
t c 0.551 0.24 0.17 1.5E-01 0 7.8E-01 26046 
rs7181659 15 95,267,483 MCTP2 Winkler A a g 0.618 0.12 0.17 5.0E-01 0 6.0E-01 26045 
rs11866815 16 387,867 AXIN1 Winkler T t c 0.220 0.11 0.20 6.0E-01 0 5.8E-01 26048 
rs12446632 16 19,935,389 GPRC5B Speliotes G g a 0.918 0.16 0.30 6.0E-01 0 6.3E-01 26020 
rs11074446 16 20,255,123 GP2 Locke T t c 0.805 0.32 0.21 1.4E-01 6 3.8E-01 26038 
rs2650492 16 28,333,411 SBK1 Locke A a g 0.140 0.41 0.24 9.1E-02 0 8.4E-01 26047 
rs3888190 16 28,889,486 ATP2A1 speliotes A a c 0.409 0.44 0.17 8.7E-03 34.4 1.7E-01 26041 
rs4787491 16 30,015,337 INO80E Locke G g a 0.428 0.36 0.17 3.2E-02 8.6 3.6E-01 26047 
rs9925964 16 31,129,895 KAT8 Locke A a g 0.596 0.47 0.17 6.5E-03 38.5 1.4E-01 26047 
rs2080454 16 49,062,590 CBLN1 Locke C a c 0.637 0.01 0.17 9.7E-01 60.7 1.8E-02 26045 
rs1558902*** 16 53,803,574 FTO Speliotes, 
Wen 2014 
A 
a t 0.260 1.39 0.19 5.9E-13 45.6 8.8E-02 26004 
rs17817964*** 16 53,828,066 FTO Monda T t c 0.253 1.37 0.19 2.1E-12 47.2 7.8E-02 26046 
rs889398 16 69,556,715 NFAT5 Winkler T t c 0.343 0.07 0.17 6.8E-01 0 7.1E-01 26048 
rs9914578 17 2,005,136 SMG6 Locke G g c 0.275 0.11 0.19 5.5E-01 0 5.6E-01 25996 
rs1000940 17 5,283,252 RABEP1 Locke G a g 0.652 0.23 0.17 1.8E-01 0 8.0E-01 26043 
rs4986044 17 21,261,560 KCNJ12 Winkler T t c 0.469 0.00 0.17 9.9E-01 0 7.9E-01 26046 
rs12150665 17 34,914,787 GGNBP2 Winkler T t c 0.697 0.45 0.18 1.3E-02 33.5 1.7E-01 26045 
rs11652097 17 45,316,717 ITGB3  Winkler T c t 0.658 0.25 0.17 1.5E-01 0 9.5E-01 26046 
rs6504108 17 46,292,923 SKAP1 Winkler T t c 0.760 0.14 0.19 4.7E-01 3.5 4.0E-01 26046 
rs8075273* 17 61,728,881 unknown Winkler C c a 0.771 0.21 0.19 2.8E-01 27.8 2.2E-01 26040 
rs312750 17 68,343,539 KCNJ2 Winkler A a g 0.599 0.15 0.17 3.8E-01 0 7.7E-01 26047 
rs12940622 17 78,615,571 RPTOR Locke** G g a 0.659 0.25 0.18 1.6E-01 38.4 1.4E-01 26036 
rs1808579 18 21,104,888 C18orf8 Speliotes C c t 0.420 0.38 0.17 2.5E-02 0 6.4E-01 26031 
rs7239883 18 40,147,671 LOC28426
0 
Locke G 
g a 0.319 0.05 0.18 7.7E-01 0 8.8E-01 26024 
rs7243357 18 56,883,319 GRP Locke T g t 0.240 0.06 0.19 7.6E-01 0 7.1E-01 26048 
rs2331841 18 57,828,637 MC4R Okada A a g 0.344 0.39 0.17 2.6E-02 0 5.3E-01 26041 
rs6567160 18 57,829,135 MC4R Speliotes, 
Pei 
C 
c t 0.146 1.12 0.24 3.3E-06 53 4.7E-02 26047 
rs591166 18 57,841,589 MC4R Wen 2014 A a t 0.389 0.41 0.17 1.6E-02 0 5.2E-01 26045 
rs9944545 18 57,958,244 MC4R Locke T t c 0.229 0.44 0.20 2.9E-02 0 9.5E-01 26046 
rs17066842 18 58,040,624 MC4R Locke G g a 0.953 0.58 0.42 1.7E-01 14.7 3.2E-01 26035 
rs17724992 19 18,454,825 PGPEP1 Locke A a g 0.664 0.63 0.18 4.3E-04 0 6.0E-01 26045 
rs17513613 19 30,286,822 CCNE1 Winkler T c t 0.193 0.21 0.21 3.2E-01 30.4 2.0E-01 26048 
rs29941 19 34,309,532 KCTD15 Speliotes G g a 0.646 0.15 0.17 4.0E-01 0 7.0E-01 26043 
rs2075650 19 45,395,619 TOMM40 Speliotes A a g 0.898 0.35 0.27 2.1E-01 0 9.8E-01 26047 
rs11671664 19 46,172,278 GIPR, 
QPCTL 
Wen 2014 G 
g a 0.906 0.80 0.28 4.5E-03 46.5 8.2E-02 26046 
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rs2287019 19 46,202,172 QPCTL Speliotes C c t 0.871 0.64 0.25 9.1E-03 0 5.5E-01 26048 
rs3810291 19 47,569,003 ZC3H4 Speliotes A a g 0.529 0.56 0.17 8.2E-04 59.7 2.1E-02 26014 
rs4802349 19 47,874,510 DHX34 Gong 2013 G t g 0.241 0.33 0.20 9.1E-02 0 8.1E-01 26023 
rs8123881* 20 15,819,495 MACROD
2 
Winkler G 
g a 0.150 0.72 0.24 2.5E-03 42.8 1.1E-01 26045 
rs6091540 20 51,087,862 ZFP64 Locke** C t c 0.315 0.07 0.18 7.1E-01 0 5.6E-01 26045 
rs2836754 21 40,291,740 ETS2 Locke C c t 0.434 0.26 0.17 1.3E-01 0 9.1E-01 26038 
rs4820408 22 40,604,945 TNRC6B Winkler T t g 0.338 0.04 0.18 8.1E-01 54.6 4.0E-02 26048 
Abbreviations: A1=coded allele, A2=non-coded allele, Bp37=base pair Build 37, Chr=chromosome, 
FE=Fixed-Effect, HetP=heterogeneity p-value, P=p-value, Prep=prepared reference, Ref=reference, 
Sub=submitted reference, SNPs=single nucleotide polymorphisms. 
*When the index SNP was not genotyped on the MetaboChip, the proxy SNP in tight linkage 
disequilibrium (r2≥0.8 in 1000 Genomes pilot 1 CEU, YRI, CHB+JPT depending on the population of 
discovery) with the lowest p-value in the African American sample was chosen to represent the index 
signal. The decreasing and increasing alleles for proxies were assigned assuming that the risk index 
SNP would have a similar allele frequency in the 1000 Genomes population (EUR, AFR, or EAS 
depending on the discovery population) as the risk proxy SNP. 
**These loci were also described by Berndt et al. for obesity (maximum sample size of 263,407) [29].  
The most recent BMI references per racial/ethnic group are noted above by their first author and 
publication year, if applicable [21, 25, 26, 30, 32, 33, 186, 195, 204]. 
***For GWAS SNPs a Bonferroni correction for multiple tests in the fixed-effect analyses reflected the 
number of independent previously-reported signals tested (=0.05/166). The 4 noted SNP pairs above 
were in tight linkage disequilibrium [r2≥0.8 in non-European 1000 genomes pilot populations(s)] with 
each other, but because they were reports from distinct discovery populations we retained them in 
this inventory in case they were population-specific variants. Therefore, our Bonferroni correction was 
penalized for only 166 (=170-4) tests. 
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APPENDIX M: ASIAN DESCENT GENETIC EFFECT ESTIMATES FOR 170 BMI INDEX 
SNPS FROM GWAS, INCLUDING SECONDARY SIGNALS IN EUROPEAN DESCENT 
POPULATIONS AND/OR POPULATION-SPECIFIC MARKERS. 
rsID* Chr Bp37 Gene Ref. First 
Author 
Ref. 
Risk 
Allele 
A
1 
A
2 
Freq β 
(%) 
SE 
(%) 
P*** I2 HetP N 
rs2803328 1 1,874,326 KIAA1751 Winkler C g c 0.497 0.15 0.16 3.7E-01 21.5 2.6E-01 14209 
rs2271928 1 32,127,953 COL16A1 Winkler A g a 0.326 0.02 0.18 9.2E-01 0 7.1E-01 14225 
rs2275426 1 46,487,552 MAST2 Winkler A a g 0.581 0.17 0.17 3.3E-01 0 5.5E-01 14222 
rs977747 1 47,684,677 TAL1 Locke T t g 0.896 0.68 0.37 6.9E-02 0 6.3E-01 14223 
rs657452 1 49,589,847 AGBL4 Locke A a g 0.646 0.33 0.17 5.9E-02 22.1 2.6E-01 13928 
rs11583200 1 50,559,820 ELAVL4 Locke C c t 0.815 0.41 0.22 5.8E-02 0 8.8E-01 14226 
rs3101336 1 72,751,185 NEGR1 Speliotes C c t 0.910 0.46 0.24 5.4E-02 0 4.7E-01 22462 
rs12566985 1 75,002,193 FPGT-
TNNI3K 
Speliotes G 
g a 0.867 0.45 0.27 9.1E-02 0 8.5E-01 14174 
rs12401738 1 78,446,761 FUBP1 Locke** A a g 0.064 0.70 0.70 3.2E-01 0 6.2E-01 14225 
rs11165643 1 96,924,097 PTBP2 Speliotes T c t 0.263 0.14 0.19 4.5E-01 39.7 1.1E-01 14216 
rs17024393 1 110,154,688 GNAT2 Locke** C          
rs4357530* 1 151,103,153 SEMA6C Winkler G g a 0.119 0.55 0.26 3.5E-02 16.8 3.0E-01 14225 
rs10913118 1 175,954,755 RFWD2 Winkler A a c 0.558 0.10 0.17 5.3E-01 0 9.1E-01 14214 
rs574367*** 1 177,873,210 SEC16B Wen 2014 T t g 0.195 0.61 0.17 4.3E-04 0 6.7E-01 22452 
rs543874*** 1 177,889,480 SEC16B Speliotes, 
Monda 
G 
g a 0.195 0.61 0.17 4.2E-04 0 6.5E-01 22464 
rs10920678 1 190,239,907 FAM5C Winkler A a g 0.351 0.60 0.18 6.1E-04 40.5 1.1E-01 13789 
rs2820292 1 201,784,287 NAV1 Locke C c a 0.269 0.25 0.19 1.9E-01 0 4.7E-01 14224 
rs2820436 1 219,640,680 LYPLAL1 Gong 
(sub.) 
A 
a c 0.195 0.21 0.21 3.2E-01 24.2 2.4E-01 14210 
rs12463617*** 2 629,244 TMEM18 Wen 2014 C c a 0.914 0.61 0.24 1.0E-02 0 7.0E-01 22465 
rs13021737*** 2 632,348 TMEM18 Speliotes G g a 0.913 0.61 0.24 1.0E-02 0 6.3E-01 22417 
rs11676272*,*** 2 25,141,538 ADCY3 Wen 2014 G g a 0.474 0.50 0.16 2.2E-03 18.8 2.8E-01 14224 
rs10182181*** 2 25,150,296 ADCY3 Speliotes G g a 0.477 0.51 0.16 1.9E-03 10.3 3.5E-01 14218 
rs11126666 2 26,928,811 KCNK3 Locke A g a 0.349 0.07 0.18 7.0E-01 0 8.6E-01 14225 
rs116612809 2 28,301,171 BRE Gong 
2013 
G 
         
rs1016287 2 59,305,625 FLJ30838 Speliotes T t c 0.189 0.06 0.21 7.7E-01 50.9 4.7E-02 14202 
rs11688816 2 63,053,048 EHBP1 Locke G g a 0.740 0.30 0.19 1.1E-01 0 9.9E-01 14226 
rs12622013* 2 79,501,362 REG3A Winkler G g a 0.181 0.44 0.22 4.7E-02 0 7.0E-01 14226 
rs7570971 2 135,837,906 RAB3GA
P1 
Winkler A 
c a 0.109 0.84 0.61 1.7E-01 28.9 2.0E-01 14224 
rs4988235 2 136,608,646 MCM6 Winkler A a g 0.110 0.88 0.60 1.5E-01 39.8 1.1E-01 14225 
rs2121279 2 143,043,285 LRP1B Speliotes T          
rs1460676 2 164,567,689 FIGN Locke C c t 0.368 0.23 0.17 1.9E-01 0 7.1E-01 14224 
rs10184004 2 165,508,389 GRB14/C
OBLL1 
Gong 
(sub.) 
T 
t c 0.103 0.48 0.29 9.2E-02 0 8.9E-01 14224 
rs10930502 2 172,890,588 METAP1
D 
Gong 
(sub.) 
A 
a g 0.333 0.57 0.18 1.3E-03 46.9 6.8E-02 14220 
rs1528435 2 181,550,962 UBE2E3 Locke T t c 0.699 0.05 0.18 7.8E-01 15.2 3.1E-01 14226 
rs972540 2 207,244,783 ADAM23 Winkler A g a 0.182 0.11 0.21 5.9E-01 0 7.6E-01 14226 
rs17203016 2 208,255,518 CREB1 Locke G g a 0.204 0.18 0.21 3.9E-01 17.1 2.9E-01 14214 
rs7599312 2 213,413,231 ERBB4 Locke G g a 0.934 0.11 0.38 7.8E-01 0 5.3E-01 14223 
rs492400 2 219,349,752 USP37 Locke C c t 0.239 0.37 0.20 6.2E-02 0 9.8E-01 14035 
rs2176040 2 227,092,802 LOC6467
36 
Speliotes A 
a g 0.099 0.21 0.28 4.6E-01 0 8.2E-01 14226 
rs9845966 3 13,433,158 NUP210 Winkler T t g 0.577 0.31 0.17 6.0E-02 0 4.9E-01 14220 
rs6804842 3 25,106,437 RARB Locke G g a 0.612 0.36 0.17 3.5E-02 0 6.7E-01 14223 
rs7613875 3 49,971,514 MON1A Winkler A a c 0.202 0.15 0.22 4.8E-01 0 7.9E-01 14192 
rs2365389 3 61,236,462 FHIT Locke C c t 0.128 0.31 0.27 2.5E-01 53.1 3.7E-02 14224 
rs333495* 3 78,834,343 ROBO1 Winkler G g t 0.280 0.60 0.18 1.2E-03 0 9.6E-01 14223 
rs13078960 3 85,807,590 CADM2 Speliotes G g t 0.035 0.66 0.72 3.6E-01 0 7.3E-01 22466 
rs1720825 3 138,108,083 MRAS Graff 
(prep.) 
A 
a g 0.037 0.13 0.59 8.3E-01 0 4.9E-01 14226 
rs2640017* 3 141,335,121 RASA2 Locke G g a 0.275 0.35 0.19 6.8E-02 0 5.1E-01 14223 
rs11927381 3 185,508,591 IGF2BP2 Gong 
(sub.) 
T 
t c 0.672 0.36 0.18 4.2E-02 39.6 1.2E-01 14201 
rs1516725 3 185,824,004 ETV5 Speliotes C c t 0.930 0.52 0.31 9.3E-02 0 5.9E-01 22446 
rs16992647 4 36,813,105 KIAA1239 Winkler T t c 0.460 0.00 0.17 9.9E-01 67 3.5E-03 14225 
rs16858082 4 45,175,804 GNPDA2 Wen 2014 T t c 0.345 0.42 0.14 3.0E-03 12.5 3.3E-01 22441 
rs10938397 4 45,182,527 GNPDA2 Speliotes G g a 0.279 0.55 0.15 2.6E-04 24 2.3E-01 22386 
rs348495 4 45,184,442 GNPDA2 Monda G g a 0.364 0.42 0.17 1.3E-02 0 6.1E-01 15429 
rs13107325 4 103,188,709 SLC39A8 Speliotes T          
rs11727676 4 145,659,064 HHIP Locke T t c 0.984 0.30 1.24 8.1E-01 11.2 3.4E-01 13682 
rs2112347 5 75,015,242 POC5 Speliotes T t g 0.443 0.45 0.14 9.0E-04 10.3 3.5E-01 22464 
rs6870983 5 87,697,533 TMEM161
B−AS1 
Winkler T 
t c 0.057 0.44 0.73 5.5E-01 16.6 3.0E-01 13682 
rs11951673* 5 95,861,012 PCSK1 Wen 2014 C c t 0.423 0.73 0.17 1.7E-05 34 1.6E-01 14221 
rs6864049 5 124,330,522 ZNF608 Winkler A g a 0.677 0.24 0.18 1.8E-01 21.1 2.6E-01 14206 
rs13174863 5 139,080,745 CXXC5 Winkler A g a 0.066 0.07 0.34 8.3E-01 0 9.6E-01 14226 
rs4569924* 5 153,540,025 GALNT10 Monda T c t 0.174 0.16 0.35 6.6E-01 0 6.4E-01 14223 
rs2228213 6 12,124,855 HIVEP1 Winkler A g a 0.734 0.37 0.19 5.2E-02 0 5.6E-01 14226 
rs9356744 6 20,685,486 CDKAL1 Wen 2014 T t c 0.595 0.86 0.14 5.3E-10 42.6 8.4E-02 22461 
rs943466 6 33,731,787 LEMD2 Winkler A g a 0.866 0.11 0.25 6.6E-01 42 9.9E-02 14226 
rs205262 6 34,563,164 C6orf106 Speliotes G a g 0.857 0.06 0.27 8.4E-01 37.4 1.3E-01 14223 
rs2033529 6 40,348,653 TDRG1 Locke G g a 0.284 0.10 0.19 6.0E-01 0 4.7E-01 14223 
rs2207139 6 50,845,490 TFAP2B Speliotes G g a 0.210 0.29 0.17 8.5E-02 0 6.0E-01 22464 
rs9400239 6 108,977,663 FOXO3 Locke C c t 0.708 0.19 0.19 3.2E-01 18.2 2.9E-01 14224 
rs9374842 6 120,185,665 LOC2857
62 
Locke T 
c t 0.176 0.27 0.22 2.3E-01 25.2 2.3E-01 14217 
rs13201877 6 137,675,541 IFNGR1 Locke G a g 0.944 0.50 0.36 1.7E-01 0 6.9E-01 14226 
rs1281962 6 153,431,376 RGS17 Winkler C c g 0.820 0.18 0.22 4.1E-01 0 4.8E-01 14222 
rs3127574 6 160,791,370 SLC22A3 Winkler C c g 0.433 0.06 0.17 7.2E-01 0 7.2E-01 14223 
rs13191362 6 163,033,350 PARK2 Locke A          
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rs10499694* 7 50,614,173 DDC Winkler G g a 0.399 0.06 0.17 7.3E-01 0 8.2E-01 14226 
rs1167827 7 75,163,169 HIP1 Locke G g a 0.104 0.05 0.36 8.9E-01 0 4.7E-01 14224 
rs6465468 7 95,169,514 ASB4 Locke T t g 0.068 0.65 0.34 5.5E-02 36.2 1.4E-01 14222 
rs6990042 8 14,173,974 SGCZ Winkler T g t 0.264 0.28 0.19 1.3E-01 0 9.2E-01 14225 
rs7844647* 8 34,503,776 Intergenic Winkler T t c 0.506 0.53 0.17 1.2E-03 0 5.0E-01 14225 
rs17405819 8 76,806,584 HNF4G Locke** T t c 0.609 0.11 0.17 5.3E-01 0 8.5E-01 14222 
rs16907751 8 81,375,457 ZBTB10 Locke C c t 0.853 0.10 0.24 6.7E-01 58.8 1.7E-02 14224 
rs2033732 8 85,079,709 RALYL Locke C c t 0.723 0.29 0.19 1.3E-01 0 5.0E-01 14085 
rs4740619 9 15,634,326 C9orf93 Locke T t c 0.248 0.06 0.19 7.7E-01 0 9.9E-01 14223 
rs10968576 9 28,414,339 LINGO2 Speliotes G g a 0.180 0.32 0.18 7.2E-02 45.2 6.8E-02 22465 
rs6477694 9 111,932,342 EPB41L4
B 
Locke C 
c t 0.592 0.17 0.17 3.0E-01 46.8 6.9E-02 14226 
rs1928295 9 120,378,483 TLR4 Locke T t c 0.581 0.43 0.17 1.2E-02 46.6 7.0E-02 14219 
rs10733682 9 129,460,914 LMX1B Locke A g a 0.273 0.21 0.19 2.7E-01 7.9 3.7E-01 14225 
rs2270204 9 131,042,734 SWI5  Winkler T g t 0.566 0.16 0.17 3.4E-01 0 8.7E-01 14020 
rs7899106 10 87,410,904 GRID1 Locke G          
rs17094222 10 102,395,440 HIF1AN Locke C c t 0.324 0.13 0.18 4.8E-01 2.4 4.1E-01 14224 
rs11191560 10 104,869,038 NT5C2 Locke, 
Wen 2012 
C 
c t 0.270 0.45 0.15 4.0E-03 25 2.2E-01 22458 
rs7903146 10 114,758,349 TCF7L2 Locke C c t 0.934 1.49 0.32 4.6E-06 50.6 4.0E-02 22465 
rs10886017 10 118,672,531 KIAA1598 Winkler A a c 0.364 0.23 0.17 1.7E-01 35.9 1.4E-01 14223 
rs2237897 11 2,858,546 KCNQ1 Wen 2014 T t c 0.353 0.73 0.18 3.5E-05 62.1 9.9E-03 14181 
rs4256980 11 8,673,939 TRIM66 Speliotes G g c 0.398 0.35 0.14 1.0E-02 0 7.4E-01 22462 
rs7928810 11 17,372,443 NCR3LG1 Winkler A a c 0.682 0.22 0.18 2.2E-01 0 5.0E-01 14222 
rs1557765 11 17,403,639 KCNJ11 Winkler T c t 0.665 0.28 0.18 1.1E-01 17.2 2.9E-01 14222 
rs11030104 11 27,684,517 BDNF Speliotes, 
Wen 2014 
A 
a g 0.566 0.10 0.14 4.5E-01 61.9 7.2E-03 22465 
rs10835210 11 27,695,910 BDNF Locke C c a 0.664 0.02 0.17 9.0E-01 46.4 6.1E-02 16161 
rs652722 11 31,905,534 PAX6 Wen 2012 C          
rs2176598 11 43,864,278 HSD17B1
2 
Locke T 
c t 0.863 0.09 0.25 7.1E-01 1.5 4.2E-01 14225 
rs3817334 11 47,650,993 MTCH2 Speliotes T t c 0.312 0.23 0.14 1.2E-01 0 8.7E-01 22447 
rs1865732* 11 112,960,722 NCAM1 Winkler C c t 0.161 0.03 0.24 9.1E-01 0 5.3E-01 14225 
rs12286929 11 115,022,404 CADM1 Locke G g a 0.243 0.27 0.20 1.7E-01 0 9.4E-01 14214 
rs11611246 12 939,480 WNK1 Winkler T t g 0.288 0.08 0.19 6.9E-01 5 3.9E-01 14034 
rs7970953 12 24,075,508 SOX5 Winkler A a g 0.692 0.23 0.18 2.1E-01 0 6.0E-01 14202 
rs1405552 12 41,746,673 PDZRN4 Winkler A g a 0.435 0.30 0.17 7.6E-02 0 4.3E-01 14223 
rs11181001 12 41,948,196 PDZRN4 Winkler A a g 0.390 0.36 0.17 3.6E-02 0 7.1E-01 14218 
rs7138803 12 50,247,468 BCDIN3D Speliotes A a g 0.309 0.28 0.15 5.4E-02 35.7 1.3E-01 22463 
rs1438994* 12 90,594,389 Intergenic Winkler T t c 0.372 0.10 0.17 5.6E-01 0 6.2E-01 14226 
rs11065987 12 112,072,424 BRAP Winkler A g a 0.078 0.60 0.66 3.7E-01 67.9 2.7E-03 14224 
rs17630235 12 112,591,686 TRAFD1 Winkler A a g 0.076 0.65 0.66 3.3E-01 71.4 9.3E-04 14140 
rs11057405 12 122,781,897 CLIP1 Locke G g a 0.984 0.49 1.21 6.8E-01 17.9 2.9E-01 14137 
rs1885988* 13 28,010,262 MTIF3 Speliotes C t c 0.825 0.29 0.22 2.0E-01 0 7.4E-01 14226 
rs12429545 13 54,102,206 OLFM4 Speliotes A a g 0.208 0.44 0.20 3.1E-02 0 5.8E-01 14221 
rs9540493 13 66,205,704 MIR548X
2 
Locke A 
g a 0.280 0.08 0.19 6.8E-01 50.9 4.7E-02 14223 
rs1441264 13 79,580,919 MIR548A
2 
Locke A 
a g 0.543 0.29 0.17 7.9E-02 0 6.2E-01 14226 
rs9634489 13 97,049,004 HS6ST3 Winkler A g a 0.494 0.15 0.17 3.5E-01 0 4.7E-01 14225 
rs10132280 14 25,928,179 STXBP6 Locke C a c 0.088 0.08 0.30 8.0E-01 0 6.6E-01 14225 
rs12885454 14 29,736,838 PRKD1 Locke C c a 0.502 0.21 0.17 2.1E-01 57.1 2.2E-02 14225 
rs11847697 14 30,515,112 PRKD1 Speliotes T c t 0.962 0.46 0.93 6.2E-01 0 7.4E-01 14444 
rs17522122 14 33,302,882 AKAP6 Winkler T t g 0.379 0.26 0.17 1.3E-01 29.2 2.0E-01 14121 
rs7141420 14 79,899,454 NRXN3 Speliotes T c t 0.621 0.17 0.17 3.1E-01 0 7.6E-01 14223 
rs3783890 14 93,790,276 BTBD7 Winkler T t c 0.635 0.28 0.17 1.1E-01 0 4.4E-01 14223 
rs7143963 14 103,304,425 TRAF3 Winkler T t c 0.415 0.10 0.17 5.8E-01 0 5.3E-01 14222 
rs709400 14 104,149,475 KLC1 Winkler A a g 0.870 0.08 0.25 7.6E-01 0 6.8E-01 14222 
rs3736485 15 51,748,610 DMXL2 Locke A a g 0.753 0.16 0.19 4.1E-01 0 5.3E-01 14225 
rs16951275 15 68,077,168 MAP2K5 Speliotes T t c 0.407 0.16 0.14 2.5E-01 2 4.2E-01 22462 
rs4776970 15 68,080,886 MAP2K5 Wen 2012 A a t 0.238 0.36 0.16 2.3E-02 30.6 1.7E-01 22464 
rs7164727 15 73,093,991 LOC1002
87559 
Locke T 
c t 0.766 0.05 0.20 7.9E-01 13.5 3.2E-01 14224 
rs7181659 15 95,267,483 MCTP2 Winkler A a g 0.450 0.23 0.17 1.8E-01 29.7 1.9E-01 14194 
rs11866815 16 387,867 AXIN1 Winkler T c t 0.804 0.01 0.21 9.7E-01 15.1 3.1E-01 14188 
rs12446632 16 19,935,389 GPRC5B Speliotes G          
rs11074446 16 20,255,123 GP2 Locke T t c 0.828 0.70 0.22 1.7E-03 16.1 3.0E-01 14212 
rs2650492 16 28,333,411 SBK1 Locke A a g 0.082 0.94 0.28 7.0E-04 33.8 1.5E-01 22457 
rs3888190 16 28,889,486 ATP2A1 speliotes A a c 0.151 0.37 0.20 5.8E-02 57.2 1.7E-02 22463 
rs4787491 16 30,015,337 INO80E Locke G g a 0.348 0.19 0.18 2.8E-01 0 6.9E-01 14220 
rs9925964 16 31,129,895 KAT8 Locke A g a 0.838 0.16 0.25 5.3E-01 0 9.1E-01 14226 
rs2080454 16 49,062,590 CBLN1 Locke C c a 0.506 0.36 0.17 2.8E-02 0 6.9E-01 14223 
rs1558902*** 16 53,803,574 FTO Speliotes, 
Wen 2014 
A 
a t 0.201 1.73 0.20 1.2E-17 0 8.0E-01 16185 
rs17817964*** 16 53,828,066 FTO Monda T t c 0.223 1.28 0.17 2.2E-14 0 4.9E-01 22465 
rs889398 16 69,556,715 NFAT5 Winkler T c t 0.800 0.09 0.23 6.8E-01 0 9.2E-01 14084 
rs9914578 17 2,005,136 SMG6 Locke G c g 0.802 0.16 0.21 4.4E-01 22.3 2.5E-01 14224 
rs1000940 17 5,283,252 RABEP1 Locke G g a 0.600 0.07 0.17 6.9E-01 0 5.0E-01 14225 
rs4986044 17 21,261,560 KCNJ12 Winkler T c t 0.369 0.25 0.17 1.4E-01 0 8.8E-01 14221 
rs12150665 17 34,914,787 GGNBP2 Winkler T t c 0.625 0.36 0.17 3.8E-02 0 7.0E-01 14221 
rs11652097 17 45,316,717 ITGB3  Winkler T c t 0.619 0.29 0.17 8.6E-02 0 4.5E-01 14182 
rs6504108 17 46,292,923 SKAP1 Winkler T c t 0.204 0.35 0.21 8.6E-02 60.9 1.2E-02 14222 
rs8075273* 17 61,728,881 unknown Winkler C a c 0.087 0.10 0.33 7.6E-01 25.4 2.3E-01 13835 
rs312750 17 68,343,539 KCNJ2 Winkler A g a 0.340 0.02 0.18 9.3E-01 0 7.0E-01 14224 
rs12940622 17 78,615,571 RPTOR Locke** G g a 0.665 0.49 0.18 5.7E-03 0 5.1E-01 14224 
rs1808579 18 21,104,888 C18orf8 Speliotes C t c 0.662 0.61 0.18 5.7E-04 0 5.7E-01 14224 
rs7239883 18 40,147,671 LOC2842
60 
Locke G 
g a 0.277 0.08 0.19 6.9E-01 33.8 1.6E-01 14198 
rs7243357 18 56,883,319 GRP Locke T t g 0.865 0.44 0.25 7.8E-02 0 4.4E-01 14224 
rs2331841 18 57,828,637 MC4R Okada A a g 0.229 0.46 0.16 4.1E-03 0 6.0E-01 22447 
rs6567160 18 57,829,135 MC4R Speliotes, 
Pei 
C 
c t 0.197 0.67 0.17 9.0E-05 0 5.8E-01 22461 
rs591166 18 57,841,589 MC4R Wen 2014 A a t 0.231 0.43 0.16 6.8E-03 0 7.7E-01 22455 
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rs9944545 18 57,958,244 MC4R Locke T t c 0.133 0.03 0.21 8.9E-01 47.4 5.5E-02 22458 
rs17066842 18 58,040,624 MC4R Locke G g a 0.980 0.12 0.49 8.1E-01 0 6.3E-01 22148 
rs17724992 19 18,454,825 PGPEP1 Locke A g a 0.472 0.06 0.17 7.3E-01 24.5 2.3E-01 14219 
rs17513613 19 30,286,822 CCNE1 Winkler T c t 0.109 0.11 0.28 6.9E-01 0 9.4E-01 14226 
rs29941 19 34,309,532 KCTD15 Speliotes G g a 0.238 0.23 0.16 1.5E-01 7.8 3.7E-01 22456 
rs2075650 19 45,395,619 TOMM40 Speliotes A g a 0.169 0.09 0.23 6.8E-01 0 5.2E-01 14224 
rs11671664 19 46,172,278 GIPR, 
QPCTL 
Wen 2014 G 
g a 0.531 0.57 0.14 4.2E-05 0 8.4E-01 22460 
rs2287019 19 46,202,172 QPCTL Speliotes C c t 0.789 0.56 0.17 6.7E-04 0 5.7E-01 22465 
rs3810291 19 47,569,003 ZC3H4 Speliotes A          
rs4802349 19 47,874,510 DHX34 Gong 
2013 
G 
g t 0.613 0.12 0.17 4.8E-01 0 6.9E-01 14193 
rs8123881* 20 15,819,495 MACROD
2 
Winkler G 
a g 0.906 0.15 0.28 6.0E-01 34.7 1.5E-01 14218 
rs6091540 20 51,087,862 ZFP64 Locke** C c t 0.643 0.33 0.17 5.5E-02 0 5.3E-01 14223 
rs2836754 21 40,291,740 ETS2 Locke C c t 0.272 0.06 0.19 7.7E-01 0 7.9E-01 14219 
rs4820408 22 40,604,945 TNRC6B Winkler T t g 0.534 0.40 0.17 1.6E-02 36.4 1.4E-01 14220 
Abbreviations: A1=coded allele, A2=non-coded allele, Bp37=base pair Build 37, Chr=chromosome, 
FE=Fixed-Effect, HetP=heterogeneity p-value, P=p-value, Prep=prepared reference, Ref=reference, 
Sub=submitted reference, SNPs=single nucleotide polymorphisms. 
*When the index SNP was not genotyped on the MetaboChip, the proxy SNP in tight linkage 
disequilibrium (r2≥0.8 in 1000 Genomes pilot 1 CEU, YRI, CHB+JPT depending on the population of 
discovery) with the lowest p-value in the African American sample was chosen to represent the index 
signal. The decreasing and increasing alleles for proxies were assigned assuming that the risk index 
SNP would have a similar allele frequency in the 1000 Genomes population (EUR, AFR, or EAS 
depending on the discovery population) as the risk proxy SNP. 
**These loci were also described by Berndt et al. for obesity (maximum sample size of 263,407) [29].  
The most recent BMI references per racial/ethnic group are noted above by their first author and 
publication year, if applicable [21, 25, 26, 30, 32, 33, 186, 195, 204]. 
***For GWAS SNPs a Bonferroni correction for multiple tests in the fixed-effect analyses reflected the 
number of independent previously-reported signals tested (=0.05/166). The 4 noted SNP pairs above 
were in tight linkage disequilibrium [r2≥0.8 in non-European 1000 genomes pilot populations(s)] with 
each other, but because they were reports from distinct discovery populations we retained them in 
this inventory in case they were population-specific variants. Therefore, our Bonferroni correction was 
penalized for only 166 (=170-4) tests.  
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APPENDIX N: EUROPEAN DESCENT GENETIC EFFECT ESTIMATES FOR 170 BMI 
INDEX SNPS FROM GWAS, INCLUDING SECONDARY SIGNALS IN EUROPEAN 
DESCENT POPULATIONS AND/OR POPULATION-SPECIFIC MARKERS. 
rsID* Chr Bp37 Gene Ref. First 
Author 
Ref. 
Risk 
Allele 
A
1 
A
2 
Freq β 
(%) 
SE 
(%) 
P*** I2 HetP N 
rs2803328 1 1,874,326 KIAA1751 Winkler C c g 0.527 0.00 0.23 1.0E+00 0 3.7E-01 17859 
rs2271928 1 32,127,953 COL16A1 Winkler A g a 0.599 0.36 0.20 8.0E-02 0 8.9E-01 17859 
rs2275426 1 46,487,552 MAST2 Winkler A a g 0.439 0.11 0.20 5.6E-01 0 7.5E-01 17859 
rs977747 1 47,684,677 TAL1 Locke T t g 0.403 0.13 0.20 5.2E-01 23.7 2.5E-01 17859 
rs657452 1 49,589,847 AGBL4 Locke A          
rs11583200 1 50,559,820 ELAVL4 Locke C c t 0.387 0.14 0.20 4.9E-01 5.4 3.0E-01 17859 
rs3101336 1 72,751,185 NEGR1 Speliotes C c t 0.625 0.61 0.20 3.0E-03 0 4.4E-01 17859 
rs12566985 1 75,002,193 FPGT-
TNNI3K 
Speliotes G 
         
rs12401738 1 78,446,761 FUBP1 Locke** A g a 0.651 0.31 0.21 1.4E-01 0 5.9E-01 17859 
rs11165643 1 96,924,097 PTBP2 Speliotes T t c 0.584 0.01 0.20 9.8E-01 0 9.3E-01 17859 
rs17024393 1 110,154,688 GNAT2 Locke** C c t 0.029 1.48 0.61 1.5E-02 83.6 1.3E-02 17859 
rs4357530* 1 151,103,153 SEMA6C Winkler G g a 0.318 0.26 0.21 2.3E-01 0 7.6E-01 17859 
rs10913118 1 175,954,755 RFWD2 Winkler A c a 0.333 0.06 0.21 7.8E-01 0 4.7E-01 17859 
rs574367*** 1 177,873,210 SEC16B Wen 2014 T t g 0.195 0.71 0.25 4.8E-03 0 5.5E-01 17858 
rs543874*** 1 177,889,480 SEC16B Speliotes, 
Monda 
G 
g a 0.191 0.75 0.25 2.8E-03 0 5.6E-01 17859 
rs10920678 1 190,239,907 FAM5C Winkler A a g 0.424 0.42 0.19 2.9E-02 63.7 9.7E-02 17858 
rs2820292 1 201,784,287 NAV1 Locke C c a 0.545 0.20 0.19 3.1E-01 0 9.7E-01 17858 
rs2820436 1 219,640,680 LYPLAL1 Gong (sub.) A a c 0.324 0.55 0.21 9.8E-03 0 3.6E-01 17859 
rs12463617*** 2 629,244 TMEM18 Wen 2014 C c a 0.825 1.07 0.26 5.2E-05 33.4 2.2E-01 17859 
rs13021737*** 2 632,348 TMEM18 Speliotes G g a 0.825 1.07 0.25 3.0E-05 34.4 2.2E-01 17858 
rs11676272*,*** 2 25,141,538 ADCY3 Wen 2014 G g a 0.472 0.51 0.19 8.4E-03 0 3.4E-01 17859 
rs10182181*** 2 25,150,296 ADCY3 Speliotes G g a 0.473 0.50 0.19 1.1E-02 0 4.1E-01 17859 
rs11126666 2 26,928,811 KCNK3 Locke A g a 0.734 0.14 0.23 5.4E-01 0 4.2E-01 17859 
rs116612809 2 28,301,171 BRE Gong 2013 G a g 0.998 5.18 3.51 1.4E-01 0 4.1E-01 10048 
rs1016287 2 59,305,625 FLJ30838 Speliotes T t c 0.296 0.22 0.21 3.1E-01 0 9.3E-01 17859 
rs11688816 2 63,053,048 EHBP1 Locke G g a 0.512 0.14 0.19 4.7E-01 0 3.9E-01 17859 
rs12622013* 2 79,501,362 REG3A Winkler G a g 0.890 0.12 0.31 7.1E-01 0 5.7E-01 17859 
rs7570971 2 135,837,906 RAB3GAP
1 
Winkler A 
         
rs4988235 2 136,608,646 MCM6 Winkler A          
rs2121279 2 143,043,285 LRP1B Speliotes T t c 0.129 0.47 0.29 1.1E-01 60.2 1.1E-01 17858 
rs1460676 2 164,567,689 FIGN Locke C c t 0.165 0.42 0.26 1.1E-01 0 8.9E-01 17859 
rs10184004 2 165,508,389 GRB14/C
OBLL1 
Gong (sub.) T 
t c 0.404 0.43 0.20 3.7E-02 0 9.0E-01 17859 
rs10930502 2 172,890,588 METAP1D Gong (sub.) A a g 0.697 0.56 0.21 8.9E-03 0 9.9E-01 17859 
rs1528435 2 181,550,962 UBE2E3 Locke T t c 0.623 0.44 0.20 3.0E-02 51.7 1.5E-01 17859 
rs972540 2 207,244,783 ADAM23 Winkler A a g 0.728 0.04 0.22 8.7E-01 28.6 2.4E-01 17859 
rs17203016 2 208,255,518 CREB1 Locke G g a 0.186 0.31 0.25 2.2E-01 64.4 9.4E-02 17858 
rs7599312 2 213,413,231 ERBB4 Locke G g a 0.736 0.63 0.22 4.6E-03 0 8.9E-01 17859 
rs492400 2 219,349,752 USP37 Locke C c t 0.427 0.34 0.21 1.1E-01 68.7 7.4E-02 17841 
rs2176040 2 227,092,802 LOC64673
6 
Speliotes A 
a g 0.351 0.41 0.20 4.5E-02 0 5.6E-01 17859 
rs9845966 3 13,433,158 NUP210 Winkler T t g 0.449 0.16 0.19 4.2E-01 45.9 1.7E-01 17859 
rs6804842 3 25,106,437 RARB Locke G g a 0.584 0.05 0.19 8.0E-01 0 8.2E-01 17858 
rs7613875 3 49,971,514 MON1A Winkler A          
rs2365389 3 61,236,462 FHIT Locke C c t 0.592 0.28 0.20 1.8E-01 0 7.8E-01 17859 
rs333495* 3 78,834,343 ROBO1 Winkler G g t 0.415 0.29 0.20 1.6E-01 0 9.5E-01 17859 
rs13078960 3 85,807,590 CADM2 Speliotes G t g 0.792 0.07 0.24 7.8E-01 30.3 2.3E-01 17859 
rs1720825 3 138,108,083 MRAS Graff (prep.) A a g 0.197 0.18 0.25 4.8E-01 0 4.2E-01 17859 
rs2640017* 3 141,335,121 RASA2 Locke G g a 0.064 0.84 0.42 4.4E-02 0 8.4E-01 17859 
rs11927381 3 185,508,591 IGF2BP2 Gong (sub.) T t c 0.684 0.50 0.21 2.0E-02 0 9.5E-01 17857 
rs1516725 3 185,824,004 ETV5 Speliotes C c t 0.866 0.77 0.29 8.3E-03 63.8 9.6E-02 17859 
rs16992647 4 36,813,105 KIAA1239 Winkler T c t 0.840 0.25 0.27 3.5E-01 82.8 1.6E-02 17859 
rs16858082 4 45,175,804 GNPDA2 Wen 2014 T t c 0.587 0.40 0.20 4.8E-02 0 3.4E-01 17858 
rs10938397 4 45,182,527 GNPDA2 Speliotes G g a 0.434 0.36 0.19 6.8E-02 0 5.9E-01 17859 
rs348495 4 45,184,442 GNPDA2 Monda G          
rs13107325 4 103,188,709 SLC39A8 Speliotes T t c 0.075 1.17 0.39 3.0E-03 20.8 2.6E-01 17859 
rs11727676 4 145,659,064 HHIP Locke T t c 0.905 0.58 0.37 1.2E-01 0 6.7E-01 17859 
rs2112347 5 75,015,242 POC5 Speliotes T t g 0.640 0.26 0.20 2.1E-01 86.3 6.9E-03 17859 
rs6870983 5 87,697,533 TMEM161
B−AS1 
Winkler T 
c t 0.770 0.09 0.23 7.1E-01 0 5.5E-01 17859 
rs11951673* 5 95,861,012 PCSK1 Wen 2014 C c t 0.614 0.35 0.20 8.5E-02 0 8.2E-01 17859 
rs6864049 5 124,330,522 ZNF608 Winkler A g a 0.527 0.21 0.19 2.7E-01 62 1.0E-01 17859 
rs13174863 5 139,080,745 CXXC5 Winkler A g a 0.153 0.03 0.30 9.3E-01 0 4.1E-01 17859 
rs4569924* 5 153,540,025 GALNT10 Monda T c t 0.570 0.01 0.19 9.7E-01 0 7.7E-01 17859 
rs2228213 6 12,124,855 HIVEP1 Winkler A g a 0.655 0.12 0.20 5.6E-01 0 5.2E-01 17859 
rs9356744 6 20,685,486 CDKAL1 Wen 2014 T t c 0.690 0.06 0.21 7.9E-01 0 5.8E-01 17859 
rs943466 6 33,731,787 LEMD2 Winkler A g a 0.770 0.08 0.23 7.4E-01 0 6.2E-01 17859 
rs205262 6 34,563,164 C6orf106 Speliotes G g a 0.284 0.27 0.22 2.2E-01 0 7.0E-01 17859 
rs2033529 6 40,348,653 TDRG1 Locke G g a 0.282 0.20 0.21 3.5E-01 0 7.0E-01 17859 
rs2207139 6 50,845,490 TFAP2B Speliotes G g a 0.172 0.49 0.26 6.1E-02 0 9.7E-01 17859 
rs9400239 6 108,977,663 FOXO3 Locke C c t 0.699 0.35 0.21 1.0E-01 0 8.8E-01 17858 
rs9374842 6 120,185,665 LOC28576
2 
Locke T 
t c 0.765 0.19 0.23 4.1E-01 85.2 9.3E-03 17858 
rs13201877 6 137,675,541 IFNGR1 Locke G g a 0.136 0.18 0.29 5.4E-01 0 7.8E-01 17859 
rs1281962 6 153,431,376 RGS17 Winkler C c g 0.529 0.32 0.19 9.8E-02 72.7 5.6E-02 17859 
rs3127574 6 160,791,370 SLC22A3 Winkler C g c 0.518 0.07 0.19 7.3E-01 0 9.7E-01 17859 
rs13191362 6 163,033,350 PARK2 Locke A a g 0.883 0.71 0.30 1.9E-02 76.2 4.0E-02 17859 
rs10499694* 7 50,614,173 DDC Winkler G a g 0.482 0.53 0.19 6.2E-03 0 8.7E-01 17859 
rs1167827 7 75,163,169 HIP1 Locke G g a 0.561 0.36 0.20 7.8E-02 0 4.2E-01 17859 
rs6465468 7 95,169,514 ASB4 Locke T          
rs6990042 8 14,173,974 SGCZ Winkler T g t 0.477 0.20 0.20 3.4E-01 42.7 1.9E-01 17859 
rs7844647* 8 34,503,776 Intergenic Winkler T t c 0.738 0.07 0.23 7.7E-01 90.4 1.3E-03 17859 
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rs17405819 8 76,806,584 HNF4G Locke** T t c 0.699 0.56 0.21 8.4E-03 0 6.6E-01 17859 
rs16907751 8 81,375,457 ZBTB10 Locke C t c 0.105 0.08 0.33 8.1E-01 0 3.4E-01 17859 
rs2033732 8 85,079,709 RALYL Locke C t c 0.251 0.42 0.22 6.3E-02 0 5.3E-01 17859 
rs4740619 9 15,634,326 C9orf93 Locke T t c 0.547 0.66 0.20 1.1E-03 16.8 2.7E-01 17851 
rs10968576 9 28,414,339 LINGO2 Speliotes G g a 0.306 0.55 0.21 1.0E-02 0 8.5E-01 17859 
rs6477694 9 111,932,342 EPB41L4B Locke C c t 0.344 0.47 0.21 2.6E-02 0 5.0E-01 17859 
rs1928295 9 120,378,483 TLR4 Locke T t c 0.552 0.08 0.19 6.8E-01 66.4 8.4E-02 17859 
rs10733682 9 129,460,914 LMX1B Locke A a g 0.482 0.58 0.20 4.3E-03 0 7.1E-01 17859 
rs2270204 9 131,042,734 SWI5  Winkler T g t 0.255 0.42 0.23 7.2E-02 7.7 3.0E-01 17857 
rs7899106 10 87,410,904 GRID1 Locke G g a 0.049 0.32 0.47 4.9E-01 0 8.1E-01 17859 
rs17094222 10 102,395,440 HIF1AN Locke C c t 0.215 0.12 0.25 6.4E-01 0 3.2E-01 17859 
rs11191560 10 104,869,038 NT5C2 Locke, Wen 
2012 
C 
c t 0.091 0.73 0.35 3.6E-02 0 9.6E-01 17859 
rs7903146 10 114,758,349 TCF7L2 Locke C c t 0.705 0.54 0.21 1.1E-02 0 4.7E-01 17859 
rs10886017 10 118,672,531 KIAA1598 Winkler A a c 0.250 0.29 0.23 2.2E-01 0 8.0E-01 17859 
rs2237897 11 2,858,546 KCNQ1 Wen 2014 T c t 0.952 0.02 0.50 9.7E-01 64 9.6E-02 17859 
rs4256980 11 8,673,939 TRIM66 Speliotes G g c 0.639 0.16 0.20 4.4E-01 0 7.8E-01 17397 
rs7928810 11 17,372,443 NCR3LG1 Winkler A a c 0.621 0.52 0.21 1.5E-02 0 7.2E-01 17398 
rs1557765 11 17,403,639 KCNJ11 Winkler T c t 0.621 0.47 0.20 2.1E-02 0 5.7E-01 17398 
rs11030104 11 27,684,517 BDNF Speliotes, 
Wen 2014 
A 
a g 0.791 0.89 0.24 2.5E-04 91.5 6.1E-04 17398 
rs10835210 11 27,695,910 BDNF Locke C c a 0.570 0.13 0.20 5.2E-01 0 5.5E-01 17396 
rs652722 11 31,905,534 PAX6 Wen 2012 C t c 0.259 0.48 0.22 3.2E-02 0 7.2E-01 17859 
rs2176598 11 43,864,278 HSD17B1
2 
Locke T 
t c 0.253 0.48 0.22 3.2E-02 41.4 1.9E-01 17859 
rs3817334 11 47,650,993 MTCH2 Speliotes T t c 0.407 0.21 0.20 3.0E-01 0 5.9E-01 17859 
rs1865732* 11 112,960,722 NCAM1 Winkler C c t 0.556 0.18 0.20 3.7E-01 7.4 3.0E-01 17398 
rs12286929 11 115,022,404 CADM1 Locke G g a 0.534 0.59 0.20 3.9E-03 0 4.3E-01 17859 
rs11611246 12 939,480 WNK1 Winkler T t g 0.205 0.03 0.25 9.2E-01 77.1 3.7E-02 17836 
rs7970953 12 24,075,508 SOX5 Winkler A a g 0.298 0.01 0.21 9.7E-01 72 5.9E-02 17859 
rs1405552 12 41,746,673 PDZRN4 Winkler A g a 0.545 0.11 0.20 6.0E-01 0 7.8E-01 17398 
rs11181001 12 41,948,196 PDZRN4 Winkler A a g 0.466 0.04 0.20 8.3E-01 21.5 2.6E-01 17398 
rs7138803 12 50,247,468 BCDIN3D Speliotes A a g 0.378 0.52 0.20 1.1E-02 0 6.8E-01 17859 
rs1438994* 12 90,594,389 Intergenic Winkler T c t 0.747 0.17 0.23 4.7E-01 0 9.9E-01 17398 
rs11065987 12 112,072,424 BRAP Winkler A a g 0.569 0.40 0.20 5.0E-02 76.1 4.1E-02 17859 
rs17630235 12 112,591,686 TRAFD1 Winkler A g a 0.575 0.39 0.21 7.0E-02 73.1 5.4E-02 17858 
rs11057405 12 122,781,897 CLIP1 Locke G g a 0.904 0.99 0.35 4.6E-03 65.9 8.7E-02 17859 
rs1885988* 13 28,010,262 MTIF3 Speliotes C c t 0.180 0.28 0.26 2.8E-01 55 1.4E-01 17398 
rs12429545 13 54,102,206 OLFM4 Speliotes A a g 0.127 0.53 0.30 8.0E-02 43.8 1.8E-01 17859 
rs9540493 13 66,205,704 MIR548X2 Locke A g a 0.565 0.18 0.20 3.8E-01 0 5.5E-01 17859 
rs1441264 13 79,580,919 MIR548A2 Locke A a g 0.602 0.50 0.21 1.8E-02 0 6.3E-01 17398 
rs9634489 13 97,049,004 HS6ST3 Winkler A g a 0.507 0.36 0.20 8.0E-02 0 6.5E-01 17859 
rs10132280 14 25,928,179 STXBP6 Locke C c a 0.689 0.40 0.21 6.3E-02 43.6 1.8E-01 17857 
rs12885454 14 29,736,838 PRKD1 Locke C c a 0.665 0.57 0.21 8.0E-03 0 6.4E-01 17398 
rs11847697 14 30,515,112 PRKD1 Speliotes T t c 0.046 0.12 0.49 8.1E-01 0 7.7E-01 17398 
rs17522122 14 33,302,882 AKAP6 Winkler T t g 0.481 0.67 0.20 9.8E-04 5.4 3.0E-01 17842 
rs7141420 14 79,899,454 NRXN3 Speliotes T t c 0.526 0.38 0.19 5.3E-02 0 9.0E-01 17859 
rs3783890 14 93,790,276 BTBD7 Winkler T c t 0.184 0.28 0.25 2.6E-01 0 7.8E-01 17859 
rs7143963 14 103,304,425 TRAF3 Winkler T t c 0.177 0.28 0.26 2.8E-01 0 5.5E-01 17859 
rs709400 14 104,149,475 KLC1 Winkler A a g 0.625 0.16 0.20 4.4E-01 0 5.8E-01 17859 
rs3736485 15 51,748,610 DMXL2 Locke A a g 0.470 0.35 0.20 8.4E-02 0 5.9E-01 17858 
rs16951275 15 68,077,168 MAP2K5 Speliotes T t c 0.765 0.27 0.23 2.4E-01 0 7.9E-01 17859 
rs4776970 15 68,080,886 MAP2K5 Wen 2012 A a t 0.629 0.31 0.20 1.3E-01 0 7.1E-01 17859 
rs7164727 15 73,093,991 LOC10028
7559 
Locke T 
t c 0.674 0.26 0.20 2.1E-01 57.3 1.3E-01 17859 
rs7181659 15 95,267,483 MCTP2 Winkler A a g 0.493 0.02 0.19 9.2E-01 0 5.4E-01 17858 
rs11866815 16 387,867 AXIN1 Winkler T c t 0.751 0.04 0.23 8.6E-01 0 7.6E-01 17859 
rs12446632 16 19,935,389 GPRC5B Speliotes G g a 0.857 0.83 0.28 3.2E-03 0 9.9E-01 17398 
rs11074446 16 20,255,123 GP2 Locke T t c 0.868 0.71 0.29 1.6E-02 0 8.2E-01 17396 
rs2650492 16 28,333,411 SBK1 Locke A a g 0.267 0.21 0.27 4.4E-01 0 9.1E-01 15676 
rs3888190 16 28,889,486 ATP2A1 speliotes A a c 0.382 0.26 0.21 2.3E-01 81.9 1.9E-02 17858 
rs4787491 16 30,015,337 INO80E Locke G g a 0.536 0.37 0.20 6.8E-02 0 7.3E-01 17859 
rs9925964 16 31,129,895 KAT8 Locke A a g 0.626 0.54 0.20 8.4E-03 72.1 5.9E-02 17398 
rs2080454 16 49,062,590 CBLN1 Locke C c a 0.378 0.02 0.20 9.2E-01 74.4 4.8E-02 17398 
rs1558902*** 16 53,803,574 FTO Speliotes, 
Wen 2014 
A 
a t 0.414 1.20 0.20 5.1E-09 0 8.2E-01 17832 
rs17817964*** 16 53,828,066 FTO Monda T t c 0.404 1.14 0.20 2.7E-08 0 6.7E-01 17859 
rs889398 16 69,556,715 NFAT5 Winkler T c t 0.576 0.57 0.20 5.0E-03 78.1 3.3E-02 17398 
rs9914578 17 2,005,136 SMG6 Locke G c g 0.801 0.19 0.25 4.5E-01 0 5.1E-01 17859 
rs1000940 17 5,283,252 RABEP1 Locke G g a 0.308 0.45 0.21 3.5E-02 0 1.0E+00 17859 
rs4986044 17 21,261,560 KCNJ12 Winkler T c t 0.528 0.15 0.21 4.7E-01 0 6.4E-01 15215 
rs12150665 17 34,914,787 GGNBP2 Winkler T t c 0.590 0.33 0.20 1.1E-01 0 4.8E-01 17859 
rs11652097 17 45,316,717 ITGB3  Winkler T t c 0.388 0.40 0.20 5.0E-02 0 3.2E-01 17859 
rs6504108 17 46,292,923 SKAP1 Winkler T c t 0.287 0.22 0.21 3.0E-01 0 6.0E-01 17859 
rs8075273* 17 61,728,881 unknown Winkler C c a 0.723 0.27 0.22 2.3E-01 0 4.4E-01 17859 
rs312750 17 68,343,539 KCNJ2 Winkler A a g 0.489 0.15 0.19 4.3E-01 0 7.7E-01 17859 
rs12940622 17 78,615,571 RPTOR Locke** G g a 0.569 0.15 0.19 4.5E-01 0 5.6E-01 17859 
rs1808579 18 21,104,888 C18orf8 Speliotes C c t 0.524 0.63 0.19 1.3E-03 0 7.1E-01 17859 
rs7239883 18 40,147,671 LOC28426
0 
Locke G 
g a 0.391 0.43 0.20 3.6E-02 0 5.2E-01 17859 
rs7243357 18 56,883,319 GRP Locke T t g 0.827 0.08 0.26 7.6E-01 0 3.5E-01 17859 
rs2331841 18 57,828,637 MC4R Okada A a g 0.430 0.57 0.19 3.2E-03 0 4.5E-01 17859 
rs6567160 18 57,829,135 MC4R Speliotes, 
Pei 
C 
c t 0.234 0.83 0.23 4.0E-04 24.3 2.5E-01 17859 
rs591166 18 57,841,589 MC4R Wen 2014 A a t 0.435 0.56 0.19 3.8E-03 0 5.9E-01 17859 
rs9944545 18 57,958,244 MC4R Locke T t c 0.295 0.74 0.22 9.4E-04 41.4 1.9E-01 17859 
rs17066842 18 58,040,624 MC4R Locke G g a 0.964 1.06 0.55 5.3E-02 10.2 2.9E-01 17852 
rs17724992 19 18,454,825 PGPEP1 Locke A a g 0.732 0.08 0.22 7.1E-01 0 4.9E-01 17859 
rs17513613 19 30,286,822 CCNE1 Winkler T c t 0.328 0.15 0.21 5.0E-01 75.2 4.5E-02 17398 
rs29941 19 34,309,532 KCTD15 Speliotes G g a 0.677 0.50 0.21 2.1E-02 0 9.3E-01 17859 
rs2075650 19 45,395,619 TOMM40 Speliotes A a g 0.870 0.91 0.29 1.9E-03 43.1 1.8E-01 17398 
rs11671664 19 46,172,278 GIPR, 
QPCTL 
Wen 2014 G 
g a 0.891 0.42 0.33 2.0E-01 69.9 6.8E-02 17398 
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rs2287019 19 46,202,172 QPCTL Speliotes C c t 0.806 0.88 0.26 8.1E-04 59.5 1.2E-01 17398 
rs3810291 19 47,569,003 ZC3H4 Speliotes A          
rs4802349 19 47,874,510 DHX34 Gong 2013 G t g 0.104 0.16 0.33 6.3E-01 0 9.1E-01 17858 
rs8123881* 20 15,819,495 MACROD
2 
Winkler G 
a g 0.875 0.13 0.30 6.7E-01 0 9.3E-01 17398 
rs6091540 20 51,087,862 ZFP64 Locke** C c t 0.717 0.23 0.22 3.0E-01 0 6.0E-01 17398 
rs2836754 21 40,291,740 ETS2 Locke C c t 0.625 0.31 0.20 1.2E-01 0 7.8E-01 17859 
rs4820408 22 40,604,945 TNRC6B Winkler T t g 0.411 0.46 0.19 1.8E-02 67.4 8.0E-02 17859 
Abbreviations: A1=coded allele, A2=non-coded allele, Bp37=base pair Build 37, Chr=chromosome, 
FE=Fixed-Effect, HetP=heterogeneity p-value, P=p-value, Prep=prepared reference, Ref=reference, 
Sub=submitted reference, SNPs=single nucleotide polymorphisms. 
*When the index SNP was not genotyped on the MetaboChip, the proxy SNP in tight linkage 
disequilibrium (r2≥0.8 in 1000 Genomes pilot 1 CEU, YRI, CHB+JPT depending on the population of 
discovery) with the lowest p-value in the African American sample was chosen to represent the index 
signal. The decreasing and increasing alleles for proxies were assigned assuming that the risk index 
SNP would have a similar allele frequency in the 1000 Genomes population (EUR, AFR, or EAS 
depending on the discovery population) as the risk proxy SNP. 
**These loci were also described by Berndt et al. for obesity (maximum sample size of 263,407) [29].  
The most recent BMI references per racial/ethnic group are noted above by their first author and 
publication year, if applicable [21, 25, 26, 30, 32, 33, 186, 195, 204]. 
***For GWAS SNPs a Bonferroni correction for multiple tests in the fixed-effect analyses reflected the 
number of independent previously-reported signals tested (=0.05/166). The 4 noted SNP pairs above 
were in tight linkage disequilibrium [r2≥0.8 in non-European 1000 genomes pilot populations(s)] with 
each other, but because they were reports from distinct discovery populations we retained them in 
this inventory in case they were population-specific variants. Therefore, our Bonferroni correction was 
penalized for only 166 (=170-4) tests. 
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APPENDIX O: STATISTICAL POWER TO DETECT LOW FREQUENCY TO COMMON 
VARIANTS (1% LIGHT GRAY, 5% MEDIUM GRAY, 10% DARK GRAY) ACROSS A 
RANGE OF BMI GENETIC EFFECTS (% CHANGE PER ALLELE) WHILE VARYING 
SAMPLE SIZES AND BMI MEAN (STANDARD DEVIATIONS) OF THE VARIOUS 
RACIAL/ETHNIC STRATIFIED (PANELS A-D) AND THE TRANS-ETHNIC META-
ANALYSES (PANEL E), AND ASSUMING A WORST-CASE SCENARIO LOCUS-
SPECIFIC ALPHA OF 6.31X10-5 (E.G. 792 INDEPENDENT TESTS AT TRAFD1). 
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APPENDIX P: TRANS-ETHNIC DESCENT GENETIC EFFECT ESTIMATES FOR 170 BMI INDEX SNPS FROM PREVIOUS 
REPORTS, INCLUDING SECONDARY SIGNALS IN EUROPEAN DESCENT POPULATIONS AND/OR POPULATION-SPECIFIC 
MARKERS. 
     FIXED EFFECTS MANTRA 
rsID* Chr Bp37 Gene Ref. 
Risk 
Allele 
A1 A2 Freq Min Freq  Max Freq β (%) SE 
(%) 
P** I2 HetP*** N log
10 
BF 
Post 
prob 
het 
N 
rs2803328 1 1,874,326 KIAA1751 C g c 0.435 0.4855 0.8039 0.01 0.09 8.8E-01 0 5.7E-01 93701    
rs2271928 1 32,127,953 COL16A1 A g a 0.498 0.4011 0.6739 0.06 0.08 4.6E-01 5.5 3.7E-01 93721 -0.4 1.6E-02 93721 
rs2275426 1 46,487,552 MAST2 A a g 0.481 0.4155 0.5807 0.14 0.08 1.1E-01 0 7.8E-01 93725    
rs977747 1 47,684,677 TAL1 T t g 0.581 0.403 0.8956 0.08 0.10 3.8E-01 1.7 3.8E-01 93726    
rs657452 1 49,589,847 AGBL4 A               
rs11583200 1 50,559,820 ELAVL4 C c t 0.598 0.1852 0.6135 0.35 0.09 1.5E-04 0 5.0E-01 93736 2.7 1.3E-02 93736 
rs3101336 1 72,751,185 NEGR1 C c t 0.655 0.0901 0.4591 0.17 0.09 6.8E-02 69.4 2.0E-02 101969 -0.1 4.1E-02 101969 
rs12566985 1 75,002,193 FPGT-
TNNI3K 
G g a 0.719 0.1328 0.3962 0.42 0.11 2.8E-04 0 5.2E-01 75627 2.1 8.0E-03 75627 
rs12401738 1 78,446,761 FUBP1 A a g 0.258 0.0636 0.3487 0.00 0.12 1.0E+00 59.6 5.9E-02 93732 -1.1 5.1E-02 93732 
rs11165643 1 96,924,097 PTBP2 T t c 0.524 0.2202 0.7368 0.23 0.09 1.2E-02 66.4 3.0E-02 93704 1.0 4.8E-02 93704 
rs17024393 1 110,154,688 GNAT2 C c t 0.067 0.9174 0.9763 0.20 0.23 3.9E-01 60.6 7.9E-02 77687 -0.4 7.3E-02 77687 
rs4357530* 1 151,103,153 SEMA6C G g a 0.423 0.2812 0.881 0.10 0.10 3.5E-01 53.9 8.9E-02 89077    
rs10913118 1 175,954,755 RFWD2 A a c 0.694 0.5584 0.8501 0.02 0.10 8.1E-01 24.4 2.6E-01 93715 -0.4 1.0E-02 93715 
rs574367*** 1 177,873,210 SEC16B T t g 0.176 0.1099 0.1954 0.70 0.11 2.9E-11 0 6.1E-01 101913 9.1 1.4E-02 101913 
rs543874*** 1 177,889,480 SEC16B G g a 0.213 0.7507 0.8087 0.90 0.10 3.5E-21 72.9 1.1E-02 101972 19.1 2.5E-01 101972 
rs10920678 1 190,239,907 FAM5C A a g 0.374 0.2964 0.4242 0.39 0.09 5.0E-06 0 5.4E-01 93066    
rs2820292 1 201,784,287 NAV1 C c a 0.400 0.4554 0.7315 0.16 0.09 6.7E-02 0 9.1E-01 93725 0.3 6.0E-03 93725 
rs2820436 1 219,640,680 LYPLAL1 A a c 0.388 0.1952 0.4781 0.50 0.09 3.2E-08 0 4.7E-01 93721 6.0 6.0E-03 93721 
rs12463617*** 2 629,244 TMEM18 C c a 0.865 0.0864 0.1751 0.94 0.14 1.5E-11 33.7 2.2E-01 66370 9.4 2.3E-02 66370 
rs13021737*** 2 632,348 TMEM18 G g a 0.873 0.087 0.1748 1.05 0.12 3.0E-18 42 1.6E-01 101832 16.0 3.8E-02 101832 
rs11676272*,*** 2 25,141,538 ADCY3 G g a 0.523 0.1669 0.5856 0.58 0.09 1.3E-10 18.2 3.0E-01 93729 8.4 2.2E-02 93729 
rs10182181*** 2 25,150,296 ADCY3 G g a 0.523 0.1699 0.5858 0.57 0.09 2.9E-10 0 4.0E-01 93709 8.2 9.0E-03 93709 
rs11126666 2 26,928,811 KCNK3 A g a 0.651 0.1942 0.6513 0.05 0.10 6.3E-01 0 5.5E-01 93728 -0.6 5.0E-03 93728 
rs116612809 2 28,301,171 BRE G g a 0.088 0.903 0.9982 1.05 0.23 8.8E-06 87.9 2.6E-04 68016 5.1 9.4E-01 68016 
rs1016287 2 59,305,625 FLJ30838 T t c 0.242 0.1892 0.2959 0.15 0.10 1.2E-01 0 9.2E-01 93705 0.1 4.0E-03 93705 
rs11688816 2 63,053,048 EHBP1 G g a 0.606 0.2596 0.488 0.01 0.09 8.7E-01 31 2.3E-01 93729 -0.4 1.3E-02 93729 
rs12622013* 2 79,501,362 REG3A G g a 0.174 0.7996 0.8899 0.33 0.11 3.2E-03 51.6 1.0E-01 93693    
rs7570971 2 135,837,906 RAB3GAP1 A c a 0.183 0.7794 0.8915 0.08 0.15 5.9E-01 42.1 1.8E-01 75848    
rs4988235 2 136,608,646 MCM6 A a g 0.186 0.1104 0.2257 0.13 0.14 3.8E-01 56.7 9.9E-02 75871    
rs2121279 2 143,043,285 LRP1B T t c 0.087 0.0316 0.1285 0.22 0.20 2.6E-01 0 5.0E-01 79468 -0.2 1.3E-02 79468 
rs1460676 2 164,567,689 FIGN C c t 0.259 0.6324 0.8663 0.31 0.10 2.4E-03 0 8.9E-01 93734 1.6 4.0E-03 93734 
rs10184004 2 165,508,389 GRB14/CO
BLL1 
T t c 0.452 0.103 0.7186 0.52 0.10 1.3E-07 0 5.5E-01 93726 5.6 1.1E-02 93726 
rs10930502 2 172,890,588 METAP1D A a g 0.593 0.3328 0.7 0.48 0.09 1.4E-07 0 8.7E-01 93721    
rs1528435 2 181,550,962 UBE2E3 T t c 0.646 0.6115 0.6993 0.26 0.09 3.6E-03 18.4 3.0E-01 93739 1.4 5.0E-03 93739 
rs972540 2 207,244,783 ADAM23 A g a 0.203 0.7281 0.8253 0.20 0.10 5.6E-02 48.9 1.2E-01 93737 0.4 9.0E-03 93737 
rs17203016 2 208,255,518 CREB1 G g a 0.163 0.7962 0.9595 0.24 0.13 5.8E-02 0 7.5E-01 93700 -0.2 8.0E-03 93700 
rs7599312 2 213,413,231 ERBB4 G g a 0.715 0.0658 0.3767 0.29 0.10 5.1E-03 31.5 2.2E-01 93703    
rs492400 2 219,349,752 USP37 C c t 0.364 0.5734 0.7614 0.36 0.11 1.4E-03 0 9.9E-01 56322    
rs2176040 2 227,092,802 LOC646736 A a g 0.275 0.0986 0.3506 0.50 0.10 4.0E-07 0 5.5E-01 93732 5.1 6.0E-03 93732 
rs9845966 3 13,433,158 NUP210 T t g 0.466 0.2319 0.5767 0.20 0.09 2.4E-02 0 7.3E-01 87968 0.7 5.0E-03 87968 
rs6804842 3 25,106,437 RARB G g a 0.530 0.388 0.5883 0.14 0.08 8.6E-02 0 5.2E-01 93722 0.3 9.0E-03 93722 
rs7613875 3 49,971,514 MON1A A a c 0.455 0.2015 0.6741 0.13 0.11 2.3E-01 0 9.0E-01 68026    
rs2365389 3 61,236,462 FHIT C c t 0.349 0.4078 0.8724 0.30 0.10 3.0E-03 0 9.6E-01 93732 1.2 7.0E-03 93732 
rs333495* 3 78,834,343 ROBO1 G g t 0.431 0.4993 0.7202 0.15 0.09 8.3E-02 71.7 1.4E-02 93735    
rs13078960 3 85,807,590 CADM2 G t g 0.857 0.792 0.9648 0.00 0.15 9.8E-01 0 8.2E-01 101976 -0.4 1.7E-02 101976 
rs1720825 3 138,108,083 MRAS A g a 0.865 0.0372 0.1966 0.01 0.14 9.4E-01 0 8.0E-01 93739 -0.4 1.0E-02 93739 
rs2640017* 3 141,335,121 RASA2 G g a 0.210 0.725 0.9819 0.46 0.13 4.6E-04 0 7.3E-01 93609 2.2 1.1E-02 93609 
rs11927381 3 185,508,591 IGF2BP2 T t c 0.563 0.2551 0.684 0.49 0.09 1.3E-07 0 8.4E-01 93626 5.5 3.0E-03 93626 
rs1516725 3 185,824,004 ETV5 C c t 0.864 0.0698 0.1832 0.69 0.13 1.0E-07 0 8.7E-01 101811 5.6 9.0E-03 101811 
rs16992647 4 36,813,105 KIAA1239 T t c 0.273 0.1306 0.4603 0.00 0.11 9.7E-01 0 5.3E-01 93609    
rs16858082 4 45,175,804 GNPDA2 T t c 0.505 0.345 0.5987 0.42 0.08 2.1E-07 0 9.9E-01 101873 5.4 8.0E-03 101873 
rs10938397 4 45,182,527 GNPDA2 G g a 0.325 0.5657 0.7499 0.60 0.08 7.3E-13 1.7 3.8E-01 101782 10.5 1.0E-02 101782 
rs348495 4 45,184,442 GNPDA2 G               
rs13107325 4 103,188,709 SLC39A8 T t c 0.053 0.0188 0.0745 1.05 0.25 3.4E-05 0 8.7E-01 79090 3.2 1.5E-02 79090 
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rs11727676 4 145,659,064 HHIP T t c 0.936 0.9046 0.9842 0.04 0.23 8.7E-01 59 6.3E-02 93185 -0.5 4.2E-02 93185 
rs2112347 5 75,015,242 POC5 T t g 0.531 0.4432 0.6402 0.28 0.08 4.3E-04 3.3 3.8E-01 101972 2.2 1.1E-02 101972 
rs6870983 5 87,697,533 TMEM161B
−AS1 
T c t 0.666 0.0573 0.4458 0.19 0.11 7.3E-02 0 6.4E-01 93190    
rs11951673* 5 95,861,012 PCSK1 C c t 0.560 0.3858 0.5768 0.50 0.08 3.5E-09 0 4.4E-01 93717    
rs6864049 5 124,330,522 ZNF608 A g a 0.679 0.1969 0.473 0.15 0.09 9.4E-02 9.3 3.5E-01 93676    
rs13174863 5 139,080,745 CXXC5 A g a 0.109 0.8467 0.94 0.21 0.15 1.6E-01 0 8.1E-01 93734    
rs4569924* 5 153,540,025 GALNT10 T t c 0.486 0.3547 0.8263 0.26 0.10 5.6E-03 69.4 2.0E-02 93730    
rs2228213 6 12,124,855 HIVEP1 A g a 0.742 0.109 0.345 0.20 0.10 4.6E-02 0 4.8E-01 93739    
rs9356744 6 20,685,486 CDKAL1 T t c 0.562 0.3735 0.6899 0.42 0.08 2.6E-07 81.2 1.2E-03 101966 5.9 7.4E-01 101966 
rs943466 6 33,731,787 LEMD2 A g a 0.733 0.1343 0.3242 0.10 0.10 3.0E-01 0 9.9E-01 93735    
rs205262 6 34,563,164 C6orf106 G g a 0.399 0.3697 0.8571 0.24 0.10 1.5E-02 0 6.7E-01 93730    
rs2033529 6 40,348,653 TDRG1 G g a 0.231 0.7164 0.8354 0.05 0.10 6.5E-01 0 6.6E-01 93730 -0.5 8.0E-03 93730 
rs2207139 6 50,845,490 TFAP2B G g a 0.211 0.7062 0.9036 0.41 0.10 1.0E-04 2 3.8E-01 101973 2.9 1.2E-02 101973 
rs9400239 6 108,977,663 FOXO3 C c t 0.549 0.292 0.7448 0.14 0.09 1.4E-01 0 6.3E-01 93726 -0.1 8.0E-03 93726 
rs9374842 6 120,185,665 LOC285762 T c t 0.213 0.765 0.8243 0.01 0.10 8.9E-01 0 5.2E-01 93654 -0.7 9.0E-03 93654 
rs13201877 6 137,675,541 IFNGR1 G a g 0.904 0.864 0.9674 0.01 0.16 9.7E-01 0 4.1E-01 93739    
rs1281962 6 153,431,376 RGS17 C c g 0.667 0.5291 0.8202 0.14 0.09 1.3E-01 0 6.3E-01 93718 0.1 6.0E-03 93718 
rs3127574 6 160,791,370 SLC22A3 C c g 0.497 0.4325 0.5868 0.13 0.08 1.2E-01 51.7 1.0E-01 93727 0.0 5.0E-03 93727 
rs13191362 6 163,033,350 PARK2 A a g 0.912 0.8825 0.9465 0.48 0.18 7.1E-03 70 3.6E-02 79492 0.9 4.4E-02 79492 
rs10499694* 7 50,614,173 DDC G a g 0.578 0.4816 0.6405 0.11 0.09 2.0E-01 57.2 7.2E-02 93731 -0.1 2.1E-02 93731 
rs1167827 7 75,163,169 HIP1 G g a 0.548 0.1298 0.896 0.33 0.11 2.9E-03 0 7.1E-01 93725    
rs6465468 7 95,169,514 ASB4 T g t 0.823 0.0681 0.2286 0.03 0.13 8.4E-01 69.7 3.7E-02 75841 -0.7 5.6E-02 75841 
rs6990042 8 14,173,974 SGCZ T g t 0.406 0.4865 0.7356 0.14 0.09 1.0E-01 49.2 1.2E-01 93729    
rs7844647* 8 34,503,776 Intergenic T t c 0.509 0.2848 0.7379 0.32 0.09 3.4E-04 72.1 1.3E-02 93735    
rs17405819 8 76,806,584 HNF4G T t c 0.707 0.6087 0.9166 0.20 0.10 4.5E-02 21.5 2.8E-01 93726 0.4 1.0E-02 93726 
rs16907751 8 81,375,457 ZBTB10 C c t 0.893 0.0747 0.1472 0.08 0.14 5.7E-01 0 9.6E-01 93735    
rs2033732 8 85,079,709 RALYL C t c 0.222 0.1194 0.2766 0.11 0.10 3.1E-01 83.4 4.3E-04 93533    
rs4740619 9 15,634,326 C9orf93 T t c 0.447 0.2481 0.5519 0.11 0.09 2.3E-01 71.9 1.4E-02 93693 -0.4 9.7E-02 93693 
rs10968576 9 28,414,339 LINGO2 G g a 0.217 0.6942 0.8301 0.52 0.10 1.1E-07 0 5.9E-01 101976 5.6 1.1E-02 101976 
rs6477694 9 111,932,342 EPB41L4B C c t 0.446 0.4083 0.6563 0.19 0.09 2.9E-02 0 4.9E-01 93735    
rs1928295 9 120,378,483 TLR4 T t c 0.565 0.5517 0.581 0.15 0.08 6.3E-02 47.6 1.3E-01 93717 0.3 2.2E-02 93717 
rs10733682 9 129,460,914 LMX1B A a g 0.508 0.2881 0.727 0.28 0.09 2.1E-03 68.2 2.4E-02 93718 1.7 1.4E-01 93718 
rs2270204 9 131,042,734 SWI5  T g t 0.504 0.3096 0.7451 0.24 0.09 7.3E-03 0 6.3E-01 93431 1.1 5.0E-03 93431 
rs7899106 10 87,410,904 GRID1 G g a 0.095 0.8783 0.9511 0.17 0.18 3.6E-01 0 8.3E-01 79503 -0.3 9.0E-03 79503 
rs17094222 10 102,395,440 HIF1AN C c t 0.241 0.6756 0.9455 0.19 0.11 9.5E-02 0 9.2E-01 93727 -0.4 9.0E-03 93727 
rs11191560 10 104,869,038 NT5C2 C c t 0.204 0.7305 0.9583 0.54 0.11 1.8E-06 0 7.8E-01 101966 4.4 8.0E-03 101966 
rs7903146 10 114,758,349 TCF7L2 C c t 0.739 0.0658 0.2949 0.75 0.10 2.2E-13 54 8.9E-02 101975 11.2 6.3E-02 101975 
rs10886017 10 118,672,531 KIAA1598 A a c 0.370 0.2499 0.4623 0.16 0.09 7.8E-02 38.9 1.8E-01 93694 0.2 6.0E-03 93694 
rs2237897 11 2,858,546 KCNQ1 T t c 0.237 0.0476 0.3527 0.66 0.12 3.3E-08 0 4.0E-01 93516 6.2 9.0E-03 93516 
rs4256980 11 8,673,939 TRIM66 G g c 0.509 0.3614 0.6023 0.22 0.08 5.2E-03 0 5.4E-01 101492 1.1 9.0E-03 101492 
rs7928810 11 17,372,443 NCR3LG1 A a c 0.690 0.6206 0.9151 0.31 0.10 1.9E-03 34 2.1E-01 93268 1.6 1.7E-02 93268 
rs1557765 11 17,403,639 KCNJ11 T c t 0.686 0.1071 0.3794 0.31 0.10 1.5E-03 0 5.0E-01 93268 1.8 1.0E-03 93268 
rs11030104 11 27,684,517 BDNF A a g 0.694 0.5664 0.9513 0.40 0.10 7.3E-05 79.5 2.2E-03 101516 3.2 3.1E-01 101516 
rs10835210 11 27,695,910 BDNF C c a 0.686 0.1318 0.4298 0.12 0.10 2.2E-01 0 9.0E-01 89057 -0.3 8.0E-03 89057 
rs652722 11 31,905,534 PAX6 C               
rs2176598 11 43,864,278 HSD17B12 T t c 0.323 0.1371 0.4054 0.10 0.10 3.0E-01 23 2.7E-01 93731 -0.3 1.6E-02 93731 
rs3817334 11 47,650,993 MTCH2 T t c 0.338 0.2663 0.4073 0.28 0.08 6.3E-04 0 5.0E-01 101940 2.0 6.0E-03 101940 
rs1865732* 11 112,960,722 NCAM1 C t c 0.619 0.4436 0.8391 0.01 0.09 9.0E-01 0 6.9E-01 93268 -0.5 4.0E-03 93268 
rs12286929 11 115,022,404 CADM1 G g a 0.488 0.4298 0.7569 0.26 0.09 3.3E-03 36.2 2.0E-01 92926    
rs11611246 12 939,480 WNK1 T t g 0.261 0.2049 0.2881 0.25 0.12 3.4E-02 50.8 1.3E-01 57861    
rs7970953 12 24,075,508 SOX5 A a g 0.426 0.2359 0.692 0.12 0.09 2.0E-01 0 8.7E-01 93676    
rs1405552 12 41,746,673 PDZRN4 A g a 0.558 0.1015 0.5654 0.13 0.10 1.8E-01 11.2 3.4E-01 93274 0.0 8.0E-03 93274 
rs11181001 12 41,948,196 PDZRN4 A a g 0.480 0.39 0.5806 0.13 0.08 1.1E-01 29 2.4E-01 93264    
rs7138803 12 50,247,468 BCDIN3D A a g 0.285 0.179 0.3777 0.35 0.09 9.0E-05 0 4.8E-01 101969 2.9 3.0E-03 101969 
rs1438994* 12 90,594,389 Intergenic T t c 0.266 0.1124 0.3721 0.09 0.10 3.7E-01 10.5 3.4E-01 93273 -0.2 7.0E-03 93273 
rs11065987 12 112,072,424 BRAP A a g 0.716 0.5693 0.9221 0.21 0.12 8.8E-02 17.8 3.0E-01 93730 0.2 1.5E-02 93730 
rs17630235 12 112,591,686 TRAFD1 A g a 0.723 0.0762 0.4249 0.21 0.13 9.9E-02 23.3 2.7E-01 93617 0.2 1.9E-02 93617 
rs11057405 12 122,781,897 CLIP1 G g a 0.919 0.0156 0.0956 0.58 0.23 1.2E-02 18.1 3.0E-01 57987    
rs1885988* 13 28,010,262 MTIF3 C c t 0.144 0.8201 0.9602 0.11 0.13 4.3E-01 45.4 1.4E-01 93277 -0.4 4.8E-02 93277 
rs12429545 13 54,102,206 OLFM4 A a g 0.203 0.0491 0.2728 0.63 0.12 8.4E-08 0 5.2E-01 93719    
rs9540493 13 66,205,704 MIR548X2 A a g 0.567 0.4347 0.7201 0.19 0.09 2.5E-02 68.1 2.4E-02 93669    
rs1441264 13 79,580,919 MIR548A2 A a g 0.632 0.5428 0.6933 0.25 0.09 4.9E-03 0 4.1E-01 93240 1.2 1.0E-02 93240 
rs9634489 13 97,049,004 HS6ST3 A g a 0.508 0.381 0.6009 0.15 0.09 7.9E-02 0 6.8E-01 93735    
rs10132280 14 25,928,179 STXBP6 C c a 0.622 0.0877 0.5253 0.32 0.10 8.4E-04 47.4 1.3E-01 93686 1.9 2.3E-02 93686 
rs12885454 14 29,736,838 PRKD1 C c a 0.669 0.1338 0.4983 0.27 0.10 5.8E-03 0 4.4E-01 93255 0.9 8.0E-03 93255 
rs11847697 14 30,515,112 PRKD1 T t c 0.258 0.0384 0.3313 0.01 0.14 9.3E-01 0 9.5E-01 93490 -0.5 1.1E-02 93490 
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rs17522122 14 33,302,882 AKAP6 T t g 0.412 0.3787 0.481 0.37 0.10 3.9E-04 36.8 2.1E-01 57936 2.3 1.2E-02 57936 
rs7141420 14 79,899,454 NRXN3 T t c 0.535 0.3788 0.6255 0.27 0.08 1.3E-03 69.5 2.0E-02 93721 1.8 1.6E-01 93721 
rs3783890 14 93,790,276 BTBD7 T t c 0.756 0.6348 0.9017 0.11 0.10 2.9E-01 59.6 5.9E-02 93736    
rs7143963 14 103,304,425 TRAF3 T t c 0.432 0.1767 0.6178 0.19 0.09 3.9E-02 0 6.5E-01 93731    
rs709400 14 104,149,475 KLC1 A a g 0.748 0.6251 0.8703 0.08 0.10 4.4E-01 0 9.0E-01 93730 -0.3 4.0E-03 93730 
rs3736485 15 51,748,610 DMXL2 A a g 0.570 0.47 0.7527 0.17 0.09 4.6E-02 0 8.0E-01 93693    
rs16951275 15 68,077,168 MAP2K5 T t c 0.542 0.4071 0.765 0.35 0.08 2.5E-05 27.3 2.5E-01 101972 2.4 1.2E-02 101972 
rs4776970 15 68,080,886 MAP2K5 A a t 0.422 0.2375 0.6294 0.38 0.08 6.1E-06 0 9.0E-01 101972 4.1 4.0E-03 101972 
rs7164727 15 73,093,991 LOC100287
559 
T t c 0.450 0.234 0.6741 0.10 0.09 2.8E-01 0 4.5E-01 93729 -0.2 1.5E-02 93729 
rs7181659 15 95,267,483 MCTP2 A a g 0.558 0.4499 0.6466 0.09 0.09 2.9E-01 0 7.4E-01 93699    
rs11866815 16 387,867 AXIN1 T t c 0.299 0.1958 0.4172 0.08 0.09 3.8E-01 0 8.4E-01 93635 -0.3 1.3E-02 93635 
rs12446632 16 19,935,389 GPRC5B G               
rs11074446 16 20,255,123 GP2 T t c 0.765 0.678 0.8677 0.52 0.10 3.8E-07 0 5.6E-01 93229    
rs2650492 16 28,333,411 SBK1 A a g 0.146 0.0644 0.2669 0.54 0.14 9.5E-05 26.1 2.5E-01 99770 2.8 2.0E-02 99770 
rs3888190 16 28,889,486 ATP2A1 A a c 0.307 0.1509 0.4086 0.44 0.09 1.6E-06 0 5.8E-01 101949 4.6 1.3E-02 101949 
rs4787491 16 30,015,337 INO80E G g a 0.464 0.4636 0.6518 0.31 0.09 3.7E-04 0 8.9E-01 93728 2.2 6.0E-03 93728 
rs9925964 16 31,129,895 KAT8 A a g 0.585 0.1625 0.8666 0.34 0.10 1.1E-03 48 1.2E-01 92510    
rs2080454 16 49,062,590 CBLN1 C c a 0.488 0.346 0.6373 0.17 0.09 4.5E-02 9.7 3.4E-01 93270 -0.5 1.6E-02 93270 
rs1558902*** 16 53,803,574 FTO A a t 0.290 0.2006 0.4135 1.44 0.11 2.4E-36 44.6 1.6E-01 60021 34.0 1.7E-02 60021 
rs17817964*** 16 53,828,066 FTO T t c 0.256 0.1177 0.4037 1.23 0.10 7.1E-36 0 7.1E-01 101976 33.5 5.0E-03 101976 
rs889398 16 69,556,715 NFAT5 T c t 0.682 0.1996 0.4244 0.13 0.09 1.8E-01 55 8.3E-02 93115 -0.4 2.9E-02 93115 
rs9914578 17 2,005,136 SMG6 G c g 0.651 0.4728 0.8023 0.04 0.09 6.7E-01 0 7.2E-01 93666 -1.0 8.0E-03 93666 
rs1000940 17 5,283,252 RABEP1 G g a 0.384 0.3996 0.7629 0.10 0.09 2.8E-01 58.2 6.6E-02 93726 -0.2 1.1E-02 93726 
rs4986044 17 21,261,560 KCNJ12 T c t 0.432 0.4694 0.6543 0.07 0.09 4.2E-01 0 5.3E-01 90325 -0.4 1.1E-02 90325 
rs12150665 17 34,914,787 GGNBP2 T t c 0.681 0.5904 0.8752 0.30 0.10 1.5E-03 12.5 3.3E-01 93726    
rs11652097 17 45,316,717 ITGB3  T c t 0.634 0.3421 0.3875 0.12 0.09 1.8E-01 64.5 3.8E-02 93646 -0.4 4.4E-02 93646 
rs6504108 17 46,292,923 SKAP1 T c t 0.264 0.6981 0.7958 0.14 0.09 1.5E-01 9.9 3.4E-01 93726    
rs8075273* 17 61,728,881 unknown C c a 0.719 0.0872 0.3655 0.12 0.10 2.5E-01 0 6.8E-01 93099 -0.1 1.5E-02 93099 
rs312750 17 68,343,539 KCNJ2 A a g 0.638 0.4891 0.8103 0.09 0.09 3.4E-01 0 8.9E-01 93734 -0.2 8.0E-03 93734 
rs12940622 17 78,615,571 RPTOR G g a 0.571 0.3349 0.5544 0.28 0.09 9.9E-04 0 5.9E-01 93722    
rs1808579 18 21,104,888 C18orf8 C c t 0.464 0.4518 0.6622 0.11 0.09 1.9E-01 88.5 9.3E-06 93711 2.2 9.9E-01 93711 
rs7239883 18 40,147,671 LOC284260 G g a 0.363 0.5684 0.7229 0.11 0.09 2.0E-01 7.2 3.6E-01 93477    
rs7243357 18 56,883,319 GRP T t g 0.822 0.7605 0.8721 0.23 0.11 4.4E-02 48.4 1.2E-01 93737    
rs2331841 18 57,828,637 MC4R A a g 0.373 0.2293 0.4857 0.54 0.08 8.6E-11 0 5.3E-01 101933 8.8 8.0E-03 101933 
rs6567160 18 57,829,135 MC4R C c t 0.193 0.7662 0.8544 0.89 0.10 9.4E-19 13.8 3.2E-01 101966 16.2 1.1E-02 101966 
rs591166 18 57,841,589 MC4R A a t 0.443 0.231 0.7417 0.41 0.09 1.5E-06 0 7.5E-01 101953 4.3 5.0E-03 101953 
rs9944545 18 57,958,244 MC4R T t c 0.346 0.1334 0.5432 0.32 0.09 7.3E-04 54.2 8.8E-02 101966 2.1 2.0E-02 101966 
rs17066842 18 58,040,624 MC4R G g a 0.874 0.0204 0.1731 0.41 0.16 1.1E-02 0 5.7E-01 101605 0.9 1.4E-02 101605 
rs17724992 19 18,454,825 PGPEP1 A a g 0.670 0.5282 0.8874 0.30 0.10 2.6E-03 73.3 1.1E-02 93722 1.5 5.7E-02 93722 
rs17513613 19 30,286,822 CCNE1 T c t 0.200 0.6719 0.8911 0.09 0.12 4.5E-01 0 6.6E-01 93277 -0.4 1.3E-02 93277 
rs29941 19 34,309,532 KCTD15 G g a 0.562 0.1824 0.7617 0.26 0.09 3.9E-03 0 6.2E-01 101951 1.1 4.0E-03 101951 
rs2075650 19 45,395,619 TOMM40 A a g 0.866 0.8308 0.8978 0.22 0.13 8.1E-02 65.2 3.5E-02 93271 0.2 5.1E-02 93271 
rs11671664 19 46,172,278 GIPR, 
QPCTL 
G g a 0.688 0.0936 0.4691 0.40 0.11 1.5E-04 79.9 1.9E-03 101500 3.0 6.6E-01 101500 
rs2287019 19 46,202,172 QPCTL C c t 0.813 0.1294 0.211 0.65 0.12 1.4E-07 0 5.9E-01 65911 5.6 1.3E-02 65911 
rs3810291 19 47,569,003 ZC3H4 A               
rs4802349 19 47,874,510 DHX34 G g t 0.631 0.1035 0.4808 0.28 0.09 2.8E-03 88.4 1.0E-05 93581    
rs8123881* 20 15,819,495 MACROD2 G g a 0.238 0.6429 0.9057 0.25 0.11 2.2E-02 60.2 5.7E-02 93265    
rs6091540 20 51,087,862 ZFP64 C c t 0.702 0.2247 0.3572 0.18 0.09 5.4E-02 0 4.2E-01 93270    
rs2836754 21 40,291,740 ETS2 C c t 0.417 0.3746 0.7276 0.22 0.09 1.5E-02 0 8.1E-01 93717 0.9 6.0E-03 93717 
rs4820408 22 40,604,945 TNRC6B T t g 0.385 0.1071 0.5338 0.25 0.10 8.5E-03 33.7 2.1E-01 93733    
Abbreviations: A1=coded allele, A2=non-coded allele, BF=Bayes Factor, Bp37=base pair Build 37, Chr=chromosome, FE=Fixed-Effect, 
HetP=heterogeneity p-value, Max=maximum, Min=minimum, P=p-value, Post Prob Het=posterior probability of heterogeneity, Prep=prepared 
reference, Ref=reference, Sub=submitted reference, SNPs=single nucleotide polymorphisms. 
*When the index SNP was not genotyped on the MetaboChip, the proxy SNP in tight linkage disequilibrium (r2≥0.8 in 1000 Genomes pilot 1 CEU, 
YRI, CHB+JPT depending on the population of discovery) with the lowest p-value in the African American sample was chosen to represent the 
index signal. The decreasing and increasing alleles for proxies were assigned assuming that the risk index SNP would have a similar allele 
frequency in the 1000 Genomes population (EUR, AFR, or EAS depending on the discovery population) as the risk proxy SNP. 
**For GWAS SNPs a Bonferroni correction for multiple tests in the fixed-effect analyses reflected the number of independent previously-reported 
signals tested (=0.05/166). The 4 noted SNP pairs above were in tight linkage disequilibrium [r2≥0.8 in non-European 1000 genomes pilot 
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populations(s)] with each other, but because they were reports from distinct discovery populations we retained them in this inventory in case they 
were population-specific variants. Therefore, our Bonferroni correction was penalized for only 166 (=170-4) tests. 
***Bonferroni significant heterogeneity p-values in italics.  
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APPENDIX Q: FOREST PLOT OF EFFECT HETEROGENEITY (PHET=1.16X10-4, I2=69.0) 
AT TRAF3 (RS7143963-T, 62% RISK ALLELE FREQUENCY, RANGE 59-67%) IN 35,602 
AFRICAN DESCENT ADULTS IN PAGE. 
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APPENDIX R: FOREST PLOT OF EFFECT HETEROGENEITY (PHET=2.71X10-4, I2=74.5) 
AT MAP2K5 (RS182297248-C, 0.9% RISK ALLELE FREQUENCY, RANGE 0.2-1.2%) IN 
21,974 ASIAN DESCENT ADULTS IN PAGE.  
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APPENDIX S: COMPARISON OF AFRICAN AND EUROPEAN DESCENT LINKAGE 
DISEQUILIBRIUM (LD) PATTERNS AT THREE LOCI WITH SIGNIFICANT TRANS-
ETHNIC FIXED-EFFECT (FE, -LOG10 P-VALUES SHOWN HERE) ESTIMATES AND 
DIFFERING TOP SNPS IN THE FIXED-EFFECT AND BAYESIAN TRANS-ETHNIC META-
ANALYSES (LABELED AND SHOWN IN PURPLE, REFERENCE FOR LD). 
 
   
  
206 
APPENDIX T: REGIONAL PLOTS OF TRANS-ETHNIC FIXED-EFFECT ESTIMATES (I, 
INDEX SNPS; FE, TOP FINDING) AND BAYESIAN FINE-MAPPING OF 6 SIGNIFICANT 
BMI LOCI TO SELECT THE SNP WITH THE HIGHEST POSTERIOR PROBABILITY (M, 
SHOWN IN PURPLE AND REFERENCE FOR TRANS-ETHNIC LINKAGE 
DISEQUILIBRIUM) AND NARROW THE PUTATIVE INTERVAL OF INTEREST TO 13-29 
SNPS IN A SAMPLE OF UP TO 101,979 INDIVIDUALS.  
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APPENDIX U: REGIONAL PLOTS OF TRANS-ETHNIC FIXED-EFFECT ESTIMATES (I, 
INDEX SNPS; FE, TOP FINDING) AND BAYESIAN FINE-MAPPING OF 4 BMI 
SIGNIFICANT LOCI TO SELECT THE SNP WITH THE HIGHEST POSTERIOR 
PROBABILITY (M, SHOWN IN PURPLE AND REFERENCE FOR TRANS-ETHNIC 
LINKAGE DISEQUILIBRIUM) AND TO NARROW THE PUTATIVE INTERVAL OF 
INTEREST TO 30-88 SNPS IN A SAMPLE OF UP TO 101,979 INDIVIDUALS. 
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APPENDIX V: REGIONAL PLOTS OF 7 BMI LOCI WITH SIGNIFICANT TRANS-ETHNIC 
FIXED-EFFECT ESTIMATES (I, INDEX SNPS; FE, TOP FINDING; M, HIGHEST 
POSTERIOR PROBABILITY, SHOWN IN PURPLE AND REFERENCE FOR TRANS-
ETHNIC LINKAGE DISEQUILIBRIUM) IN A SAMPLE OF UP TO 101,979 INDIVIDUALS. 
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APPENDIX W: REGIONAL PLOTS OF 7 BMI LOCI WITH NON-SIGNIFICANT TRANS-
ETHNIC FIXED-EFFECT ESTIMATES (I, INDEX SNPS; FE, TOP FINDING; M, HIGHEST 
POSTERIOR PROBABILITY, SHOWN IN PURPLE AND REFERENCE FOR TRANS-
ETHNIC LINKAGE DISEQUILIBRIUM) IN A SAMPLE OF UP TO 101,979 INDIVIDUALS. 
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APPENDIX X: THE COMPARISON OF THE STATISTICAL SIGNIFICANCE (-LOG10 OF 
THE P-VALUE), EFFECT SIZE (% CHANGE IN BMI PER RISK ALLELE) AND CODED 
ALLELE FREQUENCIES (ORIENTED TO THE RISK ALLELE IN THE TRANS-ETHNIC 
META-ANALYSIS) ACROSS AFRICAN, HISPANIC/LATINO, ASIAN AND EUROPEAN 
ANCESTRIES OF 9 DENSELY-GENOTYPED REGIONS WITH EVIDENCE OF MULTIPLE 
SIGNALS (RSID OF PRIMARY SIGNALS IN BLACK; RSID OF OTHER SIGNALS IN 
GRAY). 
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APPENDIX Y: FUNCTIONAL ANNOTATION IN HAPLOREG (VERSION 4.1) OF THE LEAD SNPS REPRESENTING MULTIPLE 
LOCUS-SPECIFIC BONFERRONI SIGNALS IN A JOINT FIXED-EFFECTS MODEL AT THE 28 OF THE 36 DENSELY-
GENOTYPED BMI LOCI. 
Gene rsID Chr Bp37 Enhancer DNAse Proteins 
Bound 
Motifs 
Changed 
GWAS catalog 
report  
(P<5x10-8) 
Selected eQTL Hits 
(Correleated gene [tissue, 
Pvalue]) 
GENCODE 
Genes 
RefSeq 
Genes 
In-
tron 
N
S 
r2>0.8 
with NS  
TNNI3K rs12566985 1 75,002,193    AP-1, TATA BMI  FPGT-
TNNI3K 
FPGT-
TNNI3K 
x   
SEC16B rs543874 1 177,889,480 MUS   Pbx-1, TCF4 BMI, age at 
menarche 
 3.6kb 3' of 
RP4-
798P15.2 
8.8kb 3' of 
SEC16B 
   
LYPLAL1*
* 
rs2820436 1 219,640,680 FAT, STRM, 
SKIN, BONE 
  MZF1::1-
4,PLAG1,TFIIA 
Waist to hip 
ratio 
RP11-392O17.1 [Skin-
Leg,P=6.1E-9] 
25kb 5' of 
RP11-
95P13.1 
254kb 3' of 
LYPLAL1 
   
LYPLAL1*
* 
rs4445477 1 219,759,481 ESDR, BRST, 
BLD, FAT, GI, 
ADRL, 
PLCNT, HRT, 
SPLN 
SKIN,ADRL,PL
CN 
 Ets,HEN1,LBP-
1,RFX5 
Waist to hip 
ratio 
 28kb 3' of 
RP11-
95P13.2+W
6:AJ7 
287kb 5' of 
RNU5F 
   
TMEM18 rs6731872 2 624,205    BCL,TR4 BMI  43kb 3' of 
TMEM18 
44kb 3' of 
TMEM18 
   
COBLL1* rs10184004 2 165,508,389  SKIN MAFK ATF4,Maf,NF-
E2,Nrf-
2,PLZF,RREB-
1 
Waist to hip 
ratio 
SLC38A11 
[Muscle_Skeletal, P=5.19E-
6] 
1.7kb 3' of 
COBLL1 
30kb 5' of 
GRB14 
   
COBLL1* rs17244444 2 165,548,415 ESDR, LNG, 
LIV 
  ELF1,NERF1a,
Nrf-2,p300 
Waist to hip 
ratio 
 COBLL1 COBLL1 x   
LOC64673
6* 
rs2176040 2 227,092,802 ESDR, LIV   Nr2e3,Pax-2  RP11-395N3.2 
[Adipose_Subcutaneous, 
P=5.35E-8], IRS1 
[Adipose_Subcutaneous, 
P=3.78E-6] 
43kb 5' of 
AC068138.1 
503kb 3' of 
IRS1 
   
LOC64673
6* 
rs2673147 2 227,177,202 BRN, LNG LNG  Foxp3,RXRA,SI
X5 
 RP11-395N3.2 
[Adipose_Subcutaneous, 
P=1.46E-5], IRS1 
[Adipose_Subcutaneous, 
P=1.42E-5] 
127kb 5' of 
AC068138.1 
419kb 3' of 
IRS1 
   
IGF2BP2** rs11927381 3 185,508,591 ESDR, IPSC, 
ESC, FAT, 
BRST, STRM, 
BLD, MUS, 
SKIN, ADRL, 
LIV, VAS, 
BRN, BONE 
   Type 2 diabetes IGF2BP2 [Thyroid, 
P=23.4E06] 
IGF2BP2 IGF2BP2 x   
  
 
2
1
5
 
ETV5 rs7647305 3 185,834,290    Cdx2,Foxj1,Fox
l1,Foxp1,Gfi1,P
ou1f1,RREB-
1,TATA 
BMI, Weight  DGKG 7.4kb 5' of 
ETV5 
   
GNPDA2 rs12507026 4 45,181,334  BRST,SKIN JUND HNF1,Hic1,RX
RA,TCF12 
BMI  128kb 3' of 
RP11-
362I1.1 
453kb 5' of 
GNPDA2 
   
SLC39A8* rs28392891 4 103,134,678    Nkx3,Pou5f1,S
ox,p300 
BMI  38kb 3' of 
SLC39A8 
38kb 3' of 
SLC39A8 
   
SLC39A8* rs13107325 4 103,188,709    Arid5a,PRDM1,
Pax-1 
HDL 
cholesterol,BMI, 
diastolic & 
systolic blood 
pressure, 
hypertension 
 SLC39A8 SLC39A8  x  
FLJ35779 rs60493905 5 75,038,426 THYM   Duxl,GATA,Lhx
4,Lhx8,Myf 
BMI POC5 
[Lymphoblastoid,P=2.33E-
8],ANKDD1B 
[Thyroid,P=1.46E-6] 
25kb 5' of 
POC5 
25kb 5' of 
POC5 
   
CDKAL1* rs67131976 6 20,686,878  ESC, IPSC, 
BLD 
 AP-1 BMI  CDKAL1 CDKAL1 x   
TFAP2B rs2744475 6 50,784,880 ESDR, ESC ESDR,GI  EWSR1-
FLI1,GATA,HD
AC2,Irf,PRDM1,
TATA 
BMI  1.6kb 5' of 
TFAP2B 
1.6kb 5' of 
TFAP2B 
   
TFAP2B rs2397016 6 50,929,066  BLD  Cdx2,PLZF,ST
AT 
   114kb 3' of 
TFAP2B 
114kb 3' of 
TFAP2B 
   
LRPN6C rs17770336 9 28,414,625    GCM,Mef2,TEF BMI  LINGO2 LINGO2 x   
NT5C2* rs11191447 10 104,652,323     BMI 31 hits - only relevant ones 
listed here: MARCKSL1P1 
[Adipose_Subcutaneous, 
P=6.57E-7], MARCKSL1P1 
[Adrenal_Gland, P=8.0E-6], 
MIR1307 
[Muscle_Skeletal,P=4.06E-
10]; MIR1307 
[Thyroid,P=1.08E-7] 
AS3MT C10orf32-
AS3MT 
x   
TCF7L2* rs7903146 10 114,758,349 FAT, BRST, 
MUS, BRN, 
GI, LNG, 
OVRY 
  Dbx1,Dobox4,E
4BP4,HLF,PLZ
F,Pou3f2,TATA 
Type 2 
diabetes, 
Metabolic 
Syndrome, 
Fasting 
glucose, 
HbA1c, 
Proinsulin 
 TCF7L2 TCF7L2 x   
  
2
1
6
 
levels, 
KCNQ1* rs2237896 11 2,858,440 ESC, ESDR, 
LNG, IPSC, 
FAT, BRST, 
BLD, SKIN, 
GI, ADRL, 
HRT, MUS, 
PLCNT, 
THYM, PANC, 
SPLN 
ESC,ESDR,ES
DR,ESDR,ESC,
LNG,IPSC,IPS
C,BLD,SKIN,SK
IN,ADRL,HRT,
GI,GI,KID,LNG,
MUS,MUS,PLC
NT,GI,THYM,GI
,OVRY,PANC,
MUS,GI,LNG,C
RVX,LIV,MUS,
MUS,BLD,BLD,
SKIN,LNG 
CTCF,A
P2ALPH
A,AP2G
AMMA,P
OL2,RA
D21,SM
C3 
AP-
2,MAZ,Pbx3,SR
F,YY1 
BMI  KCNQ1 KCNQ1 x   
OVCH2 rs76633799 11 8,599,566 FAT, SKIN LNG,BRST,SKI
N,SKIN,SKIN,A
DRL,CRVX,BR
ST,MUS,SKIN,
LNG 
 Foxa,HDAC2,T
CF12 
BMI  STK33 STK33 x   
OVCH2 rs76876925 11 8,650,183    Foxp1,HDAC2 BMI  TRIM66 TRIM66 x   
BDNF rs1519480 11 27,675,712 BRN ESDR,LNG,BR
N,LNG 
GATA2,
YY1 
Gfi1,Hoxb8,SP1 BMI LIN7C[Thyroid, P=7.88E-
6],BDNF-
AS1[Lung,P=1.82E-8] 
BDNF 
Antisense 
RNA 
BDNF-AS1 x   
BDNF rs19066691
2 
11 27,737,969 LNG, STRM, 
BRN 
ESDR,SKIN,BR
N,BRN 
 Fox,Foxp1 BMI  BDNF  BDNF  x   
MTCH2 rs896817 11 47,394,305 BLD, SKIN ESDR,SKIN,BR
N,BRN 
  BMI 16 hits, relevants ones 
listed here: 
C1QTNF4[Adipose_Subcut
aneous,P=7.1E-6], RP11-
750H9.5[Brain_Cerebellar_
hemisphere,P=2.95E-7], 
PSMC3[Cerebellum,P=3.9E
-6] 
SPI1 SPI1 x   
FAIM2 rs7138803 12 50,247,468 ESC    ERalpha-
a,NR4A,RAR,S
F1 
BMI, Weight, 
Waist 
circumference, 
Obesity, Age at 
menarche 
GAR1[Blood,P=6.3E-9], 
HOXD13[Blood, P=4.38E-6] 
7.5kb 5' of 
RP11-
70F11.7 
11kb 5' of 
BCDIN3D 
   
MAP2K5 rs4776970 15 68,080,886 IPSC IPSC  DMRT5,Foxa,Irf
,Mef2,PPAR,Pa
x-
5,RXRA,STAT,
ZEB1,p300 
BMI 7 hits, relevant ones listed 
here: 
SKOR1[Adipose_Subcutan
eous, P=8.96E-8], 
SKOR1[Muscle_Skeletal,P
=8.73E-6], 
MAP2K5[Whole_Blood,P=9
MAP2K5 MAP2K5 x   
  
 
2
1
7
 
.38E-5] 
GPRC5B/
GP2 
rs67501351 16 20,006,745    Foxm1,Obox6,
Pax-5,Pax-
8,Pbx3 
  36kb 3' of 
GPR139 
36kb 3' of 
GPR139 
   
SH2B1 rs8061590 16 28,895,130 ESC, ESDR, 
IPSC 
IPSC,IPSC,MU
S,THYM 
 Ets,Zfp410 4 hits 191 hits, only relevant ones 
listed here, all results listed 
have Pvalues<5E-
6:CDC37P1,EIP3C,EPI3CL
,RP11-
1348G14.4,SH2B1,SULT1
A2,TUFM[Adipose_Subcuta
neous], CDC37P1,RP11-
1348G14.4,SH2B1,SULT1
A2 
[Adipose_Visceral_Omentu
m], RP11-1348G14.4 
[Brain_cerebellar_hemisph
ere], 
TUFM[Brain_Hippocampus, 
Brain_Nucleus_basal_gang
lia], CCDC101,LAT,RP11-
1348G14.4,SULT1A1,SULT
1A2[Muscle_Skeletal]  
ATP2A1 ATP2A1 x   
FTO rs7206790 16 53,797,908 ESDR, BRST, 
STRM, BRN, 
BLD, MUS, 
LNG, LIV 
IPSC,BLD  Irf,Nkx3,PRDM
1,SETDB1,STA
T 
   FTO FTO x   
FTO rs73612011 16 53,809,861 FAT, BRST, 
BLD, STRM, 
MUS, BRN, 
SKIN, LIV, GI, 
HRT, ADRL, 
ESC, ESDR, 
LNG, IPSC, 
PANC, 
PLCNT, 
OVRY, BONE 
ESDR,LNG,CR
VX 
FOXA1,F
OXA2 
Arid5a,DMRT2,
Foxa,Foxc1,Fox
k1,HDAC2,Pax-
4,Pou2f2,Pou3f
2,Sox,p300 
   FTO FTO x   
FTO rs3751812 16 53,818,460 ESDR, LNG, 
STRM, BRST, 
BLD, SKIN, 
BRN, PANC, 
CRVX, LIV, 
MUS, BONE 
ESDR,BRST,S
KIN,BRST,BRN
,SKIN,LNG 
 Mrg,TBX5,Tgif1 BMI  FTO FTO x   
FTO rs9936385 16 53,819,169 FAT, STRM, 
BRST, MUS, 
LNG,BRST,SKI
N,HRT,GI,THY
 HDAC2,Pax-5 Type 2 diabetes  FTO FTO x   
  
2
1
8
 
SKIN, PANC, 
LNG, BONE 
M,BRST,MUS,
BRN,LNG 
MC4R rs6567160 18 57,829,135 BLD  MUS  Hoxb13,Hoxb9,
Hoxd10,Mef2,P
ou5f1 
BMI, Fat body 
mass 
 1.7kb 5' of 
U4 
209kb 3' of 
MC4R 
   
MC4R rs77901086 18 58,083,923    Foxp1,HDAC2,
Sin3Ak-20 
BMI  44kb 5' of 
MC4R 
44kb 5' of 
MC4R 
  x 
KCTD15 rs368794 19 34,320,452    HMG-IY,HP1-
site-factor,Pax-
4,Pax-6,Zfp105 
BMI  14kb 3' of 
KCTD15 
14kb 3' of 
KCTD15 
   
QPCTL* rs1800437 19 46,181,392 ESDR, BRST, 
BLD, STRM, 
BRN, FAT, 
LIV, GI, HRT, 
MUS, THYM, 
LNG, PLCNT, 
SPLN, VAS 
ESC,ESDR,ES
C,IPSC,IPSC,B
LD,BLD,BLD,B
LD,BLD,BLD,S
KIN,SKIN,SKIN,
SKIN,HRT,GI,K
ID,LNG,PLCNT,
GI,THYM,GI,PA
NC,GI,LNG,LIV,
MUS,BLD,SKIN
,LNG 
CTCF,C
MYC 
BDP1,CTCF,L
mo2-
complex,Myf,Ra
d21,SMC3,TAL
1,TCF12 
BMI FBXO46[Whole_blood, 
P=5.44E-
6],VASP[Whole_blood,P=2.
75E-10] 
GIPR GIPR   x   
General Abbreviations: Bp37=base pair Build 37, Chr=chromosome, GWAS=Genome-wide association study, NS=Non-synonymous mutation, 
SNPs=single nucleotide polymorphisms. 
Tissue Abbreviations: BLD [blood], BRN [brain], MUS [skeletal muscle], FAT [adipose], GI [digestive], HRT [heart], LIV [liver], LNG [lung], STRM 
[Mesenchymal Stem Cell], BRST [breast], SKIN [skin, epithelial], THYM [thymus], ADRL [adrenal gland], ESC [embryonic stem cells], ESDR 
[embryonic stem cells, derived from iPSC cells], IPSC [induced pluripotent stem cells], PANC [pancreas], PLCNT [placenta], OVRY [ovary], BONE 
[osteoblast]. 
*Note: Starred genes represent fine-mapped loci, which were associated with BMI after the design of the MetaboChip in 2009. 
**PAGE trans-ethnic discovery signal (Gong et al., submitted to Nature Communications).  
***Total SNPs in signal (r2>0.8 in 1000 Genomes AFR) including the queried SNP.
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